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SUMMARY
This study was undertaken to examine the 
organisation and structures of mRNAs mapping at the herpes 
simplex virus type 2 (HSV-2) ribonucleotide reductase 
locus. From comparisons between equivalent HSV-2 and HSV-1 
nucleotide sequences, putative transcription control 
signals were identified, and functional analysis of certain 
control elements was performed. The positions of translated 
regions within the mRNAs encoding ribonucleotide reductase 
were identified as were conserved amino acid domains 
between viral and cellular reductases. During the course of 
these comparisons, a conserved DNA sequence, YGTGTTYY (Y = 
pyrimidine), located 30nuc downstream from the 
polyadenylation (AATAAA) signal of both viral and cellular 
genes, was identified. Functional tests showed that the 
YGTGTTYY signal was required for efficient formation of 
mRNA 3' termini.
Arrangement of mRNAs and DNA Sequence Comparisons at the 
HSV-2 Ribonucleotide Reductase Locus.
Four overlapping mRNAs have been identified at the 
ribonucleotide reductase locus. These mRNAs are unspliced 
and share common 5' and 3' termini. Two early mRNAs with 
sizes of 4.5kb and 1.2kb have a common 3' terminus and 
encode HSV-2 polypeptides Vmwl38 and Vmw38 respectively 
which are almost certainly components of the viral 
ribonucleotide reductase. The other two mRNAs are late, 5' 
co-terminal species with sizes of 6.4kb and 1.7kb which
appear to encode an identical 54,000 mol. wt. protein; the 
6.4kb transcript is 3' co-terminal with the early mRNAs. As 
a consequence of this mRNA arrangement, the 5' termini of 
the 4.5kb and 1.2kb mRNAs and the 3' terminus of the 1.7kb 
mRNA are located within larger, overlapping transcripts.
The genome region adjacent to the 6.4kb and 1.7kb mRNAs 
specifies three late transcripts which are synthesised in 
the opposite orientation; the 5' terminal region of one of 
these species overlaps with the 6.4kb and 1.7kb mRNAs.
The 3' terminus of the late 1.7kb mRNA is located 
within the transcribed region of the 6.4kb species. 
Previously, it has been proposed that read-through of HSV 
poly A sites is due to inefficient processing at certain 3' 
termini. The ability of sequences flanking the 1.7kb mRNA 
3' terminus to produce functional mRNA was tested using a 
plasmid containing the bacterial chloramphenicol 
acetyltransferase (CAT) protein coding sequences fused to 
an HSV-2 immediate early promoter. CAT activities produced 
in HeLa cells by a plasmid carrying the 1.7kb mRNA 3' 
terminal sequences were comparable to activities obtained 
with a plasmid containing the 3' processing signals from a 
non-internal poly A site. Read-through of HSV poly A sites 
may therefore reflect a general reduction in mRNA 3' 
processing efficiency rather than differences in the 3' 
processing signals of individual genes.
The HSV-1 transcripts equivalent to the 4.5kb and 
1.2kb mRNAs have sizes of 5.Okb and 1.2kb and encode HSV-1 
polypeptides Vmwl36 and Vmw38 respectively. Nucleotide
sequence comparisons between the 5' flanking regions of 
these equivalent HSV-2 and HSV-1 mRNAs have revealed the 
following homologies:
1) upstream from the 4.5kb and 5.Okb mRNA 5' termini, 
blocks of conserved sequences are present which resemble 
transcription control signals at the promoter regions of 
other genes; TATA box homologues, C-rich tracts and 
A+C-rich elements have been identified. The C-rich tracts 
are similar to the consensus sequence for the binding site 
of Spl, a transcription control factor, and, from other 
studies, the A+C-rich sequences could be a component of 
other HSV early promoter regions.
2) the 5' terminal region of the HSV-2 1.2kb mRNA is 
located within the polypeptide coding region of Vmwl38; an 
identical situation exists for the equivalent HSV-1 
transcript. The HSV-2 and HSV-1 5' flanking sequences show 
high homology, and both sets of nucleotide sequences 
contain inverted repeats which could form stem and loop 
structures. Possible effects of these structures on 
transcription of the HSV-2 and HSV-1 1.2kb mRNAs are 
discussed.
Amino Acid Conservation Between Herpesvirus and Cellular 
Ribonucleotide Reductases.
The amino acid sequences for the Vmwl38 N- and 
C-terminal regions and all of the Vmw38 polypeptide have 
been predicted from the nucleotide sequences. Comparisons 
with coding regions of the corresponding HSV-1 proteins,
Vmwl36 and Vmw38, reveal high homology apart from areas at 
the N-termini of equivalent proteins. Poorly conserved 
N-terminal regions have been identified in other equivalent 
HSV-2 and HSV-1 proteins; these may be non-essential for 
function.
In common with other ribonucleotide reductases with 
similar enzymatic properties, HSV ribonucleotide reductase 
appears to contain two non-identical polypeptides, and 
HSV-2 polypeptides Vmwl38 and Vmw38 almost certainly 
represent components of the virus enzyme. The amino acid 
sequences of Vmwl38 and Vmw38 share areas of homology with 
coding regions on the Epstein-Barr virus (EBV) and 
varicella-zoster virus genomes; this allows identification 
of putative proteins which appear to be ribonucleotide 
reductase components specified by these viruses. These 
blocks of homology extend to cellular ribonucleotide 
reductases of eukaryotic and prokaryotic origin and thus 
may represent domains involved in enzyme function.
Interestingly, Vmwl38 and Vmwl36 both contain large 
N-terminal domains which are absent in equivalent 
herpesvirus and in cellular ribonucleotide reductase 
proteins. These N-terminal domains could have arisen by 
gene fusion and may represent functions not essential for 
ribonucleotide reductase activity.
The EBV polypeptide which shares homology with 
HSV-2 Vmwl38 has a size of 93,000 mol. wt. The C-terminal 
portions of both proteins contain the 5' terminal regions 
of the mRNAs specifying the proposed small subunit of
ribonucleotide reductases. However, these 5' termini are 
not located at equivalent positions in the Vmwl38 and 
93,000 mol. wt. polypeptides and separate evolutionary 
routes are proposed in the formation of these internal 
promoters.
HSV has the ability to transform cells and is 
potentially oncogenic; the transformating ability of HSV 
may be linked to its action as a mutagen. One possibility 
is that this mutagenic effect is due to the expression of 
HSV ribonucleotide reductase and this is discussed.
Sequences Downstream from the AATAAA Signal Required for 
mRNA 3' End Formation.
Comparisons of the regions flanking HSV mRNA 3' 
termini identified conserved sequences downstream from poly 
A sites. From more extensive comparisons, 67% of the 
mammalian and viral genes examined contained 3' flanking 
sequences similar to those conserved in HSV. A consensus 
sequence, YGTGTTYY (Y = pyrimidine), was derived for a 
conserved downstream element, preferentially located 24 to 
35nuc beyond the AATAAA signal. Downstream from the 
YGTGTTYY sequence, other G-rich and T-rich segments also 
were conserved but to a lesser extent. To test the 
functional significance of YGTGTTYY in mRNA 3' end 
formation, deletions produced in the 3' flanking sequences 
of HSV-2 IE gene-5 were inserted into a CAT plasmid. Levels 
of correctly-terminated mRNA from plasmid constructions, 
both with and without deletions, were estimated by assaying
CAT activities and by nuclease SI analysis. Deletion of 
downstream sequences which extended up to the YGTGTTYY 
sequence reduced CAT levels to values 35% of those obtained 
with undeleted plasmids. Removal of a further 14bp, which 
deleted YGTGTTYY but not the poly A site, reduced CAT 
activities to levels of 1% to 4%. The levels of CAT mRNA 3' 
termini reflected the reductions in CAT activities, but, in 
contrast, levels of mRNA 5' termini were unaffected by 
these deletions.
These results demonstrate a requirement of 3' 
flanking sequences, in particular the YGTGTTYY signal, for 
efficient 3' end formation of poly A mRNAs. An analogy is 
drawn between those sequences required for efficient 3' end 
formation of poly A mRNAs with those required for 3' end 
processing of the non-polyadenylated histone genes. 
Alternative functions for the YGTGTTYY sequence in either 
mRNA termination or mRNA processing are discussed. These 
proposals lead to the possibility that the presence of the 
trinucleotide, GTG, a component of the consensus which is 
associated with local alterations in DNA structure, could 
be a more general feature of the sequences involved in 
DNA-protein interactions. The possible interaction of 
precursor RNAs with small nuclear ribonucleoprotein 
particles and the limits of sequences involved in mRNA 3* 
end formation also are discussed.
ABBREVIATIONS
The following list gives the key to abbreviations 
used in the text. A number of abbreviations for buffers and 
media are given in the Materials and Methods section, and 
those describing the segments comprising herpesvirus 
genomes are on Pages 5 to 7 and Page 13. The key to 
abbreviations in figures is provided on accompanying figure 
legends.
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INTRODUCTION
The herpesviruses are a family of DNA viruses with 
large double-stranded genomes which infect a wide range of 
organisms from lower order to higher order eukaryotes. This 
thesis is concerned with herpes simplex virus (HSV), in 
particular HSV-2 which causes clinical disease in man. The 
studies presented deal with the organisation of the mRNAs 
and the DNA sequences which specify a virus enzyme, 
ribonucleotide reductase. In addition, these studies 
identify transcription control signals involved in gene 
expression, in particular sequences required for 3' end 
formation of polyadenylated mRNAs.
This Introduction provides an overall review of 
herpesvirus biology, and focusses on the properties of HSV. 
The HSV-2 genomic region analysed has been implicated in 
cellular transformation, thus a more complete description 
of this topic is given. The results are interpreted in 
relation to data in addition to that obtained for HSV, 
hence the Introduction contains general sections on the 
properties of ribonucleotide reductases, and on eukaryotic 
transcription with emphasis on the arrangements of mRNAs 
and mRNA 3' end formation.
SECTION A .
PROPERTIES OF THE HERPESVIRUSES.
1. Classification of Herpesviruses.
Members of the Herpetoviridae family (Fenner, 1976) 
are identified by morphology of the virus particle which 
comprises four distinct components, namely:
1) the core which consists of an electron-dense toroid 
structure (Epstein, 1962; Furlong et al., 1972). The torus 
contains DNA wound around a less dense proteinaceous 
cylinder (Chai, 1971; Furlong et al., 1972).
2) surrounding the core is the capsid, an icosahedral 
structure with a diameter of lOOnm, consisting of 162 
capsomeres (Wildy et al., 1960).
3) a fibrous layer termed the tegument (Roizman and 
Furlong, 1974) the width of which varies markedly within 
the Herpetoviridae family (Nayak, 1971).
4) the outer envelope (Wildy et al., 1960) which 
herpesvirus virions acquire by budding through the inner 
nuclear membrane. This component is a bilayered membrane, 
probably composed of lipid, which has periodic surface 
projections (Spring et al., 1968). In addition, the 
envelope contains most of the virus-specified glycoproteins 
(Spear and Roizman, 1972).
To date, at least eighty different herpesviruses 
with a wide variety of biological properties have been 
isolated (listed in Roizman, 1982), hence classification
of such a diverse family is difficult. However, viruses 
within the Herpetovir idae family have been categorised on 
the basis of either a) their biological properties or b) 
structural arrangements of their genomes (Roizman et al., 
1978; Roizman, 1982).
a ) Classification on the basis of biological properties.
From the biological properties of host range, 
duration of reproductive cycle, cytopathology and 
characteristics of latent infection, herpesviruses can be 
divided into three sub-families, the alpha-, beta- and 
gammaherpesvirinae (Roizman et al., 1978; Matthews, 1982; 
Roizman, 1982).
The alphaherpesvirinae are cytolytic herpesviruses 
which have a variable host range both in vivo and in vitro, 
a short reproductive cycle, spread rapidly during infection 
and frequently establish latent infections in ganglia. 
Members of this sub-family include HSV-1 and HSV-2, equid 
herpesvirus 1 (EHV-1; Randall et al., 1953), bovine 
mammilitis virus (BMV; Martin et al., 1966), pseudorabies 
virus (PRV; Gustafsohn, 1970), varicella-zoster virus (VZV; 
Weller, 1953) and channel catfish virus (CCV; Wolf and 
Darlington, 1971; Chousterman et al., 1979). The 
betaherpesvirinae are typified by a narrow host range, a 
relatively long reproductive cycle, slow progression in 
culture and may establish a latent state in secretory 
glands and lymphoreticular cells. Murine cytomegalovirus 
(MCMV; Smith, 1954) and human cytomegalovirus (HCMV;
Smith, 1956) are members of this group. The 
gammaherpesvirinae are specific for either T- or 
B-lymphocytes in vitro, have a variable reproductive cycle 
and cytopathology, and frequently give rise to a latent 
infection in lymphoid tissue. Viruses within this group are 
Epstein-Barr virus (EBV; Epstein et al., 1965), Marek's 
disease virus (MDV; Marek, 1907; Churchill and Biggs,
1967), herpesvirus saimiri (HVS; Melendez et al., 1968) and
herpesvirus ateles (HVA; Melendez et al., 1972).
b) Classification by genome structure.
Herpesviruses contain DNA genomes of at least 
130kbp in length which consist of unique and reiterated 
sequences. Furthermore, the G+C content of herpesvirus DNAs 
varies from 33% to 75% (reviewed in Honess and Watson,
1977). Variability in the above genomic features forms the
basis of a further method for categorisation of the
Herpetoviridae family, in particular the different 
arrangements of unique and reiterated sequences within 
genomes. A limited number of herpesviruses have been 
studied in sufficient detail to allow classification by 
this method, however, five distinct groups have been 
identified (Fig. 1).
1) Group A . CCV is the sole identified member of this 
group and CCV DNA consists of a unique segment of 90kbp 
flanked by direct repeats of 20kbp which are not highly 
reiterated (Chousterman et al., 1979).
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Figure 1. Genome structures representing five herpesvirus 
groups. Virus examples are given for each group and genomes 
are drawn to scale. Boxed areas represent repetitive 
sequences and single lines indicate unique segments. The 
letters, a, b and c show the arrangement of sequences 
within the repeats of each group; sequences arranged in 
inverse orientation relative to a, b and c are denoted by 
a ’, b ' and c '. Arrows below boxed areas indicate the 
relative orientations of repeats. Tandemly reiterated 
sequences within repeats are shown by vertical lines within 
boxed regions. The number of copies of tandemly reiterated 
sequences is represented by subscripts (n, m and x) and 
different subscripts within a group indicate that copy 
numbers differ between repeats. Segments which invert are 
shown by double-headed arrows above unique sequences; 
unique sequences which do not invert are indicated by 
single-headed arrows. The key to abbreviations is:
CCV, channel catfish virus; HVS, herpesvirus saimiri;
EBV, Epstein-Barr virus; PRV, pseudorabies virus;
HSV, herpes simplex virus.
2) Group B . In this group, the genome arrangement consists 
of a unique segment flanked by direct repeats which are 
composed of a series of reiterated sequences arranged as 
multiple tandem copies. These reiterated sequences are 
about 1.5kbp in length in HVS, a member of this group
(Fleckenstein and Wolf, 1974; Fleckenstein and Bornkamm, 
1975; Simonds et al., 1975; Bornkamm et al., 1976). The HVS 
genome is approximately 160kbp in length (Fleckenstein and 
Wolf, 1974) with most of the genetic information contained 
within the long unique (U^) segment which is 112kbp (Knust 
et al., 1983). Thus, reiterated sequences account for 
approximately 30% of the unit-length genome, however, the 
repeat copy numbers vary at either terminus (Fleckenstein 
and Mulder, 1980). The G+C content of HVS DNA varies 
between 36% in the unique segment to 71% in the repetitive 
sequences (Fleckenstein and Wolf, 1974). The nucleotide 
sequence of the 1.5kbp repeat unit appears not to contain 
transcription control signals and transcripts generated 
from the repetitive sequences have not been detected in 
HVS-infected cells (Bankier et al., 1985). Two other 
herpesviruses of New World primates, herpesvirus aotus type 
2 (Barahona et al., 1973; Fuchs et al., 1985) and HVA 
(Fleckenstein et al., 1978) and also bovine herpesvirus 
type 4 (Todd and Storz, 1983; Storz et al., 1984) have 
similar genome arrangements to HVS DNA.
3) Group C . This group includes EBV, whose DNA has a mean 
G+C content of 58% (Schulte-Holthausen and zur Hausen,
1970), and its simian counterpart, herpesvirus papio (HVP; 
Falk et al., 1976). The entire sequence of EBV strain B95-8 
has been determined and is about 172kbp (Baer et al.,
1984). The termini of the EBV genome consist of multiple 
tandem repeats (up to twelve copies) of a SOObp nucleotide 
sequence (Given and Kieff, 1978; Given et al., 1979;
Kintner and Sugden, 1979) through which DNA circularisation 
is mediated in the infected cell nucleus (Lindahl et al.,
1976). Another major set of up to twelve direct repeats, 
each of 3kbp, are located internally within the genome 
(Given and Kieff, 1979; Cheung and Kieff, 1981; Hayward e^ 
al., 1982). These internal repeats are not related to the 
terminal repeats (Cheung and Kieff, 1982; Jones and 
Griffin, 1983; Baer et al., 1984) and therefore, the unique 
tracts of EBV DNA do not invert (see Page 13). The terminal 
and major internal repeats separate the genome into large 
and small unique segments with lengths of 125kbp and 14kbp 
respectively (Baer et al., 1984). In addition, shorter 
repetitive regions are scattered throughout the genome 
(Baer et al., 1984). The HVP genome is structurally 
equivalent to that of EBV (Lee et al., 1980; Heller et al.,
1981); both genomes appear to be colinear (Heller and 
Kieff, 1981; Lee et al., 1981) and exhibit approximately 
40% homology (Falk et al., 1976).
4) Group D . Characteristically, members of this group have 
genomes comprising sets of long and short unique sequences, 
Ul and Ug, one of which is bracketed by terminal (TR) and
inverted internal (IR) repeat sequences. Included in this 
group are the genomes of PRV and EHV-1 which have sizes of 
approximately 130kbp (Darlington and Randall, 1963; 
Rubenstein and Kaplan, 1975) and G+C contents of 73% 
(Ben-Porat and Kaplan, 1962) and 56% (Darlington and 
Randall, 1963) respectively. The Ul segments of these 
genomes are not flanked by inverted repeats and are unable 
to invert (see Page 13). However, the Ug portions are 
bracketed by inverted repeats and do invert, generating two 
isomeric forms of both the PRV (Stevely, 1977; Ben-Porat ejt 
al., 1979) and EHV-1 genomes (Henry et al., 1981; Whalley 
et al., 1981). The termini of PRV DNA do not appear to be 
terminally redundant as sequence homology cannot be 
detected either by hybridisation or sequence analysis of 
cloned terminal DNA fragments (Ben-Porat and Kaplan, 1985).
The VZV genome closely resembles those of PRV and 
EHV-1, and consists of two unique segments, Uj^  and Ug, with 
the Ug region flanked by inverted repeats, TRg and IRg 
(Dumas et al., 1981; Ecker and Hyman, 1982; Straus et al.,
1982). However, Uj^  is flanked by a short inverted repeat of 
89bp which allows limited inversion of the L segment 
(Davison, 1984). Thus, a genomic population of VZV will 
contain two major forms of VZV DNA (95% of the genomic 
pool), resulting from free inversion of the S segment and 
two minor forms (5% of the genomic pool), resulting from 
limited inversion of the L segment (Davison, 1984).
85) Group E . HSV is a member of this group and its genome 
structure will be fully described on Page 13, The 
arrangement of unique and reiterated sequences in HCMV DNA 
resembles that of HSV (Kilpatrick and Huang, 1977; LaFemina 
and Hayward, 1980) and both genomes have other common 
structural features. HCMV DNA is 240kbp in length (Geelen 
et al., 1978; DeMarchi et al., 1978; Westrate et al.,
1980), approximately 50% longer than the HSV genome, and 
has a mean G+C content of 59% (Crawford and Lee, 1964;
Huang et al., 1973). In common with HSV DNA, there are four 
isomeric forms of HCMV DNA (LaFemina and Hayward, 1980; 
Westrate et al., 1980) and the genome circularises 
following brief digestion with a processive exonuclease 
(Geelen and Westrate, 1982), suggesting that the DNA ends 
are terminally redundant. This terminal redundancy is 600 
to 7 50bp in length as suggested by the 'stepwise' 
heterogeneity of the repeat sequences (LaFemina and 
Hayward, 1980; Spector et al., 1982). DNA sequence analysis 
of HCMV AD169 (Tamashiro et al., 1984) and Towne strains 
(Spaete and Mocarski, 1985) has located the terminal 
redundancy to a fragment which contains dispersed repeat 
sequences, however, precise limits for the terminal 
redundancy have not been defined. These data indicate that 
the HCMV terminal redundancy has features similar to the 
HSV 'a' sequence (see Page 16). Multiple copies of a 200bp 
fragment adjacent to the HCMV terminal redundancy have also 
been identified (Tamashiro et al., 1984). The AD169, Towne 
and C87 strains of HCMV show approximately 80% DNA homology
(Huang et al., 1976), and there is inter-strain size 
heterogeneity of up to 8kbp which is associated primarily 
with the TRl and IR^ repeats (Pritchett, 1980; LaFemina and 
Hayward, 1980).
2. Biology and Pathogenesis of Herpesviruses.
Herpesviruses are known to infect a wide range of 
eukaryotic organisms from fungi (Kazama and Schornstein, 
1972) to man. A total of five herpesviruses have been 
isolated from humans, namely HSV-1, HSV-2, VZV, HCMV and 
EBV.
HSV-1 is commonly associated with facial lesions, 
primarily around the mouth (Fiddian et al., 1983) but the 
virus can infect many organs. Primary infection may be 
asymptomatic or lead to development of a range of clinical 
symptoms including fever, sore throat, ulcerative and 
vesicular lesions,oedema, localised lymphadenopathy and 
malaise (Whitley, 1985). Following primary infection, a 
latent state is normally established with the virus 
residing in the trigeminal ganglia (Bastian et al., 1972). 
Analysis of the banding patterns of viral DNAs cleaved with 
restriction endonucleases has indicated that viruses 
isolated from recurrent and primary lesions are identical 
(Lonsdale et al., 1979). Therefore, most recurrent 
outbreaks are due to reactivation of latent virus rather 
than to secondary infection.
The majority of genital HSV infections are caused 
by HSV-2 (Kessler, 1977), however a variable number are
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attributable to HSV-1 (Kalinyak et al., 1977; Wolontis and 
Jeansson, 1977; Peutherer et al., 1981). In one study,
HSV-1 was identified in half of the isolates from female 
genitalia (Chaney et al., 1983). HSV-2 genital infections 
can recur due to reactivation of latent virus from the 
sacral ganglia (Baringer, 1974); the number of HSV-2 
genital infections attributed to reactivation as compared 
to primary infection varies between 43% to 75% (Rawls et 
al. , 1971; Josey et al., 1972; Smith et al., 1981). HSV-2 
has also been associated with cervical carcinoma, details 
of which are described in Section C (Page 45).
VZV is the causative agent of chickenpox 
(varicella) usually in childhood, and of shingles (herpes 
zoster; Weller, 1976) which is normally found in adults. In 
common with other alphaherpesvirinae, VZV can establish a 
latent state and reactivation of the virus is at least 
partly dependent upon the immunological status of the 
infected host (Rifkind, 1966) . VZV is difficult to 
propagate in tissue culture (Weller et al., 1958; Gilden et 
al., 1978; Grose et al., 1979), however, it does have the 
ability to transform cells in vitro (Gelb et al., 1980).
Infection by HCMV induces a number of syndromes, in 
particular intrauterine death and congenital defects 
(Weller, 1971; Rapp, 1980) and is associated with Kaposi's 
sarcoma (Giraldo et al., 1975). Reactivation of the virus 
is usually associated with immuno-suppression due to a 
variety of situations such as malignant disease and 
chemotherapy (Weller, 1971; Plummer, 1973; Gold and 
Nankervis, 1976) .
11
EBV infects specifically B-lymphocytes in vitro and 
is the causative agent of infectious mononucleosis 
(glandular fever; Evans et al., 1968; Henle et al., 1968; 
Evans and Niederman, 1976). It has also been associated 
with the incidence of two cancers, Burkitt's lymphoma 
(Epstein et al., 1964; de The et al., 1978) and 
nasopharyngeal carcinoma (zur Hausen et al., 1970; Nonayama 
and Pagano, 1973).
3. Structure of the HSV Genome.
The relationship between the HSV-1 and HSV-2 
genomes has been studied by both intertypic recombination 
and intertypic complementation data (Timbury and 
Subak-Sharpe, 1973; Esparza et al., 1976; Marsden et al., 
1978; Schaffer et al., 1978) along with DNA/DNA 
hybridisation studies (Davison and Wilkie, 1983a). Results 
indicate that the HSV-1 and HSV-2 genomes are essentially 
colinear with viral genes mapping at equivalent positions 
on both genomes. Most studies have focussed on the HSV-1 
genome arrangement, however, the information available for 
HSV-2 DNA will be presented where appropriate.
a ) Chemical composition.
HSV-1 DNA is a linear duplex molecule (Ben-Porat 
and Kaplan, 1962; Russell, 1962; Russell and Crawford, 1963 
and 1964) which is approximately 155kbp in length (Becker 
et al. , 1968; Kieff et al. , 1971; Wilkie, 1973 and 1976; 
Clements et al., 1976) and has a mean G+C content of 67%
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(Kieff et al., 1971). The G+C content of HSV-2 DNA is 
slightly higher at 69% (Goodheart et al., 1968;
Halliburton, 1972) and the HSV-2 short genome segment is 
3kbp longer than that of HSV-1 (Cortini and Wilkie, 1978). 
These additional HSV-2 nucleotide sequences have been 
located to an area of the short unique segment of HSV-2 DNA 
(for a description of the HSV genome arrangement, see Page 
13); the equivalent region of the HSV-1 genome encodes Ug 
gene-4 (Fig. 3; Rixon and McGeoch, 1985) and most of the 
additional HSV-2 sequences probably contribute to the 
coding region of a g92K glycoprotein (see Page 40; D.J. 
McGeoch, personal communication).
b) Alkaline lability.
Both HSV-1 and HSV-2 DNAs are fragmented by 
treatment with alkali (Kieff et al., 1971; Wilkie, 1973), 
suggesting that the HSV genome may contain single-stranded 
nicks (Ecker and Hyman, 1981) or alternatively, that 
ribonucleotides are present in the genome (Gordin et al., 
1973; Muller et al., 1979). The sedimentation profile in 
neutral sucrose solutions is similar for DNA denatured 
either by formamide or alkali, indicating that the presence 
of ribonucleotides alone could not account for 
fragmentation of the DNA (Spear and Roizman, 1980). It has 
been suggested that alkali-sensitive regions are positioned 
at specific sites (Frenkel and Roizman, 1972), however, 
other studies have shown them to be distributed randomly 
(Wilkie, 1973; Ecker and Hyman, 1981).
TR,a u, IRl IRg Ug TRgZ D — O P
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Figure 2. Four possible isomeric forms of the HSV genome 
generated by inversion of the long and short unique 
segments (U^ and Ug). The terminal and internal repeats of 
L and S segments are represented by TR^/TRg and by IR^/lRg. 
The distance between markers in ( ■  ) and Ug ( #  ) 
components is dependent upon the relative orientations of 
unique regions. Sequence arrangements at the termini and 
joint regions are shown below the various isomeric forms. 
The letter, a, represents the terminal redundancy and b and 
c denote sequences flanking the terminal redundancy in the 
long repeat (R^) and short repeat (Rg) respectively, primed 
letters at the joint indicate that sequences are inverted 
relative to those at the termini. Arrows show the location, 
orientation and number of copies of direct repeat, DRI.
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c ) Genome arrangement.
Electron microscopy studies of structures produced 
by intra-molecular hybridisation of single-stranded DNA 
(Sheldrick and Berthelot, 1974) have shown that the HSV 
genome consists of long and short segments termed L and S 
respectively; the region at which these segments are linked 
is termed the joint. The L and S segments are composed of 
unique regions (Ul and Ug) flanked by inverted repeat 
sequences which are located internally (IRl and IRg) and 
terminally (TRl and TRg). Sheldrick and Berthelot (1974) 
further suggested that either intermolecular or 
intramolecular recombination occurring within repetitive 
sequences flanking the Ul and Ug segments could result in 
the inversion of unique DNA regions between participating 
repetitive regions thus generating four possible isomeric 
forms of HSV DNA (Fig. 2). These isomeric forms are termed 
P (prototype), Ig, II and IgL (Roizman et al., 1979), each 
of which is likely to produce viable progeny. Unless stated 
otherwise, diagrams in this thesis will depict only the P 
genome arrangement. Partial dénaturation mapping confirmed 
that four isomeric forms do exist in populations of HSV DNA 
molecules and in approximately equal amounts (Hayward et 
al., 1975; Delius and Clements, 1976). Additional evidence
for inversion of L and S segments was derived from 
restriction endonuclease analysis of HSV-1 and HSV-2 DNA 
which showed that the relative molarities of terminal and 
junction fragments were 0.5 and 0.25 respectively with 
respect to fragments derived from other regions of the
IRl o' IRs Us TRc 0
IE-1 IE -3  . IE -4  US2 US4
vm IX X X I IX I I  n m  iv
IUS12) 
gE IE -5^  IE -3
US3 go US11
US3 US7 US10
V VIVII V mil I
Figure 3. Locations of short tandemly reiterated 
sequences within the S segment and regions of HSV-1 
strain 17+ DNA. Positions of reiterated sequences (numbered 
I to XII) are shown relative to the locations of mRNAs 
mapping in this region of the HSV-1 genome. Transcripts 
referred to in the text are labelled. The locations of 
spliced regions in immediate early (IE) genes-1, -4 and -5 
are shown by ( A ). gD and gE are the abbreviations for 
glycoproteins D and E. mRNA mapping data were taken from 
the following references; transcripts other than IE mRNAs, 
Rixon and McGeoch, 1984 and 1985; IE mRNA-1, F.J. Rixon, 
personal communication; IE mRNA-3, Rixon et al., 1982; IE 
mRNAs-4 and -5, Watson et al., 1981a; Rixon and Clements, 
1982. Positions for the reiterated sequences are taken from 
Rixon et al., 1984 apart from reiterations VIII, IX and XI 
whose locations were determined by L. Perry (personal 
communication).
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genome (Hayward et al., 1975; Clements et al., 1976; Wilkie 
and Cortini, 1976; Cortini and Wilkie, 1978).
d) Locations of short tandem reiterations.
In addition to large repeat units, the HSV-1 and 
HSV-2 genomes contain shorter segments of tandemly 
reiterated sequences which vary in length between 5bp 
(Whitton and Clements, 1984b) and 54bp (L . Perry, personal 
communication) and generally have high G+C contents (Rixon 
et al., 1984). The locations of these repeats are shown in 
Fig. 3. Tandem repeat sequences have been identified in the 
translated regions of Ug genes-7, -10 and -11 (Rixon and 
McGeoch, 1984; McGeoch et al., 1985), the introns of 
immediate early (IE) mRNAs-1, -4 and -5 (Watson et al., 
1981a, b ; Murchie and McGeoch, 1982; Rixon and Clements, 
1982; L. Perry and F.J. Rixon, personal communication), the 
terminal redundancy (Davison and Wilkie, 1981; Mocarski and 
Roizman, 1981) and downstream from mRNA 3' termini (Davison 
and Wilkie, 1961; Rixon et al., 1984; McGeoch et al.,
1985); additional reiterated sequences have been located 
within the long repeat (R^) segments, however, their 
positions with respect to HSV genes have not been 
rigorously determined (Fig. 3; L. Perry, personal 
communication). The copy number of repeated sequences 
varies between virus isolates (Davison and Wilkie, 1981; 
Watson et al., 1981b; Murchie and McGeoch, 1982) and, 
comparing HSV-1 and HSV-2 genomes, the nucleotide 
sequences of reiterations at equivalent positions are
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either poorly conserved (reiteration IV in Fig. 3; Whitton 
and Clements, 1984b) or absent in the HSV-2 genome 
(reiterations I and VI in Fig. 3; Davison and Wilkie, 1981; 
Whitton, 1984).
IE mRNAs-1 and -3 are located entirely within the 
Rl and Rg segments respectively and thus are diploid genes 
(Fig. 4; Rixon and Clements, 1982 and 1984). Reiterations 
flanking these genes may serve to increase the level of 
genetic exchange between the repeats, thus mutations 
arising in one copy of the large repeat regions would 
spread to both copies of the repeats (Rixon et al., 1984). 
By this mechanism, the probability of accumulating 
recessive mutations within repeat regions would be reduced 
as deleterious mutations would generate a non-viable 
product. This model for the role of reiterations is based 
on two assumptions (Rixon et al., 1984);
1) reiterations are located in non-essential regions of the 
genome; recent evidence indicates that removal of sequences 
between the terminal redundancy and the 3' terminus of IE 
mRNA-3, a region which contains repetitive elements 
(reiterations II and III in Fig. 3), does not reduce the 
viability of virus progeny (Hubenthal-Voss and Roizman, 
1985).
2) reiterations promote a high frequency of recombination; 
in support of this suggestion, one set of repeat sequences 
beyond the 3' terminus of IE mRNA-3 (reiteration II in Fig.
3) has homology with sequences at immunoglobulin (Ig) 
class-switch recombination sites (Gomez-Marquez et al.,
1985) .
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e ) The 'a ' sequence.
Treatment of HSV-1 genomic termini with 5'- or 
3'-exonucleases followed by renaturation generates circular 
DNA molecules of genomic length, suggesting that the genome 
is terminally redundant (Grafstrom et al., 1974 and 1975; 
Sheldrick and Berthelot, 1974). This terminal redundancy, 
termed the 'a' sequence, is present in the direct 
orientation at the termini and in the inverse orientation 
at the junction between IRl and IRg (Fig. 2; Grafstrom e^ 
al., 1974 and 1975; Wadsworth et al., 1976; Wagner and 
Summers, 1978). The regions which bound the 'a' sequence in 
TRl /IRl and TRg/iRg are termed the 'b ' and 'c ' sequences 
respectively (Fig. 2; Davison and Wilkie, 1981). Nucleotide 
sequences for the 'a' sequences of four HSV-1 strains 
(Glasgow strain 17+ and USA-8, Davison and Wilkie, 1981; 
strain F, Mocarski and Roizman, 1981; strain KOS, Varmuza 
and Smiley, 1985) and HSV-2 strain HG52 (Davison and 
Wilkie, 1981) have been determined. These data indicate 
firstly, that a direct repeat (DRI) brackets the 'a' 
sequence at the joint and secondly that the HSV-1 'a'
sequence varies in size from 250bp to 500bp due to a
reiteration I in Fig. 3)
variable number of tandemly reiterated sequences (DRII;^
Nucleotide sequences of the various 'a' sequences are not 
identical for different HSV-1 strains, with the region of 
lowest homology occurring in the DRII reiterations. The 
HSV-2 'a' sequence does not contain a reiteration and has a 
constant size of 251bp. Most HSV molecules have a single 
'a' sequence at both termini and joint regions, however
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some molecules possess two or more 'a' sequences present as 
tandem direct repeats at the joint and L terminus with a 
single copy at the S terminus (Wagner and Summers, 1978; 
Davison and Wilkie, 1981; Mocarski and Roizman, 1982a).
The 'a* sequence is thought to play a role in two 
processes: 1) inversion of the L and S segments and 2) DNA 
maturation and encapsidation.
1) Genome inversion. The 'a' sequence appears to contain a 
cis-acting signal which functions in inversion of the L and 
S genome segments (Mocarski et al., 1980; Mocarski and 
Roizman, 1981 and 1982a; Smiley et al., 1981). Insertion of 
HSV-1 DNA fragments from either the L or S termini into the 
HSV-1 thymidine kinase (TK) locus within resulted in 
formation of twelve isomers, the predicted number from free 
inversion about the various 'a' sequences (Mocarski and 
Roizman, 1982a). Moreover, inversion requires DNA fragments 
to be flanked by inverted 'a' sequences; DNA fragments 
bounded by 'a' sequences in the same orientation do not 
invert (Mocarski et al., 1980; Mocarski and Roizman, 1981; 
Smiley et al., 1981). Studies with intertypic HSV-l/HSV-2 
recombinants have further indicated that inversion requires 
a DNA segment to be flanked by homotypic 'a' sequences. 
Recombinant RE4, which possesses HSV-1 'a' sequences at the 
termini and an inverted HSV-2 'a' sequence at the joint 
region, fails to invert normally and RE4 DNA is present 
predominantly in the Ig arrangement (Davison and Wilkie, 
1983b). Removal of most of DRI does not prevent inversion
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(Mocarski and Roizman, 1982a) and further deletion studies 
indicate that tandem, direct repeats within the 'a' 
sequence may constitute the sites through which inversion 
is mediated (Chou and Roizman, 1985).
Inversion could occur either by a recombination 
mechanism or by circularisation of the genome (see Page 19) 
and subsequent recleavage. The presence of two complete 
directly repeated 'a' sequences at the joint region 
suggests that circular DNA would be formed by direct 
ligation of the termini rather than by processive 
exonuclease digestion and ligation (Davison and Wilkie, 
1981).
2) DNA maturation and encapsidation. DNA replication is 
thought to occur by a rolling circle mechanism (see Page 
23; Jacob et al., 1979), generating concatemers of DNA 
which are cleaved to produce unit-length molecules. Viral 
DNA termini are then generated by two separate cleavage 
events which occur at a distance from cleavage signals 
located within the 'a' sequence (Varmuza and Smiley, 1985). 
The cleavage sites are located within the direct repeat, 
DRI, such that essentially the L terminus contains two 
copies of DRI with one copy at the S terminus (Fig. 2; 
Davison and Wilkie, 1981; Mocarski and Roizman, 1982a).
DNA maturation appears to be tightly coupled to 
encapsidation as indicated from studies of PRV and HSV-1 
mutants (Ladin et al., 1980; V.G. Preston and N.D. Stow, 
personal communication). Plasmids containing an HSV-1
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origin of replication and fragments from either genome 
terminus are amplified and packaged as concatemers into 
capsids (Stow et al., 1983). The 'a' sequence is the only 
DNA common to both termini suggesting that the signals 
required for encapsidation are contained within this 
sequence. The nucleotide sequences which direct DNA 
maturation and encapsidation have not been separated by 
deletion analysis of the 'a' sequence (N.D. Stow, personal 
communication). Studies with defective HSV genomes have 
shown that only capsids containing DNA of approximately the 
same size as unit-length non-defective molecules are 
transported to the cytoplasm (Vlazny et al., 1982).
f) Interaction of proteins with the *a* sequence.
The functions of the 'a' sequence presumably 
require the interaction of specific proteins. For example, 
genomic inversion requires at least one trans-acting viral 
component (Mocarski and Roizman, 1982b) and 
circularisation, which occurs soon after infection in the 
absence of de novo protein synthesis (Poffenberger and 
Roizman, 1985), may be mediated either by a host enzyme or 
by a viral protein in the inoculum. Moreover, a protein 
which may be bound close to one or both HSV DNA termini 
inhibits digestion from the 3' ends of duplex DNA (Kudler 
and Hyman, 1979). Electron microscopy studies have 
suggested that protein is bound close to the joint region 
and the termini (Wu et al., 1979) and therefore possibly to 
the 'a' sequence. Two virus-induced late polypeptides with
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mol. wts. of 21,000 and 22,000, which may correspond to the 
20,000 mol. wt. DNA binding protein identified by Hyman 
(1980), interact specifically with the HSV-1 'a* sequence 
(Dalziel and Marsden, 1984). One of these polypeptides 
appears to be encoded by Ug mRNA-11 (Fig. 3) which contains 
a reiterated amino acid triplet X-Pro-Arg (X = any amino 
acid) in the central portion of the protein coding region 
(Rixon and McGeoch, 1984).
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SECTION B .
PROCESSES INVOLVED IN PRODUCTIVE HSV INFECTIONS.
4. Effects of HSV Infection on Host Cell Metabolism.
Productive infection with either HSV-2 or HSV-I 
results in alterations in the synthesis and metabolism of 
cellular macromolecules. Following infection, cellular DNA 
synthesis ceases (Aurelian and Roizman, 1964; Roizman and 
Roane, 1964) and disaggregation of host polyribosomes 
results in decreased polypeptide synthesis (Sydiskis and 
Roizman, 1967 and 1968); the polyribosomes which reform 
contain predominantly virus-encoded mRNAs (Stringer et al., 
1977). A decrease in the steady-state levels of host RNAs 
also occurs, however, the degree of inhibition is less 
marked than that observed with DNA and protein synthesis 
(Hay et al., 1966; Flanagan, 1967). In contrast to the
general reduction in levels of RNA and protein synthesis, 
production of heat shock proteins is stimulated in HSV-I- 
(Notarianni and Preston, 1982) and HSV-2-infected cells 
(LaThangue et al., 1984). Moreover, certain host RNAs 
continue to be synthesised at late times post infection 
(p.i.; Stringer et al., 1977) and the promoters of genes 
integrated into the genomes of biochemically transformed 
cells are activated on virus infection (Everett, 1985).
Analysis of the steady-state levels of individual 
host cell mRNAs indicates that the abundance of 
polyadenylated species is greatly reduced by 4h p.i.
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(Nishioka and Silverstein, 1977 and 1978; Inglis, 1982; 
Nakai et al., 1982; Mayman and Nishioka, 1985) and it has 
been suggested that a decrease in host mRNA stability is 
due to deadenylation (Nakai et al., 1982; Mayman and 
Nishioka, 1985). In support of this proposal, the 
steady-state level of histone H3 mRNA, a non-polyadenylated 
transcript, does not decrease in Friend erythroleukaemia 
cells at early times p.i. (Mayman and Nishioka, 1985), 
however, infection of Vero cells induced similar rates of 
reduction of H3 and H4 mRNA levels as that observed with 
actin poly A mRNA (Schek and Bachenheimer, 1985).
The effects of HSV infection on cellular 
macromolecular synthesis appear to be mediated by a 
virus-encoded 'shut-off' function (Halliburton and Timbury, 
1973; Yamanishi et al., 1975) and 'shut-off' is more rapid 
following infection by HSV-2 than by HSV-1 (Powell and 
Courtney, 1975; Pereira et al., 1977; Fenwick et al., 1979; 
Schek and Bachenheimer, 1985). A 'shut-off' function has 
been mapped between 0.52 and 0.59 map units on the HSV-2 
genome (Morse et al., 1978; Fenwick et al., 1979), however, 
it is possible that more than one 'shut-off' function is 
associated with HSV infection. Inhibition of host RNA and 
protein synthesis appears to be induced by a virion 
function for both HSV-2 (Fenwick and Walker, 1978) and 
HSV-1 (Nishioka and Silverstein, 1977 and 1978; Read and 
Frenkel, 1983; Schek and Bachenheimer, 1985) while, in 
certain cell lines, viral gene expression is required for 
host RNA degradation (Nishioka and Silverstein, 1978; 
Stenberg and Pizer, 1982; Nishioka et al., 1983).
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5. Virus DNA Replication.
Under one-step growth conditions, HSV DNA 
replication initiates some 2h p.i. and increases in rate 
for the following 8h (Munk and Sauer, 1964; Wilkie, 1973).
A small fraction of the input HSV DNA is utilized for 
replication (Jacob and Roizman, 1977) but this is not the 
general situation for all herpesviruses as the majority of 
input DNA is replicated following PRV infection (Jean and 
Ben-Porat, 1976).
The mode of DNA replication is unclear, however, it 
has been suggested that HSV DNA circularises after 
infection and thereafter replication proceeds by a 'rolling 
circle' mechanism (Jacob et al., 1979). Supportive evidence 
for this model has been the detection of circular 
unit-length HSV DNA molecules by electron microscopy 
(Shlomai et al., 1976; Friedmann et al., 1977; Hirsch et 
al. , 1977; Jacob and Roizman, 1977). Furthermore, 
restriction endonuclease data has demonstrated that 
replicative DNA contains fewer terminal fragments than 
genomic DNA, indicative of concatemeric or circular DNA 
forms (Jacob et al., 1979; Jongeneel and Bachenheimer,
1981) .
The approximate locations of HSV DNA origins of 
replication have been deduced by characterisation of two 
classes of defective genomes which accumulate in virus 
stocks following serial passage at high multiplicities of 
infection. Class I defectives contain a replication origin 
from TRg and IRg and class II defectives possess an origin
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from Ul (Vlazny and Frenkel, 1981; Spaete and Frenkel,
1982), thus, the HSV genome contains three potential 
origins of replication.
The accurate location of the IRg/TRg origin has 
been mapped by measuring levels of plasmid DNA 
amplification following deletion of sequences from cloned 
HSV-1 fragments (Stow, 1982; Stow and McMonagle, 1983).
From these data, nucleotide sequences essential for DNA 
replication have been located to a 90bp segment which has a 
45bp palindromic sequence containing 18 centrally-located A 
or T residues flanked by G+C-rich sequences (Murchie and 
McGeoch, 1982; Watson and Vande Woude, 1982; Stow and 
McMonagle, 1983). This 90bp segment is located in a 
non-transcribed region between the 5' termini of HSV-1 IE 
mRNAs-3 and -4/-5 (Fig. 4; Rixon and Clements, 1982; Rixon 
et al., 1982). The equivalent HSV-2 region contains two 
copies of a DNA sequence which is almost identical to the 
45bp palindrome in HSV-1 (Whitton and Clements, 1984a). 
Moreover, HSV-2 DNA fragments spanning Ug and TRg/iRg which 
contain these sequences are amplified by HSV-1 
super infection (J.L. Whitton and N.D. Stow, personal 
communication).
The Ul origin has been located between the 5' 
termini of mRNAs encoding the DNA polymerase and major DNA 
binding protein (see Fig. 5; Holland et al., 1984; Quinn,
1984) and the DNA sequences within this region have been 
determined for two HSV-1 wild-type (wt) strains (Quinn,
1984; Weller et al., 1985). A portion of the DNA sequence
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contains a 72bp palindrome which has homology to sequences 
comprising the IRg/TRg origin of replication; a defective of 
HSV-1 Angelotti strain contains two copies of this 
palindromic sequence (Gray and Kaerner, 1984). Cloned DNA 
from this region contains deletions of variable size which 
arise spontaneously (Spaete and Frenkel, 1982; Weller e_t 
al., 1983; Quinn, 1984) and plasmid constructions with such 
deletions are unable to support DNA replication (Weller et 
ad., 1985).
Following replication, HSV DNA is cleaved and 
packaged into capsids; the signals involved in these events 
are described on Page 18.
6. HSV mRNA Biosynthesis.
Following transport to the nucleus (Hummeler e^ 
al., 1969), mRNA is synthesised from viral DNA by RNA
polymerase II as indicated by the sensitivity of 
transcription to oC-amanitin (Alwine et al., 1974; Ben-Zeev 
et al., 1976); this sensitivity continues throughout all 
stages of virus infection (Costanzo et al., 1977). Failure 
to detect a novel RNA polymerase activity in infected cells 
further implies that HSV transcription is mediated by 
cellular RNA polymerase II (Lowe, 1978). Moreover, HSV mRNA 
synthesis is maintained in o^-amanitin treated cells 
possessing an endogenous oC-amanitin-resistant RNA 
polymerase (Ben-Zeev and Becker, 1977; Costanzo et al.,
1977). However, it is possible that the cellular polymerase 
is modified during the course of virus infection.
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HSV transcription is temporally regulated and can 
be sub-divided into three broad classes, IE, early and late 
(Swanstrom and Wagner, 1974; Clements et al., 1977; Jones 
and Roizman, 1979).
a ) Immediate early transcription.
IE transcripts are operationally defined as those 
virus mRNAs which are transcribed by an unmodified cellular 
RNA polymerase II in the absence of de novo protein 
synthesis (Kozak and Roizman, 1974; Roizman et al., 1974). 
The locations of IE transcripts have been mapped using 
cycloheximide, a protein synthesis inhibitor, (Clements et 
al. , 1977 and 1979; Anderson et al., 1980; Easton and 
Clements, 1980) and also temperature sensitive (ts) mutants 
(Watson and Clements, 1978). Hybridisation of in 
vivo-labelled RNA to Southern blots (Southern, 1975) 
containing HSV-1 DNA fragments generated by restriction 
enzymes has shown that IE transcription is limited to 
restricted regions of the genome (Clements et al., 1977; 
Anderson et al., 1980). The mapping and orientation of 
these transcripts on the HSV-1 genome has revealed that 
there are five IE mRNAs (Watson et al., 1979; Clements e_t 
al. , 1979; Anderson et al., 1980), two of which, IE mRNAs-1 
and -3, are contained entirely within the TR^/lR^ and 
TRg/iRg segments respectively and are therefore diploid 
genes (Fig. 4; see Page 15). The 5* termini of IE mRNAs-4 
and -5 are located within TRg/iRg, thus these mRNAs have 
common promoter and 5' untranslated leader sequences (Fig.
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4; Watson et al., 1981a; Rixon and Clements, 1982). From 
structural analysis using nuclease digestion techniques 
(Berk and Sharp, 1978a, b), three IE transcripts have been 
shown to be spliced (Page 34; Watson et al., 1981a; Rixon 
and Clements, 1982; F.J. Rixon, personal communication).
The polypeptides encoded by the HSV-1 IE mRNAs have been 
identified by in vitro translation of purified mRNA species 
(Watson et al., 1979). HSV-2 also specifies five IE mRNAs 
which map at equivalent genomic locations and encode 
similar-sized polypeptides to their HSV-1 counterparts 
(Easton and Clements, 1980). Following the switch to early 
mRNA synthesis, the abundance of IE polypeptides decreases 
(Honess and Roizman, 1974; Marsden et al., 1976; Preston, 
1979; Dixon and Schaffer, 1980); IE (Dixon and Schaffer, 
1980), early (Honess and Roizman, 1974) and late products 
(DeLuca et al., 1984) have been implicated in this negative 
regulation of IE polypeptide synthesis. However, the 
cytoplasmic levels of IE mRNAs do not decrease at late
times p.i. (see Page 38; Whitton, 1984; Harris-HamiIton and
Bachenheimer, 1985; F.J. Rixon, personal communication).
A great deal of attention has focussed on the
sequences which activate IE genes and the factors mediating
this activation. Studies with the HSV-1 TK gene show that 
this early viral gene is regulated as an IE product 
following fusion of IE promoter sequences to the TK 
structural region (Post et al., 1981; Mackem and Roizman, 
1982a; Cordingley et al., 1983). Linkage of far upstream 
regions of IE promoters to a truncated TK promoter
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similarly confers an IE pattern of regulation to TK gene 
expression (Mackem and Roizman, 1982a; Cordingley et al.,
1983), demonstrating that IE promoter and regulatory 
sequences are separable. From deletion mutant studies 
(Cordingley et al., 1983; Preston et al., 1984a) and DNA 
sequence comparisons of regions upstream from IE mRNA 5* 
termini (Mackem and Roizman, 1982b; Whitton et al., 1983; 
Whitton and Clements, 1984a), an 'activator' sequence with 
the core consensus TAATGARAT (R = purine) has been derived 
which is present as one or more copies between -100 and 
-300 upstream from IE mRNA cap sites. A fragment upstream 
from IE mRNA-3 containing this sequence possesses 
enhancer-like properties (Lang et al., 1984), however, the 
role of TAATGARAT motifs in this enhancer activity is 
unclear. The equivalent HSV-2 IE genes also contain 
activator elements which have an identical consensus 
sequence to that of HSV-1, however, HSV-1 and HSV-2 early 
and late promoters lack the TAATGARAT sequence as does the 
25kb nucleotide sequence of the HSV-1 Ug region (Whitton 
and Clements, 1984a; McGeoch et al., 1985). Further 
evidence for the similarity between the HSV-1 and HSV-2 
activator sequences is demonstrated by the ability to 
stimulate HSV-2 IE gene expression by HSV-1 infection and 
the converse also is true (Cordingley et al., 1983; Gaffney 
et al., 1985). It has been suggested that the sequence 
TAATGARAT alone is not sufficient for IE gene activation 
and that G+C-rich motifs flanking this activator element 
are required for full induction (Kristie and Roizman, 1984;
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Preston et al., 1984a). Stimulation of chloramphenicol 
acetyltransferase (CAT) enzyme activity under IE conditions 
has been demonstrated from plasmids containing a synthetic 
activator sequence but lacking G+C-rich flanking regions 
when linked to an IE promoter in which TAATGARAT homologues 
are absent (Gaffney et al., 1985).
The trans-activating component which induces IE 
gene expression is present in the virus inoculum (Post et 
al., 1981; Mackem and Roizman, 1982a, b ; Cordingley et al., 
1983; Preston et al., 1984a) and has been identified as a 
tegument protein with a mol. wt. of 65,000 (Campbell e_t 
al., 1984). This protein has been mapped to a sub-fragment 
of HSV-1 Bam HI ^ (Campbell et al., 1984) and is possibly 
specified by a 1.9kb mRNA (Fig. 4; Hall et al., 1982). The 
nucleotide sequence specifying the trans-activating 
component has been determined (Dalrymple et al., 1985; 
Pellett et al., 1985b) and the predicted amino acid 
sequence of this protein shares homology with a proposed 
VZV 40,000 mol. wt. polypeptide (Dalrymple et al., 1985).
b) Early transcription.
Early mRNAs are produced in the presence of IE gene 
products prior to the onset of DNA replication (Wagner,
1972; Swanstrom and Wagner, 1974; Swanstrom et al., 1975; 
Clements et al., 1977). Early transcripts are readily 
detectable at 2h p.i. and increase in abundance until 6h to 
8h p.i., after which the levels of individual early mRNAs 
either decrease or remain unaltered (McLauchlan and
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Clements, 1982; Sharp et al., 1983; Harris-HamiIton and 
Bachenheimer, 1985). Inhibition of DNA replication results 
in an accumulation of early species within the cytoplasm 
(Swanstrom and Wagner, 1974; Swanstrom et al., 1975, 
Stringer et al., 1977) and an over-representation of 
individual transcripts (Harris-Hamilton and Bachenheimer,
1985). Early mRNAs map across the entire length of the 
genome (Clements et al., 1977) and a number of their 
protein products are involved in priming the infected cell 
for DNA replication (reviewed in Wagner, 1985).
At least two IE polypeptides are essential for 
maximal synthesis of early messages (Everett, 1984b; O'Hare 
and Hayward, 1985; Quinlan and Knipe, 1985). The presence 
of IE polypeptide Vmwl75 is required throughout infection 
to maintain early transcription (Watson and Clements, 1978; 
Preston, 1979; Watson and Clements, 1980) and cell lines 
which constitutively produce this protein stimulate 
expression of early genes (Davidson and Stow, 1985; Persson 
et al., 1985). Activation in trans of plasmid-borne HSV 
early promoters by IE gene products, synthesised from 
co-transfected plasmids, has indicated that full activity 
of the glycoprotein D (gD) promoter is mediated by a 
combination of the IE Vmwl75 and IE VmwllO polypeptides 
(Everett, 1984b). Individually, IE Vmwl75 increases 
transcription from the gD promoter poorly and IE VmwllO 
fails to activate (Everett, 1984b). However, the promoter 
for the HSV-2 1.2kb mRNA which encodes Vmw38 (see Page 59) 
is stimulated by either IE Vmwl75 or IE VmwllO and maximal
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expression from this promoter requires IE Vmwl2 in addition 
to IE Vmwl75 and IE VmwllO (O'Hare and Hayward, 1985). 
VmwllO also stimulates transcription from plasmids carrying 
the promoters for the TK (Gelman and Silverstein, 1985; 
O'Hare and Hayward, 1985) and major DNA binding protein 
genes (Quinlan and Knipe, 1985). Thus, the various early 
mRNA promoters may not have identical IE polypeptide 
requirements for stimulation.
Deletion mutant studies on the HSV-1 gD promoter 
linked to rabbit p-globin coding sequences have revealed 
that the DNA sequences required for full activity of this 
promoter, following infection by either HSV-1 or HSV-2, lie 
within 83bp of the mRNA 5* terminus (Everett, 1983).
Further deletions within this 83bp region failed to detect 
regulatory sequences specific for early mRNA synthesis 
(Everett, 1984a). Moreover, virus infection stimulates 
transcription from a plasmid-borne rabbit |S -globin 
promoter to similar levels as the gD promoter (Everett,
1983). Additional evidence for the lack of HSV-specific 
early regulatory sequences is that the gD promoter is 
activated by a number of herpesviruses and by adenovirus 
type 2 (Ad2; Everett and Dunlop, 1984) which synthesises 
proteins functionally equivalent to HSV-1 IE Vmwl75 
(Feldman et al., 1982). Deletion analysis of the HSV-1 TK 
promoter has revealed three regions required for 
constitutive mRNA synthesis (McKnight et al., 1981;
McKnight and Kingsbury, 1982; McKnight et al., 1984). Two 
of these regions, distal signals II and III, consist of
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G+C-rich tracts which are recognised by the cellular 
factor, Spl (see Page 63; Jones et al., 1985). ElKareh e^ 
al. ( 1985) have suggested that sequences which respond to 
trans-activation by viral polypeptides lie between -39 and 
-109 from the TK mRNA 5' terminus, however, an alternative 
interpretation of similar data indicates that 
early-specific regulatory signals do not exist in the TK 
promoter (Eisenberg et al., 1985).
c ) Late transcription.
HSV-1 and HSV-2 late mRNAs map across the entire 
length of the genome (Clements et al., 1977; Easton and 
Clements, 1980) and a number of their encoded proteins are 
structural virion polypeptides. Late transcripts have been 
operationally divided into two classes, the early-late and 
true lates. Early-late mRNAs are synthesised at low levels 
prior to DNA replication while true late transcripts are 
detected only after the onset of DNA replication (Holland 
et al., 1979 and 1980; Jones and Roizman, 1979). Both 
classes of mRNA increase in abundance following the onset 
of DNA replication and inhibitors of DNA replication such 
as phosphonoacetic acid (PAA) and cytosine arabinoside (ara 
C) prevent full expression of late genes (Clements et al., 
1977; Jones and Roizman, 1979; Holland et al., 1980). 
Individual late transcripts are either barely detectable or 
undetectable at early times p.i., however, they increase in 
abundance until about lOh p.i. and persist in the cytoplasm 
at a high level for up to 14h p.i. (Harris-Hamilton and 
Bachenheimer, 1985).
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It is possible that late transcription is not 
directly coupled to DNA replication. Viral genes, under the 
control of late promoters which have been integrated into 
the cellular genome, are stimulated by HSV infection 
(Sandri-Goldin et al., 1983; Dennis and Smiley, 1984;
Silver and Roizman, 1985), thus amplification of DNA 
sequences does not appear to be necessary for promoter 
activity. Moreover, plasmid-borne HSV late promoters do not 
require a cis-acting origin of DNA replication in order to 
initiate mRNA synthesis (P. Johnson, personal 
communication). Two viral products have been suggested as 
having a direct role in late gene expression. Firstly, 
mutations within the IE Vmw63 protein do not inhibit DNA 
replication but late polypeptide synthesis is significantly 
reduced in cells infected with these mutants (Sacks et al., 
1985). Secondly, prior to DNA replication, the major DNA 
binding protein appears to repress synthesis of the late 
gene encoding gC; the mechanism of this repression is 
unclear (Godowski and Knipe, 1985).
7. Post-transcriptional Modification of HSV mRNAs.
a ) Capping and méthylation.
In common with most other eukaryotic mRNAs, HSV 
transcripts are capped at their 5' termini (Bartkoski and 
Roizman, 1976; Moss et al., 1977). Cap structures contain a 
methyl-7-guanosine (m7Q) residue which is attached to the 
5' terminal base through a 5'-5' linkage (see Page 60);
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major 5' terminal structures detected in HSV mRNAs are 
m^GpppGMpNp, m^GpppmGAMpNp and m^CpppA^pNp (Moss et al., 
1977). In addition, HSV transcripts can be modified by 
méthylation of internal A residues (Moss et al., 1977), 
however, viral mRNAs labelled at late times during 
infection are not methylated, possibly as a result of 
inhibition by a virus-specified product (Bartkoski and 
Roizman, 1976).
b) Splicing.
Three HSV IE mRNAs, some minor mRNA species of the 
HSV-1 gC gene and a late 2.7kb mRNA are spliced.
HSV-I/HSV-2 IE mRNAs-4 and -5 have a single splice within 
their common transcribed regions located within IRg/TRg 
(Fig. 3; Watson et al., 1981a; Rixon and Clements, 1982; 
Whitton and Clements, 1984b); this splice is 5' to the 
polypeptide coding region (Murchie and McGeoch, 1982;
Watson and Vande Woude, 1982; Whitton and Clements, 1984b), 
however, minor unspliced species have been detected in 
HSV-1 (Rixon and Clements, 1982). The HSV-1 intron DNA 
sequence is approximately 200bp in length and is composed 
of tandemly reiterated copies of a short 22bp sequence in 
HSV-1 strain 17+ (Murchie and McGeoch, 1982) which, in 
strain Patton, varies in copy number and is one residue 
longer (Watson et al., 1981b). The HSV-2 IEmRNA-4/-5 intron 
is approximately 540bp in length and comprises multiple 
tandem copies of three short G+C-rich DNA sequences, the 
number and arrangement of which differ between
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independently-cloned isolates (Whitton and Clements,
1984b). HSV-1 IE mRNA-1 contains two introns with sizes of
765nuc and 135nuc, both of which are located in the
translated portion of the gene (F.J. Rixon and L. Perry, 
personal communication). The 5' proximal intron DNA 
sequence possesses three tandemly arranged copies of an 
imperfect repeat of 54bp (L . Perry, personal 
communication).
Minor spliced species of HSV-1 gC have introns 
located close to the 5' terminus which range in size from
100 to 300nuc (Frink et al., 1981 and 1983). Apart from one
spliced mRNA, these minor species would not encode a 
full-length gC polypeptide. A late 2.7kb transcript which 
maps at approximately 0.2 map units contains a large intron 
of 4kb (Fig. 4; Costa et al., 1985); interestingly, the 
intron encodes a family of unspliced 3' co-terminal mRNAs 
which are transcribed from the opposite DNA strand. The 
predicted amino acid sequence specified by this 2.7kb 
transcript shares homology with proposed protein coding 
regions in EBV (Baer et al., 1984; Costa et al., 1985).
c ) Polyadenylation.
HSV mRNAs are polyadenylated (Bachenheimer and 
Roizman, 1972; Stringer et al., 1977) with the majority of 
cytoplasmic poly A transcripts containing a poly A tail of 
approximately 155 A residues (Silverstein et al., 1976). To 
date, DNA sequences encoding the 3' portions of HSV mRNAs 
contain the polyadenylation signal, AATAAA (Proudfoot and
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Figure 4 . Organisation of HSV-1 mRNAs and regions of the 
HSV-1 genome for which nucleotide sequences have been 
determined. Locations of transcripts are shown below the 
genome and spliced regions within mRNAs are shown by ( A ). 
Hatched areas indicate genomic regions which have been 
sequenced. Transcripts which specify known virus-encoded 
proteins are shown and the key to abbreviations is as 
follows: IE, immediate early; Exo, alkaline exonuclease; 
MCP, major capsid protein; TK, thymidine kinase; gB to gE, 
glycoproteins B to E ; DBP, major DNA binding protein; Pol, 
DNA polymerase; RR, ribonucleotide reductase; 65K, IE 
stimulatory polypeptide. The following references do not 
represent a complete list of the literature on HSV 
transcript mapping and nucleotide sequence data and, where 
appropriate, only those references which describe HSV-1 
strain 17+ data are given. References used to compile the 
mRNA mapping data were: the Exo 3' co-terminal family,
Costa et al., 1983; mRNAs at 0.2 map units including the 
spliced species, Costa et al., 1985; the MCP 3' co-terminal 
family, Costa et al., 1981; mRNAs mapping between 0.29 to 
0.46 map units were taken from Holland et al. , 1984; m^As 
at the RR locus, Anderson et al., 1981, McLauchlan and 
Clements, 1982 and 1983a; mRNAs mapping between 0.60 to 
0.65 map units, Frink et al., 1981; mRNAs mapping between 
0.65 to 0.72, Hall et al., 1982; IE mRNA-2, Whitton et al., 
1983; IE mRNA-1, F.J. Rixon, personal communication; IE 
mRNA-3, Rixon et al., 1982; IE mRNAs-4 and -5, Rixon and 
Clements, 1982; mRNAs located within Ug^ Rixon and McGeoch,
1984 and 1985. References used to compile the regions which 
have been sequenced were: Exo locus, Costa et al., 1983, 
E.K. Wagner, personal communication; region encoding 
spliced species at 0.2 map units, Costa et al., 1985; 5* 
end of MCP mRNA, Costa et al., 1984; TK locus, McKnight, 
1980, Wagner et al., 1981, Sharp et al., 1983; gB gene,
Bzik et al., 1984, Pellett et al. , 1985a; the remaining 
sequences between 0.29 to 0.35 have been determined by D.J. 
McGeoch, personal communication; DBP and Pol loci, Quinn, 
1984; RR locus. Draper et al., 1982, McLauchlan and 
Clements, 1982 and 1983a, I. Nikas, personal communication; 
gC gene, Frink et al., 1983; region between 0.65 to 0.69 
map units, including the 65K gene, Dalrymple et al., 1985, 
M.L. Dalrymple, personal communication; region between 0.73 
to 0.76 map units, Whitton et al., 1983, Debroy et al.,
1985, L. Perry, personal communication; the TR^ and IR^ 
repeats, L. Perry, personal communication; the S segment; 
Davison and Wilkie, 1981, Murchie and McGeoch, 1982,
McGeoch et al., 1985.
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Brownlee, 1976), with the exception of gE mRNA which 
possesses the hexanucleotide sequence, ATTAAA, upstream 
from the poly A site (McGeoch et al., 1985; Rixon and 
McGeoch, 1985).
8 . Locations and Arrangements of HSV Transcription Units.
Individual HSV transcripts have been mapped using 
the techniques of Northern blot analysis (Alwine et al., 
1977; Spandidos and Paul, 1982) and nuclease digestion of 
DNA/RNA hybrids (Berk and Sharp, 1978a, b; Weaver and 
Weissman, 1979). The structural analysis and map locations 
of HSV mRNAs is incomplete, however, the majority of 
transcripts are unspliced (reviewed by Wagner, 1985) and 
the transcripts in certain regions of the genome have been 
fully characterised (Rixon and McGeoch, 1985). In addition, 
nucleotide sequences for large areas of the HSV-1 genome 
have been determined, allowing precise localisation of mRNA 
termini and splice sites and the predicted translated 
regions of HSV genes. HSV-1 transcripts which have been 
mapped and genomic regions for which nucleotide sequence 
data are available are indicated in Fig. 4; the known 
functions of certain genes also are indicated.
A large number of HSV mRNAs are arranged as 
families of overlapping, unspliced transcripts with common 
3' termini and unique 5' termini. In certain cases, 5' 
co-terminal mRNAs have been identified which have 
alternative 3' termini (Anderson et al., 1981; Hall et al., 
1982; Holland et al., 1984). The transcripts within a mRNA
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family do not invariably belong to the same temporal class. 
For example, the UglO, -11 and -12 mRNAs share an identical 
3' terminus and are early, late and IE species respectively 
(Rixon and McGeoch, 1984), thus the pattern of 
transcription from a mRNA family may alter during the 
course of infection. Overlaps between transcripts 
synthesised from opposite strands of HSV DNA have been 
identified (see Page 35). For example, Ug2 and Ug3 mRNAs 
are divergently transcribed and their 5' termini overlap 
(Fig. 3; Rixon and McGeoch, 1985). Similarly, the 3' 
terminal portion of the DNA polymerase transcript overlaps 
with that of a transcript which is synthesised in the 
opposite direction (Fig. 4; Quinn, 1984).
9. HSV Polypeptide Synthesis.
HSV-1 infection induces synthesis of about 50 novel 
polypeptides as identified by one-dimensional SDS-PAGE 
analysis (Honess and Roizman, 1973; Powell and Courtney, 
1975; Marsden et al., 1976). Increased resolution by 
two-dimensional polyacrylamide gel techniques has revealed 
that the infected cell contains some 230 virus-induced 
polypeptide species, however a number of these species 
represent related forms of the same polypeptide (Haarr and 
Marsden, 1981).
HSV polypeptide synthesis is temporally regulated 
and there are three broad groups of
coordinately-synthesised polypeptides, IE (or CX^  ), early 
(or ^ ) and late (or ^ ; Honess and Roizman, 1974). Both the
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^ and y  proteins have been further sub-divided into 
subsets of pi, p 2  (Pereira et al. , 1977) and i, Y  2 
(Powell et al., 1975). proteins are produced in the
presence of canavanine and azetidine, amino acid analogues 
which result in the production of non-functional cK. 
polypeptides; p 2 protein synthesis requires fully 
functional o< products (Pereira et al., 1977). The ^ ^  and 
y  2 proteins are analogous to early-late and true late 
mRNAs respectively. HSV infection is regulated 
predominantly at the transcriptional level, although, there 
is evidence that translational regulation occurs also. At 
late times p.i., gD mRNA continues to accumulate while the 
level of gD polypeptide synthesis is reduced (Johnson and 
Spear, 1984). Similarly, the levels of IE Vmwl75 are 
reduced at early and late times p.i. (see Page 27), 
possibly as a result of this polypeptide regulating IE mRNA 
synthesis (Dixon and Schaffer, 1980). However, IE mRNA-3, 
which encodes IE Vmwl75, is abundant at later stages of the 
lytic cycle (Harris-Hamilton and Bachenheimer, 1985; F.J. 
Rixon, personal communication); this lack of correlation 
between the levels of IE mRNA-3 and IE polypeptide Vmwl75 
may be due to translational regulation although this 
possibility has not been rigorously examined.
a) Post-translational modification of proteins.
A number of HSV polypeptides produced in vitro do 
not co-migrate with their in vivo counterparts (Preston, 
1977), indicating that HSV polypeptides undergo
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modification (Morse et al., 1978; Marsden et al., 1982). 
Four types of modification have been identified, namely 
phosphorylation, glycosylation, sulphation and cleavage.
There are eighteen HSV-2 phosphoproteins and
sixteen HSV-1 phosphoproteins (Pereira et al., 1977;
Marsden et al., 1978), nine of which have been mapped by
analysis of HSV-l/HSV-2 intertypic recombinants (Marsden et
al. , 1978). The phosphorylation pattern of a number of
proteins differs at various stages of infection (Wilcox e_t
al., 1980). Moreover, phosphorylation decreases the DNA
binding ability of Vmwl36, a protein involved in
ribonucleotide reductase activity (see Page 59), however, a
54,000 mol. wt. protein has an increased affinity for DNA
following phosphorylation (Wilcox et al., 1980).
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HSV-1 specifies at least five^glycoproteins, gB, 
gC, gD (Spear, 1976), gE (Baucke and Spear, 1979), gH 
(Buckmaster et al., 1984) and possibly a sixth, gY 
(Palfreyman et al., 1983). Apart from gH and gY, precise 
map locations and the DNA sequences of the HSV-1 
glycoproteins have been determined (Fig. 4; gB, Bzik e^ 
al., 1984; Pellett et al., 1985a; gC, Frink et al., 1983; 
Draper et al., 1984a; gD, Watson et al., 1982; McGeoch e^ 
al., 1985; gE, McGeoch et al., 1985). Immunoprécipitation 
data using type common antibodies have shown that HSV-2 
infection induces equivalent glycosylated species to HSV-1 
gB (Pereira et al., 1981), gC (Para et al., 1983; Zezulak 
and Spear, 1983; Zweig et al., 1983), gD (Balachandran e^ 
al., 1982) and gE (Para et al., 1982). In addition, HSV-2
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specifies a g92k glycoprotein which maps in the Ug region 
(Marsden et al., 1978 and 1984); this protein may be 
identical to the gG protein identified by Roizman et al. 
(1984). To date, an HSV-1 glycoprotein equivalent to g92K 
has not been identified, however, this HSV-2 genome region 
contains additional nucleotide sequences compared with the 
equivalent locus on HSV-1 DNA (see Page 12; D.J. McGeoch, 
personal communication). Glycosylation is either partially 
or completely inhibited by tunicamycin (Pizer et al., 1980; 
Norrild and Pedersen, 1982; Hope and Marsden, 1983; 
Kousoulas et al., 1983; Roizman et al., 1984) which 
specifically blocks production of an intermediate required 
for transfer of oligosaccharides to asparagine residues 
(Struck and Lennarz, 1980). Hence, glycosylation 
in HSV probably occurs by the addition to asparagine 
residues of a core oligosaccharide containing N-acetyl 
glucosamine (NAG) and mannose; this oligosaccharide may be 
further modified by addition of sugar residues (Marshall 
and Neuberger, 1964; Marshall, 1974). Both N- and 0-linked 
oligosaccharides have been identified (Pizer et al., 1980; 
Hope and Marsden, 1983; Johnson and Spear, 1983) and 
glycosylation occurs in discrete steps (Cohen et al., 1980; 
Haarr and Marsden, 1981; Palfreyman et al., 1983).
Most HSV glycoproteins are sulphated (Hope et al., 
1982) with the majority of sulphate residues attached to 
N-linked oligosaccharides (Hope and Marsden, 1983). The 
major sulphated protein is gE (Hope et al., 1982).
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b) HSV structural polypeptides.
The HSV-1 virion contains approximately 33 
structural proteins, ranging in mol. wt. up to 290,000 
(Spear and Roizman, 1972; Heine et al., 1974). The majority 
or all of the virus-specified glycoproteins are located in 
the envelope (Spear and Roizman, 1972). In addition, a
65,000 mol. wt. polypeptide, involved in IE gene 
activation, has been assigned to the tegument (Campbell e_t 
al., 1984). Seven major capsid proteins ranging from 12,000 
to 155,000 mol. wt. have been identified (Cohen et al., 
1980). The 155,000 mol. wt. major capsid protein, which 
maps between 0.23 and 0.27 map units (Marsden et al., 1978) 
and is encoded by a 6kb mRNA (Fig. 4; Costa et al., 1981 
and 1984), is involved in disulphide bonding within the 
virion structure (Zweig et al., 1979). A 51,000 mol. wt. 
capsid protein has DNA binding properties and may function 
in the packaging or anchoring of DNA in the capsid (Braun 
et al., 1984). Finally, a third capsid protein with a mol. 
wt. of 40,000 is involved in encapsidation of viral DNA 
(Preston et al., 1983).
c ) HSV-induced enzymes.
The HSV genome encodes a number of enzymic 
activities whose biochemical specificities differ from 
those of endogenous cellular enzymes. The HSV enzymes 
identified to date include DNA-dependent DNA polymerase 
(Keir and Gold, 1963), deoxynucleoside pyrimidine kinase 
(thymidine kinase; Kit and Dubbs, 1963; Jamieson et al.,
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1974), alkaline deoxyribonuclease (Morrison and Keir,
1968), nucleoside phosphotransferase (Jamieson et al.,
1974), deoxyuridine triphosphate nucleotidylhydrolase 
(dUTPase; Caradonna and Cheng, 1981; Williams, 1984), 
uracil-DNA glycosylase (Caradonna and Cheng, 1981), cyclic 
AMP independent protein kinase (Blue and Stobbs, 1981), a 
topoisomerase (Biswal et al., 1983; Leary and Francke,
1984) and ribonucleotide reductase (Cohen, 1972; Dutia, 1983)
1) DNA polymerase. HSV DNA polymerase differs from the 
cellular polymerase in its requirement for high salt (Keir 
et al., 1966) and sensitivity to PAA (Mao et al., 1975).
The purified enzyme has a mol. wt. of 150,000 (Powell and 
Purifoy, 1977). Additional polypeptides co-purify with DNA 
polymerase, in particular a 54,000 mol. wt. species appears 
to be a consistent component of polymerase preparations 
(Powell and Purifoy, 1977; Knopf, 1979; Derse et al.,
1982). The genomic region encoding the polymerase has been 
mapped to between 0.396 to 0.418 map units (Chartrand e^
al. , 1979 and 1980), and two overlapping early mRNAs with 
sizes of 4.3kb and 4.2kb probably encode the enzyme (Fig.
4; Holland et al., 1984; Quinn, 1984). The DNA sequence of 
this portion of the genome has been determined and the 
presumed reading frame encoding the polymerase has been 
identified (Quinn, 1984).
2) Thymidine kinase. The viral TK enzyme maps between 0.30 
and 0.31 map units (Halliburton et al., 1980) and has a
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number of different properties from its cellular 
counterpart, including an insensitivity to inhibition by 
dTTP which is widely applied for assay purposes (Klemperer 
et al., 1967). The enzyme consists of a dimer with subunits 
of 42,000 mol. wt. (Honess and Watson, 1974; Jamieson and 
Subak-Sharpe, 1978). The mRNA encoding HSV-1 TK is 1.5kb in 
length (McKnight, 1980) and the DNA sequences encoding both 
HSV-1 (McKnight, 1980; Wagner et al., 1981; D.J. McGeoch, 
personal communication) and HSV-2 enzymes (Swain and 
Galloway, 1983) have been determined. The HSV-1 TK mRNA 
specifies three proteins with mol. wts. of 43,000, 39,000 
and 38,000 (Preston and McGeoch, 1981; Marsden et al.,
1983) which are translated from three in-phase initiation 
codons (Haarr et al., 1985). Comparison of DNA sequences 
encoding the reading frames of the HSV-1 and HSV-2 enzymes 
has revealed that the initiation codons for the 39,000 and
38,000 mol. wt. HSV-1 proteins are not present in HSV-2 DNA 
(Swain and Galloway, 1983).
3) Alkaline deoxyribonuclease. The viral enzyme is a 
DNA-specific exonuclease (Morrison and Keir, 1968) which 
increases in activity during the course of virus infection 
(Keir and Gold, 1963; Keir, 1968). The enzymatic activity 
has been mapped to a region between 0.12 and 0.21 map units 
(Moss et al., 1979) which specifies a 85,000 mol. wt. 
polypeptide (Preston and Cordingley, 1982) encoded by an 
early 2.3kb mRNA (Fig. 4; Costa et al., 1983). Monoclonal 
antibodies directed against the 85,000 mol. wt. protein 
neutralise exonuclease activity, implying that this protein 
is involved in enzymatic activity (Banks et al., 1983).
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4) dUTPase. HSV dUTPase converts dUTP to dUMP, thereby- 
preventing the incorporation of dUTP, a substrate for HSV 
DNA polymerase (Ostrander and Cheng, 1980), into HSV DNA. 
The enzyme has a mol. wt. of 53,000 (Williams, 1984) and is 
specified by an early 1.5kb mRNA which maps at 0.69 to 0.71 
map units on the HSV-1 genome (Fig. 4; Hall et al., 1982; 
Preston and Fisher, 1984).
5) Topoisomerase. HSV-1 topoisomerase binds to 
single-stranded DNA through a 3' phosphoryl link and alters 
the linking number of a unique topoisomer in steps of one 
(Muller et al., 1985). In addition, the enzyme does not 
require either ATP or MgCl2 for activity. These properties 
indicate that the HSV enzyme is a type I topoisomerase 
which probably catalyses the breaking and rejoining of 
single-stranded DNA. Enzymatic activity is associated with 
a 65,000 mol. wt. protein which binds to DNA (H.S. Marsden, 
personal communication). The suggestion that HSV-1 
topoisomerase may be the virion component involved in IE 
gene activation (see Page 29; Muller et al., 1985) appears 
unlikely as these polypeptides map at different genomic 
locations (H.S. Marsden, personal communication). While the 
precise map position for the topoisomerase is not known, it 
has been tentatively located to between 0.60 to 0.63 map 
units (H.S. Marsden, personal communication).
6) Ribonucleotide reductase. Properties of the 
ribonucleotide reductase are described in Section 17 (Page
58).
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SECTION C .
HSV CELLULAR TRANSFORMATION AND ONCOGENICITY.
10. The Association of HSV with Cervical Carcinoma.
HSV-2 is the primary cause of genital herpes and 
has also been implicated as an aetiological agent in 
development of cervical carcinoma. Preliminary evidence for 
the association of HSV with cervical neoplastic disease was 
obtained from epidemiological and serological studies (Naib 
et al., 1966; Rawls et al., 1969; Nahmias et al., 1970;
Adam et al., 1972). There is also an increased incidence of
HSV antibodies and specific HSV antigens in patients with 
cervical intraepithélial neoplasia (CIN) or cancer (Rawls 
et al., 1969; Royston and Aurelian, 1970; Skinner et al., 
1977; Dreesman et al., 1980; Gilman et al., 1980). In situ 
hybridisation techniques demonstrated that HSV-specific RNA 
was present in tissue from cervical biopsies (McDougall e_t 
al., 1980; Eglin et al., 1981b) and that the most abundant
transcripts were derived from limited regions of the 
genome. These regions were the IRg/TRg repeats and from 
between 0.07 to 0.4 map units (Eglin et al., 1981a; 
McDougall et al., 1982) and, in one study, from between 
0.58 to 0.63 map units (McDougall et al., 1982). Viral DNA
has not been detected in all tumours (zur Hausen et al.,
1974; Pagano, 1975), however, DNA probes from the genomic 
region between 0.58 to 0.612 map units hybridised to DNA 
isolated from one out of eight carcinoma tissues (Park e_t
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al., 1983); other DNA fragments spanning most of the genome 
failed to detect viral DNA in these samples. In a separate 
study, DNA from three out of nine cervical tumours had 
homology to specific HSV-2 DNA probes (McDougall et al., 
1982), one of which, Bgl II n, maps between 0.58 and 0.63 
map units.
11. Cellular Transformation In Vitro.
The transformation potential of HSV has been 
studied in rodent embryo cells transformed with 
U.V.-inactivated virus, ts mutants (Macnab, 1974) and 
sheared HSV DNA (Wilkie et al., 1974). The ability to 
rescue ts+ virus from HSV-transformed cells infected with 
ts mutants has indicated that viral sequences are 
maintained in transformed cell lines (Park et al., 1980). 
However, these data contrast with the failure to detect 
viral DNA in all transformants (Minson et al., 1976;
Cameron et al., 1985), possibly as a result of either the 
low level of DNA retained in transformed cell lines (<1 
copy/cell) or insertion of short HSV fragments into the 
cell genome. Several HSV-specific proteins have been 
detected in cells transformed with inactivated virus (Duff 
and Rapp, 1973; Reed et al., 1975; Jamieson et al., 1976; 
Flannery et al., 1977; Macnab et al., 1980; Lewis et al., 
1982) although no polypeptide was invariably present in all 
transformants.
The use of specific HSV DNA fragments has 
identified three genomic regions which are involved in
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Figure 5. Locations and arrangements of mRNAs which map 
in HSV-1 transforming region, Bgl II i. The positions of 
HSV-2 transforming fragments, Bgl II c and n, are shown 
ahove the HSV genome. mRNAs which encode specific viral 
functions are labelled and the location of an origin of DNA 
replication within (OriL) is shown. The key to 
abbreviations and the references which describe mRNAs 
mapping in this region are given in the legend to Fig. 4.
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cellular transformation; two of these regions, 
morphological transforming region (mtr) II (Bgl II n, 0.58 
to 0.63 map units; Reyes et al., 1979; Cameron and Macnab, 
1980; Galloway and McDougall, 1981; Cameron et al., 1985) 
and Bgl II c (0.43 to 0.58 map units; Jariwalla et al.,
1980 and 1983), are located on the HSV-2 genome and the 
third, mtr I (Bgl II i^, 0.31 to 0.42 map units; Camacho and 
Spear, 1978; Reyes et al., 1979), is on the HSV-1 genome 
(Fig. 5). Interestingly, the mtr I and mtr II regions do 
not map at equivalent positions on HSV-1 and HSV-2 DNAs. 
Cells transformed with fragments encompassing mtr I and mtr 
II exhibit different properties from those transformed with 
Bgl II c. Mtr I- and mtr II-transformed cells are selected 
by focus formation of morphologically-altered cells in low 
serum (Camacho and Spear, 1978; Reyes et al., 1979;
Galloway and McDougall, 1981; Cameron et al., 1985) whereas 
Bgl II c induces rapidly proliferating Syrian hamster cells 
which do not senesce and overgrow non-transformed cells 
(Jariwalla et al., 1979 and 1980).
The mtr-1 region encodes a number of viral proteins 
including gB (Fig. 5; Little et al., 1981; DeLuca et al.,
1982) which has been detected in cells transformed by 
inactivated virus (Lewis et al., 1982) and by mtr-1 DNA 
(Camacho and Spear, 1978). Cells transformed by mtr-1 
appear to be tumorigenic in rodents (J.C.M. Macnab, 
personal communication).
It has been proposed that immortalisation of cells 
by Bgl II c is an early transformation event, however.
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tumorigenicity in hamsters is acquired only upon further in 
vitro passage (Jariwalla et al., 1980). Two separate 
transforming functions have been identified within Bgl II c 
(Jariwalla et al., 1983). The leftmost 64% of the fragment 
is sufficient to induce immortalisation of hamster cells 
which are, however, non-tumorigenic. Therefore, Jariwalla 
et al. (1983) have proposed that conversion to 
tumorigenicity requires the right-hand 36% of the Bgl II c 
fragment. In a small number of transformed cell lines 
tested, radiolabelled Bgl II c hybridised to restriction 
enzyme fragments with sizes identical to those of fragments 
derived from the DNA probe. These data suggested that viral 
sequences were present in transformants, although Bgl II c 
has a background of homology with normal Syrian hamster DNA 
which appears to be located in the left-hand 64% portion of 
the fragment (Jariwalla et al., 1983). One viral 
polypeptide with a mol. wt. of 120,000 has been detected in 
Bgl II c-transformed cells (Jariwalla et al., 1980).
Cells transformed by mtr II are oncogenic in 
rodents, the latent period for the appearance of tumours 
being similar to that for cells transformed with 
U.V.-inactivated virus (Macnab, 1979; Cameron et al.,
1985). A transforming region within mtr II has been located 
to a 2. Ikb Bam Hl/Pst I subfragment of Bam HI _t (0.584 to 
0.602 map units), however, the resultant transformed cell 
lines appear not to retain viral sequences (Galloway and 
McDougall, 1983). In vitro translation of hybrid-selected 
RNA has shown that three proteins with mol. wts. of
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138,000, 38,000 and 61,000 are partially or wholly encoded 
within this fragment (Docherty et al., 1981; Galloway et 
al. f 1982). A DNA segment of 737bp located within the 
coding sequences of the 61,000 mol. wt. protein induces 
transformation in NIH 3T3 cells; a portion of this sequence 
could form a hairpin structure with a loop of 129b and a 
stem of 8bp flanked by repeated sequences of 7b (Galloway 
et al., 1984). This structure has been compared to 
insertion sequence (IS) elements which may initiate 
transformation by insertion into the cellular genome 
(Rechavi et al., 1982).
Viral sequences, which are present in cells 
transformed with HSV-2 DNA fragments at early passages, are 
not detectable in later passages (Cameron et al., 1985). 
Therefore, a 'hit and run' mechanism is favoured whereby 
maintenance of the transformed phenotype does not appear to 
require the continuous presence of viral sequences which 
may be lost by the cell following induction of the 
transformation process (Galloway and McDougall, 1983). 
Alternatively, HSV may initiate transformation by 
introducing chromosomal aberrations into cellular DNA. HSV 
infection causes chromosomal damage (Hampar and Ellison, 
1963; Stich et al., 1964; Schlehofer and zur Hausen, 1982) 
which is possibly mediated by early functions (Waubke et 
al., 1968; O'Neill and Rapp, 1971); thus, HSV enzymes 
involved in DNA biosynthesis may act as cellular mutagens 
and Huszar and Bacchetti (1983) have suggested that HSV-2 
ribonucleotide reductase may be involved in the
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transformation process. Infection with U.V.-inactivated 
HSV-1 and HSV-2 (Boyd et al., 1978) and transfection with 
isolated HSV-1 restriction enzyme fragments (Boyd et al., 
1980) also activates synthesis of mouse xenotropic (MuX) 
retrovirus, an endogenous C-type virus present in mouse 
Balb/c-3T3 cells. While xenotropic viruses appear to be 
non-pathogenic, this activation raises the possibilty that 
other endogenous retroviruses associated with malignant 
disease (reviewed in Teich et al., 1982) are induced by HSV 
infection and thus lead to transformation.
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SECTION D .
RIBONUCLEOTIDE REDUCTASES.
12. General Properties of Ribonucleotide Reductases.
Conversion of the four ribonucleotides to the 
corresponding deoxyribonucleotides by ribonucleotide 
reductase represents the first unique step in DNA 
biosynthesis (Larsson and Reichard, 1966a, b; reviewed by 
Thelander and Reichard, 1979) and the level of DNA 
synthesis correlates closely with but is not regulated 
solely by ribonucleotide reductase activity (Thelander and 
Reichard, 1979). The enzyme catalyses replacement of the 
hydroxyl group by a hydrogen atom at the 2 ' position of the 
ribose residue on the ribonucleotide. Certain 
ribonucleotide reductases may be associated with a 
multienzyme complex in vivo which channels high 
concentrations of dNTPs to sites of DNA replication 
(Flanegan and Greenberg, 1977; Forsdyke and Scott, 1979). 
For example, the bacteriophage T4-induced ribonucleotide 
reductase is bound along with most of the enzymes involved 
in deoxyribonucleotide synthesis to a multienzyme aggregate 
(Greenberg and Chiu, 1978; Allen et al., 1980; Chiu et al., 
1980 and 1982), from which ribonucleotide reductase is 
reaaily dissociable (Chiu et al., 1982).
Reductases have been isolated from a number of 
sources and two classes of enzyme have been characterised 
according to the components required for activity 
(Thelander and Reichard, 1979):
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1) the first class is represented by the Lactobacillus 
leichmanii (L. leichmanii) enzyme which is a monomer 
composed of a single polypeptide with a mol. wt. of 76,000 
(Panagou et al., 1972; Chen et al., 1974). The enzyme 
requires adenosylcobalamin (coenzyme 6 ^2 ) as a dissociable 
co-factor (Vitols et al., 1967; Singh et al., 1977) and 
uses ribonucleoside triphosphates as substrates (NTPs; Chen 
et al., 1974; Singh et al., 1977). This class of enzyme is 
more commonly found among prokaryotes than eukaryotes 
(Gleason and Hogenkamp, 1972).
2) the second class is represented by the Escherichia coli 
(E. coli) enzyme which has a mol. wt. of 240,000 
(Thelander, 1973) and consists of two non-identical 
subunits, B1 and B2 (Brown and Reichard, 1969b). Both 
subunits are required for enzyme activity (Brown and 
Reichard, 1969a; Thelander, 197 3) and the substrates are
ribonucleoside diphosphates (NDPs; Larsson and Reichard, 
1966a, b). The E. coli enzyme has no requirement for 
coenzyme B12, however, each B2 subunit contains two bound 
iron atoms (Brown et al., 1969a) and a free radical located 
on a tyrosine residue (Ehrenberg and Reichard, 1972;
Sjoberg et al., 1977) which are involved in the enzyme 
reaction. Results by Reichard and Ehrenberg (1983) have 
suggested that generation of the free radical requires 
oxygen. Removal of iron leads to loss of the tyrosine 
radical (Atkin et al., 1973) while removal of the radical 
by hydroxyurea treatment leaves the iron centre intact 
(Atkin et al., 1973; Sjoberg et al., 1982). Eukaryotic 
enzymes which have similar properties to the E. coli
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reductase have been isolated from green algae, yeast, 
higher plants and mammalian species (Gleason and Hogenkamp, 
1972; Feller and Follman, 1976; Gleason and Wood, 1976).
Ribonucleotide reductases of cellular origin are 
tightly regulated by the reaction products, the 
deoxyribonucleoside triphosphates (dNTPs), which act as 
both positive and negative effectors, modifying substrate 
specificity as well as enzyme activity (see following 
section).
13. E. coli Ribonucleotide Reductase.
The B1 and B2 subunits of the E. coli enzyme (Brown 
and Reichard, 1969b; Brown et al., 1969b) are encoded by 
the nrdA and nrdB genes respectively (Fuchs and Karlstrom, 
1976) which are located at adjacent sites on E. coli DNA 
(Bachman et al., 1976; Yamada et al., 1982). The B1 subunit 
contains three classes of binding site; one for the 
substrates (von Dobeln and Reichard, 1976) and two 
different sites for the allosteric effectors (Brown and 
Reichard, 1969b). There are two substrate binding sites on 
each B 1 subunit which bind all four NDPs (von Dobeln and 
Reichard, 1976). The two classes of allosteric effector 
sites are termed h- and 1-sites with each class consisting 
of two subsites (Brown and Reichard, 1969a, b). The h-sites 
are defined by their high affinity for dATP while the 
1-sites have a low affinity for this metabolite. 
Furthermore, the h-sites bind ATP, dTTP and dGTP whereas 
the 1-sites bind only ATP in addition to dATP. The 1-sites
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Figure 6 . Allosteric control of E . coli ribonucleotide 
reductase. Substrates and reaction products are shown, with 
the direction of reaction pathways indicated by thick, 
arrowed lines. Reactions inhibited by negative effectors 
are shown by open bars; dashed lines indicate reactions 
stimulated by positive effectors.
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regulate the general enzyme activity with ATP acting as a 
positive effector and dATP as a negative effector (Fig. 6 ). 
The presence of effector molecules at h-sites changes the 
active site conformation thereby altering substrate 
specificity (Brown and Reichard, 1969b). The active site of 
the enzyme comprises portions of both B1 and B2 subunits 
(von Dobeln and Reichard, 1976).
The B1 subunit consists of two polypeptides with 
mol. wts. of 80,000 which have identical C-termini but 
different N-termini (Thelander, 1973) and DNA sequence 
analysis of the nrd locus indicates that the different 
N-termini are produced by differential processing of a 
precursor polypeptide (Carlson et al., 1984). The B2 
subunit is composed of two identical polypeptides with mol. 
wts. of 40,000 (Thelander, 1973) and requires Mg2+ for 
binding to the B1 subunit (Brown and Reichard, 1969a; 
Thelander, 1973).
The polypeptides which comprise the two subunits 
are both specified by a 3.2kb dicistronic mRNA (Hanke and 
Fuchs, 1983b) and their synthesis is coordinately regulated 
(Fuchs, 1977). Inhibition of DNA synthesis induces an 
increase in enzyme activity which is reflected in higher 
levels of mRNA synthesis (Hanke and Fuchs, 1983a); this 
increase in transcription requires continuous protein 
synthesis (Hanke and Fuchs, 1984).
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14. Bacteriophage Ribonucleotide Reductases.
Bacteriophages T2, T4, T5 and T6 encode viral 
ribonucleotide reductases (Cohen and Barner, 1962; Biswas 
et al., 1965; Berglund et al., 1969; Eriksson and Berglund, 
1974), however, bacteriophages T7 and X do not synthesise 
a novel enzyme during infection. T4 ribonucleotide 
reductase has a mol. wt. of 225,000 and a structure similar 
to that of the E. coli enzyme (Berglund, 1975) represented 
as 2 p 2. The oC and ^ polypeptides are encoded by the 
nrdA and nrdB genes which map at adjacent sites on the T4 
genome (Yeh et al., 1969). In contrast to the E. coli 
enzyme, the T4 subunits do not require Mg2+ for binding and 
are not easily dissociable (Berglund, 1975). The oC 
polypeptides synthesised by nrdB mutants which fail to 
produce an oC2 ^ 2 structure are degraded to three fragments 
with sizes of 61,000, 57,000 and 24,500, indicating that 
the 1^2 subunit protects the oÇ 2 moiety from proteolytic 
cleavage (Cook and Greenberg, 1983). Moreover, the 
C-terminal portion of the o( polypeptide is required for 
binding to dATP (Cook and Greenberg, 1983). The T4 enzyme 
is inhibited neither by dATP, which acts only as a positive 
effector in reduction of CDP and UDP (Berglund, 1972), nor 
by the accumulation of dNTPs. Therefore, it is possible 
that the T4 enzyme may not contain an allosteric site 
analogous to the 1-site of E . coli ribonucleotide reductase 
which regulates enzyme activity (see Page 53). T4 also 
encodes a thioredoxin (nrdC; Berglund et al., 1969) which 
does not map at the nrdA/B locus (Yeh and Tessman, 1972) 
t>ut is the specific hydrogen donor for T4 ribonucleotide 
reductase (Berglund and Sjoberg, 1970).
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15. Mammalian Ribonucleotide Reductases.
Ribonucleotide reductase activity has been detected 
in a range of cell types from different mammalian species 
including rat hepatoma (Moore, 1977), calf thymus (Engstrom 
et al., 1979; Eriksson et al., 1979; Thelander et al.,
1980), rabbit bone marrow (Hopper, 1972 and 1978) and human 
tissue culture cell lines (Chang and Cheng, 1979). The 
mammalian enzyme consists of two non-identical subunits. Ml 
and M2 (Thelander et al., 1980), and has similar properties 
to those of the E. coli enzyme. For example, the Ml and M2 
subunits are easily separable (Hopper, 1972), enzymatic 
activity does not require cobalamin coenzymes and the 
enzyme contains non-heme iron centres (Thelander et al.,
1985) and a tyrosine free radical (Graslund et al., 1982). 
Homogenous preparations of both subunits have been 
isolated. The Ml subunit consists of two polypeptides, each 
with a mol. wt. of 90,000 which contain the nucleotide 
binding sites responsible for allosteric regulation of the 
enzyme (Thelander et al., 1980). Similarly, the M2 subunit 
is composed of two proteins with mol. wts. of 44,000 which 
contain the iron centres and free radical (Thelander e_t 
al., 1985). Allosteric regulation of the mammalian enzyme 
appears to be similar to that of E. coli ribonucleotide 
reductase; results suggest that the mammalian enzyme 
contains two classes of effector sites (Thelander et al.,
1980) which are analogous to the h- and 1-sites of the E . 
coli B1 subunit (see Page 53). Photolabelling techniques 
have shown that the Ml subunit is directly involved in
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substrate binding and that a non-functional M2 subunit 
prevents the attachment of NDPs to this site (Caras et al.,
1983).
While both subunits of the E. coli enzyme are 
coordinately expressed, the Ml and M2 subunits are 
differentially regulated. During cellular proliferation, 
the levels of the Ml subunit do not increase at the same 
rate as those of the M2 subunit (Eriksson and Martin, 1981) 
and the increased abundance of the M2 subunit is a result 
of de novo protein synthesis (Eriksson et al., 1984). The 
subcellular location of mammalian reductases is currently 
the subject of debate. Reddy and Pardee (1980 and 1982) 
have proposed that ribonucleotide reductase is associated 
with a multienzyme complex in the nucleus, termed the 
replitase, which channels NDPs to sites of DNA replication. 
More recently, results from immunofluorescent staining of 
cells using monoclonal antibodies directed against the Ml 
subunit have located this protein in the cytoplasm at all 
stages of the cell cycle (Engstrom et al., 1984).
The mutagenic effect of ribonucleotide reductase 
has been demonstrated in cell lines which possess an 
altered enzymatic activity. In such cell lines, the levels 
of dNTPs are abnormal and mutations accumulate in marker 
genes at a higher than normal frequency (Meuth et al.,
1979; Weinberg et al., 1981). Results from one study have 
shown that two out of three cell lines contained Ml 
subunits with an altered allosteric control (Weinberg et 
al., 1981).
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16. Animal Virus Ribonucleotide Reductases.
Virus-induced ribonucleotide reductase activity, 
which differs from the endogenous cellular enzyme, has been 
identified in cells infected with vaccinia virus (Slabaugh 
and Mathews, 1984; Slabaugh et al., 1984) and a number of 
herpesviruses, namely HSV-1 (Cohen, 1972), HSV-2 (Cohen e^ 
al. , 1974), PRV (Lankinen et al., 1982), EBV (Henry et al., 
1978), and EHV serotypes 1 and 3 (Cohen et al., 1977; Allen 
et al., 1978). Direct evidence that the novel enzymatic 
activities in infected cells are virus-encoded has not been 
determined for most of these viruses. Of the 
herpesvirus-induced enzymes only those of PRV and HSV have 
been well characterised. The PRV-induced reductase contains 
a tyrosine free radical and the lack of allosteric control 
of CDP-reductase activity (Lankinen et al., 1982) is very 
similar to that of the HSV enzyme (Ponce de Leon et al., 
1977; Langelier et al., 1978; Huszar and Bacchetti, 1981).
17. HSV Ribonucleotide Reductase.
The enzymatic properties of the HSV-1- and 
HSV-2-induced enzymes appear to be identical (Ponce de Leon 
et al., 1977; Langelier et al., 1978; Huszar and Bacchetti, 
1981; Averett et al., 1983 and 1984). In contrast to the 
cellular enzyme, the HSV reductase does not require Mg2+ 
for activity and is not inhibited by dNTPs (Ponce de Leon 
et al., 1977, Langelier et al., 1978; Huszar and Bacchetti, 
1981; Langelier and Buttin, 1981; Averett et al., 1983), 
suggesting that there is no allosteric control. ATP, which
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activates the cellular enzyme, inhibits the HSV enzyme in 
the absence of Mg2+, however this inhibition is abolished 
in the presence of Mg2+, possibly due to formation of a 
Mg.ATP complex (Ponce de Leon et al., 1977; Huszar and 
Bacchetti, 1981; Averett et al., 1983). Analysis by marker 
rescue techniques of HSV-1 ts mutant, 17tsVP1207, which 
induces a thermolabile enzymatic activity (Dutia, 1983), 
has shown that a virus-encoded early protein, Vmwl36 (mol. 
wt. 136,000), is a component of the ribonucleotide 
reductase (Preston et al., 1984b). This protein is a 
phosphoprotein (Marsden et al., 1978) which has cleavage 
products with sizes of 100,000 and 90,000 mol. wt. in 
infected cells (H.S. Marsden, personal communication). 
Vmwl36 is encoded by an unspliced 5.Okb mRNA (RRl in Fig. 
4) which is 3' co-terminal with a 1,2kb mRNA (RR2 in Fig. 
4) specifying a 38,000 mol. wt. polypeptide (Vmw38; 
Anderson et al., 1981; McLauchlan and Clements, 1982 and 
1983a); this protein is likely to be a second component of 
the HSV-1 ribonucleotide reductase (Frame et al., 1985).
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SECTION E.
ARRANGEMENT AND REGULATION OF OVERLAPPING EUKARYOTIC mRNAS.
18. Transcription of RNA Polymerase II Genes.
RNA synthesis is mediated by a number of processes, 
the simplest pathway requiring an initiation event followed 
by elongation and finally termination. In eukaryotes, the 
following additional processes occur during the synthesis 
of mRNAs by RNA polymerase II (reviewed in Darnell, 1982 
and Nevins, 1983):
1) following initiation, a m^G cap is added to the 5' 
terminal nucleotide by a 5'-5' hydroxyl group linkage 
through a triphosphate bridge (reviewed in Shatkin, 1976). 
The presence of this cap structure may be required for 
translation (Both et al., 1975).
2) the mature mRNA 3' terminus is generated by cleavage of 
a primary transcript which extends beyond the cleavage 
site. In poly A+ mRNAs, about 200 residues are added to the 
mature 3' terminus (Brawerman, 1981). The
cleavage/polyadenylation process is described in detail in 
Section 23 (Page 84).
3) in mammalian mRNAs, a methyl group is acquired by about 
1% of A residues at the N^ position (reviewed in Banerjee,
1980) .
4) finally, introns are removed by splicing mechanisms to 
generate mature mRNA (Gilbert, 1978).
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The locations at which these events occur are 
largely determined by nucleotide sequences serving as 
recognition signals for processing complexes. Consensus 
sequences for a number of these signals have been derived 
from DNA sequence comparisons and their functions evaluated 
by both in vivo and in vitro analysis. The following 
sections describe those conserved sequences which are 
present in most genes and have a role in transcription.
a) Signals involved in the initiation of mRNA synthesis.
The control signals required to initiate 
transcription can be divided into two categories; firstly, 
sequences which are involved in constitutive mRNA synthesis 
and secondly, sequences which modulate the level of 
transcription.
1) Constitutive control sequences. A highly conserved 
sequence at mRNA 5' termini is the TATA box homology which 
has the consensus gÇaTAaJaAG (Busslinger et al., 1980; 
Proudfoot, 1978; Gannon et al., 1979) and is located 25 to 
35nuc upstream from the mRNA start site. Both in vivo and 
in vitro studies have shown that point mutations within the 
TATA box homology significantly reduce the level of 
transcription (Wasylyk et al., 1980; Grosschedl et al.,
1981). Furthermore, alteration of the TATA box produces 
heterogeneous mRNA 5' termini in many genes (Mathis and 
Chambon, 1981; Grosveld et al., 1982a; Lebowitz and Ghosh,
1982) but not in every case (Wasylyk et al., 1980).
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Clearly, the TATA box homology has a crucial role in the 
initiation of mRNA synthesis, however, absence of a TATA 
box homology in a number of genes (Haegeman and Fiers,
1978; Baker and Ziff, 1981; Ghosh and Lebowitz, 1981)
indicates that this sequence alone is not an obligatory 
requirement in vivo.
A second sequence homology, the CAAT box (consensus 
GGYCAATCT where Y = pyrimidine; Benoist et al., 1980; 
Efstratiadis et al., 1980) is present at -70 to -80 
upstream from the 5' termini of a number of genes, in 
particular the oC~ and (3-globin genes (Liebhaber et al., 
1981; van Ooyen et al., 1979; Efstratiadis et al., 1980), 
HSV-1 TK gene (McKnight, 1980), simian virus 40 (SV40)
early mRNAs (Benoist and Chambon, 1981) and the sea urchin
histone H2A gene (Grosschedl and Birnstiel, 1980a, b). This 
signal is important in vivo for the expression of p-globin 
mRNA (Dierks et al., 1981; Grosveld et al., 1982a, b) and 
possibly oC-globin transcription (Mellon et al., 1981). In 
contrast, removal or mutation of CAAT box homologues had no 
effect on the expression of SV40 early (Benoist and 
Chambon, 1981) or HSV-1 TK mRNAs (McKnight and Kingsbury,
1982). Indeed, transcription of the sea urchin histone H2A 
gene was increased by deleting the CAAT box (Grosschedl and 
Birnstiel, 1980a).
The 5' flanking sequences of some promoters contain 
tracts of either G-rich or C-rich residues which are of 
functional significance. Analysis of linker scanning 
mutants of the HSV-1 TK promoter identified two upstream
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G-rich and C-rich segments as being important 
transcriptional elements (see Page 31); distal signal II, 
GGGGCGGCGCGG, at —47 to —61 and distal signal III which 
included the sequence CCCCGCCC at -80 to -105 (McKnight and 
Kingsbury, 1982). Similar G— and C-rich sequences contained 
within two perfect 21bp repeats and an imperfect 22bp copy 
upstream from the SV40 early promoter are essential for the 
efficient expression of early transcripts (Fromm and Berg, 
1982; Everett et al., 1983). These repeat units contain a 
total of six CCGCCC segments, each of which is functional 
in increasing mRNA synthesis and can operate in either 
orientation (Everett et al., 1983; Baty et al., 1984). 
G-rich and C-rich sequences within the SV40 early promoter 
are binding sites for the cellular protein, Spl, a factor 
required for synthesis of SV40 mRNA (Dynan and Tjian,
1983). Similar sequences present in the intergenic region 
between HSV-1 IE mRNAs-3 and -4/-5 and in the HSV-1 TK 
promoter also bind Spl (Jones and Tjian, 1985; Jones ejt 
al., 1985); from these studies, the consensus Çg gGCGG§§Ç 
has been proposed for Spl binding sites (Dynan and Tjian, 
1985). Within the HSV-1 gD promoter (see Page 31), two 
tracts of a G-rich motif between -83 and -40 are required 
for constitutive mRNA synthesis and function in either 
orientation (Everett, 1983). Sequences similar to these 
G-rich motifs or their complement are also present upstream 
from other HSV mRNA 5 ‘ termini (Everett, 1983).
Efficient expression of rabbit ^ -globin mRNA 
requires a C-rich element with consensus CCNCACCC (N = any
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base; Dierks et al., 1983) which is also present in mouse 
(van Ooyen et al., 1979) and human ^ -globin genes (Orkin 
et al., 1982). This element is located approximately lOObp 
from the mRNA start site and a C to G mutation within this 
sequence which alters CCACACCC to CCACACGC results in 
p-thalassaemia (Orkin et al., 1982).
2) Sequences involved in modulating gene expression. In 
addition to the sequences necessary for constitutive mRNA 
synthesis, regulatory signals which modulate the level of 
transcription in response to various stimuli have been 
identified. Examples of such control elements are enhancers 
which confer tissue- or cell-specific properties on some 
genes (de Villiers et al., 1982; Banerji et al., 1983; 
Gillies et al., 1983) and sequences that respond to 
induction by steroid hormones (Schrader et al., 1981; 
Compton et al., 1983; Scheidereit and Beato, 1984), heat 
shock (Ashburner and Bonner, 1979; Pelham, 1982; Amin e^ 
al., 1985), heavy metal ions (Mayo and Palmiter, 1981;
Karin et al., 1984; von der Ahe et al., 1985), light 
(Morelli et al., 1985) and viral proteins (Nevins, 1982; 
Elkaim et al., 1983; Impériale et al., 1983; Campbell e_t 
al., 1984). The metallothionein gene (Karin et al., 1984) 
contains more than one class of regulatory elements and 
therefore responds directly to induction by at least two 
different stimuli. Regulatory sequences are frequently 
located upstream from mRNA 5' termini, however, these 
signals have been identified within the intron of the mouse
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heavy chain Ig gene (Banerji et al., 1983; Gillies et al.,
1983), downstream from the 5 ' termini of human x -  and 
p-globin genes (Charnay et al., 1984; Wright et al., 1984) 
and beyond the 3' terminus of bovine papillomavirus (BPV) 
early mRNA (Lusky et al., 1983). Synthetic oligomers 
containing sequences corresponding to consensus signals for 
heavy metal ion (Searle et al., 1985), heat shock (Pelham 
and Bienz, 1982) and HSV IE gene stimulation (Gaffney et 
al., 1985) can confer inducibility on linked promoters. In 
general, induction of modulator sequences will increase 
mRNA expression, however, in constructs containing viral 
enhancers linked to heterologous promoters, transcription 
was repressed by products of the Ad2 Ela transcription unit 
(Borrelli et al., 1984). Therefore, transcription can be 
both positively and negatively regulated through these 
sequences. In addition, regulatory sequences which have the 
ability to selectively inhibit transcription in the 
presence of cholesterol have been located to within 500bp 
upstream from the 5' terminus of 3-hydroxy-3-methylglutaryl 
coenzyme A reductase (HMG CoA reductase) mRNA (Osborne ejt 
^., 1985).
b) Sequences involved in mRNA splicing.
Recent studies have suggested that the pathway for 
splicing involves the excision of introns as 'lariat' or 
'branched-circle' structures (Grabowski et al., 1984; 
Padgett et al., 1984; Ruskin et al., 1984). This structure 
appears to be formed by cleavage at the splice donor site
66
followed by joining a G residue from the 5' end of the 
intron to an internal A residue through a 2'-5' 
phosphodiester bond (Konarska et al., 1985). This branch 
point is nuclease-resistant (Grabowski et al., 1984;
Padgett et al., 1984; Ruskin et al., 1984) and blocks 
reverse transcriptase (Ruskin et al., 1984). Cleavage at 
the splice acceptor site removes the intron and exons 
flanking the intervening sequence are ligated. It is not 
known whether these events occur through 
transestérification reactions or by a series of 
cleavage/ligation steps. Small nuclear ribonucleoproteins 
(snRNPs) which contain U1 small nuclear RNA (snRNA) are 
thought to be involved in the selection of splice sites by 
base pairing (Mount et al., 1983) as removal of 8nuc from 
the 5' end of U1 snRNA abolishes splicing activity in vitro 
(Kramer et al., 1984).
Consensus sequences for both splice donor 
(^AGGT^AGT) and splice acceptor sites (Y^NCAGGÇ; Y = 
pyrimidine, N = any base) have been deduced from DNA 
sequence comparisons of splice sites from a large number of 
genes (Breathnach and Chambon, 1981; Sharp, 1981; Mount, 
1982). Both mutations generated in vitro and 
naturally-occurring alterations within these sequence 
motifs either abolish or reduce splicing activity (Solnick, 
1981; Felber et al., 1982; Montell et al., 1982; Treisman 
et al., 1983; Wieringa et al., 1983). Inactivation of 
authentic splice sites both in vivo (Treisman et al., 1983) 
and in vitro (Krainer et al., 1984) may stimulate the
67
utilisation of cryptic splice sites and, therefore, 
formation of incorrectly-spliced transcripts. Moreover, the 
creation of novel splice sites by mutations may alter the 
mRNA splicing pattern (Busslinger et al., 1981; Felber e^ 
al. , 1982; Fukumaki et al., 1982; Treisman et al., 1983). 
Specific nucleotide sequences within the large intron of 
rabbit ^-globin mRNA do not appear to be essential for 
efficient splicing (Wieringa et al., 1984), however, Ruskin 
et al. (1984) have noted that the sequence YNYTRAY (Y = 
pyrimidine, R = purine, N = any base) is conserved in the 
vicinity of mammalian p -globin splice acceptor sites. This 
motif is similar to the consensus sequence TACTAAC which is 
present upstream from the splice acceptor sites of yeast 
genes (Langford and Gallwitz, 1983; Pikielny et al., 1983; 
Langford et al., 1984) and is involved in branch point 
formation in the lariat structure (Pikielny et al., 1983; 
Domdey et al., 1984; Rodriguez et al., 1984). The lariat 
branch point maps at the sequence TGCTAAC in rabbit 
P -globin precursor RNA (Zeitlin and Efstratiadis, 1984) 
which is 31nuc upstream from the splice acceptor site and 
fits the consensus YNYTRAY proposed by Ruskin et al.
(1984). However, precursor RNAs are accurately spliced in 
vitro following the removal of sequences at the branch 
point within the human p-globin gene (Ruskin et al.,
1985). The deletion of these sequences activates cryptic 
branch points which are located 22 to 37nuc upstream from 
the splice acceptor site.
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c ) Termination of transcription.
The possible mechanisms and DNA sequences which are 
required to form mature mRNA 3' termini are described in 
detail in Section F (Page 80).
19. Arrangements of Transcription Units.
As described in the previous section, the processes 
and DNA sequences required for production of a mature mRNA 
are numerous, however, an additional level of complexity is 
created by overlapping mRNAs which share common 
transcription control signals. Many different arrangements 
of overlapping mRNAs have been identified and these range 
from simple transcription units which specify a single 
message to more complex arrangements from which a number of 
mRNA species can be produced by differential selection of 
alternative termini and splice sites. The following 
sections describe possible arrangements of mRNAs and 
provide examples for each type.
a ) Simple transcription units.
Simple transcription units do not contain 
alternative control sites which can be differentially 
selected and thus specify a single mRNA species.
Previously, simple transcription units have been defined as 
encoding a single polypeptide (Darnell, 1982), however, 
this definition appears inadequate as the selection of 
alternative control sites outwith a protein coding region 
could generate a number of different mRNA species which
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encode the same protein. For example, the Ad5 DNA binding 
protein is specified by two mRNAs which have different 5' 
termini at early and late times p.i. (Kruijer et al.,
1981). Simple transcription units may be further 
categorised according to the processes required to form a 
mature mRNA (Fig. 7).
1) mRNAs which are neither polyadenylated nor spliced.
Most histone mRNAs (reviewed in Hentschel and Birnstiel,
1981) are typical of this group. While the majority of 
histone mRNAs are not polyadenylated, their mature 3' 
termini are generated by post-transcriptional modification 
of a precursor mRNA (see Page 89).
2) Unspliced mRNAs which are polyadenylated. Examples of 
this type include HSV-1 and HSV-2 IE mRNA-2 (Whitton e^
al., 1983), HSV-1 IE mRNA-3 (Rixon et al., 1982), the human 
(Nagata et al., 1980) and mouse -interferons (Shaw e^ 
al., 1983).
3) mRNAs which are both spliced and polyadenylated. A 
number of mammalian transcripts including the oc - (Nishioka 
and Leder, 1979) and ^-globins (Konkel et al., 1978) are 
produced in this way as is HSV-1 IE mRNA-1 (see Page 35; 
F.J. Rixon, personal communication).
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Figure 7. Arrangements of simple transcription units. 
Boxed regions indicate the regions of DNA present in mature 
mRNA. Poly A tails are shown by 'AAAA' and dashed lines 
indicate regions in precursor RNA which are removed by 
splicing. The locations of certain control signals, 
numbered 1 to 5, which are involved in mRNA synthesis and 
processing are indicated.
a) mRNAs which are neither polyadenylated nor spliced. The 
example shown is the human histone H4 gene (Heintz et al.,
1981).
b) unspliced mRNAs which are polyadenylated. The example 
given is the human oC-interferon gene (Nagata et al.,
1980) .
c) spliced mRNAs which are polyadenylated. The example 
shown is the mouse #^-globin (Nishioka and Leder, 1979).
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b) Complex transcription units.
A consequence of mRNAs sharing common signals is 
that fewer transcription control signals may be necessary 
for expression of a number of polypeptides. This form of 
gene organisation has been utilised by the adenovirus 
(reviewed in Shenk and Williams, 1984), papovavirus (Fiers 
et al., 1978) and retrovirus groups (Coffin, 1982) whose 
genomes contain tightly-packed translated regions. Some 
functionally related cellular proteins are also produced 
from mRNAs generated by differential selection of control 
sites. There are a total of seven possible arrangements of 
overlapping mRNAs, each of which is described below and 
shown in Fig. 8.
1) mRNAs with alternative 3' termini. Overlapping
transcripts which have common 5' termini and identical 
splicing patterns but different poly A sites invariably 
encode the same protein. Alternative poly A sites are 
located in the untranslated regions of genes specifying 
chick pro o(^(1) collagen (Aho et al., 1983),
^2-microglobulin (Parnes et al., 1983) and mouse 
dihydrofolate reductase (Setzer et al., 1980). In most 
examples, the multiple 3' termini are selected with 
different efficiencies. The distribution of mRNAs with 
different 3' termini for the p 2-microglobulin gene, which 
contains three possible poly A sites, is identical in a
number of tissues (Parnes et al., 1983). However, the
sequence content of the different 3' untranslated regions
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Figure 8. Arrangements of mRNAs in complex transcription 
units. The organisation or exons (boxed regions) and 
introns (solid lines) on genomic DNA is shown above the 
arrangements of mRNAs. Dashed lines indicate sequences 
removed by splicing and solid lines interrupted by (//) in 
(c) and (d) denote introns of greater than SOunuc. Examples 
or mRNA families with alternative 5' termini, and 
alternative 5' and 3' termini are not given here; 
overlapping transcripts with these arrangements are shown 
in Fig. 4. The genes described below are drawn to scale 
apart from the Ad2 E2 transcription unit in (e). References 
for the mapping of these genes are given in the text.
a) shows the alternative 3' termini of the
P 2-microglobul in ( 2 ) transcripts.
b) indicates the alternative splicing within Ad2 Ela 
transcription unit.
c) shows the alternative 5' termini and splice sites used
in the myosin light chain (LC) gene, generating transcripts
DZ 1 ana LC 3 .
d) shows the alternative poly A sites and splice sites for 
the rat calcitonin gene. CGRP is the abbreviation for 
calcitonin gene-related peptide.
e) indicates the arrangement of the mRNAs in the Ad2 E2 
transcription unit, comprising early families E2a and E2b, 
and the IVa2 gene.
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may affect either the subcellular location or stability of 
P 2-microglobulin transcripts; to date, these possibilities 
remain untested.
2) mRNAs with alternative splice sites. In most cases, 
differential splicing allows expression of more than one 
protein from a region of DNA which specifies transcripts 
with common 5' and 3' termini. The use of alternative 
splice sites within a protein coding region may generate 
transcripts which encode polypeptides with common epitopes. 
For example, the mouse A^^^-crystallin gene has an 
identical amino acid sequence to the oCA^-crystallin 
protein except for an additional 22 amino acids between 
residues 63 and 64 (Cohen et al., 1978; de Jong et al.,
1980). The exon containing this small peptide is inserted 
into the oCA2-crystallin protein by the selection of splice 
sites within the first intron of the o(A2-crystallin gene 
(King and Piatigorsky, 1983). A further example is the Ad 
Ela region which specifies three mRNAs; two transcripts 
(13S and 12S) are early species while the third (9S) is 
synthesised only at late times (Berk and Sharp, 1978b; Chow 
et al., 1979; Perricaudet et al., 1979). Ela transcripts 
share common 5' and 3' termini, however, the different 
mRNAs are produced by splicing between three potential 
splice donor sites and one common splice acceptor site. The 
splice donor and acceptor sites are located in the 
translated regions of all three mRNAs, thus the different 
Ela polypeptides share common amino acid residues
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(Perricaudet et al., 1979). The 13S transcript encodes a
51.000 mol. wt. protein which stimulates transcription of 
Ad genes during virus infection (Ricciardi et al., 1981; 
Montell et al., 1982). The 12S mRNA specifies a 48,000 mol. 
wt. polypeptide which is 46 amino acids shorter than the
51.000 mol. wt. product. To date, the splice donor site for 
the 9S mRNA has not been accurately positioned and a 
protein specified by this transcript has not been detected 
in infected cells.
3) mRNAs with alternative 5' termini. The majority of 
overlapping HSV mRNAs which are 3' co-terminal are 
unspliced and the individual members of each family have 
unique 5' termini (reviewed in Wagner, 1985). A description 
of the transcripts encoded by HSV DNA is given in Section 8 
(Page 36) .
4) mRNAs with alternative 5' and 3* termini. Again, the 
HSV genome specifies mRNA families with this type of 
arrangement. In addition, the transcripts of vaccinia virus 
are unspliced and form families of nested mRNAs (Cooper et 
al., 1981; Mahr and Roberts, 1984a, b; Morgan and Roberts,
1984) .
5) mRNAs with alternative 5* termini and splice sites. In
chicken muscle cells, myosin light chains are encoded by a 
single gene of size 18kbp (Nabeshima et al., 1984). From 
this gene, two distinct light chain proteins, LCl and LC 3,
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are produced by differential splicing of two precursor RNAs 
which have different initiation sites (Nabeshima et al.,
1984). LCl mRNA differs from the LC3 transcript only at the 
5' terminal region where the two 5' proximal exons of each 
mRNA species are encoded by unique DNA segments. The 
remaining exons are common to both transcripts and 
consequently, the predicted amino acid sequences for LCl 
and LC3 proteins are identical except for the N-terminal 
region.
6) mRNAs with alternative 3* termini and splice sites. The 
Ad2 E3 transcription unit contains three possible poly A 
sites, two splice donor sites and five splice acceptor 
sites (Berk and Sharp, 1978b; Chow et al., 1979). In total, 
eight different E3 mRNAs have been identified, each with an 
identical 5' terminus. In eukaryotes, similar mRNA 
arrangements have been described for the Ig heavy chain 
genes (Alt et al., 1980; Early et al., 1980), the 
glycinamide ribotide transformylase gene of Drosophila 
melanoqaster (D. melanogaster; Henikoff et al., 1983b) and 
the calcitonin gene (Amara et al., 1982 and 1984; Edbrooke 
et al., 1985).
7) mRNAs with alternative termini and splice sites. Such 
complex organisation occurs in the Ad E2 transcription unit 
which comprises two mRNA families designated E2a and E2b 
that utilise different poly A sites (Stillman et al.,
1981); the poly A site for E2a mRNA is located within the
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transcribed region of the E2b family. The E2a region 
specifies two mRNA species with different 5' termini and 5‘ 
terminal leader sequences which are selected at different 
times during the virus growth cycle (Kruijer et al., 1981). 
The E2b region produces three mRNA species which have 
identical leader sequences but differ in the location of 
their 3' proximal splice acceptor sites. A third promoter, 
within the coding sequences of the E2b transcripts, 
specifies the 5' terminus of IVa2 mRNA.
These seven arrangements for overlapping trancripts 
relate only to those mRNAs synthesised from the same DNA 
strand. Overlaps occur between transcripts produced from 
opposite strands of DNA, for example transcription of the 
Ad E2 and late transcription units (reviewed in Shenk and 
Williams, 1984). Divergently transcribed mRNAs with 
overlapping 5' termini have been identified in the HSV-1 Ug 
region (Rixon and McGeoch, 1985) and the 3' termini of SV40 
early and late mRNAs also overlap (Fiers et al., 1978).
20. Regulation of Overlapping mRNAs.
a) Poly A site selection in immunoglobulins.
The heavy chains of antibodies are composed of 
variable (V^) and constant (Cjj) regions; the Cjj regions 
encode the 3' portion of Ig mRNA and contain at least one 
poly A site. The effector or class of antibody is 
determined by the selection of one out of eight possible
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Fiaure_9. Differential selection of splice sites and 3' 
termini for IgM and IgD mRNAs. Locations of the polypeptide 
coding regions for variable (represented by L, V, D and J) 
and constant (C/i and C ^  ) regions on genomic DNA are shown 
by boxed regions on the top line. Positions for the poly A 
sites of membrane-bound (M) and secreted forms (S) of IgM 
and IgD are indicated by closed circles. Dashed lines 
denote the regions removed from precursor RNAs by splicing.
75
regions (reviewed in Marcu, 1982 and Shimizu et al., 1982). 
In most cases, a change in the class of antibody is due to 
DNA rearrangements mediated through switch recombination 
sites which juxtapose the Vy region to an alternative Cy 
region. Thus, removal of potential poly A sites by DNA 
rearrangements influences the selection of Ig mRNA 3' 
termini. In contrast, production of IgD, which is 
co-expressed with IgM in mature resting B cells (Cooper et 
al., 1976; Pernis et al., 1976), does not require the 
deletion of DNA sequences; rather, IgD expression is 
determined by differential processing of precursor mRNAs 
(Maki et al., 1981; Knapp et al., 1982). Both IgM and IgD 
exist as secretory and membrane-bound species and the 
species expressed is governed by poly A site selection and 
differential splicing processes. Therefore, there are at 
least four potential poly A sites involved in IgM and IgD 
expression; the 5' proximal poly A sites produce mRNAs 
encoding IgMg and IgM^ respectively (Fig. 9; Alt et al., 
1980; Early et al., 1980) while the 5' distal poly A sites 
generate transcripts specifying IgDg and IgD# respectively 
(Cheng et al., 1982).
It has been suggested that poly A site selection in 
IgM and IgD transcription is regulated by alterations in 
the level of an 'endase' enzyme which cleaves precursor 
RNAs at poly A sites (Blattner and Tucker, 1984). In 
resting B cells, this enzyme would be present at low levels 
and the choice of poly A site is determined by an affinity 
for the 'endase*. B cell differentiation increases the
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level of 'endase' and subsequently the number of cleavage 
events at poly A sites on the precursor RNA. Thus, the poly 
A site proximal to the mRNA 5' terminus is preferentially 
selected and cleavage at this site defines the mRNA 3' 
terminus irrespective of further downstream cleavage 
events. Such a model would account for a number of 
observations including the disappearance of IgD following 
activation of resting B cells and the concomitant rise in 
IgMg (Parker et al., 1979; Isakson et al., 1981) whose poly 
A site is the most proximal to the mRNA 5' terminus. 
Furthermore, putative RNA processing intermediates have 
been detected which correspond to the distance between two 
poly A sites; such products would be predicted from more 
than one cleavage event on a precursor RNA molecule (Kemp 
et al., 1983).
b) Formation of differentially spliced mRNAs.
Two possible mechanisms for the selection of 
alternative splice sites have been proposed (Sharp, 1981; 
Kuhne et al., 1983). Both models suggest that nucleotide 
sequences flanking the splice donor and acceptor sites 
influence the efficiency of splicing at a particular site, 
however, they differ on the additional factors which 
determine splice site selection.
The first model (Sharp, 1981) proposes a 
'scanning-type' mechanism whereby a splicing complex 
attaches to a splice donor or acceptor site and moves along 
the RNA molecule until it encounters a splice acceptor or
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donor site at which point the intervening sequence between 
the splice sites is removed. Further scanning of the RNA by 
the complex and additional splicing reactions may give rise 
to a number of mRNAs with different splicing patterns. 
Evidence for this proposal is derived from the probable 
stepwise excision of introns from procollagen RNA 
(Avvedimento et al., 1980).
To test this model, Kuhne et al. (1983) inserted a 
duplication of the rabbit ^-globin splice donor site 
upstream from the normal donor site and, in a separate 
construction, the splice acceptor site was positioned 
downstream from the normal acceptor site. The 
'scanning-type' model predicts that donor and acceptor 
sites proximal to the 5' and 3' termini would be utilised. 
However, analysis of the resultant ^-globin mRNAs 
indicated that splicing occurred at splice sites distal to 
the 5' and 3' termini, thus arguing against a 
'scanning-type' mechanism. From these data, a separate 
model has been proposed suggesting that the relative 
positions of splice sites determines the probability of a 
splicing reaction occurring between them. Therefore, 
stability of both the enzyme-splicing region complexes and 
the secondary or tertiary structure of the RNA would have a 
role in splice site selection. This model would account for 
the different splicing patterns of mRNAs which have 
alternative 5' and 3' termini such as the membrane and 
secretory forms of IgD and IgM, the calcitonin gene, the 
glycinamide ribotide transformylase gene of D. melanogaster
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and the myosin light chain gene (see Pages 72 and 73 for 
references). However, neither model explains the shift in 
splicing pattern of Ad LI mRNAs during the course of viral 
infection (Akusjarvi and Persson, 1981a).
c ) Tissue-specific selection of termini and splice
sites.
Expression of some eukaryotic genes which specify 
more than one transcript is controlled by tissue 
specificity. The chicken myosin light chain gene comprises 
LCl and LC3 mRNAs which have different 5' termini and 
splicing patterns (Page 72; Nabeshima et al., 1984). Both 
transcripts are produced in skeletal muscle, however, 
cardiac muscle expresses a light chain homologous to LCl 
while a light chain homologous to LC3 is synthesised in 
gizzard muscle. Similarly, the hormone calcitonin is 
produced in thyroid 'C ' cells while the calcitonin 
gene-related peptide (CGRP) is expressed in brain cells 
(Rosenfeld et al., 1983). The mRNAs which encode these 
polypeptides have common 5' termini and the N-terminal 
protein sequences are identical (Fig. 8; Amara et al., 1982 
and 1984; Edbrooke et al., 1985). Differential selection of 
two poly A sites and alternative splicing pathways enables 
expression of the unique C-terminal portions of both 
proteins. Selection of the 3' distal poly A site produces a 
CGRP-specific transcript, however, mRNAs which terminate at 
the 5' proximal poly A site encode calcitonin. 
Calcitonin-specific coding sequences and the 5' proximal
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poly A site are removed from the CGRP-specific mRNA by 
splicing. The mouse oC-amylase also is encoded by two 
tissue-specific transcripts (Young et al., 1981). in this 
case, the mRNAs utilise alternative 5' termini in the liver 
and parotid gland and have different splicing patterns. 
These differences in the mRNAs occur in the 5' untranslated 
region and therefore both transcripts contain identical 
protein coding sequences. The promoters which specify the 
different oC-amylase 5' termini are differentially 
activated during parotid gland development (Shaw et al.,
1985).
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SECTION F.
RNA TERMINATION AND 3* END PROCESSING IN EUKARYOTES.
The processes and DNA sequences involved in 
termination of transcription and formation of mature RNA 3' 
termini are not yet fully understood. There are two 
possible mechanisms by which RNA 3' termini can be 
generated :
1) termination at the RNA 3' terminus and no further 
cleavage of the transcript. Yeast RNA may be further 
processed by the addition of a poly A tail to the 3' 
terminus (Zaret and Sherman, 1982).
2) synthesis of a precursor RNA which is cleaved to produce 
the mature 3' terminus. This 3' terminus may be further 
processed by addition of either a poly A tail to poly A 
mRNAs and some histone messages or a terminal CCA sequence 
to tRNAs.
The DNA sequences which control these events have 
been partially characterised, however their functions 
remain unclear. The following sections review the processes 
and DNA sequences involved in the 3' end formation of RNAs 
transcribed by RNA polymerases I, II and III.
21. Termination and Processing of RNA Polymerase I 
Transcripts.
RNA polymerase I transcribes a precursor RNA which 
is subsequently cleaved by a number of pathways to generate 
the mature ribosomal RNAs (Bowman et al., 1981; Fetherston
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et al., 1984). The only rRNA not produced by RNA polymerase 
I is the 5S species which is synthesised by RNA polymerase 
III (McReynolds and Penman, 1974). Xenopus laevis (X. 
laevis) precursor RNA sediments at 408 (Wellauer and Dawid, 
1974) and is cleaved to produce the mature 288, 188 and 
5.88 rRNAs (Landesman and Gross, 1968; 8peirs and 
Birnstiel, 1974; Wellauer and Dawid, 1974). By nuclease 81 
analysis, the 3' termini of 408 and 288 RNAs are identical 
and therefore, following termination of 408 RNA synthesis, 
there are no further cleavage events at the 3 ' terminus 
(8ollner-Webb and Reeder, 1979).
DNA sequences at the termination site consist of a 
cluster of T residues in a G+C-rich environment 
(8ollner-Webb and Reeder, 1979). Measurement of the length 
of transcripts produced by plasmids with deleted sequences 
immediately downstream from the 3' terminus has shown that 
the cluster of T residues is not only the termination site 
but also delimits the 3' boundary of the termination signal 
(Bakken et al., 1982). Plasmids in which the distal T 
residue of a four T residue cluster was deleted continued 
to produce correctly-terminated RNA. However, removal of an 
additional T residue abolished termination at this site and 
extended RNAs were detected. The presence of stretches of T 
residues within rRNA coding sequences suggests that T 
residues alone are not sufficient for termination 
(Sollner-Webb and Reeder, 1979; Gourse and Gerbi, 1980); at 
present, no additional signals have been identified.
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22. Termination and Processing of RNA Polymerase III 
Transcripts.
RNA polymerase III is responsible for transcription 
of a number of RNA species including tRNAs, 58 RNAs 
(McReynolds and Penman, 1974), Alu RNAs (Haynes and 
Jelinek, 1981; Pan et al., 1981), virus-associated RNAs 
such as Ad VAI and VAII (8oderland at al., 1976) and other 
snRNAs (reviewed in Busch et al., 1982).
In almost all cases, the termination sites of 58 
RNA transcripts are located within a cluster of T residues 
(Brown and Brown, 1976; Korn and Brown, 1978). Analysis of 
X. laevis 58 RNA in vitro has indicated that the DNA 
sequences involved in termination are very similar to those 
signals required for termination by RNA polymerase I, 
namely a cluster of T residues flanked by G or C 
nucleotides; stretches of A residues in the vicinity of the 
T cluster will reduce termination efficiency (Bogenhagen 
and Brown, 1981). Furthermore, no extensive sequences 
flanking the T cluster are necessary for efficient 
termination. The minimum sequence length required is 2 to 
Snuc on the 5' side of the T cluster and 2nuc on the 3' 
side. Plasmids with deletions extending into the T cluster 
fail to terminate at the correct site. A common feature of 
Xenopus 58 genes is the presence of secondary termination 
sites downstream from the preferred site; these secondary 
termination sites are thought to prevent read-through 
transcription beyond the region encoding 58 RNA (Korn and 
Brown, 1978).
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The 3' termini of precursor and mature 5S 
transcripts are identical in X. laevis (Birkenmeier et al., 
1978), however, post-transcriptional processing does occur 
at the 3' termini of 5S RNAs in other organisms. Isolated 
nuclei from rat liver and HeLa cells synthesise a precursor 
RNA species which is 8nuc longer at the 3' terminus than 
the mature 5S form (Hamada et al., 1979) and, in D. 
melanogaster, 15nuc are removed from a precursor transcript 
to generate the mature 5S species (Jacq et al., 1977). In 
yeast, up to lOnuc are removed from the precursor 5S RNA 
(Tekamp et al., 1980).
Mature tRNA 3' termini are generated by 
endonuclease cleavage of a precursor form and by addition 
of the trinucleotide sequence CCA (Melton et al., 1980; 
Frendewey et al., 1985). Presumed terminator sequences in 
the precursor RNA are T-rich and therefore similar to the 
sequences at 58 RNA 3' termini (Hosbach et al., 1980). 
Efficient synthesis in vitro of a D. melanogaster tRNA^RG 
gene requires approximately 35bp of flanking sequences and 
additional factors other than RNA polymerase III are 
essential for formation of a stable transcription complex 
(Schaak et al., 1983 and 1984). This requirement for 3* 
flanking sequences in a tRNA gene contrasts with that of X . 
laevis 58 RNA in which removal of flanking sequences does 
not affect termination efficiency (Bogenhagen and Brown,
1981). Moreover, X. laevis RNA polymerase III, purified to 
greater than 90% homogeneity is able to accurately and 
efficiently terminate 58 RNA transcription (Cozzarelli ejb
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al» » 1983). A possible explanation for these differences is 
that the 3' flanking sequences and binding factors are 
required for processing of precursor tRNA^RG 3 - terminus; 
the 3' terminus of the X. laevis 5S primary transcript is 
not modified and therefore may not require flanking 
sequences and additional factors other than RNA polymerase 
III.
23. Termination and Processing of RNA Polymerase II 
Transcripts.
RNA polymerase II is responsible for the synthesis 
of poly A mRNAs, histone messages (see Page 60) and snRNAs 
which have a high uridylic acid content (U-snRNAs; reviewed 
in Busch et al., 1982). Current models for 3' end formation 
in higher eukaryotes and animal DNA viruses suggests that 
mature 3' termini are generated by post-transcriptional 
cleavage of a longer precursor RNA, however, these 
processes are poorly understood. For poly A mRNAs, a 
stretch of up to 200 A residues is then added to the mature 
3' terminus. The following sections describe those 
processes and DNA sequences which are involved in 3' end 
formation of poly A and histone mRNAs.
a) Termination of transcription.
Studies on a number of genes have shown that 
transcription continues beyond the poly A site (reviewed in 
Darnell, 1982 and Nevins, 1983). Examination of nuclear RNA 
produced at late times in Ad2-infected HeLa cells indicated
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that the mature 3' termini did not correspond to the RNA 
polymerase termination site. Primary transcripts, which are 
initiated at the major late promoter, extend across most of 
the Ad2 genome from map coordinate 16.4 to between map 
coordinates 91.9 and 99.0 (Nevins and Darnell, 1978; Fraser 
et al., 1979); mature mRNA 3' termini are generated by 
selection of one of five possible poly A sites from within 
the primary transcripts. Again in Ad2, the primary 
transcripts for the E2 and E4 early transcription units 
extend for some distance beyond their respective poly A 
sites (Nevins et al., 1980). Analysis of late mRNAs in 
SV40-infected cells by short-term pulse-labelling methods 
has demonstrated that transcription continues for at least 
Ikb beyond the late RNA poly A site (Ford and Hsu, 1978). 
Termination has been studied extensively in the mouse 
pmaj-giobin gene. RNase fingerprint analysis of in 
vitro-labelled RNA from isolated nuclei and hybridisation 
of in vivo-labelled nuclear RNA to sequences spanning the 
^maj_giobin gene have indicated that nascent RNA contains 
sequences downstream from the poly A site (Hofer and 
Darnell, 1981). Further analysis of this gene has focussed 
on identification of a downstream termination site and 
recent evidence suggests that termination occurs within a 
region 0.7 to 2kb downstream from the poly A site but not 
at particularly favoured sites (Citron et al., 1984). This 
downstream region contains A-rich and T-rich segments which 
are conserved in other globin genes, however their function 
is unknown. A portion of the DNA sequence which is not
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transcribed and is approximately 2kb downstream from the 
poly A site contains a stem and loop structure followed by 
a stretch of fifteen consecutive T residues (Citron et al.,
1984). Insertion of a mouse pmaj-globin fragment, which 
spans the poly A signal and proposed termination region, 
into the Ad5 Ela transcription unit generates mRNA which is 
processed exclusively at the p-globin poly A site 
(Falck-Pedersen et al., 1985). In contrast, transcripts are 
processed at the normal Ela poly A site in recombinants 
which contain the proposed p-globin termination region but 
lack the ^-globin poly A signal. Thus, discrete 
termination events appear not to occur in the absence of a 
functional poly A site.
Mature histone mRNA 3' termini also are generated 
by processing of a primary transcript. RNA precursors, 
synthesised in vitro and subsequently injected into Xenopus 
oocytes, are processed to form mature 3' termini and it has 
been suggested that termination occurs heterogeneously 
within a 100 to 200nuc stretch of spacer DNA (Birchmeier e_t 
al., 1984; Krieg and Melton, 1984).
b ) 3* end formation of poly A mRNAs.
The DNA sequences required for 3' end formation of 
poly A mRNAs can be divided into two categories; 1) the 
polyadenylation signal and 2) DNA sequences downstream from 
the polyadenylation signal.
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1) The polyadenylation signal. The polyadenylation signal, 
AATAAA, is located 10 to 30nuc upstream from the poly A 
site of poly A mRNAs and is well conserved in mammalian and 
viral genes (Proudfoot and Brownlee, 1976). The functional 
significance of this sequence has been demonstrated in a 
number of studies. SV40 mutants which lack an AATAAA signal 
in the late transcription unit fail to produce late poly A 
mRNA (Fitzgerald and Shenk, 1981). In other mutants which
retain an AATAAA signal, removal of sequences between the 
AATAAA sequence and the poly A site does not dramatically 
affect SV40 late mRNA production. The mRNA 3' termini from 
these constructions are located at a similar distance from 
the AATAAA signal as in wild-type SV40 late mRNA, thus 
sequences between the AATAAA signal and the poly A site do 
not appear to be necessary for positioning the 3' terminus. 
Recent studies with these SV40 mutants indicate that 
deletion of sequences downstream from the poly A signal 
decreases the efficiency with which the normal poly A site 
is utilised (Sadofsky and Alwine, 1984; Conway and Wickens,
1985) .
Point mutations generated in vitro within the poly A 
signals of SV40 late and Ad2 Ela transcription units 
dramatically reduce the level of detectable poly A mRNA 
(Montell et al., 1983; Wickens and Stephenson, 1984). The 
altered AATAAA sequences examined in SV40 were A AC AAA, 
AATTAA, AATACA and AATGAA (Wickens and Stephenson, 1984) 
and in Ad2 the mutated sequence AAGAAA was analysed 
(Montell et al., 1983). These point mutations did not
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prevent polyadenylation; the low level of detectable mRNA 
was polyadenylated, indicating that the poly A signal is 
possibly involved in cleavage of the primary transcript.
The failure to detect cleaved RNA products which were not 
polyadenylated further suggests that polyadenylation 
rapidly follows cleavage and the two reactions may be 
coupled (Manley et al., 1982; Wickens and Stephenson,
1984). Evidence from in vivo studies reveal that a mutated 
signal with the DNA sequence AATAAG results in 
c<-thalassaemia (Higgs et al., 1983). o^-globin RNA 
produced in vivo extends beyond the normal poly A site and 
is unstable giving rise to deficient o(-globin production.
Certain alterations within the AATAAA sequence can 
be tolerated. For example, a high proportion of RNA 
molecules are processed at the major poly A site of the X . 
laevis pi globin gene following mutation of the AATAAA 
sequence to AATACA (Mason et al., 1985) and a number of 
genes utilise the sequence AATTAA as a poly A signal 
(Wickens and Stephenson, 1985).
2) DNA sequences downstream from the poly A signal. The 
hexanucleotide sequence, AATAAA, occurs in regions of DNA 
which do not contain a poly A site (Fiers et al., 1978; 
Perricaudet et al., 1980; Tosi et al., 1981), therefore, 
sequences other than AATAAA must be involved in determining 
the location of 3' termini. Benoist et al., (1980) have 
described a model sequence TTTTCACTGC which was present at 
the 3' termini of five out of nine mRNAs. In another
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report, Taya et al., (1982) noted that the DNA sequence 
GTGTTG was present at approximately lOnuc downstream from 
the 3* termini of six mRNAs.
Analysis of transcripts produced by plasmids with 
deletions at 3' termini has indicated that DNA sequences 
downstream from the AATAAA signal are required for 
efficient cleavage and polyadenylation. Removal of 3' 
flanking sequences from the Ad5 E2a transcription unit has 
demonstrated that 35bp distal to the poly A site are 
necessary for the efficient formation of mature mRNA 3' 
termini (McDevitt et al., 1984). Deletion of an additional 
15bp abolishes the ability to produce functional E2a mRNA 
and the level of correctly-terminated mRNA is reduced but 
remains detectable. Plasmids with a further deletion of 
22bp, removing the poly A site, fail to produce 
correctly-terminated transcripts. Efficient production of 
rabbit ^-globin 3' termini requires 31bp of 3' flanking 
DNA sequences (Gil and Proudfoot, 1984) and an 18bp region 
immediately downstream from the HSV-1 TK mRNA poly A site 
is critical for 3' end formation (Cole and Stacy, 1985). 
Sequences at a similar distance from the poly A site of 
SV40 late transcripts have been implicated in efficient 3' 
end processing (Sadofsky and Alwine, 1984; Conway and 
Wickens, 1985).
c ) 3* end formation in histone mRNAs.
The majority of histone mRNAs are not 
polyadenylated (Adesnik and Darnell, 1972; Greenberg and
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perry, 1972), however, examples of polyadenylated histone 
transcripts include X. laevis H4 mRNA, chicken H5 mRNA 
(Krieg et al., 1983) and yeast histone messages (Fahrner et 
al., 1980). DNA sequence comparisons have revealed that 
many but not all histone mRNAs have a conserved sequence
ACC(C )A at the 3' terminus and a short palindromic sequence 
upstream from the 3' end which may form a stem and loop 
structure (Busslinger et al., 1979; Hentschel et al., 1980; 
Childs et al., 1982; Turner and Woodland, 1982; Krieg e± 
al., 1983). Insertion of point mutations within the stem 
portion of this structure abolishes the ability to generate 
correctly-terminated sea urchin H2A mRNA following 
micro-injection of the mutated DNA into Xenopus oocytes 
(Birchmeier et al., 1983). Pseudorevertants with 
complementary point mutations within the palindrome produce 
authentic 3' termini, suggesting that the presence of a 
stem and loop structure within precursor RNA is essential 
for 3' end formation rather than a requirement for specific 
DNA sequences (Birchmeier et al., 1983).
In addition to the dyad symmetry and the 3' 
terminal ACC(C )A motif, sequences up to 78nuc downstream 
from the 3' terminus are essential for efficient 3' end 
production (Birchmeier et al., 1982 and 1983). Within this 
78nuc segment, correctly-processed mRNA is produced at a 
sub-optimal level by the 24nuc proximal to the 3' end 
(Birchmeier et al., 1983). This 24nuc sequence contains a 
CAAGAAAGA motif which is highly conserved in sea urchin 
histone mRNA species and is located approximately 8nuc
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downstream from 3' termini (Busslinger et al., 1979; 
Birnstiel et al., 1985). This sequence motif is essential 
for RNA processing and increasing the distance between the 
CAAGAAAGA sequence and the palindrome abolishes 3' end 
formation (Georgiev and Birnstiel, 1985).
d) Termination and polyadenylation in lower eukaryotes.
Little is known of the DNA sequences and processing 
events which are essential for the generation of yeast mRNA 
3' termini. The AATAAA sequence which is essential for 
processing of higher eukaryote poly A mRNAs is not present 
at the 3' termini of most yeast mRNAs (Zaret and Sherman, 
1982). A spontaneous mutant of Saccharomyces cerevisae (S . 
cerevisae) has a 38bp deletion downstream from the 
translated region of the CYCl locus. Absence of these DNA 
sequences results in the production of extended transcripts 
which are polyadenylated, leading Zaret and Sherman (1982 
and 1984) to propose that polyadenylation of yeast mRNAs is 
directly coupled to termination and that primary 
transcripts are not cleaved. From comparisons of this 38bp 
sequence to regions upstream from other yeast poly A sites, 
alternative consensus sequences have been proposed for 
termination (Zaret and Sherman, 1982; Bennetzen and Hall,
1982). A third possible consensus sequence has been 
suggested from a separate study which examined the 
termination and polyadenylation of a Drosophila DNA segment 
in yeast using deletion mutant analysis (Henikoff et al., 
1983a). The three proposed consensus sequences are;
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1) (T-rich) . .TAG......TA(T)GT. . (A/T-rich) . .TTT (Zaret and
Sherman, 1982).
2) TTTTTATA (Henikoff et al., 1983a; Henikoff and Cohen, 
1984) .
3) TAAATAA§ (Bennetzen and Hall, 1982).
24. In Vitro Formation of mRNA 3' Termini.
Synthesis in vitro of mRNA species in whole-cell 
extracts has demonstrated that efficient cleavage and 
polyadenylation does not require primary transcripts which 
extend to specific termination sites. Precursor RNAs 
synthesised in vitro from DNA templates which are cleaved 
either at or just downstream from the mature mRNA 3' 
terminus are accurately and efficiently polyadenylated by 
HeLa cell extracts (Manley, 1983; Manley et al., 1985). In 
contrast, longer precursor RNAs are processed inefficiently 
and the poly A tail is added to the 3' terminus of 
uncleaved primary transcripts (Moore and Sharp, 1984;
Manley et al., 1985). However, cell extracts, possessing 
both transcription and processing activities, efficiently 
produce correctly-processed mRNAs from precursor RNAs 
synthesised from DNA templates which extend at least 50bp 
beyond the mature 3 ' end; these results suggest that 
processing rapidly follows transcription beyond the poly A 
site (Moore and Sharp, 1984).
Processing of precursor RNAs probably requires 
cleavage of the primary transcript followed by 
polyadenylation. Purified poly A polymerase does not
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possess either of these activities (Brawerman, 1981). The 
inhibition of cleavage/polyadenylation by mouse monoclonal 
antibodies which immunoprecipitate ribonucleoproteins 
containing Ul, U2, U4, U5 and U6 RNAs suggests a role for 
snRNAs in 3' end processing (Moore and Sharp, 1984) and it 
has been proposed that U4 snRNA may hybridise to 
complementary sequences at poly A sites (Berget, 1984). 
Processing of a histone H3 precursor RNA synthesised in 
vitro requires the prior injection into Xenopus oocytes of 
a 60nuc RNA (termed U7 RNA; Strub et al., 1984) which 
appears to be a component of a snRNP in sea urchin embryos 
(Galli et al., 1983; Birchmeier et al., 1984). Similar 
experiments with purified Drosophila H3 precursor RNA 
demonstrated that authentic 3' termini were produced by a 
nuclear extract from Drosophila cultured cells (Price and 
Parker, 1984). This processing activity was isolated and 
two RNA species were present in highly purified 
preparations.
MATERIALS AND METHODS
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SECTION A .
MATERIALS
1. Viruses.
HSV-2 strain HG52 (Timbury, 1971) and HSV-1 Glasgow 
strain 17+ (Brown et al., 1973) were used during the course 
of this worK.
2. Cells.
Baby hamster kidney cells (BHK-C13; MacPherson and 
Stoker, 1962) were used for growth and assay of virus and 
in the preparation of viral RNA. HeLa cells (a gift from R. 
Everett) were used for short-term transfection assays of 
plasmid constructions.
3. Tissue Culture Media.
BHK cells were propagated using modified Eagle's 
medium (Busby et al., 1964) containing lOOpg/ml 
streptomycin, lOOunits/ml penicillin, 0.2^g/ml n-butyl 
p-hydroxybenzoate and O.UU2% (w/v) phenol red. The growth 
medium, ETC1Û, comprised 80% Eagle's, 10% tryptose 
phosphate and 10% calf serum. To titrate virus, tryptose 
phosphate and calf serum were replaced with human serum 
which was added to a final concentration of 5% to give 
EHu5.
HeLa cells were grown in Dulbecco's medium (Flow 
Laboratories), a modified version of Eagle's medium,
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supplemented with 20mM glutamine, lOOunits/ml of 
streptomycin and penicillin and 0.55ml of 0.025% (w/v) 
amphotericin. In addition to the above ingredients, growth 
medium contained 2.5% calf serum and 2.5% foetal calf serum 
(Gibco Ltd) .
PBS contained 170mM NaCl, 3.4mM KCl, ImM Na2HP04, 
2mM KH2PO4 (pH 7.2) in distilled water. Versene consisted 
of PBS containing 6mM EDTA with 0.0015% (w/v) phenol red. 
Trypsin comprised 25% (w/v) Difco trypsin dissolved in 
Tris-saline. The constituents of Tris-saline were 140mM 
NaCl, 30mM KCl, 0.28mM Na2HP0 4, Img/ml dextrose, 25mM Tris 
HCl (pH 7.4), 0.005% (w/v) phenol red supplemented with
lOOunits/ml penicillin and lOOpg/ml streptomycin.
4. Bacterial Culture Media.
Bacteria were grown in L-broth which consisted of 
177mM NaCl, lOg/l bactopeptone and 5g/l yeast extract (pH 
7.5, presterilisation). For agar plates, L-broth contained 
1.5% (w/v) agar. Where appropriate, ampicillin was added to 
both the culture medium and L-broth/agar at a final 
concentration of lOOpg/ml.
5. Buffer Solutions.
TE ImM Tris HCl (pH 7.5), 0.05mM EDTA
HBS 140mM NaCl, 50mM HEPES (pH 7.12), 1.5mM
Na2HPO4
TNE 40mM Tris HCl (pH 7.8), 120mM NaCl, lOmM EDTA
ILB 150mM NaCl, 1.5mM MgCl2, lOmM Tris HCl (pH
7.8), 0.65% (v/v) NP40
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PEB 7.0M urea, 350mM NaCl, lOmM EDTA, lOmM Tris
HCl (pH 7.9), 1% (w/v) SDS 
TBE 120mM Tris (pH 9.3), 40.4mM boric acid, 2.7mM
EDTA
TAE 0.04M Tris HAc (pH 8.0), 0.002M EDTA
STET 50mM EDTA, 5UmM Tris HCl (pH 8 .u), 8% (w/v)
sucrose, 5% (v/v) Triton XlOO 
SSC 0.15M NaCl, U.U15M sodium citrate (pH 7.5) 
MOPS 20mM sodium morpholino-propane sulphonate,
5mM NaAc (pH 7.0), ImM EDTA 
STES 200mM NaCl, 25mM Tris HCl (pH 7.9), 5mM EDTA, 
0 .1% (v/v) sarkosyl,
Denhardt's solution 0.02% (w/v) Ficoll, 0.02% 
(w/v) polyvinylpyrrolidone, 0.02% (w/v) 
bovine serum albumin (BSA; Denhardt, 1966)
6. Enzymes.
All enzymes were obtained from Bethesda Research 
Laboratories (BRL) or New England Biolabs with the 
exception of nuclease SI, calf intestinal alkaline 
phosphatase and Hinc II which were supplied by Boehringer 
Corporation Limited. Unless otherwise stated, enzyme 
digests were performed in Ix core buffer (50mM Tris HCl, pH 
8.0, lOmM MgCl2, 50mM NaCl), supplied by BRL.
7. Radiochemicals.
Radioisotopes were supplied by Amersham 
International PLC with the exception of I'^ C chloramphenicol
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which was obtained from NEN Research Products, Boston,
Mass. Specific activities for the various radiochemicals 
were :
5' [oC-32p] deoxynucleoside triphosphates,
300ÜC i/mmol
5' [ )f-32p] adenosine triphosphate, 5000Ci/mmol 
chloramphenicol, 45.5mCi/mmol
8. Chemicals and Miscellaneous Reagents.
Sigma Chemical Company supplied the following 
materials: agarose, SDS, Tris base, DTT, lysozyme, acetyl 
co-enzyme A (acetyl CoA), yeast RNA, BSA, dimethyl 
formamide, 5-bromo 4-chloro 3-indolyl p D 
galactopyranoside (Xgal), polyvinylpyrrolidone, 
piperazine-N,N'-bis[2-ethane sulphonic acid] (PIPES) and 
all ribo- and deoxyribonucleoside triphosphates.
Koch-Light laboratories supplied acrylamide, boric 
acid, sodium hydroxide and caesium chloride.
Methylenebisacrylamide, ammonium persulphate, TEMED 
(N,N,N',N'-tetramethylethylene diamine) and Bradford 
reagent were obtained from BioRad laboratories.
Low melting point agarose was supplied by BRL. 
Analar alcohol was supplied by James Burroughs Ltd. 
0.25mm silica gel thin layer chromatography plates 
were obtained from Camlab, Cambridge.
Tissue culture materials were supplied by Sterilin 
Ltd. and Nunc.
'Eppendorf' reaction tubes were obtained from
Sarstedt Ltd.
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Nitrocellulose paper (BA85) was obtained from 
Schleicher and Schuell.
Intensifying screens were supplied by DuPont.
All other reagents were of analytical grade and 
were supplied by BDH Chemicals Ltd.
9. Cloning Vectors.
The vectors used for cloning purposes were pAT153 
and constructs based on the pUC plasmid series. Fig. 10 
shows the various vectors and a number of useful cloning 
sites.
Plasmid pAT153 is a aerivative of pBR322 (Bolivar 
et al., 1977), an E. coli plasmid carrying genes which 
confer ampicillin (ampf) and tetracycline (tet^) 
resistance. Plasmid pAT153 was generated by removal of two 
adjacent Hae II fragments between residues 1646 to 2351 
(Sutcliffe, 1978) from pBR322 DNA. The resultant plasmid 
retains both a m p r  and tet^ genes. Useful cloning sites on 
pAT153 are unique Bam HI and Sal I sites within the tet^ 
gene and a unique Xmn I site in the ampf gene (Fig. 10).
A more versatile plasmid series are the pUC vectors 
(Vieira and Messing, 1982). These plasmids comprise 
fragments from both pBR322 and M13mp bacteriophage vectors 
(Messing et al., 1981). The pBR322 segment consists of a 
Pvu II/Eco RI fragment (positions 2067 to 4362; Sutcliffe, 
1978) which carries the ampr gene and origin of 
replication; unique Hinc II, Pst I and Acc I sites were 
removed from this fragment by in vivo mutagenesis and Bal31
EcoRI Hind HI
Bom HI 
<  Sol IX m n l
pAT153
Xmnl
AMP
pUC9
•qc
imcs
Hind in Soli Smol 
1
Pst I  Bom HI EcoRI
Xmnl
AMP
pLWI
EcoRISm oI Bom HI EcoRI Hind HI
CAT
Figure 10. Details of plasmids used for cloning purposes. 
Locations of useful restriction enzyme sites, antiobiotic 
resistant genes (AMP, ampicillin and TET, tetracycline) and 
the N-terminal portion of ^-galactosidase (lac Z) are 
shown for each vector. The location of the multiple cloning 
site in pUC9 is shown by mes. The recognition sequence for 
Sal I in pUC9 is also cleaved by Hinc II and Acc I 
restriction enzymes. Fragments carrying promoter and 
chloramphenicol acetyltransferase sequences in pLWl are 
denoted by P and CAT respectively.
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digestion. From M13mp DNA, a Hae II fragment which carries 
the promoter and N-terminal portion of the ^ -galactosidase 
gene was inserted into the Hae II site at position 2352 on 
a mutagenised Pvu Il/Eco RI fragment. This N-terminal 
portion is able to complement a defective p-galactosidase 
encoded by the host bacterium thus generating 
p-galactosidase activity (Langley et al., 1975). Within 
the polypeptide coding region carried by the plasmid is a 
multiple cloning site (mes) which comprises a series of 
unique restriction enzyme cleavage sites. Cloning sites 
within pUC9 are shown in Fig. 10; pUC8 contains the same 
restriction enzyme sites but in reverse order to those of 
pUC9. p -galactosidase activity is detected by hydrolysis 
of an indicator dye, Xgal (Miller, 1972), which produces 
bacterial colonies that are blue in colour. Insertion of a 
fragment into the mes abolishes the ability to form the 
N-terminal portion of p-galactosidase resulting in a loss 
of enzyme activity, thus generating a colony which is 
white.
The final vector used for cloning, pLWl (a gift 
from J.L. Whitton), is based on the pUC plasmid series and 
contains a promoter fragment from HSV-2 IE gene-4/-5 linked 
to the polypeptide coding region of the bacterial CAT gene 
(Gaffney et al., 1985). The CAT gene fragment was cloned 
into the Acc I site of pUC8 to yield plasmid pUCgCAT and 
the promoter sequences inserted upstream from the CAT gene 
between the Bam HI and Sma I sites in pUCgCAT to yield 
pLWl; unique restriction enzyme sites in pLWl are shown in
Fig. 10.
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10. Additional Plasmids.
A number of other plasmids were used in this study 
for either stimulating the level of gene expresion or as 
experimental controls. Important features of these 
constructs are shown in Fig. 11.
Plasmid pPRVKpnh contains Kpn I h (constructed by 
A.J. Davison and supplied by R. Everett), a fragment which 
maps in the inverted repeat segment of PRV DNA (Davison and 
Wilkie, 1983a). This region of the PRV genome encodes at 
least one viral product, an IE protein of 180,000 mol. wt. 
(Ihara et al., 1983). Co-transfection with this plasmid 
stimulates transcription of plasmid-borne HSV genes and 
other viral and cellular promoters (Green et al., 1983; 
Impériale et al., 1983; Everett et al., 1984b), presumably 
as a result of expression of the PRV polypeptide(s).
Plasmid p p(244+)g contains two copies of the 
rabbit ^ -globin gene, inserted in the same orientation 
into pBR322 DNA; these two copies are separated by a 
fragment carrying the polyoma virus enhancer (de Villiers 
and Schaffner, 19dl). A Bst NI fragment from plasmid pRED4, 
which contains the HSV-i gD promoter region fused to the 
rabbit ^ -globin structural gene, was used as a DNA probe 
to detect mRNA produced from plasmid p ^(244+)^ (see Fig.
11). These plasmids were gifts from R. Everett.
Plasmid pLW2 contains promoter and CAT fragments as 
describee for pLWl in the previous section and in addition, 
downstream from the CAT gene, a lOObp Sma l/Xba I fragment 
which includes the sequences flanking the poly A site of
pPRVKpnh
Kpn I  h
[ V/PRV
IV S 2IVS1
P-globin
Bst NI Bst NI
P-globin
PPTERI
P-globin
Figure 11. Details of plasmids used in transfection 
experiments. In all plasmids, cloning vector sequences are 
shown by a solid line and fragments inserted into vectors 
by boxed regions; boxed regions which contain a cross 
represent exons of the rabbit p -globin gene. Locations of 
antiobiotic resistance genes (AMP, ampicillin and TET, 
tetracycline) are indicated for each plasmid.
A) The location of Kpn I h, a terminal fragment, is shown 
within the short (S) segment of the PRV genome.
B) The fragment carrying the polyoma virus enhancer is 
shown by the shaded region. The structure of |3 -globin mRNA 
is indicated with the positions of intervening sequences 
(IVS 1 and IVS 2) within ^ -globin mRNA shown by dashed 
lines.
C) The dark area shows the position of the HSV-1 gD mRNA 
promoter region. Also indicated is the Bst NI fragment used 
as a DNA probe in hybridisations with p ^ (244+)^ mRNA.
D) The dark area indicates the fragment carrying CAT 
coding sequences and the stippled region represents the 
promoter region from HSV-2 IE mRNAs-4/-5. Plasmid p^TERl 
contains only a portion of the second exon and a complete 
copy of the third exon of the rabbit ^  -globin gene. The 
proposed structure of CAT mRNA from p ^ TERl is indicated, 
however, it should be noted that structural analysis of 
this transcript has not been performed.
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HSV-2 IE mRNA-5. The arrangement of DNA fragments in pLW2 
is identical to that in plasmid pTERS (see Fig. 66).
Plasmid pLW2 was a gift from J.L. Whitton.
Plasmid p g, TERl contains a 125(Jbp Bam Hl/Xho I 
fragment from the 3' portion of the rabbit p-globin gene 
(Banerji et al., 1981), inserted downstream from the CAT 
gene in pLWl. These -globin sequences include all of the
IVS 2 sequences and 600bp of flanking DNA. This plasmid was
a gift from D. Gaffney.
11. Bacterial Hosts for Plasmids.
The host bacterium for pAT153 was E. coli K12 
strain HBlOl (ramClF“Pro“Gal“Str^Rec“ ; Boyer and 
Roulland-Dussoix, 1969).
The host bacterium for the pUC plasmids and their 
derivatives was E. coli K12 strain JM83 (ara, l a c - p r o ^ e l ,  
strA, thi, ^BOdlacMlsdel; Messing, 1979) a p-galactosidase 
deficient strain which contains a phage encoding the 
^-peptide of the enzyme integrated into the chromosome.
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SECTION B .
METHODS
12. Virus Growth and Assay.
BHK-C13 cells in 8 5 0 c m 2  roller bottles were 
infected with HSV-2 strain HG52 at a multiplicity of 
infection (moi) of 1 plaque forming unit (pfu) per 350 
cells. Infected cells were maintained in 20ml of ETCIO for 
3 to 4days at 31^0. Procedures for the harvesting of virus 
from infected cells were performed at 4°c. Cells were 
removed by gentle shaking and pelletted in the cold by 
centrifugation at ISOOrpm for lOmin. The supernatant was 
removed and centrifuged at 12,000rpm for 2h. The resultant 
pellet was resuspended in approximately 5ml of ETC 10 and 
stored at -70°C as cell released virus (CRV). The pelletted 
material from the initial low speed centrifugation was 
resuspended in an equal vol of ETC 10 and the suspension 
sonicated. Following removal of cell debris by 
centrifugation at 3000rpm for 15min, the supernatant was 
recovered and stored at -70°C as cell associated virus 
(CAV).
Both CRV and CAV fractions were titrated for 
infectious virus by determining the number of pfu in serial 
dilutions of virus preparations (Brown et al., 1973).
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13. Standard Procedures.
A number of procedures were used routinely which 
are referred to in various sections; the following is a 
description of these procedures.
a) Restriction enzyme digestion of DNA.
DNA was cleaved at 370^ or, in certain cases, at 
65°C (for example, digestion with Bst Eli) for Ih to 4h. 
Digests were performed in Ix core buffer (see Page 96), 
except for digestions with Sma I which were carried out in 
15mM Tris HCl (pH 8.0), 6mM MgCl2 and 15mM KCl.
b) Phenol/chloroform extraction.
Proteins and ethidium bromide were removed by 
addition of an equal vol of phenol/chloroform (Ivol: Ivol) 
which had been equilibrated three times with either TE or 
water. The mixture was shaken and the phases separated by 
centrifugation at either 3000rpm for 5min or 12,000rpm for 
Imin. The top (aqueous) layer was then removed and either 
re-extracted or ethanol precipitated. Frequently, a final 
extraction with an equal vol of chloroform was performed to 
remove phenol from the aqueous layer prior to ethanol 
prec ipi tat ion.
c ) Precipitation of nucleic acid.
DNA and RNA were precipitated by the addition of 
3vol of Analar ethanol and l/20thvol of 5M NaCl followed by 
incubation at -20Oc for 16h or in dry ice for a minimum of
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5min. Alternatively, an equal vol of isopropanol was added 
to precipitate DNA and the mixture incubated at room 
temperature for 15min to 25min. Nucleic acid was recovered 
by centrifugation at either 12,000rpm for 5min or 7,000rpm 
for 15min and the pellet was washed with 70% ethanol prior 
to drying.
d) Visualisation of non-radioactive nucleic acid.
Ethidium bromide, an intercalating agent, was used 
for staining non-radioactive DNA and RNA. Agarose and 
acrylamide gels were soaked in a solution of 0. 5yig/ml 
ethidium bromide and bands were visualised by transmitted 
UV light. For preparative samples, long wave UV light was 
used which could detect lOng of DNA. For analytical 
samples, short wave UV light was utilised, allowing 
detection down to 2ng of DNA. Both sucrose and CsCl 
gradients contained ethidium bromide and bands were 
visualised under long wave UV light.
e) Visualisation of radiolabelled DNA and 
chloramphenicol.
Gels containing radiolabelled DNA and TLC plates 
containing chloramphenicol were covered with Clingfilm
and the surface of the Clingfilm was washed with 70% 
ethanol. Kodak XS film was pre-flashed, laid on top of the 
Clingfilm and covered with an intensifying screen. The fil 
was exposed at -70oc (for long exposures) or at room 
temperature (for short exposures).
m
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f) Recovery of DNA fragments from polyacrylamide gel 
slices.
Gel slices were extruded through a 0.7ml reaction 
tube, punctured by a 23 gauge hypodermic needle, into a 
1.5ml reaction tube by centrifugation at 12,000rpm for 
lOsec. 2vol of H2O were added, the mixture vortexed and 
incubated at 420c for 16h. DNA was recovered by filtration 
through glass wool to remove polyacrylamide followed by the 
addition of ethanol and salt to the eluate.
g) Removal of DNA from gradients.
Bands were recovered from gradients by puncturing 
the side of the centrifuge tube with a 23 gauge hypodermic 
needle and DNA was removed by a syringe attached to the 
needle.
14. Gel Electrophoresis.
a) Non-denaturing agarose gels.
Profiles of DNA cleaved with restriction enzymes 
were oDtained with these gels from which maps for DNA 
fragments were constructed. The concentration of gels 
varied from 0.6% to 1.2% (w/v) agarose dissolved in Ix TBE 
buffer and gels also contained 0.5^g/ml of ethidium 
bromide. Samples were applied in Ix TBE, 10% (w/v) sucrose, 
0*02% (w/v) bromophenol blue and xylene cyanol. Gels (260mm 
X 160mm) were electrophoresed in horizontal kits up to a 
maximum voltage of 12V/cm.
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b) Denaturing agarose/formaldehyde gels.
RNA species separated by these gels were 
subsequently transferred to nitrocellulose paper. The 
concentration of gels was 1.5% and agarose was dissolved in 
Ix MOPS buffer containing 2. 2M formaldehyde. Samples were 
prepared as described on Page 116. Gels (190mm x 160mm) 
were electrophoresed in vertical kits at 4v/cm for about 6h 
and thereafter stained with ethidium bromide prior to 
transfer to nitrocellulose paper.
c ) Low melting point agarose gels.
These gels were used to obtain fragments of at 
least SOObp for cloning purposes. The concentration of gels 
was 1% and agarose was dissolved in Ix TAB buffer. Gels 
(260mm x 160mm) were electrophoresed in horizontal kits at 
a maximum voltage of 7.5V/cm.
d) Non-denaturing polyacrylamide gels.
DNA fragments of less than Ikbp were analysed on 
polyacrylamide gels which were prepared as described by 
Maniatis et al. (1975).
A stock of 30% (w/v) polyacrylamide (acrylamide:
75m^ of
bisacrylamide, 29:1) was diluted to 6% ^n^lx TBE buffer. 
Polymerisation was effected by addition of 0.5ml of 10%
(w/v) ammonium persulphate along with 50^1 of TEMED.
Samples were prepared as described on Page 105 and gels 
(1mm X 160mm x 260mm) were electrophoresed in vertical kits 
'Jp to a maximum voltage of 16V/cm.
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e) Strand-separation polyacrylamide gels.
The strands of end-labelled DNA fragments were 
separated using gels which were prepared as described in 
the previous section with the following modifications. The 
ratio of acrylamide: bisacrylamide was adjusted to 59:1 and 
the gels (1mm x 230mm x 450mm) were electrophoresed in the 
cold at lOV/cm. Samples were prepared by dissolving 
pelletted DNA in 30% (v/v) DMSO and ImM EDTA followed by 
heating to 9QOC for 3min. Prior to loading onto the gel, 
samples were chilled in ice.
f) Denaturing polyacrylamide gels.
These gels were used to determine the nucleotide 
sequences of DNA fragments and the lengths of DNA/RNA 
hybrids following nuclease digestion. Gels were prepared as 
described by Maxam and Gilbert (1980).
A stock of 30% (w/v) polyacrylamide (acrylamide: 
bisacrylamide, 29:1) was diluted to a range of 
concentrations from 6% to 16% in Ix TBE buffer containing 
9M urea. Following polymerisation, gels (0.35mm x 230mm x 
450mm) were pre-run at 40W for Ih before the samples were 
loaded. Samples, dissolved in 90% (v/v) formamide, 0.1%
(w/v) bromophenol blue and xylene cyanol, were heated to 
90°C for 3min and chilled rapidly in ice prior to loading 
onto the gel. Gels were electrophoresed in vertical kits at 
40W.
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15. preparation of Plasmid DNA.
10ml of L-Broth supplemented with 100/ig/ml 
ampicillin was inoculated with a loop of bacteria 
containing the appropriate plasmid and the culture was 
incubated overnight at 370c. This culture was used to seed 
SÜOml to 1600ml of L-Broth containing ampicillin which was 
shaken vigorously for 6h to Bh at 37oc. Plasmids were 
amplified (Clewell, 1972) by the addition of 
chloramphenicol to 5Uyig/ml and the culture was maintained 
overnight at 370c.
Plasmid DNA was purified essentially by the 
'boiling' method (Holmes and Quigley, 1981). Bacteria were 
recovered by centrifugation at BOOOrpm for lOmin and 
resuspended in 30ml of STET followed by the addition of 4ml 
of freshly prepared lysozyme (lOmg/ml). The suspension was 
boiled for approximately Imin and cell debris removed by 
centrifugation at 15,000rpm for Ih. Plasmid DNA in the 
supernatant was precipitated with isopropanol and pelletted 
by centrifugation at 3000rpm for 15min. The pellet was 
resuspended in 10.5ml of H2O followed by the addition of 
llg of caesium chloride and 0.5ml of ethidium bromide 
(lOmg/ml). DNA was banded in a Ti50 angle rotor for 3days 
at 40,000rpm after which plasmid DNA was visualised under 
long wave UV light and recovered as described on Page 105. 
Ethidium bromide was removed by extraction with an equal 
vol of n-butanol which had been previously equilibrated 
with TE and DNA was dialysed against H20 for at least 7h. 
Samples were treated with 5C^g/ml RNase A at 6OOC for Ih
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and thereafter with 50/ig/ml proteinase K at 370c in the 
presence of 0.1% (w/v) SDS, again for Ih. These enzymes 
were removed by phenol/chloroform extraction and the DNA 
was ethanol precipitated twice. Finally, the DNA was 
pelletted, dried and dissolved in H2O; the concentration of 
DNA was estimated by spectrophotometry.
16. jjp-labelling of DNA Fragments.
a) Nick-translation.
Cleaved DNA was radiolabelled (Rigby et al., 1977) 
by addition of 1/iCi of all four [oC-32p] dNTPS and 2units 
of E. coli DNA polymerase I. The mixture was left at room 
temperature for 30min and the sample applied to a 
polyacrylamide gel. The appropriate radiolabelled band was 
recovered following visualisation by autoradiography.
b) 5* end-labelling.
DNA was digested with the appropriate restriction 
enzymes in 20Qpl and then loaded onto a pre-formed 5% to 
20% (w/v) sucrose gradient containing STES and 0.5^g/ml 
ethidium bromide. Samples were centrifuged for 16h at 
30, OOOrpm in an AH650 swing-out rotor. The banded DNA was 
recovered and ethidium bromide removed by extraction with 
phenol/chloroform. DNA was precipitated by the addition of 
3vol of ethanol and the mixture incubated at -2QOc for at 
least 16h. The DNA was pelletted, dried and dissolved in 
40^ 1 of H2O. Core buffer was added along with 20units of
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calf intestinal alkaline phosphatase and the sample 
incubated at 3V®C for Ih. Phosphatase was removed by three 
extractions with phenol/chloroform and the DNA was ethanol 
precipitated. Following recovery of DNA, the pellet was 
dissolved in a total vol of 3 0^1 containing 50mM Tris HCl 
(pH 7.6), lOmM MgCl2, 5mM DTT, 50 to lOO^Ci of [ y -32p ] r^pp 
and 5units of T4 polynucleotide kinase. After incubation at 
370c for Ih, DNA was either loaded directly onto a 
polyacrylamide gel or precipitated by the addition of 200^1 
of 2.5M ammonium acetate and 3vol of ethanol. Precipitated 
DNA was denatured and applied to a strand-separation gel 
(see Page 107).
c ) 3' end-labelling.
Digested DNA was 3' end-labelled by the addition of 
10/iCi of the appropriate [c^-32p] dNTP(s) along with 4units 
of large fragment DNA polymerase I. The mixture was 
incubated at room temperature for 30min after which the 
sample was either loaded onto a polyacrylamide gel or 
cleaved with a second restriction enzyme. Prior to 
recleavage, enzymes in the radiolabelled sample were 
inactivated by heating to 65°C for lOmin followed by rapid 
cooling in ice. The second enzyme was added and the DNA 
digested before application to a polyacrylamide gel.
17. Production of Deletions in Plasmids.
Digested DNA was purified by phenol/chloroform 
extraction and ethanol precipitation. DNA was resuspended
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in a small vol (ll/il) containing lOmM Tris HCl (pH 8.0),
50mM NaCl, 3mM MgCl2 and ImM ^-mercaptoethanol along with 
32units of exonuclease III. The mixture was incubated at 
22.50c and 4/al aliquots were removed after Imin, 4min and 
8min. Ipl of 5x Mung bean nuclease buffer (IM NaCl, 5mM 
ZnCl2, 150mM NaAc, pH 5.0) along with lOunits of Mung bean 
nuclease were added to each aliquot and samples were 
digested at 370c for lOmin. DNA was purified by 
phenol/chloroform extraction and by ethanol precipitation. 
The extent of deletions was analysed by cleaving a portion 
of each sample with a second restriction enzyme followed by 
electrophoresis on a polyacrylamide gel alongside standard 
size markers. Samples which appeared to contain deletions 
of the required length were pooled, ligated and transfected 
into competent bacteria.
18. DNA Sequencing.
The nucleotide sequences of DNA fragments, uniquely 
end-labelled at a restriction enzyme site, were determined 
by the chemical degradation procedures of Maxam and Gilbert 
( 1977 and 1980).
Chemical degradation of DNA fragments was performed 
in two steps. Firstly, DNA bases were specifically modified 
or removed by chemical reagents. Specifically, guanine 
residues were methylated using dimethyl sulphate and a 
bepurination mix containing diphenylamine and formic acid 
removed purine bases. For pyrimidines, hydrazine was used 
to open thymine and cytosine rings; C-specific reactions
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were performed in the presence of salt as, under these 
conditions, hydrazine reacts appreciably with only cytosine 
residues. Reactions were performed at 250c for periods 
which varied between 4min to 12min. Under these conditions, 
the chemical reactions do not reach completion, generating 
a series of molecules which have bases modified at random 
sites on the DNA fragments. The second step required 
reaction with IM piperidine at 9QOc which removes both 
altered bases and phosphate residues resulting in cleavage 
of the DNA backbone. Thus, a population of cleaved DNA 
molecules was generated which varied in length but were 
labelled at an identical site. Fragments resulting from 
each base-specific reaction were ry^ n in separate lanes on a 
denaturing polyacrylamide gel, producing a ladder of bands 
from which the DNA sequence was determined.
19. Ligation of DNA Fragments.
DNA fragments were produced for ligations by 
cleavage with restriction enzymes or digestion with Mung 
bean nuclease. Restriction enzyme digestion generated 
termini with either a single-stranded 5' overhang or a 
blunt-end. Alternatively, blunt-ended DNA fragments were 
produced by 'filling-in' the 5' overhang using all four 
dNTPs along with 4units of large fragment DNA polymerase I 
ând incubating the mixture at room temperature for 15min. 
Mung bean nuclease treatment of DNA also generated 
blunt-ended fragments.
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DNA fragments were ligated to a cleaved plasmid 
vector which contained termini compatible with those of the 
fragments. The fragment and vector were mixed in a 10:1 
ratio and incubated overnight at IS^C in ligation buffer 
consisting of 66mM Tris HCl (pH 7.6), 6.6mM MgCl2, lOmM DTT
and 0.4mM ATP along with 2units of DNA ligase.
20. Ligation in Low Melting Point Agarose.
DNA fragments excised from low melting point 
agarose gels did not require removal from gel slices for 
ligation purposes. Gel slices, containing DNA fragments to 
be ligated, were mixed and an equal vol of H2O was added. 
The mixture was heated to 65°C until the agarose melted, at 
which point the sample was cooled to 37°C. Ligation buffer 
and 2units of DNA ligase were added and the sample was 
incubated overnight at IS^c.
21. Preparation of Competent Bacteria.
lOUml of L-Broth was seeded with 2ml of an 
overnight culture of bacteria and the bacteria were grown 
at 370c with vigorous aeration until the O.D.55Q reached 
0.2. Following incubation in ice for lOmin, bacteria were 
pelletted by centrifugation at 7,OOOrpm for lOmin. The 
pellet was resuspended in 40ml of ice-cold 50mM CaCl2 and 
left on ice for a further 20min. Bacteria were pelletted 
again and taken up in 4ml of 50mM CaCl2 and this mixture 
left on ice overnight. Bacteria treated in this way were 
stored for up to 5days in ice and used for transformation 
by plasmid DNA.
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22. Transformation of Bacteria by Plasmid DNA.
Plasmid DNA was added to lOOpl to 200^1 of 
competent bacteria, the mixture was vortexed and left on 
ice for 40min. After heating the sample to 370c for 3min, 
70/il aliquots were spread onto L-Broth agar plates 
containing ampicillin and incubated overnight at 370c. For 
ligations performed in low melting point agarose, CaCl2 was 
added to a final concentration of 50mM to the ligation 
mixture prior to addition to competent bacteria.
Selection of pUC plasmids containing inserted 
fragments was facilitated by spreading 100^1 of 2.5% (w/v 
in dimethylformamide) Xgal onto plates before spreading the 
transformation mixture.
23. Preparation of DNA by 'Minilysis'.
2ml of L-Broth containing ampicillin was inoculated 
with a colony of bacteria and the culture grown at 370c for 
a minimum of 6h. Bacteria from half of the culture were 
pelletted by centrifugation at 12,OOOrpm for 30sec. The 
pellet was resuspended in 20(^1 of STET and 2(^1 of 
lysozyme (lOmg/ml) added. The mixture was heated in a 
boiling water bath for 40sec and then centrifuged at 
12, OOOrpm for lOmin. An equal vol of isopropanol was added 
to the supernatant to precipitate plasmid DNA. Following 
recovery of the DNA by centrifugation, the pellet was 
dissolved in 30(^1 of H2O and phenol/chloroform extracted. 
The DNA was ethanol precipitated, restricted with the 
appropriate restriction enzyme(s) and run on either agarose
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or polyacrylamide gels. Large scale preparations were 
produced from colonies containing the desired plasmids by 
seeding L-Broth with the remainder of the original 
bacterial culture.
24. DNA-mediated Transfer into Tissue Culture Cells by 
CaP04 Precipitation.
DNA transfections into HeLa cells were performed 
essentially as described by Wigler et al. (1978) and
Corsalo and Pearson (1981).
15^g of plasmid DNA was dissolved in 42(^1 of TE 
and 60^1 of 2M CaCl2 was added dropwise with constant 
agitation. For transfections which required the use of 
additional plasmids either as controls or for 
trans-activation, lOpg of the appropriate construction was 
added to the TE. This mixture was then added dropwise with 
constant agitation to 480pl of 2x HBS and the precipitate 
allowed to form at room temperature for 30min. This 
solution was pipetted dropwise onto 90mm Petri dishes 
containing HeLa cells at approximately 30% confluency which 
were then incubated at 37^0. The medium was replaced 24h 
after addition of the CaPO^ precipitate with fresh medium 
and cells were incubated at 37®C for a further 24h. For 
virus infection of transfected cells, the medium was 
removed after 24h and virus added in 5ml of fresh medium. 
Following adsorption at 370^ for Ih, a further 10ml of 
fresh medium was added and cells were harvested at the 
appropriate time p.i.
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25. Preparation of Cytoplasmic RNA.
Cytoplasmic RNA was prepared from 90mm Petri dishes 
by a modification of the Kumar and Lindberg (1972) method.
Following removal of medium, cells were washed with 
5ml of cold PBS and then harvested by scraping into 3.5ml 
of PBS. Cells were recovered by centrifugation in the cold 
at 2000rpm for 2min. The pellet was washed with a further 
4ml of PBS and centrifugation was repeated. Cells were 
carefully resuspended in 0.3ml of cold isotonic lysis 
buffer (ILB) and left on ice for 4min. Nuclei were 
separated from components of the cytoplasmic fraction by 
centrifugation in the cold at 3000rpm for 5min. Following 
addition of an equal vol of phenol extraction buffer (PEB), 
the mixture was extracted three times with
phenol/chloroform and once with chloroform. Cytoplasmic RNA 
was precipitated by the addition of 3vol of ethanol and 
incubation overnight at -2QOc. RNA was recovered by 
centrifugation, dissolved in 20(^1 of H2O and re-ethanol 
precipitated. Finally, RNA was pelleted, dried and 
dissolved in 3t)pl of H 2O. The concentration of RNA was 
estimated by spectrophotometry.
26. Northern Blot Analysis.
RNA was transferred to nitrocellulose paper and 
hybridised with radiolabelled DNA essentially as described 
by Spandidos and Paul (1982).
Cytoplasmic RNA was dissolved in SOj àI of Ix MOPS 
buffer which contained 50% (v/v) formamide and 2.2M
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formaldehyde and the mixture heated to 650c for 2min.
Sucrose was added to a final concentration of 10% (w/v) and 
the sample applied to a 1.5% denaturing 
agarose/formaldehyde gel (see Page 106). Following 
electrophoresis, the gel was shaken gently in 1 to 2vol of 
20x SSC for 40min at room temperature and RNA was blotted 
onto nitrocellulose paper for 16h using lOx SSC. The 
nitrocellulose filter was washed with 6x SSC, dried in air 
and baked at 80OC for 2h under vacuum.
Prior to hybridisation with a radiolabelled DNA 
probe, the nitrocellulose filter was soaked in 6x SSC, 5x 
Denhardt's solution, 0.1% (w/v) SDS and 20pg/ml of 
denatured calf thymus DNA at 68°C for 6h. The DNA probe was 
denatured in 90% (v/v) formamide by heating to 90°C for 
3min followed by rapid cooling in ice. Hybridisation of the 
DNA probe to the nitrocellulose filter was performed 
overnight at 6 8 ^ C in 6x SSC, lOx Denhardt's solution, 20mM 
Tris HCl (pH 7.5), ImM EDTA, 0.5% (w/v) SDS and 5(^g/ml of 
denatured calf thymus DNA.
Following hybridisation, the nitrocellulose filter 
was washed four times in 2x SSC, 0.2% (w/v) SDS at 680C for 
4h. The filter was then dried and autoradiographed. mRNA 
sizes obtained with this technique are inaccurate as the 
poly A"*" mRNAs transferred to the nitrocellulose paper 
contain tracts of adenosine residues at their 3' termini.
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spliced and unspliced^ GO transcripts. Thin lines indicate
and thicker lines present DNA. Regions of DNA, which do 
not hybridise to mature mRNA due to RNA splicing, are 
nted by loops. Closed circles indicate the DNA 
termini (either 5* 3, termini) which are r a d i o l a b e l i ^ d .
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27. Structural Analysis of mRNAs.
Structural analysis of mRNAs was performed using 
the nuclease 81 procedure of Berk and Sharp (1978a, b), 
modified by using either 5'- or 3'-labelled DNA probes 
instead of uniformly-labelled DNA (Weaver and Weissmann, 
1979). The rationale of this technique is that RNA 
hybridises to stretches of DNA containing complementary 
sequences in the presence of salt. Regions of nucleic acid 
which do not form a double-stranded hybrid can be removed 
by nuclease digestion and the length of the stable hybrid 
determined by electrophoresis alongside standard size 
markers. Nucleases used in this study were nuclease 81 and 
exonuclease VII. Nuclease 81 degrades single-stranded 
nucleic acid to yield 5' phosphoryl mono- or 
oligonucleotides (Vogt, 1973). The enzyme also removes 
looped regions generated by hybridisation of genomic DNA to 
spliced mRNA (see Fig. 12). Exonuclease VII digests the 5' 
and 3 ' termini of single-stranded DNA (Chase and 
Richardson, 1974), therefore looped regions of DNA are not 
substrates for this nuclease (see Fig. 12). The enzyme 
releases short oligonucleotides and has a preference for 
digestion at T residues. 8ubsequently, digestion products 
frequently do not contain flush-ended termini and as a 
result, exonuclease Vll-treated hyrids are frequently 
larger than nuclease 81-digested hybrids. By end-labelling 
DNA fragments at unique restriction enzyme sites, precise 
locations for mRNA termini and splice sites within regions 
of DNA can be determined. To position mRNA 5' termini and
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splice acceptor sites, 5' end—labelled DNA probes are 
utilised. Similarly, 3' end-labelled DNA probes locate mRNA 
3' termini and splice donor sites.
End-labelled DNA fragments were co-precipitated 
with 20pg to 30^g of cytoplasmic RNA and the pellet 
resuspended in 20pl of 90% (v/v) formamide (deionised with 
Amberlite monobed resin MB-1), ^OOmM NaCl, 40mM PIPES (pH 
6.8) and ImM EDTA for double-stranded DNA probes. For 
single-stranded DNA probes, the total vol was increased to 
30^ 1 and the formamide concentration adjusted to 50%. The 
mixture was heated to 9QOc for 3min and then incubated for 
16h at 56°C for double-stranded DNA probes and at 42°C for 
single-stranded DNA probes. Prior to nuclease treatment, 
hybridisation mixtures were quenched in ice.
Nuclease SI digestion was performed at 3QOc for 2h 
to 3h in 300pl of 400mM NaCl, 40mM sodium acetate pH 4.5,
ImM ZnS04 with SOOOunits of nuclease SI. Exonuclease VII 
treatment was performed at 3?oc for Ih in 200pl of 6.7mM 
potassium phosphate (pH 7.9), 8.3mM EDTA, lOmM 
P-mercaptoethanol along with 0.5units of exonuclease VII. 
Following phenol/chloroform extraction and ethanol 
precipitation, nuclease-resistant hybrids were analysed by 
denaturing polyacrylamide gel electrophoresis.
28. CAT Assays.
Cell extracts were prepared and CAT assays 
performed essentially as described by Gorman et a1. (1982).
Firstly, media was removed and the cell sheet
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washed with 5ml of cold PBS. Cells were scraped into 3.5ml 
of TEN and pelletted by centrifugation at 2,OOOrpm for 
2min. The pellet was resuspended in 200pl of 250mM Tris HCl 
(pH 7.8) and the cells were sonicated. Following removal of 
cell debris by centrifugation at 12,OOOrpm for 5min, the 
supernatant was frozen at -20Oc for periods of up to 
several months without an appreciable loss in CAT activity.
Levels of CAT activity were measured by incubating 
aliquots from cell extracts in a mixture containing ImM 
acetyl CoA, 250mM Tris HCl (pH 7.8) and 0.12^Ci 
chloramphenicol ( 68nmoles//iCi ) at 370C. Aliquots were 
removed at various times, extracted with 200pl of ethyl 
acetate and the organic phase was dried down. ^^C 
chloramphenicol was resuspended in 30pl ethyl acetate and 
spotted onto 0.25mm silica gel thin layer chromatography 
plates. Ascending chromatography was performed in 95% 
chloroform: 5% methanol (v/v), after which chromatograms 
were autoradiographed to visualise the acetylated and 
non-acetylated forms of chloramphenicol. The percentage 
conversion to acetylated chloramphenicol was calculated
by removing spots from chromatograms and counting in a 
scintillation counter. CAT activities were normalised by 
measuring the protein content of each extract which allowed 
calculation of specific activities for the CAT enzyme.
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29. Measurement of Protein Content.
The protein content of cell extracts was determined 
as described by Bradford (1976). The assay is based on the 
ability of protein to bind to Coomassie Brilliant Blue 
G-250 under acidic conditions and thereby shift the 
absorbance maximum of Coomassie Blue from 465nm to 595nm.
Following the addition of 5m1 of dye reagent to 
lOOyil aliquots of cell extracts, the mixture was incubated 
at room temperature for 5min and the absorbance of each 
sample was read at O.D.595. To estimate the protein content 
in cell extracts, various concentrations of BSA ranging 
from 0 to 7OOpg/ml were prepared in 250mM Tris HCl (pH 7.8) 
and dye reagent was added. A standard curve was derived 
from O.D.595 values of the protein standards allowing the 
protein content of extracts to be determined.
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SECTION C .
COMPUTER ANALYSIS OF SEQUENCES
31. Computer Programs.
During the course of this work, all nucleotide 
sequence data was stored in a Digital Research PDP-11/44 
computer using the RSX-llM operating system. Interpretation 
of this data was made possible by the availability of the 
following programs designed and/or modified by Dr. P.
Taylor.
1) BASES. The frequency of occurrence of a particular base 
could be counted either for an entire nucleotide sequence
or at specified positions within the sequence.
2) PROFIL. A plot of the hydropathicity of protein 
sequences was produced. The range within which the 
hydropathicity of amino acid residues was determined, could 
be defined by the operator.
3) SEQLIST. Sequences were listed and numbered in blocks 
of 10 residues.
4) PTRANS. Amino acid sequences were predicted from a 
nucleotide sequence. Positions at which translation started 
and ended were determined by the operator. In addition, 
tables presenting the amino acid content and codon usage 
within a translated region were produced.
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5) CINTHOM. A program for comparing sequences with the 
homology displayed on a graph. The similarity between 
sequences was plotted as an uppercase or lowercase letter 
of the alphabet with A representing the highest homology 
(100%) and z denoting the lowest homology. Areas with 
conserved sequences formed a diagonal on the graph and 
insertions/deletions between two sequences were identified 
by diagonals which, when extrapolated, crossed the x- and 
y-axes at different points. The range of sequence to be 
compared and minimum level of homology were set by the 
operator.
6) HOMOL. Sequences could be aligned and gaps inserted in 
order to maximise homology. By varying the parameters, the 
number and size of gaps allowed could be altered.
7) SEARCH. The locations and numbers of cleavage sites for 
a wide range of restriction enzymes within a nucleotide 
sequence could be analysed.
8) HAIRPN. Nucleotide sequences were analysed for the 
presence of inverted repeats which could form a stem and 
loop structure. Parameters for the minimum and maximum 
sizes of stems and loops were set by the operator.
RESULTS AND DISCUSSION
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Figure 13. Arrangement and orientation of mRNAs on the 
HSV-1 genome between 0.52 to 0.60 map units. Also indicated 
are leftwards-transcribed species which do not map entirely 
within this region and the locations of Hind III and Bam HI 
restriction enzyme sites for this portion of HSV-1 DNA. The 
5.Okb and 1.2kb mRNAs correspond to transcripts labe1led 
RRl and RR2 in Fig. 4. Restriction enzyme fragments shown 
on the diagram are; Hind III k (0.520 to 0.587 map units); 
Bam HI 3 ' (0.566 to 0.572 map units); Bam HI o (0.572 to
0.599 map units).
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SECTION A .
1. Identification of the mRNAs Spanning the Bgl II c and 
Bql II n Fragments.
The HSV-1 locus between 0.54 and 0.60 map units 
specifies a family of four nested mRNAs (Fig. 13) which 
comprises two early and two late transcripts (Anderson ejt 
, 1981; McLauchlan and Clements, 1982 and 1983a). The 
early mRNAs have sizes of 5.Okb and 1.2kb which encode 
polypeptides of 136,000 mol. wt. (Vmwl36) and 38,000 mol. 
wt. (Vmw38) respectively; these mRNAs are unspliced and 
share a common 3 ' terminus. The late mRNAs, which have 
sizes of 7.Okb and 1.9kb, are presumed to be 5' co-terminal 
and encode the same 54,000 mol. wt. protein. The 7.Okb mRNA 
also appears to be 3' co-terminal with both early mRNAs.
The functions encoded by the HSV-1 and HSV-2 
genomes are essentially colinear (see Introduction, Page
11). Therefore, to identify transcripts in the equivalent 
HSV-2 genomic region, a nick-translated Bgl Il/Bam HI 
fragment from 0.580 to 0.583 map units, which is located at 
the left-hand end of the Bgl II n transforming region (Fig. 
14), was hybridised to a Northern blot containing HSV-2 
early mRNA. Two bands with approximate sizes of 5.4kb and 
1.5kb were detected and the 1.5kb mRNA species was 
approximately five times more abundant; an additional band 
of 6.6kb was observed on prolonged exposure (Fig. 14). 
Jenkins et al. ( 1982) have detected mRNA species with 
similar sizes using radiolabelled Bgl II n. Since mRNA
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Figure 14. Identification of mRNAs located within the 
left-hand portion of HSV-2 Bgl II n. The Northern blot 
contains 20fig of HSV-2 early cytoplasmic RNA and the
location of the DNA probe, a nick-translated Bgl Il/Bam HI
fragment (0.580 to 0.583 map units), within Bgl II n is
indicated. The sizes of mRNAs are shown with respect to 28S
and IBS ribosomal RNA markers.
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Figure 15. Locations of the cleavage sites for a number of 
restriction enzymes within HSV-2 Bam HI fragments e and t 
(0.54 to 0.61 map units). The locations of these Bam HI 
fragments on the HSV-2 genome with respect to HSV-2 
transforming regions, Bgl II c and n, are shown.
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sizes obtained with Northern blot analysis are inaccurate 
(see Methods, Page 117), nuclease digestion techniques were 
utilised to obtain more accurate size estimates and to 
study mRNA structures.
2. structural Analysis of mRNAs.
For nuclease digestion analysis, two Bam HI 
fragments. Bam HI e and ;t, which span the region from 0.54 
to 0.60 on HSV-2 DNA, were separately cloned into the Bam 
HI site of pAT153. Restriction enzyme cleavage sites in Bam 
HI e and t used to produce DNA probes are shown in Fig. 15.
a) An unspliced mRNA of 1.2kb corresponds to the 1.5kb 
species.
The Bgl Il/Bam HI fragment, used in Northern blot 
analysis, was uniquely 5 '-labelled at the Bam HI site and 
hybridised to infected and mock-infected cell RNAs. The 
resultant hybrids were digested with nuclease SI and 
electrophoresed on a 6% denaturing polyacrylamide gel. A 
band of 143nuc was detected with infected cell RNA only 
(Fig. 16A, track 1), thus the 5' portion of a 
rightwards-transcribed mRNA is located within this 
fragment. The 5' portion of this mRNA was analysed further 
using Bam HI e, 5 '-labelled at both ends. A nuclease 81 
product of 143nuc and an exonuclease Vll-resistant product 
of 148nuc were detected (Fig. 16B, tracks 2 and 4); the 
small size difference between these protected fragments is 
due to the processive nature of exonuclease VII activity
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Ficfure 16. Structural analysis of the 1. 2kb mRNA.
A) Location of the 5' terminus of the 1.2kb transcript 
within the left-hand portion of Bgl II n. The DNA probe was 
a Bgl Il/Bam HI fragment, as indicated on the diagram 
(0.580 to 0.583 map units), which was 5'-labelled at the 
Bam HI site. RNA samples used were; track 1, HSV-2 early 
infected cell cytoplasmic RNA; track 2, mock-infected 
cytoplasmic RNA.
B) Analysis of the 5' portion of the 1.2kb mRNA. The DNA 
probe was Bam HI e (see Fig. 15), 5 '-labelled at both Bam 
HI sites. RNA samples used were: tracks 2 and 4, HSV-2 
early infected cell cytoplasmic RNA; tracks 1 and 3, 
mock-infected cytoplasmic RNA.
C) Analysis of the 3' portion of the 1.2kb mRNA. The DNA 
probe was a Bam Hl/Xho I fragment derived from Bam HI ;t, 
3'-labelled at the Bam HI site. The location of the probe 
within Bam HI ;t is indicated on the diagram. RNA samples 
used were: tracks 2 and 4, HSV-2 early infected cell 
cytoplasmic RNA; tracks 1 and 3, mock-infected cytoplasmic 
RNA.
After hybridisation at 56®C, samples 1 and 2 in 
A, B and C were digested with nuclease SI while samples 3 
and 4 in B and C were treated with exonuclease VII.
Nuclease-resistant material was electrophoresed on 6% 
denaturing polyacrylamide gels. Size standards (M) were 
^X174 DNA digested with Hinc II.
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Figure 17. Analysis of the 3' portion of the 4.5kb mRNA. 
The DNA probe, as indicated on the diagram, was a Bgl 
Il/Kpn I fragment of Bgl II n, uniquely 3 '-labelled at the 
Bgl II site. RNA samples used were: tracks 1 and 3, HSV-2 
early infected cell cytoplasmic RNA; tracks 2 and 4, 
mock-infected cytoplasmic RNA. After hybridisation at 56°C, 
samples 1 and 2 were digested with nuclease SI and samples 
3 and 4 treated with exonuclease VII. Nuclease-resistant 
material was electrophoresed on a 6% denaturing 
polyacrylamide gel. Size standards (M) were pSV40 DNA 
digested with Hinf I.
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Figure 18. Analysis of mRNAs located upstream from the 
1.2kb transcript. The DNA probes were a series of Xho I 
fragments derived from Bam HI e, numbered from 1 to 4 on 
the diagram, which were 5 '-labelled at both termini. DNA 
probes for individual hybridisations were; tracks 1 and 2, 
Xho I fragment 1; tracks 3 and 4, Xho I fragment 2; tracks 
5 to 8 , Xho I fragment 3; tracks 9 and 10, Xho I fragment 
4a; tracks 11 and 12, Xho I fragment 4b. RNA samples were 
HSV-2 early infected cell cytoplasmic RNA for the 
even-numbered tracks and mock-infected cytoplasmic RNA for 
odd-numbered tracks. After hybridisation at 56*^ C, samples 
were digested with nuclease SI apart from samples 7 and 8 
which were treated with exonuclease VII. Nuclease-resistant 
material was electrophoresed on a 6% denaturing 
polyacrylamide gel. Size markers (M) were the following Xho 
I fragments of Bam HI e:
the 1.6kb marker corresponds to Xho I fragment 1;
the 1.5kb marker corresponds to Xho I fragment 2;
the 1.2kb marker corresponds to Xho I fragment 3;
the 0.9kb marker corresponds to Xho I fragments 4a and 4b;
the 0.6kb and 0.4kb markers correspond to Xho l/Bam HI
fragments.
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(see Methods, Page 118). The result indicates that the 5' 
portion of a mRNA, transcribed across the Bam HI site, is
unspliced.
The 3' portion of this mRNA was analysed using a 
Bam Hl/Xho I fragment from Bam HI t, uniquely 3 '-labelled 
at the Bam HI site. A band of 1.06kb was detected in both 
nuclease SI- and exonuclease Vll-digested samples (Fig.
16C, tracks 2 and 4); it follows that the 3' portion is 
unspliced. Therefore, the total size of this mRNA is 
approximately 1 .2kb and it corresponds to the 1.5kb species 
detected by Northern blot analysis. Additional minor 
products produced with this DNA probe (Fig. 16C, track 4) 
were detected also with other DNA probes (see Page 139 and 
Fig . 34, track 2 ) .
b) An unspliced mRNA of 4.5kb corresponds to the 5.4kb 
species.
A mRNA was shown to be 3' co-terminal with and 
overlapping the 1.2kb mRNA by using a Bgl Il/Kpn I fragment 
(0.580 to 0.612 map units) of Bgl II n, uniquely 
3'-labelled at the Bgl II site. This Bgl II site is 
approximately 550bp upstream from the Bam HI site and 
therefore is located beyond the 1.2kb mRNA 5' terminus 
(Fig. 15). Nuclease SI- and exonuclease VII-resistant 
products of 1.6kb (Fig. 17, tracks 1 and 3) were detected 
which places the 3' terminus of this mRNA and that of the
1.2kb mRNA at the same location.
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The 5' portion of this mRNA, which maps within the 
adjacent Bgl II c fragment, was analysed using Xho I 
fragments spanning Bam HI e. The Xho I fragments were 
5'-labelled at both ends and are numbered from 1 to 4 in 
Fig. 18. Nuclease SI analysis revealed that Xho I fragments 
1 and 4a were fully protected by infected cell RNA (Fig.
18, tracks 2 and 10), indicating that mRNA is neither 
initiated nor spliced in these fragments. However, 
hybridisations with Xho I fragment 3 generated a SOOnuc 
band (Fig. 18, track 6 ); exonuclease VII analysis with this 
fragment also produced a band of similar size (Fig. 18, 
track 8), indicating that the 5' terminus of a mRNA was 
located within Xho I fragment 3. The total size of this 
mRNA is 4.5kb and it corresponds to the 5.4kb species 
detected by Northern blot analysis.
c) An unspliced 6 .4kb mRNA corresponds to the 6 .6kb 
species.
Northern blot analysis indicated that a third mRNA 
of 6.6kb spans the Bgl II site at 0.58 map units; the 
equivalent HSV-1 region specifies a 7.Okb transcript which 
is 3 ' co-terminal with the early 5.Okb and 1.2kb species 
(Fig. 13). Nuclease SI analysis with 5 '-labelled Xho I 
fragment 2, which is adjacent to Xho I fragment 3 (Fig.
18), generated a band of approximately 1.2kb with infected 
cell RNA only (Fig. 18, track 4). Exonuclease VII 
digestions produced a protected DNA fragment of similar 
size (Fig. j.9A, compare tracks 2 and 3), indicating that
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the 1.2kb segment did not contain splice sites and that the 
5' end of a HSV-2 mRNA, equivalent to the HSV-1 7.Okb 
species, is located within Xho I fragment 2. The predicted 
size of this HSV-2 transcript is 6.4kb and it corresponds 
to the 6 .6kb species detected by Northern blot analysis.
d) Mapping of additional mRNA species within Bam HI e.
Nuclease SI analysis with Xho I fragment 2 
routinely generated three additional bands with sizes of 
SOOnuc, 250nuc and 195nuc (Fig. 19A, track 3) which had 
similar sizes (SOOnuc, 270nuc and 198nuc) following 
exonuclease VII digestion (Fig. 19A, track 2). These 
nuclease-resistant fragments are thought to represent the 
S' termini of additional transcripts mapping within Xho I 
fragment 2. To establish the orientation of these 
additional mRNAs, nuclease SI digestions were performed 
using a 5 '-labelled Xho l/Sst I DNA probe from the 
left-hand end of Xho I fragment 2 (Fig. 19). A 235nuc 
protected fragment (Fig. 19B, track 1) was not detected by 
nuclease 81 analysis with Xho I fragment 2 (Fig. 19A, track
3); this therefore corresponds to the 5' end of the 6.4kb 
transcript. The additional nuclease-resistant products in 
Fig. 19B, track 2 represent species detected by Xho I 
fragment 2 other than the rightwards-transcribed 6.4kb 
niRNA. Thus, these products locate the 5' termini of 
transcripts which are leftwards-transcribed, in the 
opposite orientation to the 6.4kb mRNA. The sizes of 
protected fragments suggest that the 5' terminus of the
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Figure 19. Analysis of the 5' portions of the 6.4kb mRNA 
and a series of leftwards-transcribed species. 
a) Structural analysis of the mRNAs. The DNA probe was Xho 
I fragment 2, derived from Bam HI e (see Fig. 18), which 
was 5'-labelled at both sites. RNA samples used were: 
tracks 2 and 3, 16h infected cell cytoplasmic RNA; tracks 1 
and 4, mock-infected cytoplasmic RNA.
B) Orientation of mRNAs within Xho I fragment 2. The DNA 
probe, shown on the diagram, was a Xho l/Sst I subfragment 
of Xho I fragment 2 which was 5 '-labelled at both termini. 
RNA samples were 16h infected cell cytoplasmic RNA in track 
1 and mock-infected cytoplasmic RNA in track 2.
After hybridisation at 560c, samples 1 and 2 in 
A were digested with exonuclease VII while samples 3 and 4 
in A and samples 1 and 2 in B were treated with nuclease 
SI. Digestion products were electrophoresed on 6% 
denaturing polyacrylamide gels. Size markers (M) were 
pAT153 DNA cleaved with Hpa II.
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Figure 20. Location of the 3' end of the 1.7kb mRNA. The 
DNA probe, shown on the diagram, was a Sal l/Bst Eli 
fragment derived from Xho I fragment 3 (see Fig. 18) which 
was uniquely 3 '-labelled at the Sal I site. RNA 
preparations used were mock-infected cytoplasmic RNA in 
track 1 and 16h infected cell cytoplasmic RNA in track 2. 
After hybridisation at 56^0, samples were treated with 
nuclease SI and digestion products were electrophoresed on 
a 6% denaturing polyacrylamide gel. Size markers (M) were 
pAT153 DNA digested with Hpa II.
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6.4kb transcript overlaps with the 5' end of the mRNA 
species generating the SOOnuc fragment by approximately 30 
to 50 residues. The slight size difference between the 
SOOnuc band in Fig. 19A (track 3), and the 470nuc and 
460nuc nuclease Sl-products in Fig. 19B (track 1) probably 
results from this S' overlapping region where more 
efficient hybridisation of the aoundant 6.4kb mRNA to the 
Xho l/Sst I subfragment prevents hybridisation of the less 
abundant leftwards-transcribed species, thus generating a 
truncated nuclease SI product. Nuclease 81 analysis with 
Xho I fragment 4b produced a fully protected DNA probe
(Fig. 18, track 12) which indicates that the three
overlapping leftwards-transcribed mRNAs extend beyond this 
region. In the corresponding area of the HSV-1 genome. 
Northern blot analysis has identified a 3.8kb species (Fig. 
13; Anderson et al., 1981).
e) Location of a poly A site upstream from the 4.5kb
mRNA within the 6.4kb mRNA.
The HSV-1 locus equivalent to that analysed here, 
specifies a late 1.9kb mRNA which is presumed to be S' 
co-terminal with the 7.Okb mRNA and terminates close to the 
5.Okb mRNA 5' terminus (Anderson et al., 1981). To identify 
and map any equivalent HSV-2 transcript, a Sal l/Bst Eli 
sub-fragment of Xho I fragment 3, which lies upstream from
the 4.5kb mRNA, was 3'-labelled at the Sal I site and used
for nuclease SI analysis (Fig. 20). A protected DNA 
fragment of 348nuc in the infected cell RNA sample (Fig.
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20, track 2) located a mRNA 3' terminus at approximately 
200nuc upstream from the 4.5kb mRNA 5' terminus. As 
analysis of the 5' portion of the 6 .4kb mRNA revealed a 
single mRNA initiation site (Fig. 19A, tracks 2 and 3), the 
6.4kb mRNA and this overlapping transcript which terminates 
within the 6 .4kb mRNA have identical 5' termini; this 
transcript has a size of l.Vkb.
3. Temporal Regulation of the Overlapping mRNAs.
The levels within the cytoplasm of the four nested 
mRNAs were examined by hybridising various DNA probes to 
infected cell RNA isolated at different times p.i. DNA 
probes used were:
1) 5'-labelled Bam Hl/Bgl II fragment to detect the 1.2kb 
mRNA 5' terminus (see Fig. 16).
2) 5'-labelled Xho I fragment 3 to detect the 4.5kb mRNA 5' 
terminus (see Fig. IS).
3) 5'-labelled Xho I fragment 2 for the 5' portions of both 
6.4kb and l.Vkb mRNAs (see Fig. 19).
4) the Sal l/Bst Eli fragment, uniquely 3 '-labelled at the 
Sal I site, to detect the l.Vkb mRNA 3' terminus (see Fig. 
20).
The sizes of the various nuclease Sl-resistant 
products generated from these hybridisations have been 
described in previous sections. The 4.5kb and 1.2kb mRNAs 
(indicated by #  and O  respectively in Figs. 21A and B) 
are detectable at 2h p.i. and increase in abundance until 
to 8h p.i., after which they no longer accumulate (Figs.
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Figure 21. Temporal appearance of mRNAs located between 
0.54 to 0.60 map units on the HSV-2 genome. The DNA probes 
used were:
A) a Bgl Il/Bam HI fragment of Bgl II n (see legend to 
Fig. 16), which was 5 '-labelled at the Bam HI site, to 
identify the 5' portion of the 1.2kb mRNA (represented by
0);
B) 5'-labelled Xho I fragment 3 (see legend to Fig. 18) 
which identified the 5' end of the 4.5kb mRNA (represented 
by • ) ;
C) 5'-labelled Xho I fragment 2 (see legend to Fig. 19) 
which identified the 5' co-terminus of the 6.4kb and l.Vkb 
mRNAs (represented by ■) as well as the S' ends of the 
leftwards-transcribed species (represented by ♦);
D) the Sal l/Bst Eli fragment of Bam HI e, uniquely 
3'-labelled at the Sal I site (see legend to Fig. 20), 
which identified the 3' terminus of the l.Vkb transcript 
(represented by ■).
RNA samples used were: track 1, 16h infected 
cell cytoplasmic RNA; track 2, 8h infected cell cytoplasmic 
RNA; track 3, 6h infected cell cytoplasmic RNA; track 4, 4h 
infected cell cytoplasmic RNA; track 5, 2h infected cell 
cytoplasmic RNA; track 6 , mock-infected cytoplasmic RNA. 
Following hybridisation at 56^0, samples were digested with 
nuclease SI and the nuclease-resistant products 
electrophoresed on 6% denaturing polyacrylamide gels. Size 
standards (M) were pAT153 DNA digested with Hpa II.
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Figure 22. Arrangement and sizes of mRNAs mapping between
0.54 and 0.60 map units on the HSV-2 genome. Locations of 
the transcripts are shown with respect to Bam HI fragments 
e and ^ and the Xho I sites within these fragments.
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21A and B, tracks 1 to 6 ). In contrast, the 6.4kb and l.Vkb
mRNAs (indicated by ■  in Figs. 21C and D) do not appear in
the cytoplasm until 6h p.i. and increase in abundance
throughout the remainder of the infectious cycle (Figs. 21C
and D, tracks 1 to 6 ). A similar pattern of temporal
appearance was detected for the leftwards-transcribed
species which map in Xho I fragment 2 (Fig. 21C, tracks 1
although the mRNA generating the 
to 6, mRNAs indicated by ♦ )a Thus, the 4.5kb and 1.2kb 
SOOnuc band does appear later than the other two transcripts 
mRNAs are early species while the 6.4kb, l.Vkb and
leftwards-transcribed transcripts are late products.
Fig. 22 details the organisation of this group of 
nested mRNAs between 0.54 to 0.60 map units; these HSV-2 
mRNAs are arranged identically and have similar sizes to 
those of HSV-1. Furthermore, equivalent HSV-2 and HSV-1 
transcripts share similar patterns of temporal appearance 
within the cytoplasm. HSV-2 polypeptides which map in this 
region have sizes of 138,000 mol. wt. (Vmwl38) and 38,000 
mol. wt. (Vmw38; Docherty et al., 1981; Galloway et al., 
1982). Similarities in the sizes and arrangement of the 
HSV-1 and HSV-2 mRNAs suggest that the HSV-2 4.5kb mRNA 
encodes Vmwl38 while the HSV-2 1.2kb mRNA specifies Vmw38. 
The 6.4kb and l.Vkb mRNAs are assumed to encode a 
polypeptide equivalent in size to the HSV-1 54,000 mol. wt. 
protein. Supportive evidence for this assumption is 
presented on Page 163.
DNA Sequencing Studies within Bam HI e and t.
The nucleotide sequences of two HSV-1 DNA segments 
this genome region have been published. These are:
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1) DNA sequences flanking the 5' terminus of the early 
5.Okb message (McLauchlan and Clements, 1983a) and
2) DNA sequences encoding the entire 1.2kb mRNA, including 
regions flanking the 5' and 3' termini (Draper et al.,
1982; McLauchlan and Clements, 1982 and 1983a).
Nucleotide sequences were determined for the 
following corresponding regions encoding the equivalent 
HSV-2 mRNAs (Fig. 23):
1) a 1.12kbp DNA segment encompassing the 5' portion of the 
4.5kb mRNA and the 3' terminal region of the l.Vkb mRNA.
2) a 1. 6kbp segment which contains the transcribed region 
of the 1. 2kb mRNA and the mRNA 5' and 3 ' terminal flanking 
sequences.
Restriction enzyme sites used to determine 
nucleotide sequences are shown in Figs. 23A and 23B and the 
complete nucleotide sequences are shown in Figs. 25 and 31.
The following section shows precise positions for 
the mRNA termini and identifies potential transcription 
control elements revealed by comparisons with the 
corresponding HSV-1 DNA sequences. Polypeptide coding 
regions within mRNAs have been predicted by computer 
studies and from comparisons with the corresponding HSV-1 
DNA sequences. A complete analysis of polypeptide coding 
regions is presented in Section B (Page 148), but here, the 
positions of N- and C-termini are indicated as important 
reference points.
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Figure 23. Regions within Bam HI e and t for which 
nucleotide sequences were determined. Locations of the two 
regions, (A) and (B), which were sequenced are shown below 
the restriction enzyme map and the positions of mRNAs are 
indicated with respect to Bam HI and Xho I restriction 
enzyme sites. Region A represents Xho I fragment 3 (see 
Fig. 18) which includes 3' and 5' terminal portions 
respectively of the l.Vkb and 4.5kb mRNAs. Region B 
includes the 1 .2kb transcript and sequences flanking this 
transcript. (A) and (B) show the restriction enzyme sites 
used to determine nucleotide sequences for the respective 
regions and the extent of sequence data obtained from each 
site.
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Figure 24. Precise location of the 5' terminus of the 
4.5kb mRNA. The DNA probe was a 5 '-labelled Sal I fragment 
whose position within Xho I fragment 3 (see Fig. 18) is 
indicated on the diagram. RNA samples were HSV-2 early 
infected cell cytoplasmic RNA for track 1 and mock-infected 
cytoplasmic RNA for track 2. After hybridisation at 56^0, 
samples were treated with nuclease SI and the digestion 
products electrophoresed on a 6% denaturing polyacrylamide 
gel. The size markers (M) were pATl53 DNA digested with Hpa
II.
§gfN O
s
g
<
8u
§
yu
;
gu
s
§
g
g
s
uuu
§
u
1
g
u
g§
2 ^  o or> (g
i
8u
i
y
<
gy
I
§
I
u
0 ^4 m o
1 
5
%H
y
y
i
u
g
uw
O o O t4 o y
o o O ü o <
^ u m y \o y
y < O
y <
u
u «  4: y
y c < <o a>< o
u a H H
y _ < yo y
Ü CLy yy P y
< U yü E- y
y O << U yü U <
H E- E-—  E" O E-
< y y't f- o E-»n y E- <
O y- ^ y <G O y yk" H, y y® <1 y E4
■P 1
1 O o Cy H' o
o u
3
* .
g -Ü A ü ^  O lA t- •
B"O T3 
C 
0>
H o H o y o <
y 2 (- o y o h-E* o y "1 y
H y " y %
y
y E- y yE" E-> y y
y y < yy H y y
E- y < y
y y y y
y y y y
y ÿ < y
y y < y
y y yo y y y
y y y yy P yy y y u
E- y y E4y y y <
y < P yE< y y yEl y E- yy y y <
y P y y
g y y
S y
y y y E-E4 y < y
y y y y
y y y E-
f* < y y
y y y< y y P
y y y <
y y P y
y y y P
< y y y
y < y
y E4 y
y
y
y y y
g
P
y s S
h* y y 2
y y
y o E- y o iC
y in E-. y in <
< OO u E- o ^
y y C: y r-t OA P (D y y
y y «n y <
y y rH y y
y y 1 y yy E^ B y e< y > < P
y y _ < E-
y y B y H
y y u y yE- y • y E-
H y Y 21 y
y y 2 y
y y yy P y <
< E- E- y
y < P y
y y y y
y E4 y y
y y E- y
y E- y
y y y y
y y y P
y y < y
< y y u
y y E" y
H E' y yE- y y y
y < y y
< y < y
y y y y
y y y y
y y y P
y E- < y
y E- y y
y y <
E- E- y y
y H P y
y < y y
E- y y y
y < y y
y y y <
y < P y
E< y < y
y y y y
$
u
t4
u
i
E
Ig
u
0
1
0
1
s
g
i
o <
If» o
-g3
Figure 25. Nucleotide sequence of region (A) in Fig. 23. 
Indicated are the positions of the 3' and 5' termini of the
l.Vkb and 4.5kb mRNAs respectively. The AATAAA signal and 
TATA box homologue are underlined as are proposed locations 
for the C-terminus of the 54,000 mol. wt. polypeptide and 
the N-terminus of Vmwl38.
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5. Analysis of mRNA 5* and 3* Termini.
a) 5' end of the 4.5kb mRNA.
A precise location for the 5' terminus of this mRNA 
was determined by nuclease SI analysis using a 5 '-labelled 
Sal I fragment, derived from Xho I fragment 3 (Fig. 25, 
positions 162 to 799). A nuclease-resistant fragment of 
113nuc (Fig. 24, track 1) positioned the S' terminus on the 
A residue (Fig. 25, position 691) within the sequence 
GGTTACC, a Bst Eli restriction endonuclease cleavage site. 
Approximately 23nuc upstream from the 5' end, a TATA box 
sequence (see Introduction, Page 61) is located between 
positions 664 to 668 (Fig. 25).
HSV-2/hSV-I nucleotide sequence comparisons in this 
region indicate that both TATA box and cap site sequences 
are well conserved (Fig. 26). The nucleotide sequences are 
essentially colinear to the limit of the HSV-1 sequence 
except for an additional A residue at position 668 in the 
HSV-1 sequence and an extra G residue at position 629 of 
the HSV-2 sequence (Fig. 26). Upstream from the TATA box 
homologue, there are two regions of highly conserved DNA 
sequences which are separated by an area of lower homology. 
The 5' proximal area of high homology is located between 
positions -39 and -49 and has the sequence CCCCACCCCTG 
(Fig. 26, positions 642 to 652). The 5' distal conserved 
sequence is between positions -92 and -110 (Fig. 26, 
positions 581 to 599); this area of homology can be divided 
into two separate blocks. The first block has the sequence
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ACACCCCC which resembles A+C-rich elements located 
approximately 90 to 120nuc upstream from the 5' termini of 
a number of early HSV mRNAs (Wagner, 1985). The second 
block has the sequence TGACTCAGGA (shown by R1 in Fig. 26), 
most of which is repeated (TGACTCAG) further downstream in 
HSV-2 DNA between positions -62 and -69, however, this 
second copy is not conserved in HSV-1 DNA (Fig. 26, 
positions 622 to 629).
The distance between the cap site of the HSV-2 
4.5kb mRNA and proposed initiation codon for Vmwl38 is 
243nuc while the equivalent 5' untranslated leader sequence 
in the HSV-1 5.Okb mRNA is 17nuc shorter (Fig. 26). A 
feature of both HSV-2 and HSV-1 sequences is the occurrence 
of direct repeats which are not conserved in both 
sequences. An 18nuc segment, located between positions 781 
to 798 (shown by R2 in Fig. 26) in the HSV-2 sequence is 
repeated between positions 833 to 849 apart from an 
additional T residue in the 5' proximal R2 segment; these 
repeats are not conserved in the corresponding region of 
the HSV-1 sequence. The HSV-1 sequence contains three 
copies of a CCCGCCG motif (shown by R3 in Fig. 26) upstream 
from the initiation codon of Vmwl36. Of these three copies, 
only the 5' proximal repeat unit is present in the HSV-2 
sequence.
b) 1.7kb mRNA 3* terminus.
Nuclease SI analysis located the 3' terminus of 
this mRNA some 348nuc downstream from the Sal I site (Fig.
C-rich Ri 600 
HSV-2 TGGACATGTTACACCCCCCTGACTCAGGAGATAGGCATATCCTCCTTAGA 
**** ******** ********** * * * * * * * * * *
HSV-1 t g g a a g g a a c a c a c c c c c g t g a c t c a g g a c a t c g g t g t g t c c c t t t g g g t
Rl C-rich TATA
HSV-2 TTGACTCAGCACACGATCGCACCCCACCCCTGTGTGCCGGGGATAAAA G 
* * * * *  * * *  * * * *  * * * * * * * * * * *  * * *  * * * * * * * * *  *
HSV-1 TTCACTGA AACTGGCCCGCGCCCCACCCCTGCGTGATGTGGATAAAAAG
end
HSV-2 CCAACGCGGGCGGTCTGGGTTACCACAACAGGTGGGTGCTTCGGGGACTT 
* * *  * * * * * *  * * *  * * *  * * * *  * * * * * * * * * * * * * *  * *  * * **
HSV-1 CCAGCGCGGGTGGTTTAGGGTACC ACAGGTGGGTGCTTTGGAAACTT
750
HSV-2 GACGGTCGCCACTCTCCTGCGAGCCCTCACGTCTTCGCCCACCGATTCCT 
* * * * * * * * *  * * * * * *  * * * *  * * * * *  * * *  * *  *
HSV-1 GCCGGTCGCCGTGCTCCTGTGAGC TTGCGTCCCTCCCCGGTTTCC
R2 800
HSV-2 GTTGCGTTCCTGTCGGCCGGTGCTGTCCTGTCGACAGATTGTTGGCGACT 
* * * * *  * * *  * * * * * *  * * * * *  * * * * * *  **
HSV-1 TTTGCGCTCCCGCCTTCCGGACCTGCTCTCGCCTATCTTCTTTGG CT
________ R2______850
HSV-2 GCCCGGGTGATTCGTCGGCCGGTGCGTCCTTTCGGTCGTACCGCCCACCC 
* * * * * * * * * * *  * * * * *  * * * *  * * * *  * * * ***
HSV-1 CTCGGTGCGATTCGTCAG GCAGCGGCCTT GTCGAATCTCGACCCC
___________________  900
HSV-2 CGCCTCCCACGGGCCCGCCGCTGTTTCCGTTCATCGCGTCCGAGCCACCG 
* * *** ******* * * * * * * * **** * ***
HSV-1 ACCACTCGCCGGACCCGCCGACGTCCCCTCTCGAGCCCGCCGAAAC COG
R3 R3 R3
N-term 950
HSV-2 TCACCTTGGTTCCAATGGCCAACCGCCCTGCCGCATCCGCC 
* * * *** ******** ****** * * * * * * * * *  *
HSV-1 CCGCGTCTGTTGAAATGGCCAGCCGCCCAGCCGCATCCTCT
Figure 26. Nucleotide sequence comparison between the 5' 
terminal portions of the HSV-2 4.5kb and HSV-1 5.Okb 
transcripts. The HSV-2 sequence is numbered as in Fig. 25 
and asterisks denote conserved bases. The position of the 
5' end of the 4.5kb mRNA is indicated; the 5' terminus of 
the 5.Okb transcript is at the same position in the HSV-1 
sequence. TATA box homologues and conserved C-rich elements 
are overlined on the HSV-2 sequence and underlined on the 
HSV-1 sequence. The locations of repetitive sequences, Rl, 
R2 and R3, are indicated in a similar manner in both 
sequences. Positions for the N-termini of HSV-2 Vmwl38 and 
HSV-1 Vmwl36 are also shown.
Sau 3al
\ 400
GGGTGGCGGG CCTGCGCGTG ATCGTCTATT GACGACGGCC GCCCAACCCG
450
AGCGACCTTC CCCTCCCACT TCCCCCCCCC TACACACCAA CTCCGCCCTC
pA signal 500
GCCGTCTTGG CCGTGCGCGG CCCCGTGCGT CCGTCTCAAT AAAGCCAGGT
YGTG TTYY 550
TAAATCCGTG ACGTGGTGTG TTTGGCGTGT GTCTCTGAAA TGGCGGAAAC 
3* end f
600
CGACATGCAA ATGGGATTCA TGGACATGTT ACACCCCCCT GACTCAGGAG
650
ATAGGCATAT CCTCCTTAGA TTGACTCAGC ACACGATCGC ACCCCACCCC
Sau 3al
Figure 27. Nucleotide sequence of the Sau 3aT fragment 
which contains the 3' terminal portion and flanking 
sequences of the 1.7kb mRNA. The sequence is numbered as in 
Fig. 25 and the position of the mRNA 3' terminus is 
arrowed. Also shown are the locations of the AATAAA and 
YGTGTTYY signals.
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20, Page 129) at position 513 (Fig. 25). This location for 
the mRNA 3' terminus is downstream from a polyadenylation 
signal, AATAAA (Fig. 25, positions 488 to 493), a sequence 
which is present upstream from the poly A site of most 
eukaryotic polyadenylated transcripts (see Introduction,
Page 87). Moreover, 29nuc beyond the AATAAA signal is the 
DNA sequence TGTGTTTG (Fig. 25, positions 517 to 524) which 
fits the 3' terminal consensus sequence YGTGTTYY and is 
located at the appropriate distance from the AATAAA 
sequence (see Section E, Page 174). Thus, the 1.7kb mRNA 3' 
terminus, which lies within the transcribed region of the 
6.4kb mRNA, possesses signals similar to those present at 
other eukaryotic polyadenylation sites. The distance 
between the 1.7kb mRNA 3' terminus and the 5' terminus of 
the 4.5kb transcript is 178nuc.
c) DNA sequences flanking the 1.7kb mRNA 3' terminus
produce functional transcripts.
To verify that DNA sequences at the 1.7kb mRNA 3' 
terminus contain signals necessary to terminate 
transcription and to produce correctly-processed 
transcripts, a 265bp Sau 3al fragment (Fig. 27) which 
comprises DNA sequences flanking the 1.7kb mRNA 3' 
terminus, including the AATAAA and YGTGTTYY motifs, was 
inserted into the CAT plasmid, pLWl. Plasmid pLWl contains 
the HSV-2 IE gene-4/-5 promoter linked to the bacterial CAT 
gene but lacks signals necessary to produce 
correctly-terminated CAT mRNA (see Methods, Page 99 and
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Figure 28. Construction of plasmid pSau2. The Sau 3al 
fragment (T') shown in Fig. 27 was inserted into the Bam HI 
site of pUC9 to yield pSaul. This plasmid was cleaved with 
Hind III and Xmn I and fused to the Hind Ill/Xmn I fragment 
of pLWl, which carries the promoter (P) and CAT modules, to 
give plasmid pSau2. A number of restriction enzyme sites 
within pSau2 are shown and details of plasmids pUC9 and 
pLWl are given in Fig. 10.
1,3 A—C m -
3 A - C m
1 A - Cm -
1 2 3 4 5  6 7 8 9
Figure 29. CAT activities produced by plasmids during the 
course of virus infection as determined by thin layer 
chromatography. Extracts were incubated at 3?Oc for 30min. 
The positions of acetylated (A-Cm) and non-acetylated forms 
(Cm) of chloramphenicol are indicated. HeLa cells were 
transfected with the following plasmids: tracks 1 to 4,
pLW2; tracks 5 to 8 , pSau2; track 9, pLWl. 24h after
^ f e c t i o n , HSV—1 virus was added and cells were 
harvested at the following times p.i.: tracks 1, 5 and 9, 
mock-infected; tracks 2 and 6 , 4h p.i.; tracks 3 and 7, 8h
p.i.; tracks 4 and 8, 12h p.i.
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Fig. 10). Firstly, the 1.7kb mRNA Sau 3al fragment (T*) was 
cloned into the Bam HI site of pUC9 to yield plasmid pSaul 
(Fig. 28). A Hind Ill/Xmn I fragment containing the T ' 
fragment was then fused to a Hind Ill/Xmn I fragment of 
pLWl which contained the IE promoter and CAT gene; the 
resultant construct was termed pSau2 (Fig. 28).
The ability of pSau2 to produce functional CAT mRNA 
in HeLa cells was compared with CAT levels detected in 
cells transfected with plasmids pLW2 and pLWl. Plasmid pLW2 
possesses a 'terminator' fragment derived from the 3' 
terminal region of HSV-2 IE gene-5 and is essentially 
identical to plasmid pTERS (see Section E, Page 176).
Results indicated that plasmids pLW2 and pSau2 produced 
similar levels of CAT activity which were significantly 
higher than those produced by pLWl (Fig. 29, tracks 1, 5 
and 9; Table 1). Thus, the 3' terminal region of the 1.7kb 
mRNA does not require additional DNA sequences to terminate 
mRNA synthesis and process primary transcripts. Cells 
transformed with either pLW2 or pSau2 were super infected 
with HSV-1 strain 17'*' virus and CAT activities in pLW2- and 
pSau2-transformed cells were analysed at various times p.i. 
The increase in CAT activity during virus infection was 
similar for both pLW2 and pSau2 (Fig. 29, tracks 1 to 8; 
Table 1), further indicating that the 1.7kb mRNA 
'terminator* does not differ from other HSV 3* terminal 
sequences which are not located within overlapping
transcripts.
Plasmid
Time p.i. pLW2 pSau2 pLWl
MI 0.29 0.42 0.02
4h 0.33 0.53 ND
8h 1.87 2.43 ND
12h 2.8 2.87 ND
Table 1. CAT activities obtained with various plasmids 
during the course of virus infection. Activities are 
expressed as nmoles converted chloramphenicol/^g protein/h, 
ND indicates CAT activity not determined.
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d) 5' terminus of the 1.2kb mRNA.
Nuclease SI analysis using a Bam Hl/Bgl II 
fragment, 5'-labelled at the Bam HI site generated a 143nuc 
band which represented the 1.2kb mRNA 5' terminus (see 
Figs. 16A and B). This nuclease Sl-resistant band was 
electrophoresed alongside the sequence reaction products of 
the hybridisation probe (Fig. 30, track 2), thus locating 
the major cap site on the G residue within the sequence 
ATGTAC (Fig. 31, positions 245 to 250). Upstream from the 
5' end, a TATA box sequence is located at positions -22 to 
-28 (Fig. 31, positions 221 to 225).
HSV-2/HSV-1 nucleotide sequence comparisons in this 
region reveal that the cap site and TATA box sequences are 
completely conserved and are located at identical positions 
relative to the 5' ends of the HSV-2 and HSV-1 1.2kb mRNAs 
(Fig. 32). The proposed stop codon for Vmwl38, the protein 
encoded by the 4.5kb mRNA, is located at position 329 (Fig. 
32), some 82nuc downstream from the 1.2kb mRNA 5' terminus. 
Therefore, transcription control elements for the 1.2kb 
mRNA lie within the translated region of the 4.5kb mRNA; 
this arrangement is identical to that for the equivalent 
HSV-1 mRNAs.
As the HSV-2 and HSV-1 nucleotide sequences share 
extremely high homology in this translated region, 
identification of transcription regulatory signals is 
difficult. However, conserved sequences upstream from the 
5' termini of the HSV-1 and HSV-2 1.2kb mRNAs contain 
inverted repeat elements (Rl and Rl', R2 and R2' in Figs.
1 2 G G+AT+C C
143
' F .  ^
' h t
iXAC
A
i
Figure 30. Precise location of the 5' terminus of the 
HSV-2 1.2kb mRNA. The DNA probe was the Bam Hl/Bgl II 
fragment, uniquely 5 '-labelled at the Bam HI site, which is 
described in Fig. 16. RNA samples were early infected cell 
cytoplasmic RNA in track 2 and mock-infected cytoplasmic 
RNA in track 1. Following hybridisation, samples were 
digested with nuclease SI and the digestion products were 
electrophoresed on an 8% denaturing polyacrylamide gel 
alongside the sequence reaction products of the DNA probe. 
The position of the 5' terminus is arrowed and asterisks 
locate minor nuclease SI products which are described in 
the text.
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Figure 31. Nucleotide sequence of region (B) in Fig. 23. 
Positions of the 5' end of the 1.2kb mRNA and the 3' 
co-terminus are shown and the TATA box homologue and AATAAA 
signal are indicated; the AATAAA signal for a 
leftwards-transcribed mRNA also is underlined. Locations of 
additional 3' termini, as detected in Fig. 34, are 
indicated by closed circles. The codons which represent the 
N- and C-termini of Vmw38 and the C-terminus of Vmwl38 are 
underlined as are the inverted repeats (Rl, Rl', R2 and 
R2') which may form the stem and loop structures shown in 
Fig. 33. The position of the Dde I site used to locate the 
mRNA 3' co-terminus in Fig. 34 is arrowed.
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HSV-2 CAAGCAGTGGTCTGTGGCCCAAGCCCTGCCTTGCCTGGACCCCGCCCACC 
************ ***** * * * * * * * * ******** * * * ******
HSV-1 CAAGCAGTGGTCCGTGGCGCAGGCGCTCCCGTGCCTGGAGCCCACCCACC
100
HSV-2 CCCTCCGGCGGTTCAAGACGGCCTTCGACTACGACCAGGAACTGCTGATC 
********** ******** * * * * * * * * * * * * * * * *  * * * * * * * * *
HSV-1 CCCTCCGGCGATTCAAGACCGCGTTTGACTACGACCAGAAGTTGCTGATC
150
HSV-2 GACCTGTGTGCAGACCGCGCCCCCTATGTTGATCACAGCCAATCCATGAC 
* * * * * * * * * * *  * * * * * * * * * * * * * *  * * * * * * * * * * * * * * * * * * * *
HSV-1 GACCTGTGTGCGGACCGCGCCCCCTACGTCGACCATAGCCAATCCATGAC
Rl 200
HSV-2 TCTGTATGTCACAGAGAAGGCGGACGGGACGCTCCCCGCCTCCACCCTGG 
* * * * * * * * * * *  * * * * * * * * * * * * * * * * *  * * * * *  * * * * * * * * * * * * *
HSV-1 CCTGTATGTCACGGAGAAGGCGGACGGGACCCTCCCAGCCTCCACCCTGG
Rl' R2 TATA R2 ' 5* end # -- '
HSV-2 TCCGCCTTCTCGTCCACGCATATAAGCGCGGCCTGAAGACGGGGATGTAC 
* * * * * * * * * *  * * * * * * * * * * * * * * * * * * * *  * * * * * * * * * * * * * * *
HSV-1 TCCGCCTTCTGGTCCACGCATATAAGCGCGGACTAAAAACAGGGATGTAC
300
HSV-2 TACTGCAAGGTTCGCAAGGCGACCAACAGCGGGGTGTTCGCCGGCGACGA 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  * * * * * * * * * * * *
HSV-1 TACTGCAAGGTTCGCAAGGCGACCAACAGCGGGGTCTTTGGCGGCGACGA
C-term
HSV-2 CAACATCGTCTGCACAAGCTGCGCGCTGTAAGCAACA GCGCTCCGAT
* * * * * *  * * * * * * *  * * * * * * * * * * * * *  * * * * * * * * * * *
HSV-1 CAACATTGTCTGClATGjAGCTGCGCGCTGTGACCGACAAACCCCCTCCGCG 
350
HSV-2 CGGGGTCAGGCGTCGCT CTCGGTCCCGCATATCGCCA
* * * * * * * * * * * * * * * * * * * * * *
HSV-1 CCAGGCCCGCCGCCACTGTCGTCGCCGTCCCACGCTCTCCCCTGCTGCCA
l^term 400
HSV-2 TGGATCCCGCCGTCTC CCCCGCGAGC
* * * * *  * * * * * * * * * * *
HSV-1 TGGATTCCGCGGCCCCAGCCCTCTCCCCCGCT
Figure 32. A comparison between nucleotide sequences at 
the 5' termini of the HSV-2 and HSV-1 1.2kb mRNAs. The 
HSV-2 sequence is numbered as in Fig. 31 and identical 
bases are indicated by asterisks. The 5' terminus of the 
HSV-2 1.2kb mRNA is shown; the HSV-1 1. 2kb mRNA 5' end is 
at an identical position in the HSV-1 sequence. TATA box 
homologues are underlined as are the inverted repeats (Rl, 
Rl', R2 and R2'). Codons which represent the N-termini of 
both Vmw38 proteins and the C-termini of Vmwl38 and Vmwl36 
are marked above the HSV-2 sequence and below the HSV-1 
sequence. The first ATG codon downstream from the 5' end of 
the HSV-1 1.2kb transcript, which is not conserved in HSV-2 
DNA, is boxed.
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Figure 33. Proposed stem and loop structures formed by 
inverted repeat sequences upstream from the 5' end of the 
HSV-2 1.2kb mRNA. The structure shown in (A) would be 
formed by the Rl and Rl' inverted repeats and that in (B) 
by the R2 and R2' inverted repeats indicated in Fig. 31. 
Arrows locate minor nuclease SI products indicated in Fig. 
30. The TATA box homologue is overlined and the position of 
the mRNA 5' terminus is indicated. Sequences are numbered 
as in Fig. 31.
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31 and 32) with the potential to form two alternative stem 
and loop structures in HSV-2 and HSV-1 DNA (Fig. 33). 
Inverted repeats Rl and Rl' could form a structure 
comprising a stem of 12bp with a loop of 24b whereas the
structure formed by R2 and R2' would consist of a stem of
8bp containing two mismatches and a loop of 6b. Under the 
DNA/RNA hybridisation conditions used in transcript mapping 
experiments, a minor proportion of molecules were generated 
in which the stem and loop structures were formed by 
intra-molecular reassociation of the DNA probe. In these 
molecules, sequences within the stems and loops were 
unavailable for hybridisation to the 4.5kb mRNA, and the 
intra-molecular loops were sensitive to nuclease SI. The 
remainder of the DNA probe was available for DNA/RNA
hybridisation. Minor bands indicated in Fig. 30, track 2
correspond to nuclease 81 sensitive sites located within 
both loops; no nuclease 81 cleavage sites were detected at 
the stem regions. This indicates that the stem and loop 
structures can be generated by intra-molecular 
reassociation but does not provide evidence for their 
natural occurrence in virus DNA.
The 5' portions of the H8V-2 and H8V-1 1.2kb mRNAs 
lie within the C-terminal regions of Vmwl38 and Vmwl36 
respectively. In both mRNAs, polypeptide stop codons are 
located 82nuc downstream from the 5' terminus (Fig. 32); 
the DNA sequences for the 1.2kb mRNAs are highly conserved 
(>90% homology) and colinear in this region. However, 
heyond the polypeptide stop codons, homology decreases to a
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level of approximately 55% and the DNA sequences are no 
longer colinear. The distance between the Vmwl38/Vmwl36 
protein stop codons and the initiation codons for the Vmw38 
polypeptides is 16nuc shorter in HSV-2.
0) 3' co-terminus of the 6.4kb, 4.5kb and 1.2kb mRNAs.
The 3' co-terminus for the 6.4kb, 4.5kb and 1. 2kb 
mRNAs was positioned within a Dde l/Xho 1 fragment (Fig.
34, track 2) which had been uniquely 3 '-labelled at the Dde 
I site. The major nuclease 81 product located the 3' 
co-terminus within the sequence TTGTT (Fig. 31, positions 
1452 to 1456), 20nuc downstream from the hexanucleotide 
sequence AATAAA. Minor nuclease 81 products were detected 
reproducibly which placed other 3' termini at preferred 
positions up to VOnuc downstream from the major 3' location 
(Fig. 31); the significance of these additional sites is 
unknown.
Draper et al. (1982) reported that the major 3' 
co-terminus in this region of H8V-1 strain KO8 preceded the 
AATAAA signal. Data for both H8V-2 strain HG52 and H8V-1 
strain 17+ unambiguously locate the 3' co-termini 
downstream from the poly A signal which is consistent with 
the position of 3' ends of other eukaryotic mRNAs. A second 
AATAAA sequence which could serve as a poly A signal for a 
leftwards-transeribed mRNA, is present in the strand 
complementary to that specifying the 3' co-terminal 
transcripts (Fig. 31, positions 1605 to 1610); a poly A 
signal for a late leftwards-transcribed mRNA is present at
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Figure 34. Location of the mRNA 3' co-terminus. From Bam 
HI t, a Dde l/Xho I fragment was uniquely 3 '-labelled at 
the Dde I site and hybridised to early infected cell 
cytoplasmic RNA (track 2) and mock-infected cytoplasmic RNA 
(track 1). The Dde I site is located at position 1311 in 
Fig. 31 and the location of the Xho I site in Bam HI ;t is 
shown in Fig. 15. After hybridisation at 560c, samples were 
treated with nuclease SI and the digestion products were 
electrophoresed on an 8% denaturing polyacrylamide gel 
alongside the sequence reaction products of the DNA probe. 
Arrows indicate the major locations of the 3' co-terminus; 
the locations of additional nuclease SI products are shown 
on the nucleotide sequence in Fig. 31.
C - t e m  1410
HSV-2 CACCTCGTAC GCCGGGGCCG TCGTCAACGA TCTGTGAGGG TCTGGGCGCC
HSV-1 CACCTCGTAC GCCGGGGCGG TCGTCAACGA TCTGTGAGTG TCGCGGCGCG
pA signal \\\\\ 3' tnfl
HSV-2 CTTGTAGCGA TGTCTAACCG AAATAAAGGG GTCGAAACGG ATTGTTGGGT
♦ ** * *** * * * ****** * * h ******
HSV-1 CTTCTACCCG TGTTTGCCCA TAATAAACCT CTGAACCAAA CT TTGGGT
1510
HSV-2 CTCCGGTGTG ATT ATT AC GC AGGGGAG GGG GGTGGCGGCT GGGGAAAGGG
* * * * * * *  * * * * * * * * * * * * * * * * * * *
HSV-1 CTCAT TGTG ATTCTTGT C AGGGACGCGGG GGTGGG
1560
HSV-2 AAGGAACGCC CGAAACCAGA GAAAAGGACC AAAAGGGAAA CGCGTCCAAC
pA signal
HSV-2 CGATAAATCA AGCGCCGACC AGAACCCCGA GATGCATAAT AACGTTTATT
HSV-2 ACTCTATATT ACGG
Figure 35. A comparison between the sequences at the HSV-2 
3* co-terminus and a portion of those at the HSV-1 3' 
co-terminus. Asterisks denote conserved bases and the HSV-2 
sequence is numbered as in Fig. 31. Locations of the 3* 
co-termini are arrowed and the AATAAA signals for the 3' 
co-terminal mRNAs are underlined as is the AATAAA signal 
for a leftwards-transcribed mRNA. Translational stop codons 
for HSV-1 and HSV-2 Vmw38 proteins are also underlined. 
Regions of homology downstream from the 3' co-termini are 
indicated by two solid lines.
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the equivalent HSV-1 locus (McLauchlan and Clements, 1982). 
The distance between the poly A signals on opposite strands 
is 168nuc for HSV-2 and 125nuc for HSV-1.
HSV-2/HSV-1 nucleotide sequence comparisons reveal 
that upstream from the 3' co-terminus, in the 1.2kb mRNA 
untranslated region, the HSV-2 sequence has greater than 
60% homology with the corresponding HSV-1 segment as far as 
the AATAAA signal and both sequences are colinear (Fig.
35). Beyond the AATAAA signal, homology decreases markedly 
with the exception of three blocks of highly conserved 
sequences, downstream from the mRNA poly A sites. These 
conserved sequences, as shown in Fig. 35, are; TTGGGTCTC 
(positions 1455 to 1463); TGTGATT (positions 1467 to 1473); 
GGGGGTGG (positions 1488 to 1495). The highly conserved 
sequence between positions 1467 to 1473 is related to a 
consensus sequence YGTGTTYY (Y = pyrimidine) which is 
located approximately 24 to 35nuc downstream from the poly 
A signals of many viral and eukaryotic mRNAs. The role of 
this sequence motif in mRNA 3' end formation was analysed 
further and the results are presented in Section E (Page 
174). DNA sequences downstream from the poly A signal of 
the leftwards-transcribed mRNA share low homology with the 
corresponding HSV-1 region and do not contain a YGTGTTYY 
sequence motif.
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DISCUSSION.
6. Organisation of Overlapping HSV mRNAs.
Transcripts which span the junction between HSV-2 
transforming fragments, Bgl II c and Bgl II n, form a 
family of four unspliced, overlapping mRNAs which have an 
identical arrangement to transcripts in the corresponding 
region of HSV-1 DNA. Three mRNAs, with sizes of 6.4kb,
4.5kb and 1.2kb, share a common 3' terminus and the 6.4kb 
and 1.7kb transcripts are 5' co-terminal. As a result of 
this mRNA arrangement, DNA sequences required for 
polyadenylation of the 1.7kb transcript and for initiation 
of synthesis of the 4.5kb and 1.2kb mRNAs are located 
within the transcribed regions of overlapping messages 
(Fig. 36). The size differences between the larger HSV-2 
and HSV-1 transcripts (6.4kb and 7.0kb; 4.5kb and S.Okb) 
appear not to result from extensive insertions in the HSV-1 
DNA sequence but may reflect inaccuracy of the methods used 
to determine the lengths of transcripts.
The 5' termini of three late mRNAs transcribed in 
the opposite orientation from the 6.4kb species have been 
mapped and the 5' terminal region of one of these mRNAs 
overlaps with the 6.4kb trancript. Overlapping regions 
between 5' terminal portions of HSV-1 Ug genes-2 and -3 
(Fig. 3), which are divergently transcribed, have been 
identified (Rixon and McGeoch, 1985) and a family of 
transcripts are specified by the DNA strand complementary 
to that encoding an HSV-1 spliced mRNA (Fig. 4; Costa et
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Figure 36. A summary of the locations of mRNA termini with 
respect to transcription control signals. Boxed areas 
indicate proposed protein coding regions within the 
transcripts and the dotted lines within these regions 
represent areas for which nucleotide sequence data are not 
available.
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Figure 37. Locations of putative Spl binding sites 
upstream from the 5' termini of the HSV-2 4.5kb and 1.2kb 
mRNAs. The nucleotide sequences of both DNA strands is 
shown and the positions of mRNA 5' termini are indicated. 
TATA box homologues and the inverted repeats, Rl, R1', R2 
and R2 ', described in Fig. 31, are underlined. Residues on 
the mRNA coding strand which have homology to the consensus 
sequence for Spl binding are indicated by asterisks. The 
Spl binding consensus is written in the 3' to 5' direction.
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al » f 1985). There fore, in HSV, the DNA strand complementary 
to that specifying a transcript may contain control signals 
required for the expression of mRNA synthesised in the 
opposite orientation. Similar arrangements of genes occurs 
on the Ad genome where a number of transcripts are produced 
from opposite DNA strands (reviewed in Shenk and Williams,
1984) .
7. Signals Involved in Initiation of mRNA Synthesis.
The DNA sequences upstream from the 5' termini of 
the 4.5kb and 1.2kb mRNAs contain conserved TATA box 
homologues and C-rich motifs, elements which are present in 
the promoter regions of many eukaryotic mRNAs. Conserved 
C-rich sequences positioned approximately 40 to 70nuc 
upstream from the 5' termini of the HSV-2 and HSV-1 mRNAs 
resemble C- and G-rich tracts of sequence which have been 
identified as components required for promoter activity in 
a number of genes (see Introduction, Page 62). The HSV-1 gD 
promoter contains two tracts of G-rich sequences which are 
required for mRNA synthesis and function in either 
orientation (Everett, 1983). In SV40, C-rich motifs 
influence the level of mRNA synthesis in either orientation 
(Everett et al., 1983) and these sequences are binding 
sites for the transcriptional factor Spl (Dynan and Tjian, 
1983). From comparisons of strong binding sites, a 
consensus sequence, Çg gGCGG^Ç has been derived for Spl 
sites (Dynan and Tjian, 1985). Inspection of the complement 
of C-rich sequences conserved upstream from the 4.5kb and
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S.Okb mRNAs (Fig. 37) reveals reasonable homology with this 
consensus sequence, thus, these C—rich elements may 
represent Spl binding sites. Recent data indicates that Spl 
binds to G+C-rich elements in the promoter regions of HSV-1 
IE (Jones and Tjian, 1985) and TK genes (Jones et al.,
1 9 8 5 )  .
Tracts of sequence with homology to the second 
C-rich motif (ACACCCCC) at llünuc from the 4.5kb mRNA 5' 
terminus are located at a similar distance from the cap 
sites of a number of early HSV mRNAs (Fig. 38; Wagner,
1985). These A+C-rich elements appear to be absent from 
equivalent positions in most late promoters, although, not 
all early promoters contain these sequences. However, the 
highly conserved nature of the ACACCCCC segment would 
indicate that this sequence may be a functional component 
of the promoters for the 4.5kb and 5.0kb mRNAs.
In conclusion, the promoter regions for the 4.5kb 
and 1.2kb mRNAs, which are located within the transcribed 
regions of larger, overlapping transcripts, appear to 
contain similar control sequences to those identified in 
other HSV and in eukaryotic genes.
8. Stem and Loop Structures may Influence Transcription of 
the 1.2kb mRNA.
The 5' end of the 1.2kb mRNA is located within the 
C-terminal portion of Vmwl38, the protein encoded by the 
4.5kb transcript. Thus, transcription control elements 
involved in specifying the 1.2kb mRNA 5' terminus form part
Xl
in u in u
X X T
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Figure 38. Sequence comparison of regions upstream from 
the 5' termini of HSV mRNAs from different temporal 
classes. Locations of mRNA 5' termini are arrowed and TATA 
box homologues are underlined. Proposed A+C-rich sequences 
are underlined twice and a TAATGARAT motif in the promoter 
region of IE mRNA-3 is indicated by a dashed line. The key 
to abbreviations is given in the legend to Fig. 4. 
Nucleotide sequence data were taken from the following 
references :
I. this study; 2. McKnight, 1980; Wagner et al., 1981;
3. Swain and Galloway, 1983; 4. Watson et al., 1982;
5. Quinn, 1984; 6. Costa et al., 1983;
7. Frink et al., 1983; 8. Dowbenko and Lasky, 1984, Swain 
et al., 1985;
9. Costa et al., 1984; 10. Whitton et al., 1983;
II. Murchie and McGeoch, 1982.
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of the Vmwl38 protein coding region. The 5' terminus of the 
equivalent HSV-1 1.2kb mRNA is similarly located within the 
Vmwl36 protein coding sequences. An additional feature of 
DNA sequences upstream from the 1.2kb mRNA is the presence 
of inverted repeats which may form stem and loop structures 
(Fig. 33). The nucleotide sequences which form these 
structures are present also in the 4.5kb RNA; from 
calculations on the energy of double-strand formation in 
RNA, the larger stem and loop (A G = - 1 0.6kcal/mol.) has a 
greater stability than the smaller structure ( A g =
-0.9kcal/mol.). These structures may have no biological 
significance, however, they could act as promoter elements 
in the synthesis of the 1.2kb mRNA.
Transcription of the overlapping 4.5kb mRNA through 
this locus may generate a single-stranded DNA region which 
could facilitate the intra-strand formation of the stem and 
loop structures and thereby potentiate initiation of the 
1.2kb mRNA. As a consequence of this proposal, synthesis of 
the 1.2kb mRNA would be dependent upon transcription of the 
4.5kb mRNA and the structures would function essentially as 
transeription-activator elements. However, a plasmid 
construction consisting of the 1.2kb mRNA promoter fused to 
the bacterial CAT gene efficiently produces CAT enzyme 
activity in the absence of additional promoter sequences 
(O'Hare and Hayward, 1984). Thus, the 1.2kb mRNA promoter 
appears not to require an upstream promoter to function and 
probably contains all the transcription control signals 
necessary to initiate mRNA synthesis.
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Alternatively, the stem and loop structures may be 
stabilised by the presence of DNA binding proteins and act 
as a pause site for RNA polymerase molecules which are 
actively transcribing the 4.5kb mRNA. Studies with avian 
leukosis virus (ALV), a retrovirus which integrates into 
the cellular genome, have shown that the promoter in a 
downstream long terminal repeat (LTR) inefficiently 
expresses flanking cellular sequences in the presence of a 
transcriptionally active promoter located in an upstream 
LTR; removal of this LTR increases promoter activity from a 
downstream LTR (Cullen et al., 1984). In HSV, a structure 
which prevents transcription through the promoter region of 
the 1.2kb mRNA may facilitate initiation of this mRNA.
9. Mechanisms for Generating Transcripts with Alternative 
3‘ Termini.
The 5* co-terminal 6.4kb and 1.7kb mRNAs both 
encode a 54,000 mol. wt. protein but have different 3 
termini. The mechanism for 3' end selection is unclear, 
however, there are a number of possible mechanisms for 
generating mRNAs with alternative 3' termini. Firstly, the 
1.7kb mRNA 3‘ terminus may be an inefficient site for 
either termination or cleavage/polyadenylation of primary 
transcripts. DNA sequence analysis in this region indicates 
that the poly A site of the 1.7kb mRNA is flanked by a 
polyadenylation signal and a YGTGTTYY motif; these 
sequences also occur at the majority of mammalian and viral 
poly A sites. Moreover, plasmids carrying the 3 terminal
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sequences of the 1.7kb mRNA produce CAT activities 
comparable with those obtained from plasmids containing 
poly A site sequences which are not within an overlapping 
transcript; this suggests that there is no inherent 
inefficiency in the processing signals at the 1.7kb mRNA 3' 
terminus as compared to those at other HSV poly A sites. It 
is also unlikely that initiation at the 4.5kb mRNA 5' 
terminus hinders polyadenylation of the 1.7kb mRNA; the 
distance between the 1.7kb mRNA 3' terminus and the 4.5kb 
mRNA 5' terminus is 178nuc which is greater than the 
spacing between termini of tandemly-arranged, 
non-overlapping transcripts in the HSV-1 Ug region (McGeoch 
et al. , 1985 ) .
A second possibility is that a virus-associated 
effect on the cellular transcription machinery results in 
read-through of the 1.7kb mRNA 3' terminus by RNA 
polymerase II. HSV infection inhibits host protein 
synthesis rapidly and suppresses cellular RNA transcription 
(see Introduction, Page 21). Potentially, effects on the 
cellular polyadenylation process may result in inefficient 
polyadenylation of viral as well as host transcripts. 
Extended transcripts of up to lOkb which contain internal 
poly A sites have been detected at a number of locations on 
the HSV genome (Wagner, 1985), thus transcription through 
functional poly A sites may be a general feature of HSV 
mRNA expression. Moreover, virus infection may induce a 
reduction in the levels of cellular components necessary 
for mRNA 3' end formation. Therefore, the mechanism for
147
synthesis of 5' co-terminal HSV mRNAs with different 3' 
termini may be similar to that for the selection of poly A 
sites for IgD and IgG mRNAs which is thought to be 
controlled by the level of an 'endase' enzyme (see 
Introduction, Page 75; Blattner and Tucker, 1984). A 
reduction in the concentration of cellular factors required 
for mRNA 3' end formation as a result of virus infection 
may decrease the number of cleavage events at potential 
poly A sites in a primary transcript, thereby increasing 
the probability of generating a mRNA which is 
polyadenylated at a distal 3' site.
A alanine 
R arginine 
N asparagine 
D aspartic acid 
C cysteine 
E glutamic acid 
Q glutamine 
G glycine 
H histidine 
I isoleucine 
L leucine 
K lysine 
M methionine 
F phenylalanine 
P proline 
S serine 
T threonine 
W tryptophan
Y tyrosine
V valine
Figure 39. Key to amino acids represented by the single 
letter code.
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SECTION B .
10. Analysis of the Polypeptide Coding Regions within the 
Overlapping mRNAs.
In this section, predicted amino acids specified by 
nucleotide sequences are presented in the single letter 
code; the key to this code is given in Fig. 39.
a) C-terminal region of the polypeptide encoded by the 
6.4kb and 1.7kb mRNAs.
The HSV-1 7.0kb and 1.9kb 5' co-terminal mRNAs both 
specify a protein with a mol. wt. of 54,000 (see Page 124). 
The 3' portion of the HSV-2 1.7kb mRNA was analysed to 
identify possible polypeptide coding sequences of the 
equivalent HSV-2 protein. Computer analysis using the 
PTRANS program indicated that the longest open reading 
frame contains 122 amino acids and terminates at position 
369 (Fig. 40) which is 142nuc upstream from the 1.7kb mRNA 
3' terminus. Examination of the codon usage of HSV proteins 
has shown that, in most cases, the third base position of 
amino acid codons has a higher G+C content compared with 
the G+C content of the first and second positions (McGeoch, 
1984). The G+C content across the proposed 54,000 mol. wt. 
protein coding region is 67% and in the third base position 
the G+C content is markedly higher (82%); these data 
therefore suggest that the longest reading frame in this 
region encodes the C-terminal portion of a HSV-2 protein 
equivalent to the HSV-1 54,000 mol. wt. polypeptide.
R L P C R L K  1 T H T I B G A E D M T  P P p p „
GG CGC CTG TTC CGC CGC CTC CGC ATA ACC AAC ACC ATT CAC GGG GCC GAG GAC ATG ACC CCC CCT CCC CCG AAC CGA
M V D P P L A V L A A S S 0 s p R C S A S 0 V T
AAC CTT GAC TTT CCG CTC GCC GTC CTG GCC GCC AGC TCG CAA TCC CCG CCG TGC TCG GCG AGC CAA GTC ACG
P 0 P V D A L Y R H 0 P D L R G R P T A R T C T
CCC GAG TTT CTC GAC AGG CTG TAC CGC TGG CAG CCG GAT CTG CGG GGG CGC CCT ACC GCA CGC ACC TGC ACA
A A P A E L G V H P D D S P R C L B R T E R P G
GCC GCC TTC CCA GAG CTG GGT GTC ATG CCA GAC GAC AGC CCC CGC TGT CTG CAC CGC ACC GAG CGG TTT GGG
V G V P V V I L E G V V ¥ R P G G H R A C A
CTC GGC CTT CCG GTT GTC ATC CTG GAG GGC GTG GTG TGG CGC CCC GGC GGG TGG CGG GCC TGC GCG TGA TCG'
f - t e r »  (54R)
ACGACGGCCGCCCAACCCGAGCGACCTTCCCCTCCCACTTCCCCCCCCCTACACACCAACTCCGCCCTCGCCGTCTTGGCCGTGCGCGGCCCCGTGCGTCCG
TCTCAATA^GCCAGGTTAAATCCGTGACGTGGTGTGTTTGGCGTGTGTCTCTGAAATGGCGGAAACCGACATGCAAATGGGATTCATGGACATGTTACACC
pA s ig n a l  t  3 ' end  ( 1 .7 k b )
CCCCTGACTCAGGAGATAGGCATATCCTCCTTAGATTGACTCAGCACACGATCGCACCCCACCCCTGTGTGCCGGGGATAAAAGCCAACGCGGGCGGTrr«:
TATA
CTTACCACAACAGGTGGGTGCTTCGGGGACTTGACGGTCGCCACTCTCCTGCGAGCCCTCACGTCTTCGCCCACCGATTCCTGTTGCGTTCCTGTCGGCCGG 
»  " 5 '  end (4 .5 k b )
TGCTGTCCTGTCGACAGATTGTTGGCGACTGCCCGGGTGATTCGTCGGCCGGTGCGTCCTTTCGGTCGTACCGCCCACCCCGCCTCCCACGGGCCCGCCGCT
M A N R P A A S A L A G A R 5
GTTTCCGTTCATCGCGTCCGAGCCACCGTCACCTTGGTTCCA ATG GCC AAC CGC CCT GCC GOA TCC GCC CTC GCC GGA GCG CGG TCT
N -te rm  ( Vm w l38)
P S B R 0 B P R B P B V A P P G G D B V P C R K V
CCG TCC GAA CGA CAG GAA CCC CGG GAG CCC GAG GTC GCC CCC CCT GGC GGC GAC CAC GTG TTT TGC AGG AAA GTC
S G V H V L s S D P P G P A A T R I S D S S P V 0
AGC GGC GTG ATG GTG CTT TCC AGC GAT CCC CCC GGC CCC GCG GCC TAC CGC ATT AGC GAC AGC AGC TTT GTT CAA
C G 5 M C S M I I D G D V A R G B L R D L
TGC GGC TCC AAC TGC ACT ATG ATA ATC GAC GGA GAC GTG GCG CGC GGT CAT TTC CGT GAC CTC GA
Figure 40. Locations of proposed amino acid sequences at 
the 3' terminal portion of the 1.7kb mRNA and the 5' 
terminal region of the 4.5kb transcript. The nucleotide 
sequence is numbered as in Fig. 25. Predicted amino acid 
residues are shown above the nucleotide sequence and 
proposed locations of the C-terminus of a 54,000 mol. wt. 
protein and the N-terminus of Vmwl38 are underlined. The 5' 
and 3' termini of the 4. 5kb and 1.7kb transcripts are 
indicated as are polyadenylat ion and TATA box signals for 
these transcripts.
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Supportive evidence for this proposal is the high homology 
between amino acids in this reading frame and those of a 
putative VZV protein (see Page 163).
b) Homology between the proposed N-terminal regions of 
the HSV-2 Vmwl38 and HSV-1 Vmwl36 proteins.
The first ATG codon within the 4.5kb mRNA is 
located at position 934 (Fig. 40) which is 243nuc 
downstream from the 5' terminus. DNA sequences flanking the 
ATG triplet (CCAATGG) resemble those at other 
functional initiation codons (Kozak, 1981). This triplet 
precedes an open reading frame which extends to the limit 
of the DNA sequence and contains 86 codons; it is probable 
that this reading frame represents the N-terminal portion 
of Vmwl38.
A comparison between this region and the equivalent 
N-terminal portion of HSV-1 Vmwl36 reveals areas of high 
and low homology between both the nucleotide and the 
predicted amino acid sequences (Fig. 41). Alignment of 
amino acid sequences to maximise homology indicates that 
the N-terminal eight amino acids are identical in both . 
serotypes apart from one alteration and the sequences share 
high amino acid homology (75%) between residues 40 to 80. 
These conserved regions are separated by an area of 
considerably lower homology (61%) and computer analysis 
predicts that the HSV-1 polypeptide contains an additional 
nine amino acids between residues 31 and 32 of the HSV-2 
protein. These different levels of amino acid conservation
M A N R P A A S A L A G
HSV-2 ATG GCC AAC CGC CCT GCC GCA TCC GCC CTC GCC GGA 969
*** *** ★ * *** * ★ *** *** *** * * * ★ * * *
HSV-1 ATG GCC AGC CGC CCA GCC GCA TCC TCT CCC GTC GAA
S S p V E
A R S P S E R Q E p R E
HSV-2 GCG CGG TCT CCG TCC GAA CGA CAG GAA CCC CGG GAG 1005
*** * * * * * * * * ** *** * * * ★ * *
HSV-1 GCG CGG GCC CCG GTT GGG GGA CAG GAG GCC GGC GGC
A V G G A G G
P E V A P P G
HSV-2 CCC GAG GTC GCC CCC CCT GGC 1026
** * * *** ** * **
HSV-1 CCC AGC GCA GCC ACC CAG GGG GAG GCC GCC GGG GCC
S A T Q E A A G A
G D H V F C R K
HSV-2 GGC GAC CAC GTG TTT TGC AGG AAA 1050
*** ** *** *** * *** * *
HSV-1 CCT CTC GCC CAC GGC CAC CAC GTG TAC TGC CAG CGA
P L A H H Y Q R
V S G V M V L S S D P P
HSV-2 GTC AGC GGC GTG ATG GTG CTT TCC AGC GAT CCC CCC 1086
** * * ** * *** *** * * * *** *** * * * ***
HSV-1 GTC AAT GGC GTG ATG GTG CTT TCC GAC AAG ACG CCC
N D K T
G P A A Y R I S D S S F
HSV-2 GGC CCC GCG GCC TAC CGC ATT AGC GAC AGC AGC TTT 1122
** * * ** * ** *** *** ** *** * * ** * * * ***
HSV-1 GGG TCC GCG TCC TAC CGC ATC AGC GAT AGC AAC TTT
S S N
V Q C G S N C S M I I D
HSV-2 GTT CAA TGC GGC TCC AAC TGC AGT ATG ATA ATC GAC 1158
** *** ★ * ** * * * *** *** * * * * * * *** ***
HSV-1 GTC CAA TGT GGT TCC AAC TGC ACC
T
ATG ATC ATC GAC
G D V A R G H L R D L
HSV-2 GGA GAC GTG GCG CGC GGT CAT TTG CGT GAC CTC 1191
**★ *** *** * * *** ** * ★ * *
HSV-1 GGA GAC GTG GTG CGC GGG CGC CCC AGG ACC CGG
V R P T R
Figure 41. Alignment of the DNA sequences and predicted 
amino acid residues at the N-termini of HSV-2 Vmwl38 and 
HSV-1 Vmwl36. The HSV-2 DNA sequence is numbered as in Fig. 
25 and conserved bases are indicated by asterisks. The 
predicted amino acid sequence for Vmwl38 is shown above the 
HSV-2 DNA sequence and amino acid residues which are not 
conserved in Vmwl36 are indicated below the HSV-1 DNA 
sequence.
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reflect the nucleotide sequences in this region which show 
a similar pattern of variable homology (Fig. 41).
c) Homology between the proposed C-terminal regions of
the Vmwl38 and Vmwl36 polypeptides.
Analysis of the equivalent HSV-1 region indicates 
that the C-terminal portion of Vmwl36 extends into the 
untranslated leader sequence of the 1.2kb mRNA (see Page 
138) . The HSV-2 sequence also contains a single open 
reading frame which terminates 82nuc downstream from the
1.2kb mRNA 5' end (Fig. 42, position 329). The same open 
reading frame within equivalent HSV-2 and HSV-1 genome 
regions strongly suggests that the HSV-2 coding region is 
organised identically to that of HSV-1. This implies that 
transcription control signals required for synthesis of the 
HSV-2 1.2kb mRNA are located within the translated region 
of the 4.5kb mRNA. In this region, the HSV-2 and HSV-1 
sequences are colinear and show a high degree of homology 
(Fig. 43). There are a total of 35 nucleotide sequence 
differences, 30 of which occur in the third base position 
of amino acid codons; these nucleotide differences result 
in five amino acid changes within a region encoding 109 
amino acids. Recently, the DNA sequence of this region in 
HSV-2 strain 333 has been published (Galloway and Swain, 
1984). These authors have also identified an open reading 
frame which contains an identical amino acid sequence to 
that predicted here for HSV-2 strain HG52.
k q i i s v a q a l p c l d p a b p l r r p k t a p
c  A A G  C A G  T G G  T C T  G T G  G C C  C A A  G C C  C T G  C C T  T G C  C T G  G A C  C C C  G C C  C A C  C C C  C T C  C G G  C G G  T T C  A A G  A C G  GCC TTC
D
GAC
Y
TAC
D
GAC
Q
CAG
E
GAA
L
CTG
L
CTG
I
ATC
D
GAC
L
CTG
C
TGT
A
GCA
D
GAC
R
CGC
A
GCC
P
CCC
Y
TAT
V
GTT
D
GAT
B
CAC
S
AGC
Q
CAA
S
TCC
M T
ATG ACT 151
L
CTG
Y
TAT
V
GTC
T
ACA
E
GAG
K
AAG
A
GCG
D
GAC
G
GGG
T
ACG
L
CTC
P
CCC
A
GCC
S
TCC
T
ACC
L
CTG
V
GTC
R
CGC
L
CTT
L
CTC
V
GTC
B
CAC
A
GCA
Y K 
TAT AAG 
TATA
226
R
CGC
G
GGC
L
CTG
K
AAG
T
ACG
G
GGG
M
ATG
Y
TAC
Y
TAC
C
TGC
5 '
K
AAG
end
V
GTT
R
CGC
2kb)
K
AAG
A
GCG
T
ACC
N
AAC
S
AGC
G
GGG
V
GTG
F
TTC
A
GCC
G
GGC
D D 
GAC GAC 301
*
N
AAC
I
ATC
V
GTC
C
TGC
T
ACA
S
AGC
C
TGC
A
GCG
L
CTG TAA GCAACAGCGCTCCGATCGGGGTCAGGCGTCGCTCTCGGTCCCGCATATCGCC 
C - te rm  (Vm w l38)
M D
ATG GAT 389 
N-terœ  (Vm*38l
P
CCC
A
GCC
V
GTC
S
TCC
P
CCC
A
GCG
S
AGC
T
ACC
D
GAC
P
CCC
L
CTA
D
GAT
T
ACC
B
CAC
A
GCG
S
TCG
G
GGG
A
GCC
G
GGG
A
GCG
A
GCC
P
CCG
I
ATT
P V 
CCG GTG 464
c
TGC
P
CCC
T
ACC
P
CCC
E
GAG
R
CGG
y
TAC
F
TTC
Y
TAC
T
ACC
S
TCC
Q
CAG
C
TGC
P
CCC
D
GAC
I
ATC
N
AAC
B
CAC
L
CTT
R
CGC
S
TCC
L
CTC
S
AGC
I  L 
ATC CTG 539
N
AAC
R
CGC
W
TGG
L
CTG
E
GAG
T
ACC
E
GAG
L
CTC
V
GTG
F
TTC
V
GTG
G
GGG
D
GAC
E
GAG
E
GAG
D
GAC
V
GTC
S
TCC
K
AAG
L
CTC
S
TCC
E
GAG
G
GGC
E L
GAG CTC 614
G
GGC
F
TTC
Y
TAC
R
CGC
F
TTT
L
CTG
F
TTT
A
GCC
F
TTC
h
CTG
S
TCG
A
GCC
A
GCG
D
GAC
D
GAC
L
CTG
V
GTG
T
ACG
E
GAA
N
AAC
L
CTG
G
GGC
G
GGC
L S 
CTC TCC 689
G
GGC
L
CTC
F
TTC
E
GAA
Q
CAG
K
AAG
D
GAC
I
ATT
L
CTT
B
CAC
Y
TAC
Y
TAC
V
GTG
E
GAG
Q
CAG
E
GAA
C
TGC
I
ATC
E
GAG
V
GTC
V
GTC
H
CAC
S
TCG
R V
CGC GTC 764
Y
TAC
N
AAC
I
ATC
I
ATC
Q
CAG
L
CTG
V
GTG
L
CTC
F
TTT
H
CAC
N
AAC
N
AAC
D
GAC
Q
CAG
A
GCG
R
CGC
R
CGC
A
GCC
Y
TAT
V
GTG
A
GCC
R
CGC
T
ACC
I  N 
ATC AAC 839
B
CAC
P
CCG
A
GCC
I
ATT
R
CGC
V
GTC
K
AAG
V
GTG
D
GAC
W
TGG
L
CTG
E
GAG
A
GCG
R
CGG
V
GTG
R
CGG
E
GAA
C
TGC
D
GAC
S
TCG
V
GTC
P
CCG
B
GAG
K F
AAG TTC 914
I
ATC
L
CTC
M
ATG
I
ATC
L
CTC
I
ATC
E
GAG
G
GGC
V
GTC
F
TTT
F
TTT
A
GCC
A
GCC
S
TCG
F
TTC
A
GCC
A
GCC
I
ATC
A
GCG
Y
TAC
L
CTG
R
CGC
T
ACC
N N 
AAC AAC 989
L
CTC
L
CTG
R
CGG
V
GTC
T
ACC
C
TGC
Q
CAG
S
TCG
N
AAC
D
GAC
L
CTC
I
ATC
S
AGC
R
CGC
D
GAC
E
GAG
A
GCC
V
GTG
B
CAT
T
ACG
T
ACA
A
GCC
S
TCG
C Y 
TGC TAC 1064
I
ATC
Y
TAC
N
AAC
N
AAC
Y
TAC
L
CTC
G
GGG
D
GAC
H
CAC
A
GCC
K
AAG
P
CCC
E
GAG
A
GCG
A
GCG
R
CGC
V
GTG
Y
TAC
R
CGG
L
CTG
F
TTT
R
CGG
E
GAG
A V
GCG GTG 1139
D
GAT
I
ATC
B
GAG
I
ATC
G
GGG
F
TTC
I
ATC
R
CGA
S
TCC
Q
CAG
A
GCC
P
CCG
T
ACG
D
GAC
S
AGC
S
TCT
I
ATC
L
CTG
S
AGT
P
CCG
G
GGG
A
GCC
L
CTG
A A
GCG GCC 1214
I
ATC
B
GAG
N
AAC
Y
TAC
V
GTG
R
CGA
F
TTC
S
AGC
A
GCG
D
GAT
R
CGC
L
CTG
L
CTG
G
GGC
L
CTG
I
ATC
B
CAT
N
ATG
Q
CAG
P
CCC
L
CTG
Y
TAT
S
TCC
A P
GCC CCC 1289
A
GCC
P
CCC
D
GAC
A
GCC
S
AGC
F
TTT
P
CCC
L
CTC
S
AGC
L
CTC
M
ATG
S
TCC
T
ACC
D
GAC
K
AAA
H
CAC
T
ACC
N
AAC
F
TTC
F
TTC
E
GAG
C
TGC
R
CGC
S T
AGC ACC 1364
S
TCG
Y
TAC
A
GCC
G
GGG
A
GCC
V
GTC
V
GTC
N
AAC
D
GAT
L
CTG TGA GGGTCTGGGCGCCCTTGTAGCGATGTCTAACCGAAATAAAGGGGTCGAAACGGATTGT 1455
C - te n n  (Vmw38) pA s ig n a l
T G G G T C T C C G G T G T G A T T A T T A C G C A G G G G A G G G G G G T G G C G G C T G G G G A A A G G G A A G G A A C G C C C G A A A C C A G A G A A A A G G A C C A A A A G G G A A A C G C G T C C
t 3 ’ end
A A C C G A T A A A T C A A G C G C C G A C C A G A A C C C C G A G A T G C A T A A T A A C G T T T A T T  A C T C T A T A T T  A C G G
pA s ig n a l
1557
1624
Figure 42. Locations of the proposed protein coding 
regions for Vmw38 and the C-terminal portion of Vmwl38. The 
HSV-2 nucleotide sequence is numbered as in Fig. 31 and 
predicted amino acid residues are shown above the 
nucleotide sequence. The positions of the C-terminus of 
Vmwl38 and the N- and C-termini of Vmw38 are underlined. 
Locations of the 5' and 3' termini of the 1.2kb mRNA are 
indicated as are the TATA box homology and AATAAA signal 
for this transcript; the AATAAA signal for a 
leftwards-transcribed mRNA also is shown.
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★ ★
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A G D D N I V C T S C A
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Figure 43. A comparison between the DNA sequences and 
predicted amino acid residues at the C-termini of HSV-2 
Vmwl38 and HSV-1 Vmwl36. The HSV-2 nucleotide sequence is 
numbered as in Fig. 31 and conserved bases are indicated by 
asterisks. The amino acid sequence of Vmwl38 is shown above 
the HSV-2 DNA sequence and residues which are not conserved 
in Vmwl36 are indicated below the HSV-1 DNA sequence. The 
locations of the 5' terminus of the HSV-1 1.2kb mRNA and 
TATA box homologues are shown.
AMINO ACID COMPOSITION -------
Ala 35 10.4% Val 24 7.1% Leu 35 10.4% H e 21 6.2%
Gly 14 4.2% Pro 17 5.0% Cys 7 2.1% Met 4 1.2%
His 10 3.0% Phe 18 5.3% Tyr 15 4.5% Trp 2 0.6%
Asn 15 4.5% Gin 8 2.4% Ser 27 8.0% Thr 15 4.5%
Lys 6 1.8% Arg 21 6.2% Asp 21 6.2% Glu 22 6.5%
Approximate Molecular We ight = 37667.52
■ CODON USAGE -----
TTT Phe 7 2.1% TCT Ser 1 0.3% TAT Tyr 2 0.6% TGT Cys 0 0.0%
TTC Phe 11 3.3% TCC Ser 9 2.7% TAC Tyr 13 3.8% TGC Cys 7 2.1%
TTA Leu 0 0.0% TCA Ser 0 0.0% T A A --- 0 0.0% T G A --- 1 0.3%
TTG Leu 0 0.0% TCG Ser 8 2.4% T A G --- 0 0.0% TGG Trp 2 0.6%
CTT Leu 2 0.6% CCT Pro 0 0.0% CAT His 2 0.6% CGT Arg 0 0.0%
CTC Leu 14 4.1% CCC Pro 11 3.3% CAC His 8 2.4% CGC Arg 13 3.8%
CTA Leu 1 0.3% CCA Pro 0 0.0% CAA Gin 0 0.0% CGA Arg 2 0.6%
CTG Leu 18 5.3% CCG Pro 6 1.8% CAG Gin 8 2.4% CGG Arg 6 1.8%
ATT lie 3 0.9% ACT Thr 0 0.0% AAT Asn 0 0.0% AGT Ser 1 0.3%
ATC lie 18 5.3% ACC Thr 11 3.3% AAC Asn 15 4.4% AGC Ser 8 2.4%
ATA H e 0 0.0% ACA Thr 1 0.3% AAA Lys 1 0.3% AGA Arg 0 0.0%
ATG Met 4 1.2% ACG Thr 3 0.9% AAG Lys 5 1.5% AGG Arg 0 0.0%
GTT Val 0 0.0% GCT Ala 0 0.0% GAT Asp 5 1.5% GGT Gly 0 0.0%
GTC Val 11 3.3% GCC Ala 23 6.8% GAC Asp 16 4.7% GGC Gly 7 2.1%
GTA Val 0 0.0% GCA Ala 0 0.0% GAA Glu 4 1.2% GGA Gly 0 0.0%
GTG Val 13 3.8% GCG Ala 12 3.6% GAG Glu 18 5.3% GGG Gly 7 2.1%
- BASE COMPOSITION
Y T C A G R ALL
NUMBER 557 186 371 177 280 457 1014
PERCENT 54.9 18.3 36.6 17. 5 27.6 45.1 100.0
Figure 44. Predicted amino acid composition of HSV-2 
Vmw38. Also shown are the frequency of usage for codons 
specifying the amino acids and the G+C content in the 
protein coding region.
151
d) Homology between HSV-2 and HSV-1 Vmw38 proteins.
Previous reports have mapped Vmw38 to the region 
examined here (Docherty et al., 1981; Galloway et al.,
1982). The first ATG triplet at position 384 (Fig. 42), 
within the sequences specifying the 1.2kb mRNA, precedes a 
single open reading frame which extends for 337 codons and 
terminates with a TGA stop signal at position 1395 (Fig.
42). This sequence would specify a 37,667 mol. wt. 
polypeptide, which is close to the size of the 37,800 mol. 
wt. product obtained by in vitro translation of mRNA 
selected with HSV-2 Bgl II n (Docherty et al., 1981). The 
amino acid composition of Vmw38 is shown in Fig. 44; the 
G+C content in the third base position of the codons is 90% 
within a region whose total G+C content is 64%.
For the HSV-1 1.2kb mRNA, the first ATG triplet was 
followed by a stop codon in the same reading frame (Fig.
32, positions 314 and 329), which also marked the 
C-terminus of Vmwl36. This ATG triplet therefore does not 
encode the N-terminus of HSV-1 Vmw38 and is absent in the 
HSV-2 sequence (Fig. 32). DNA sequences flanking the first 
ATG codon of the HSV-2 1.2kb mRNA are identical to those at 
the second ATG triplet of the HSV-1 1.2kb mRNA which 
reinforces the view that this second ATG codon is used in 
the HSV-1 1.2kb mRNA.
Alignment of HSV-2 and HSV-1 sequences by the HOMOL 
program predicts that the HSV-1 protein contains an 
additional three amino acid residues between positions 2 
and 3 in the HSV-2 polypeptide (Fig. 45). Further
M D P A V S P A S
HSV-2 ATG GAT CCC GCC GTC TCC CCC GCG AGC 410
*** ** * ** * * * * * ** * * * * **
HSV-1 ATG GAT TCC GCG GCC CCA GCC CTC TCC CCC GCT CTG
S A A L L
T D P L D T H A S G A G
HSV-2 ACC GAC CCC CTA GAT ACC CAC GCG TCG GGG GCC GGG 446
* * * * * ** * ** * ** * * * * *
HSV-1 ACG GCC CTT ACG GAC CAG AGC GCG ACG GCG GAC CTG
A L T Q S T A D L
A A P I P V C P T P E R
HSV-2 GCG GCC CCG ATT CCG GTG TGC CCC ACC CCC GAG CGG 482
* * * * * * * * * * * * ** * *** * ** * ★ * * * *
HSV-1 GCG ATC CAG ATT CCA AAG TGC CCC GAC CCC GAG AGG
I Q K D
Y F Y T S Q C p D I N H
HSV-2 TAC TTC TAC ACC TCC CAG TGC CCC GAC ATC AAC CAC 518
HSV-1 TAC TTC TAC ACC TCC CAG TGT CCC GAC ATT AAC CAC
L R S L S I L N R W L E
HSV-2 CTT CGC TCC CTC AGC ATC CTG AAC CGC TGG CTG GAG 554
HSV-1 CTG CGC TCC CTC AGC ATC CTT AAC CGC TGG CTG GAA
T E L V P V G D E E D
HSV-2 ACC GAG CTC GTG TTC GTG GGG GAC GAG GAG GAC 587
HSV-1 ACC GAG CTT GTT TTC GTG GGG GAC GAG GAG GAC
Figure 45. A comparison between the DNA sequences and 
predicted amino acid residues at the N-termini of HSV-2 and 
HSV-1 Vmw38. The HSV-2 DNA sequence is numbered as in Fig. 
31 and identical bases are indicated by asterisks. The 
amino acid sequence for HSV-2 Vmw38 is shown above the 
HSV-2 DNA sequence and residues which are not conserved in 
the HSV-1 protein are indicated below the HSV-1 DNA 
sequence.
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downstream, there is a discrete region of low homology 
which results in 14 amino acid differences within a stretch 
of 22 amino acid residues (Fig. 45, positions 408 to 473). 
Following this non-homologous region, from positions 474 to 
587 (Fig. 45), which is the limit of HSV-1 strain 17+ data, 
there are few differences in the nucleotide sequences and 
the amino acid residues are identical in both serotypes. 
Draper et al. ( 1982) have published the DNA sequence for 
the 1.2kb mRNA of HSV-1 strain KOS which has subsequently 
been amended (E.K. Wagner, personal communication). The 
predicted N-terminal amino acid sequence of strain 17+ 
differs from strain KOS between residues 7 and 19; there 
are five amino acid differences and the strain 17+ sequence 
contains an additional leucine residue (Fig. 46). A 
comparison of the HSV-2 amino acid sequence with the 
amended HSV-1 strain KOS sequence from residue 30 to the 
TGA stop codon reveals that the Vmw38 polypeptides are 
colinear and are highly conserved (94%) apart from the 30 
amino acid region at the N-terminus (Fig. 46). Within the 
highly conserved region, there are only 19 amino acid 
differences; most nucleotide differences occur in the third 
base position of codons and both HSV-2 and HSV-1 reading 
frames terminate at the same stop codon. The HSV-2 strain 
HG52 amino acid sequence is identical to that of HSV-2 
strain 333 (Galloway and Swain, 1984) apart from two 
differences at residues 173 (valine— ♦-isolsucine) and 235 
(aspartic acid— ►glycine; Fig. 46).
HSV-117 + MDSAAPALS PALTALTDQS ATADLAIQ IPKCPDPERYFYTSQCPDINHL 
** * * *** * * * * * * ** ****************
HSV-2 MD PAVSPASTDPLDTHASGAGAAPIPVCPTPERYFYTSQCPDINHL 
* * * * * * * * * * * * * * * * * * * * * * * * * * *
HSV-Ik oS MDSAAPA s p p l w a h t g h s a t a d l a i q i p k c p d p e r y f y t s q c p d i n h l
50
HSV-2 r s l s i l n r w l e t e l v f v g d e e d v s k l s e g e l g f y r f l f a f l s a a d d l v t e
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  * * * * * * * * * * * * * * * * * *
HSV-1 r s l s i l n r w l e t e l v f v g d e e d v s k l s e g e l s f y r f l f a f l s a a d d l v t e
100
HSV-2 n l g g l s g l f e q k d i l h y y v e q e c i e w h s r v y n i i q l v l f h n n d q a r r a y
* * * * * * * * * * * * * * * * * * * * * * * * * *  * * * * * * * * * * * * * * * * * * * * *  *
HSV-1 n l g g l s g l f e q k d i l h y y v e q e c i e v a h s r v y n i i q l v l f h n n d q a r r e y
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300
HSV-2 PLYSAPAPDASFPLSLMSTDKHTNFFECRSTSYAGAVVNDL-
HSV-1 PLFSAPPPDASFPLSLMSTDKHTNFFECRSTSYAGAWNDL-
Figure 46. A comparison between the amino acid sequences
amended sequence fojc the 
of HSV-2 Vmw38 and the^Vmw38 polypeptide of HSV-1 strain
KOS. The HSV-2 sequence is numbered and conserved residues
are indicated by asterisks. Amino acid sequences between
residues 5 to 15 are not identical in HSV-1 17+ and HSV-1
KOS strains, therefore, the N-terminal 50 residues of HSV-1
strain 17+ Vmw38 are also compared with the HSV-2 sequence.
Amino acid differences between the two HSV-1 strains are
underlined.
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DISCUSSION.
11. Sequence Conservation between Equivalent HSV Proteins.
Proposed protein coding regions within the 
overlapping mRNAs have been predicted by DNA sequence 
analysis and comparisons between equivalent HSV-2 and HSV-1 
protein coding sequences reveal homologous and 
non-homologous regions. Most of the Vmw38 protein sequences 
are well conserved in both serotypes except for an area of 
low homology at the N-termini where the HSV-1 protein 
contains an insertion of three amino acids. The C-terminal 
portions of HSV-2 Vmwl38 and HSV-1 Vmwl36 are highly 
conserved, however, the N-termini of these proteins have 
areas of high homology separated by a poorly conserved 
region in which the HSV-1 protein contains an additional 
nine amino acids.
The DNA sequences of the gC (Frink et al., 1983; 
Dowbenko and Lasky, 1984; Draper et al., 1984a; Swain e^
^ . , 1985), gD (Watson et al., 1982; Watson, 1983; McGeoch 
et al., 1985) and TK genes (MeKnight, 1980; Wagner et al., 
1981; Swain and Galloway, 1983) have been determined for 
both serotypes. Comparisons between these equivalent HSV-2 
end HSV-1 protein coding regions have indicated that, in 
every case, there is an increased variation in amino acid 
sequences at the N-termini compared with other areas of the 
polypeptides. Furthermore, the N-terminal region of the 
HSV-1 gC polypeptide contains an insertion of 27 amino 
ecicis as compared with its HSV-2 counterpart. N —terminal
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portions of the HSV-2 IE polypeptides, for which only 
limited sequence data are available, also share low 
homology with corresponding regions of HSV-1 IE proteins 
(Whitton, 1984; Whitton and Clements, 1984b) except for the 
sequences of IE Vmw65 which are highly conserved (Whitton 
et al. , 1983 ) .
It is unlikely that low conservation between short 
stretches of amino acids at the N-termini represents 
different functional domains in equivalent HSV proteins. A 
possible explanation for low sequence homology in these 
regions is that poorly conserved residues are not 
functionally important and do not play a significant role 
in determining protein structure. Supportive evidence for 
this proposal is that removal of the initiation codon from 
the HSV-1 TK gene does not significantly reduce viral TK 
activity (Halpern and Smiley, 1984). In this HSV-1 mutant, 
translation is probably initiated from two distal in-frame 
ATG codons which denote the N-termini of proteins with 
sizes of 39,000 and 38,000 mol. wt. (Preston and McGeoch, 
1981; Marsden et al., 1983; Haarr et al., 1985); these 
polypeptides lack 45 and 59 N-terminal residues 
respectively as compared with the wild-type TK protein.
Other comparisons between amino acid sequences of 
mammalian, yeast and bacillar alcohol dehydrogenases have 
shown that conserved residues can be correlated with the 
functional properties and tertiary structure of the enzymes 
(Eklund et al., 1976b). For example, residues involved in 
subunit interactions, ADP—ribose binding and enzymatic
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activity are all well conserved. However, the N-terminal 
portions of these dehydrogenases share low homology and 
vary in length. Structural analysis of the horse liver 
alcohol dehydrogenase has indicated that the N-terminal 
region forms a loosely organised loop on the outside of the 
molecule and is not involved in enzyme function (Eklund et 
al., 1976a).
12. Components of HSV Ribonucleotide Reductase.
HSV-1 Vmwl36 is a component of the virus-induced 
ribonucleotide reductase activity (Dutia, 1983; Preston e^ 
^ . , 1984b). In vitro translation of hybrid-selected mRNAs 
has mapped Vmwl38 to the equivalent region of the HSV-2 
genome (Galloway et al., 1982) and ribonucleotide reductase 
activity can be recovered from immunoprecipitates 
containing this protein (Huszar and Bacchetti, 1983). DNA 
sequence studies presented here show that Vmwl36 and Vmwl38 
share amino acid homology, implying that Vmwl38 is a 
component of HSV-2 ribonucleotide reductase activity. The 
properties of both HSV-2 and HSV-1 enzymes are identical 
(Averett et al., 1984), further suggesting that the enzymes 
from both serotypes share common structural features.
There is accumulating evidence that the HSV 
ribonucleotide reductase contains a second component which 
is the Vmw38 protein encoded by the 1.2kb mRNA. Biochemical 
studies on the structure of HSV ribonucleotide reductase 
indicate that the enzyme has similar properties to the
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mamina 1 iân ribonucleotide reductase (see Introduction, Page 
56) and comprises two non-identical subunits. Treatment of 
partially purified cell extracts with pyridoxal phosphate 
(Pyr.P) and 4-me thy 1-5-amino-1-for my 1 i soqui nol ine
thiosemicarbozone (MAIQ), both inhibitors of mammalian 
ribonucleotide reductase activity, inactivates the HSV 
enzyme (Cohen et al., 1985); Pyr.P interacts with the Ml 
mammalian subunit, possibly at a lysine residue in either 
the allosteric or catalytic sites (Cory and Mansell, 1975) 
and MAIQ treatment destroys the tyrosine free radical on 
the M2 subunit (Thelander and Graslund, 1983). Up to 77% of 
HSV ribonucleotide reductase activity can be recovered by 
combining extracts which had been treated separately with 
the two inhibitors suggesting that the sites of action of 
the inhibitors are not on the same HSV polypeptide and that 
inactivated subunits can associate to give enzyme activity.
Immunoprécipitation studies have shown that 
monoclonal antibodies directed against Vmwl38 and Vmwl36 
also precipitated a 38,000 mol. wt. species (Galloway e;t 
al., 1982; Huszar and Bacchetti, 1983; Bacchetti et al., 
1984; Preston et al., 1984b) shown to be the Vmw38 
polypeptide encoded by the 1.2kb mRNA (Frame et al., 1985). 
There are three possible explanations for this observation:
1) firstly, it has been suggested that the coding sequences 
of Vmwl38 and Vmw38 are at least partially colinear 
(Galloway et al., 1982), possibly as a result of mRNA 
splicing. This proposal conflicts with structural analyses 
of transcripts mapping within this region which indicate
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that the mRNAs encoding these proteins are unspliced. In 
addition, the C—terminus of Vmwl38 does not overlap with 
the N-terminal region of Vmw38, as also is the case for the 
equivalent HSV-1 polypeptides.
2) it is possible that monoclonal antibodies may recognise 
a common antigenic site in both proteins. A 
computer-assisted comparison between sequences of HSV-1 
Vmwl36 and Vmw38 has revealed no significant stretches of 
common amino acids; the longest stretch of homology between 
these proteins is four amino acids (I. Nikas, personal 
communication) .
3) a third possibility is that Vmwl38 and Vmw38 are 
associated in a protein-protein complex, hence an antibody 
directed against one protein could precipitate both 
species. Monoclonal antibodies which precipitated both 
polypeptides also inhibited HSV-2 ribonucleotide reductase 
activity (Huszar and Bacchetti, 1983) and enzyme activity 
was recovered also from the pelletted material of 
precipitated antibody-antigen complexes (Huszar and 
Bacchetti, 1983; Preston et al., 1984b). Furthermore, 
antiserum induced by a synthetic oligopeptide composed of 
the seven C-terminal amino acid residues of HSV-1 Vmw38 
(McLauchlan and Clements, 1982) precipitated Vmwl36 in 
addition to Vmw38; these amino acid residues are identical 
in the HSV-2 protein, hence the antiserum also precipitated 
HSV-2 Vmwl38 and Vmw38 (Frame et al., 1985).
The HSV-1 mutant, 17tsVPl207, which contains a 
iasion in the protein coding region of Vmwl36, fails to
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Figure 47. Locations of transcripts within the Bgl II c 
and Bgl II n transforming regions. Positions for the 6.4kb, 
4.5kb, 1.7kb and 1.2kb mRNAs are taken from this study. The
sizes of the leftwards-transcribed species, whose 5' ends 
map at the 5' co-terminal region of the 6.4kb and 1.7kb 
mRNAs, are not known, however, it is assumed that they are 
similar in size to a 3.8kb species which is located at the 
equivalent HSV-1 genomic region. The hatched area indicates 
the region within Bgl II c required for tumorigenicity. The 
1. 5kb mRNA to the right of the 3* co-terminal mRNA family 
encoding ribonucleotide reductase specifies a 61,000 mol. 
wt. polypeptide which contains those sequences implicated 
in morphological transformation. The 2.7kb species encodes 
gC-2 and only the 5* portion of this mRNA maps within Bgl 
II n. Transcripts to the right of the ribonucleotide 
reductase locus were taken from Draper et a1., 1984b.
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induce a viral ribonucleotide reductase activity at the 
non-permissive temperature (npt; Dutia, 1983; Preston et 
al. / 1984b) Cells infected at the npt with 17tsVP1207 
synthesise a non-functional Vmwl36 and the 
oligopeptide-induced antiserum precipitates only Vmw38 
(Frame et al., 1985). This suggests that, in cells infected 
with l7tsVPl207, a protein complex between Vmwl36 and Vmw38 
does not form at the npt and this may be the basis of the 
ribonucleotide reductase-negative phenotype of this mutant.
13. Location of the Ribonucleotide Reductase Gene within 
HSV-2 Transforming Regions.
Studies using cloned DNA have identified two HSV-2 
fragments, Bgl II c and Bgl II n (mtr II), which are 
involved in cellular transformation (see Introduction, Page
46). The 6.4kb and 4.5kb mRNAs span both of these fragments 
while the 1.7kb and 1.2kb transcripts are contained 
entirely within Bgl II c and Bgl II n respectively (Fig.
47). The corresponding region of the HSV-1 genome, which 
specifies transcripts and proteins of similar sizes to 
those of HSV-2 DNA, does not have a comparable 
morphological transforming ability (Reyes et al., 1979); 
the ability of the HSV-1 region equivalent to Bgl II c to 
induce immortalisation of hamster cells has not been 
tested. There are no extensive insertions or deletions 
between the HSV-2 and HSV-1 DNA sequences examined here 
which may account for the different morphological 
transforming efficiences, however, there are areas of low
159
sequence homology. Within the left-hand portion of mtr II, 
there are regions of low homology downstream from the mRNA 
3' co-terminus and at the N-terminus of Vmw38. As yet, it 
is not known whether these non-homologous segments 
contribute to the different transforming abilities of DNA 
from these HSV-2 and HSV-1 genomic regions. Recent evidence 
would suggest that a DNA fragment within mtr II which 
induces morphological transformation is located to the 
right of the HSV-2 ribonucleotide reductase locus, within 
the coding sequences of a 61,000 mol. wt. polypeptide (Fig. 
47; Galloway et al., 1984).
Jariwalla et al. (1983) have proposed that 
immortalised cell lines require the right-hand 36% of Bgl 
II c for tumorigenicity (Fig. 47). This region contains 
most of the protein coding sequences of Vmwl38 and probably 
all of the 54,000 mol. wt. polypeptide sequences. In 
addition, it is likely that major portions of the 
transcripts which map to the left of the 6.4kb and 1.7kb 
mRNAs (Fig. 47) are located within this proposed 
tumor igenic region; further studies are required to analyse 
the role of these sequences in tumorigenicity.
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SECTION C .
14. Amino Acid Sequence Conservation between Proteins at 
the HSV-2 Ribonucleotide Reductase Locus and Other 
Herpesvirus Polypeptides.
The sequences of the entire genomes of EBV B95-8 
strain (Baer et al., 1984) and VZV (Davison, 1983; A.J. 
Davison, personal communication) have been determined and 
analysed for potential protein coding regions. Comparisons 
of the predicted amino acid sequences of Vmw38 and the N- 
and C-terminal portions of Vmwl38 with those of proposed 
EBV and VZV protein coding regions are presented in the 
following sections and reveal that both EBV and VZV have 
open reading frames corresponding to polypeptides which 
have homology with Vmw38 and Vmwl38. The EBV proteins 
equivalent to Vmwl38 and Vmw38 have sizes of 93,000 and
34.000 mol. wt. respectively while the equivalent VZV 
polypeptides have predicted sizes of 87,000 and 35,000 mol. 
wt. Comparisons with the proposed C-terminal portion of the 
HSV-2 54,000 mol. wt. protein with EBV and VZV sequences 
are also presented.
15. HSV-2 Vmw38 Shares Homology with Similarly-sized EBV 
and VZV Proteins.
Comparisons between the predicted amino acid 
sequence of HSV-2 Vmw38 and those of the EBV 34,000 and VZV
35.000 mol. wt. polypeptides are represented as CINTHOM 
plots in Figs. 48 and 49. Both comparisons indicate that
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Figure 48. A CINTHOM plot comparing amino acid residues of 
HSV-2 Vmw38 with those of the EBV 34,000 mol. wt. protein. 
Program settings were: range = 15; scale factor = 0.95; 
minimum value plotted = 30%; compressed x4.
VZV 35K
40 80 120 160 200  240 280
80
120
160
HSV-2
Vmw38
200
240
280
3 2 0
Figure 49. A CINTHOM plot comparing amino acid residues of 
HSV-2 Vmw38 with those of the VZV 35,000 mol. wt. protein. 
Program settings were; range = 15; scale factor = 0.95; 
minimum value plotted = 30%; compressed x4.
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Figure 50. Alignment of the amino acid residues of HSV-2  
Vmw38 with those of the EBV 34,000 mol. wt. protein. 
Asterisks denote conserved residues and the HSV-2 sequence 
is numbered. Blocks of higher homology are boxed and the 
proposed locations for the iron binding site (#) and 
tyrosine free radical (♦) are indicated.
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homology with the EBV and VZV proteins extends across most 
of the Vmw38 coding region and that there are no large 
insertions/deletions. The HSV/EBV comparison contains two 
gaps in the diagonal (Fig. 48, between HSV-2 residues 136 
to 168 and 256 to 284) and homology is not detectable at 
the N-termini (Fig. 48, HSV-2 residues 0 to 50). In 
contrast, the HSV/VZV homology is represented by an almost 
continuous diagonal which extends to the N-terminus of the 
VZV protein (Fig. 49) and there is greater homology with 
the VZV 35,000 mol. wt. protein than with the EBV 34,000 
mol. wt. polypeptide. Alignment of protein coding sequences 
using the HOMOL program indicates that the HSV/VZV amino 
acid homology is 54% while the HSV/EBV homology is 33%. 
Alignment of the HSV-2 and EBV proteins reveals blocks of 
low and high homology (indicated in Fig. 50) and the 
N-terminal portion of HSV-2 Vmw38 is longer than that of 
the EBV 34,000 mol. wt. protein (Fig. 50).
Amino acid homology is reflected by the 
conservation between nucleotide sequences encoding the 
HSV-2, EBV, and VZV proteins (Figs. 51 and 52). Again,
HSV-2 and VZV sequences share a greater degree of 
conservation than HSV-2 and EBV sequences, an interesting 
result considering the wide variation in G+C content of HSV 
(64%) and VZV DNA (38.5%) in this region. The G+C content 
of EBV DNA is 54.7% in the area encoding the 34,000 mol. 
wt. protein.
EBV
2400  2 60 0  2 8 0 0  3 00 0  3 2 0 0  3 4 0 0  3600
200
400
xw w
6 00  X .  .W.
HSV-2"
800
1000
1200 W.
1400
C-term
Niterm
w
W T
W T
OU
O
.uv..
WT
P W 
P
Figure 51. A CINTHOM plot comparing HSV-2 and EBV 
nucleotide sequences. The HSV-2 nucleotide sequence extends 
from bases 1 to 1400 as numbered in Fig. 31 and encodes the 
C-terminal portion of Vmwl38 and the entire coding region 
of Vmw38. The EBV nucleotide sequence specifies equivalent 
regions of the 93,000 and 34,000 mol. wt. proteins.
Locations of the C-terminus of Vmwl38 and the N-terminus of 
Vmw38 are arrowed. Program settings were: range = 20; scale 
factor = 0.95; minimum value plotted = 54%; compressed x20.
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Figure 52. A CINTHOM plot comparing HSV-2 and VZV 
nucleotide sequences. The HSV-2 nucleotide sequence extends 
from bases 1 to 1400 as numbered in Fig. 31 and encodes the 
C-terminal portion of VmwlSS and the entire coding region 
of Vmw38. The VZV nucleotide sequence specifies equivalent 
regions of the 87,000 and 35,000 mol. wt. proteins.
Locations of the C-terminus of Vmwl38 and the N-terminus of 
Vmw38 are arrowed. Program settings were: range = 20; scale 
factor = 0.95; minimum value plotted = 54%; compressed x20.
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Figure 53. A CINTHOM plot comparing C-terminal amino acid 
residues of HSV-2 Vmwl38 with the equivalent region of the 
EBV 93,000 mol. wt. polypeptide. Program settings were: 
range = 12; scale factor = 0.95; minimum value plotted = 
30%; compressed x2.
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16. Comparison of the HSV-2 Vmwl38 Amino Acid Sequences 
with EBV and VZV Proteins.
a) C-terminal regions.
The 109 amino acid sequence of the C-terminal 
region of HSV-2 Vmwl38 was compared with corresponding 
portions of the EBV 93,000 and VZV 87,000 mol. wt. 
polypeptides. Analysis using the CINTHOM program indicates 
that the HSV-2 and EBV sequences are essentially colinear, 
however, the EBV sequence contains a C-terminal region 
which is not present in the HSV-2 sequence (Fig. 53). The 
HSV-2 and VZV C-terminal regions are colinear with no 
extensive insertions or deletions (Fig. 54). Alignment of 
the sequences using the HOMOL program indicates that, in 
common with comparisons with HSV-2 Vmw38, the HSV-2/VZV 
homology is higher than that between HSV-2 and EBV 
sequences. Fig. 55 illustrates the HSV-2/EBV alignment and 
indicates that there are 75 additional residues at the 
C-terminus of the 93,000 mol. wt. polypeptide; homology 
between the sequences is principally associated with three 
regions shown in Fig. 55. Comparisons between nucleotide 
sequences in these polypeptide coding regions reflect the 
homology detected at amino acid level (Figs. 51 and 52).
b) N-terminal regions.
Comparisons between the N—terminal 86 amino acids 
of HSV-2 Vmwl38 and the EBV 93,000 and VZV 87,000 mol. wt. 
proteins reveals no detectable homology (data not shown).
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Figure 54. A CINTHOM plot comparing C-terminal amino acid 
residues of HSV-2 Vmwl38 with the equivalent region of the 
VZV 87,000 mol. wt. protein. Program settings were; range = 
12; scale factor = 0.95; minimum value plotted = 30%; 
compressed x2.
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Figure 55. Alignment of the C-terminal amino acid residues 
of HSV-2 Vmwl38 and the EBV 93,000 mol. wt. protein. 
Asterisks denote conserved residues and the HSV-2 sequence 
is numbered. Blocks of higher homology are boxed.
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Other comparative studies indicate that N—terminal portions 
of the EBV and VZV proteins share homology with HSV-1 
Vmwl36 beginning at approximately amino acid residue 490 in 
the HSV-1 sequence, thus Vmwl36 contains a large N-terminal 
region which is not present in either of the EBV or VZV 
proteins (I. Nikas, personal communication). Homology 
between the N-terminal regions of HSV-1 Vmwl36 and HSV-2 
Vmwl38 (see Page 149) would indicate that the HSV-2 
polypeptide also contains additional amino acid sequences 
as compared with the EBV and VZV proteins.
17. Comparison of the Proposed C-terminal Portion of the 
HSV-2 54,000 mol, wt. Protein with VZV and EBV 
Polypeptides.
The proposed C-terminal 122 amino acids of the 
HSV-2 54,000 mol. wt. protein were compared with the amino 
acid sequences of an open reading frame in VZV DNA which 
would specify a 54,000 mol. wt. protein (A.J. Davison, 
personal communication) located immediately upstream from 
the 87,000 mol. wt. protein. The HSV-2 sequence is 
homologous to the VZV sequence from approximately residue 
360 to the C-terminus of the VZV protein (Fig. 56). This 
alignment of HSV-2 and VZV amino acid sequences suggests 
that the VZV and HSV-2 54,000 mol. wt. proteins are 
functionally equivalent. Comparisons of the HSV-2 and VZV 
amino acid sequences with proposed protein coding regions 
of EBV reveal no detectable homology, thus EBV appears not 
to specify a protein which is equivalent to the HSV-2 and
VZV polypeptides.
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Figure 56» A CINTHOM plot comparing the C-terminal amino 
acid residues of the HSV-2 54,000 mol. wt. protein with the 
equivalent region of a VZV 54,000 mol. wt. polypeptide. 
Program settings were: range = 15; scale factor = 0.95; 
minimum value plotted = 25%; compressed x2.
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DISCUSSION.
18. Conservation of Proteins between Herpesviruses.
The C—terminal portion of Vmwl38, a component of 
the HSV-2-specified ribonucleotide reductase, has homology 
with VZV and EBV proteins with sizes of 87,000 and 93,000 
mol. wt. respectively; this homology extends to the 
N-terminal regions of the VZV and EBV proteins (I. Nikas, 
personal communication). These results suggest that the
87.000 and 93,000 mol. wt. proteins may form components of 
ribonucleotide reductases specified by VZV and EBV. 
Furthermore, HSV-2 Vmw38, the proposed second component of 
HSV ribonucleotide reductase, has homology with VZV and EBV 
proteins with sizes of 35,000 and 34,000 mol. wt. 
respectively, a possible indication of the structural 
similarities between HSV and proposed VZV and EBV 
ribonucleotide reductases. EBV induces a novel 
ribonucleotide reductase activity during virus infection 
(Henry et al., 1978), although, at present, a virus-induced 
enzyme has not been detected in VZV-infeeted cells (W.
Clark and M. Frame, personal communication). However, a
34.000 mol. wt. polypeptide is immunoprecipitated from 
extracts of VZV-infected cells by antiserum directed 
against the C-terminal seven amino acid residues of HSV-2 
Vmw38 (Clark et al., 1985).
Amino acid and DNA sequence conservation between 
the HSV and VZV sequences is greater than that between the 
HSV and EBV sequences. DNA/DNA hybridisation studies
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have demonstrated that the VZV genome is colinear with the 
II or IgL arrangement of the HSV genome (see Fig. 2) and 
the region encoding the HSV ribonucleotide reductase has 
homology with VZV DNA (Davison and Wilkie, 1983a). 
Nucleotide sequence comparisons between the S segments of 
HSV and VZV DNA reveal that seven of the thirteen HSV-1 
genes have homologues in VZV, however, the gene 
arrangements in the two S segments is not identical 
(McGeoch, 1984; A.J. Davison and D.J. McGeoch, personal 
communication). Similarly, the viral DNA polymerase (Quinn,
1984) and 65,000 mol. wt. structural protein (Dalrymple e^ 
aJL., 1985) involved in stimulation of IE mRNA synthesis, 
both of which are located in the HSV-1 L segment, are 
conserved in VZV.
The HSV-2 54,000 mol. wt. protein and equivalent 
VZV product have no detectable homology with any EBV 
protein coding sequences. A number of HSV genes, for 
example the 65,000 mol. wt. protein (Dalrymple et al.,
1985) and genes encoded by the HSV-1 DNA S segment (D.J. 
McGeoch, personal communication), also do not appear to be 
conserved in the EBV genome, however, there is homology 
between the HSV-1 DNA polymerase gene and an EBV 
polypeptide (Quinn, 1984). These data further confirm that 
functions specified by the HSV and VZV genomes, both 
^Iphaherpesviruses with similar biological properties, are 
®ore closely related than with those of EBV, a 
gammaherpesvirus (see Introduction, Page 3).
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19. Arrangements of the Transcripts Specifying the VZV and 
EBV Proteins Equivalent to Vmwl38 and Vmw38.
The EBV and VZV po-lypeptides having homology with 
the Vmwl38, Vmw38 and 54,000 mol. wt. proteins have the 
same genomic arrangement as the HSV-2 proteins. However, 
organisation of the EBV mRNAs encoding the 93,000 and
34.000 mol. wt. polypeptides is different from that of the 
HSV-2 4.5kb and 1.2kb 3' co-terminal transcripts. The EBV
93.000 mol. wt. protein is encoded by a 2.7kb transcript 
which has a 3' terminus located in the vicinity of the ATG 
triplet for the 34,000 mol. wt. product (Gibson et al.,
1984); the AATAAA signal for this mRNA is partially encoded 
by the stop codon for the 93,000 mol. wt. protein. The EBV
34.000 mol. wt. protein is specified by a 3.3kb message 
which has a 5' terminus located within the 93,000 mol. wt. 
polypeptide coding region. Therefore, in common with the 
HSV-2 1.2kb message, the transcription control signals 
which direct synthesis of the 3.3kb mRNA form part of the 
sequences encoding the 93,000 mol. wt. protein. Sequences 
involved in transcription of the 3.3kb mRNA will be further 
described in the General Discussion (Page 195 and Fig. 70).
The mRNAs specifying the VZV polypeptides have not 
been analysed, however, the TATA box homology, upstream 
from the HSV-2 1.2kb mRNA and within the protein coding 
region of Vmwl38, is retained in the VZV DNA sequence and 
&n AATAAA sequence does not occur immediately downstream 
from the coding region of the VZV 87,000 mol. wt. protein 
(A.J. Davison, personal communication). A potential
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polyadenylation signal is located downstream from the 
C-terminus of the 35,000 mol. wt. protein. These data 
suggest that the organisation of the VZV mRNAs specifying 
the 87,000 and 35,000 mol. wt. proteins is similar to that 
of the HSV-2 transcripts encoding Vmwl38 and Vmw38.
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Figure 57. A CINTHOM plot comparing the C-terminal amino 
acid residues of HSV-2 Vmwl38 with the equivalent region of 
the E. coli B1 polypeptide. Alternative alignments of the 
sequences are labelled A and B. Program settings were: 
range = 12; scale factor = 0.95; minimum value plotted = 
26%; compressed x2.
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SECTION D .
20. Amino Acid Conservation between HSV, Prokaryotic and 
Eukaryotic Ribonucleotide Reductases.
From the DNA sequences encoding bacterial and 
mammalian ribonucleotide reductases, amino acid sequences 
for the E. coli B1 (see Introduction, Page 53; Carlson ejt 
al., 1984) and mouse Ml subunits (see Introduction, Page 
56; Caras et al., 1985) have been predicted and these were 
compared with the HSV-2 Vmwl38 sequences. The N-terminus of 
Vmwl38 had no homology with E. coli and mouse subunits 
(data not shown), however, a low level of conservation was 
detected between the Vmwl38 C-terminus and the C-termini of 
the B1 and Ml polypeptides (Figs. 57 and 58). The CINTHOM 
plot predicts two possible alignments for the B1 and Vmwl38 
sequences (shown by A and B in Fig. 57); the alignment with 
the greater homology, marked B in Fig. 57, is shown in Fig. 
59. The viral polypeptide has greater homology with the Ml 
subunit than with either alignment of the B1 sequences 
(Fig. 58). There are two regions conserved between viral 
and mammalian proteins which correspond to areas of 
homology in the HSV and EBV proteins; these areas are 
located between residues 44 to 48 and 77 to 84 (Figs. 55 
and 59).
Low but detectable homology was observed 
principally between one area of the HSV-2 Vmw38 and E. coli 
B2 proteins (shown as A in Fig. 60). Vmw38 has more 
extensive homology with a surf clam (Spisula solidissima)
Mouse Ml
20 40 60 80 100 120 140 160
20
40
HSV-2  
Vmw138
60
80
100
Figure 58. A CINTHOM plot comparing the C-terminal amino 
acid residues of HSV-2 Vmwl38 with the equivalent region of 
the mouse Ml protein. Program settings were: range = 12; 
scale factor = 0.95; minimum value plotted = 28%; 
compressed x2.
B. coli TVFCARWCRTTSTCTTPMSCCGLCRVTMVICNVmVSCRNLSISRSLPTPT
* *
HSV-2 KQWSVAQALPCLDPAHPLRRFKTAFDYDQELLIDLCADRAPYVpHSQSMT 50
* ** * * *  * * * «
Ml GSIQSIPEIPDDLKQ LYKTVWEISQKTVLKMAAERGAFIDQSQS LN
GLKTGMYYLRTRPAANPIQFTLNK
E. coli TIRHASRQEKCPMQQLLKDLLTAYKFGVLTLYYQTPVTAVKDAQDDLGAV
* * * * * *  * * * * *
HSV-2 LYVTEKADGTLPASTLVRLLVHAYKP|GLKTGMYY|cKVRKATNSGVFAGDD 100 
* * * *
Ml IHIAEPNYGKLT SMHFYGWKQ
E. coli NPGRWLETAHVRSDIEMRIGLRLIPVRLGL 
* *
HSV-2 NIVCTSC AL-
Ml EKLKDKEKALKEEEEKERNTAAMVCSLENREECLMCGS-
Figure 59. Alignment of the C-terminal amino acid residues 
of HSV-2 Vmwl38 with equivalent regions of the mouse Ml and 
E. coli B1 proteins. Asterisks denote conserved residues 
and the HSV-2 sequence is numbered. The alignment of the 
HSV-2 and E. coli sequences is represented by B in Fig. 57. 
Blocks of homology are boxed.
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protein with a mol. wt. of 40,000 (p40; Fig. 61) which is 
translated from stored, maternal mRNA following 
fertilisation of clam oocytes (Rosenthal et al., 1980 and 
1983; Evans et al., 1983). Alignment of the sequences 
indicates that E. coli protein B2 contains two stretches of 
amino acid sequences not present in viral and clam 
polypeptides (Fig. 62, at residues 173 and 242). Regions 
conserved in all three proteins are located between 
residues 124 to 131, 191 to 193 and 213 to 221 (Fig. 62);
two of these regions (residues 191 to 193 and 213 to 221) 
are also conserved in the EBV 34,000 mol. wt. protein. The 
overall homology of Vmw38 with clam p40 is greater than 
that with the B2 protein and five areas common to the HSV-2 
and clam sequences are absent in the E. coli sequence (Fig. 
62) These areas of homology between Vmw38 and p40 
correspond to sequences conserved in the EBV 34,000 mol. 
wt. protein (Fig. 50). Interestingly, the amino acid 
sequence between residues 108 to 116 (Fig. 62) in the 
N-terminal region of the HSV-2 protein is almost completely 
conserved in the C-terminal portion of the E. coli B2 
polypeptide (Fig. 62, residues 321 to 329).
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Figure 60. A CINTHOM plot comparing amino acid sequences 
of HSV-2 Vmw38 with those of the E . coli B2 protein. The 
region of highest homology between both proteins
is labelled A. Program settings were: range = 12; scale 
factor = 0.95; minimum value plotted = 26%; compressed x4.
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Figure 61. A CINTHOM plot comparing the amino acid 
sequences of HSV-2 Vmw38 with those of surf clam p40. 
Program settings were: range = 12; scale factor = 0.95; 
minimum value plotted = 28%; compressed x4.
Cla m  MYKK
HSV-2 MDP AVSP ASTDPLDTHASGAG AAPIP VC PTPERYFYTSQC PDINHLRSLS
« * * **
E . coli MAYTTFSQTKNDQLKEPMFFGQPVNVARYDQQKYDIFEKLIEK
50
Clam a e a s f w t a e e v d l s k d m a h w e s l k k e e k h f i s h v l <a f f a a s d g i v n e n l1v
* * * * * *
HSV-2 ILNRWLETELVFVG DEEDVSKLSEGELGFYRFLFli
* * * * * * * * *  *
E.coli QLSFFWRPEEVDVSRDRIDYQALPEHEKHIFISNLKYQTLLDSIQGRSPN
98
Clam
HSV-2
ERFSKEVQVTEARCFYGFQIAMENI 
* * * *
DTYIKDPQERDFLFNA 
GGLSGLFEQ^Dn.HYYV^EC IEV\^SRVYN I iIq LVLFHNNDQARRAYV
E.coli VALLPLISIPELETWVETWAFSETIHSRSYTHIIRNIVNDPSWFDDIVT
147
lETMPCVKEKA
*
Clam
HSV- 2 ART INHP Al RVKVDWLEARVREC DS V
DWAMRWINDDSSSY 
** *
173
E.coli NEQIQKRAEGISSYYDELIEMTS YWHLLGEGTHTVNGKTVTVSLRELKKK
Clam
HSV-2
AERWAFAA
*
PEKFILMILI
E.coli LYICLMSVNALEAIRL
GIFFS IFWLKKRGIMPGLTFSNELISRDEGL
* *  * * * * * *
IAYLRTNNLLRVTCQSNDLISRDEAVÏ
* * * *
SFAFAERELMEGNAKIIBLIARDEAL
* *
222
DFAC
*
Clam
HSV-2 TASCYIYNNYLGDHAKPEAA
LMFSHLVNKPSQE
* *
* *
RIHQIID 
*
(ElAVKI 
* * *  * *
EDVFLTEALP 
* *
RVYRLFREAVDIEIGFIRSQAP 264
* *
E . col i TGTQHMLNLLRSGADDPEMAEIAEECKQACYDLFVQAAQQEKDWADYLFR
Clam CR LIGMNC DLMRQYI EFVlADRLliLELKC DKLYNKENPFDFMEHISL 
* * * * * * * *  * * * * * *
HSV-2 TDSSI LSPGALAAIENYVRFSlADRLLkLIHMQPLYSAPAP DASFPLSL 
* * * * * * * * * * *
E.coli DGSMIGLN^DÏijÇQW^ITNlRMQAVGLDLPFQTRSNPIPWINTWLVSD
312
TNFF
* * * * *
EKClam EGK
HSV-2 MSTDKHTNFFECRSTSYAGAWNDL-
RVGEYQKMGVMSGGNTGDSHAFTLDADF- 
* * *
337
E.coli NVQVAPQEVEVSS YLVGQIDSEVDTDDLSNFQL-
Figure 62. Alignment of the amino acid sequences of HSV-2 
Vmw38 with those of the surf clam p40 and E. coli B2 
proteins. Asterisks denote conserved residues and the HSV-2 
sequence is numbered. Regions of higher homology are boxed 
and dashed lines indicate the N-terminal region of Vmw38 
which has homology with residues at the C-terminus of the 
E. coli polypeptide. Proposed locations for the iron 
binding site (#) and tyrosine free radical ( ♦ ) are 
indicated.
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DISCUSSION.
21. Proposed Functional Domains within Ribonucleotide 
Reductases.
Sequence comparisons between the proposed subunits 
of the HSV-2 ribonucleotide reductase with those of 
eukaryotic and prokaryotic reductases have revealed regions 
of conserved amino acid residues. DNA hybridisation studies 
have shown that the nucleotide sequences encoding the mouse 
Ml subunit have homology with DNA sequences from a number 
of mammalian species, including humans (Caras et al.,
1985). These data suggest that ribonucleotide reductases 
from a wide variety of species and organisms are 
evolutionarily related and regions of conserved amino acid 
residues may represent domains which are necessary for 
enzyme function.
Studies on the evolution of haemoglobins suggest 
that functionally critical regions are the most conserved, 
for example, there is no structural variation in the 
histidine residues which bind the heme (Perutz et al.,
1965). In contrast, amino acids located on the surface of 
the haemoglobin molecule have evolved ten times more 
rapidly than those involved in heme binding (Kimura and 
Ohta, 1974). Other comparisons between E. coli DNA 
polymerase and T7 DNA polymerase indicate that domains 
involved in DNA binding are highly conserved and appear to 
share common structural features (Ollis et al., 1985);
^reas of low homology between these polymerases are in
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regions of less secondary structure which lie on the 
surfaces.
The longest stretch of homology between the 
proposed small subunits of viral and cellular reductases 
has the amino acid sequence LISRDE in Vmw38 (Fig. 62, 
residues 213 to 218), of which four are either charged (R,
D and E) or hydrophilic (S); the charged amino acids are 
invariant and conserved in all proposed small subunit 
proteins. In general, charged amino acids, which are 
usually located on the surfaces of proteins, are the least 
well conserved residues in related proteins (Creighton, 
1983). Highly conserved amino acids are generally those 
with non-polar groups which are located internally within 
the protein structure. Thus, retention of charged residues 
in the proteins with homology to Vmw38 suggests that these 
amino acids have an important functional role. A second 
region of lower homology is located upstream from the 
LISRDE segment between residues 191 to 193 (Fig. 62) in 
HSV-2 Vmw38. These conserved residues lie within a highly 
hydrophobic region (Fig. 63) which extends from residue 175 
to residue 197 and is present at a similar location in all 
proposed small subunit polypeptides (data not shown). The 
role of these conserved areas is unknown, however, the B2 
subunit supplies elements which form part of the active 
centre of the E. coli enzyme (von Dobeln and Reichard,
1976). One possibility is that either the LISRDE sequence 
or the conserved hydrophobic region contribute to the 
active centre.
wa :
-4 0
MDPAVSPASTDPLDTHASGAGAAFIPVCPTPERYFYTSQCPDirJHLRSLSILNRWLETELVFVGDEEDVSKLSEG
40
0 V'
-4 0
ELGFYRFLFAFLSAADDLVTEWLGGLSGLFEQKDILHYYVEQECIEVyHSRVYNIIQLVLFHNNDQARRAYVART
40
X* /V
- 4 0
INHPAIRVKVDWLEARVRECDSVPEKFILMILIEGVFFAASFAAIAYLRTNNLLRVTCQSNDLISRDEAVHTTAS
40
- 4 0
CYIYNNYLGDHAKPEAARVYRLFREAVDIEIGFIRSQAPTDSSILSPGALAAIENYVRFSADRLLGLIHMQPLÏS
40
-40
SAPAPDASFPLSLMSTDKHTNFfECRSTSYAGAVVNDL-
Figure 63. Hydropathicity plot of the HSV-2 Vmw38 amino 
acid sequence. Hydrophobic regions lie between 0 and 40 and 
hydrophilic regions lie between 0 and -40. The Vmw38 amino 
acid sequence is shown below the plot. Regions conserved 
between Vmw38, the EBV 34,000 mol. wt. and surf clam p40 
polypeptides are shown by two solid lines. Underlined are 
areas of homology between Vmw38 and the EBV 34,000 mol. wt. 
polypeptide and dashed lines locate regions conserved 
between Vmw38 and surf clam p40. Arrows delimit the 
hydrophobic region conserved in the equivalent areas of 
EBV, VZV, surf clam and E. coli proteins. Program settings 
were: group length = 9; shift = 1; spacing of plotted 
points = 10.
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In addition to supplying a portion of the enzyme 
active centre, each B2 subunit of E « coli ribonucleotide 
reductase contains a tyrosine free radical and two atoms of 
iron (see Introduction, Page 52). Iron is required to 
generate and stabilise the free radical by some unknown 
continued interaction, and removal of the iron leads to a 
loss of the free radical. Tyrosine free radicals have also 
been detected in the PRV (Lankinen et al., 1982) and 
mammalian reductases (Thelander et al., 1985), suggesting 
that the free radical may be ubiquitous in reductases which 
consist of two non-identical subunits. Locations for the 
iron binding site and tyrosine free radical within the 
small subunit polypeptide have been proposed from sequence 
comparisons (Sjoberg et al. , 1985; Standart et al., 1985); 
the positions of these sites corresponds to the conserved 
region between residues 121 to 131 (Fig. 62). The iron 
binding site has been positioned on a histidine residue 
(Fig. 62, residue 134) and a further four amino acids 
downstream, a conserved tyrosine residue has been proposed 
as the location of the free radical. This region is not 
highly conserved in EBV (Fig. 50), however, both histidine 
and tyrosine residues are retained.
The amino acid sequence (KDILHYYVE) in the 
N-terminal portion of Vmw38 between residues 108 to 116 
(Fig. 62) is almost perfectly conserved in the C-terminal 
region of the E. coli B2 protein (KDILCQYVE; Fig. 62, 
residues 272 to 280). These amino acids are poorly 
conserved in the equivalent region of the clam sequence.
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however, most of these residues are retained in EBV (Figs. 
50 and 62); the function of these amino acids is unknown. 
The presence of homologous sequences at different locations 
in Vmw38 and the B2 polypeptide is unlikely to have arisen 
by chance and may be a consequence of evolutionary 
pressure. Firstly, these N- and C-terminal positions in the 
Vmw38 and B2 proteins may be structurally related and the 
similarity in the sequences could be a result of convergent 
evolution. A second but less likely possibility is that the 
proteins have acquired these sequences following their 
divergence from a common ancestral gene. Thirdly, the 
different locations of homologous residues may be due to 
movement of protein domains. Recombination of exons into 
introns has been proposed as a mechanism for 'shuffling' 
domains and thereby increasing genetic complexity (Blake, 
1978; Gilbert, 1978). By implication, precursor 
polypeptides to the B2 and Vmw38 proteins would have 
contained introns which have subsequently been deleted; it 
has been suggested that splicing did occur in primordial 
systems (Doolittle, 1978).
Although there is homology between the viral and 
cellular components of ribonucleotide reductases, viral and 
cellular subunits appear not to bind to a significant 
extent. In cells infected at the npt with the 
ribonucleotide reductase—negative mutant, 17tsVP1207, which 
fails to produce a complex between Vmwl36 and Vmw38 (Page 
158), antiserum directed against the seven C-terminal amino 
acids of Vmw38 does not immunoprecipitate a host protein 
corresponding to the size of Ml (Frame et al., 1985).
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SECTION E .
22. Conserved DNA Sequences Downstream from mRNA 3*
Termini.
^ i e n t  polyadenylation requires the sequence 
AATAAA, a highly conserved poly A signal which is present 
upstream from the 3' termini of higher eukaryotic 
polyadenylated mRNAs (see Introduction, Page 87). However, 
this DNA sequence occurs also in regions which do not 
contain poly A sites, hence, additional sequences must be 
involved in determining the location of poly A sites. 
Comparisons between HSV-2 and HSV-1 DNA sequences at the 
poly A sites of the 3' co-terminal mRNAs revealed three 
blocks of homology downstream from the poly A sites (see 
Page 140). DNA sequences flanking the poly A sites of four 
other equivalent HSV-2 and HSV-1 genes also contained 
regions of conserved G+T-rich residues at approximately 
30bp downstream from the poly A signal (Fig. 64). In 
addition, G+T-rich motifs were present in the flanking 
sequences of a number of HSV-1 mRNA 3* termini for which no 
equivalent HSV-2 DNA sequence data are available (Fig. 64). 
The comparative analysis was extended to include a large 
number of mammalian and eukaryotic viral genes and this 
survey indicated that greater than 60% of 3' terminal 
regions possessed sequences similar to those conserved 
downstream from HSV mRNA 3’ termini (Fig. 65). From a 
compilation of these data, the consensus sequence YGTGTTYY 
was derived (Table 2); the preferred distance for sequences
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Figure 64. DNA sequence comparison at the mRNA 3' termini 
of a number of HSV-2 and HSV-1 genes. The genes for which 
DNA sequence data are available for both serotypes are 
compared. Asterisks denote nucleotides which are conserved 
and the locations of poly A sites are arrowed. The AATAAA 
signals and sequences which fit the YGTGTTYY consensus are 
indicated by a solid line. Dashed lines locate the G-rich 
sequences present downstream from the YGTGTTYY consensus. 
Tandem repetitions in the 3 ' flanking regions of HSV mRNAs 
are bracketed and the number of copies of each repeat 
indicated. DNA sequence data were taken from the following 
references :
1. Watson and Vande Woude, 1982; 2. Rixon and McGeoch,
1984;
3. Whitton and Clements, 1984b; 4. McLauchlan and Clements, 
1982;
5. this study; 6. Whitton et al., 1983; 7. McKnight, 1980;
8. Swain and Galloway, 1983; 9. Frink et al., 1983;
10. Swain et al., 1985; 11. Rixon et al., 1984;
12. Davison and Wilkie# 1981 ; 13. Rixon et al., 1982;
15^
14. McGeoch et al., 1985; Rixon and McGeoch, 1985.
il y I o
ol o
ol o
« C c XI XiC C C C c 0 0 Xia 0X» 0 0 Xi Xi XI 01 OlO O 0 0 0 1 1 OlOl Ol c 1c O' 1 Ol Ol Ol «
« 1 c Q 1 1 G G «X
II' a « Q '=Ck. tc_
ÿ« c ai c ai aiB 5 «B o U « ■ ■ XiS G 3 (J c G 3 3 Xi
« 3 0 £ 3 0 3 0 0 «£ X £ u U O ü X £ £ 06
lO
< <
O 8c Eh Eh
o Tf y yu < y
y y y yo y Eh yo y y <
< y c yu < y <
e y < y
o y 2 <o Eh y yo Eh y y
E- y Eh yo Eh < <u Eh 2 y
y Eh y Ehe < y Eh
1 e y < y
1 ^ E- Eh y1 y y < Eh
1 ^ y y y1 E- E- Eh y
Ü y Eh <y Eh y Ele Eh Eh Eh
c y y Ehy e f- <
Eh Eh y Ehy Eh Eh Eh
e y y yy Eh y< y Eh uy Eh < y< < y <y y y y
y y y Ehy Eh y y
E- y Eh y
y < y Ehy y Eh yy < Eh y
y y y Ehy y Eh yy Eh uy E- < y
Eh y 2y y y <y < < y
y < 2 <y y Eh —  y
Eh < < Eh
y y Eh <y Eh Eh y
y < Eh <y y Eh y< < y yy y Eh <y < Eh 2y 2 Eh y< y y yy y y Ehy Eh Eh y
Eh Eh Eh Eh
5 %
y 2 2yy y Eh Eh
Eh < y Eh< y y yy < y yy y < Eh< < 2 Eh
y y y Ehy Eh y yy Eh < y
< Eh Eh y
y E- <y y yy Eh y< y yy Eh <
y y yy y y
Eh Eh y y
E- E- Eh <
y < y 2
< y y y
e < y yc < y yy y < << < 2 y
Eh y Eh yy y y y
8
:
I
\t
<
g
g
g
%
1
s
I
t
Xi Xi X) c (N 0 X:0 o 0 z Z z hJ
ai b b b X
Ol Ol Ol ^  0 y < Û 01 1 Ol J Ol 3 1 1 1
-G <  Ol X % Ol aiHJ C cC c c  -H c c ai C C C c 0
u s s s * S « m ^  X « g « g GG G G HJ G G 3 Xi 0 G a G 6
X: 3 3 3  ai 3 3 0 « -H 3 3 3 3 0
y X X X  «H X X £ X  Ol X X X X  X
il l
g
ïuu
1
u
3
0 ai 
w c  o> 0
acil n
So
Figure 65. Compilation of DNA sequences at the 3' termini 
of mammalian and eukaryotic viral mRNAs. Sequences are 
aligned using the AATAAA signals which are underlined. 
Locations of poly A sites are arrowed and sequences which 
resemble the YGTGTTYY consensus are underlined. G-rich 
tracts beyond mRNA 3' termini are indicated by a dashed 
line below the sequence and T-rich tracts by a dashed line 
above the sequence.
A) IFN is the abbreviation for interferon. DNA sequence 
data were taken from the following references:
I. Liebhaber et al. , 1980; 2. Nishioka and Leder, 1979;
3. Dodgson et al., 1983; 4. Erbil and Niessing, 1983;
5. Schon et al., 1982; 6. Lawn et al., 1980;
7. Konkel et al., 1979; 8. van Ooyen et al., 1979;
9. Dolan et al., 1983; 10. Spritz et al., 1980;
II. Baralle et al. , 1980; 12. Shen et al., 1981;
13. Ellison et al., 1982; 14. Malissen et al., 1982;
15. Cheng et al., 1982; 16. Suske et al., 1983;
17. Ullrich et al. , 1982; 18. Ohno and Taniguchi, 1981;
19. Taya et al., 1982; 20. Denoto et al., 1981;
21. Page et al., 1981; 22. Woychik et al., 1982;
23. Bell et al., 1980.
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Figure 65.
B) DNA sequence data were taken from the following 
references :
24. Perler et al., 1980; 25. Kwok et al., 1983;
26. Cordell et al., 1979; 27. Lomedico et al., 1979;
28. Fiddes and Goodman, 1981 ; 29. Noda et al., 1982;
30. Chang et al., 1980; 31. Vasicek et al., 1983;
32. Shibahara et al., 1983 ; 33. Lemischka and Sharp, 1982;
34. Hurst and Parker, 1983; 35. Nudel et al., 1983;
36. Fornwald et al., 1982 ; 37. Aho et al., 1983;
38. Heilig et al., 1982; 39. Mason et al., 1983;
40. Karin and Richards, 1982; 41. Glanville et al., 1981.
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Figure 65.
C) The key to abbreviations is: BPV-1, bovine 
papillomavirus type 1; HPV-1, human papillomavirus type 1. 
DNA sequence data were taken from the following references: 
42. Gingeras et al. , 1982; 43. Dijkema et al., 1982;
44. Sugisaki et al., 1980; 45. Broker, 1980;
46. Akusjarvi et al., 1981 ; 47. Hérissé and Galibert, 1981; 
48. Akusjarvi and Persson, 1981b; 49. Hérissé et al., 1980; 
50. Fiers et al., 1978; 51. Soeda et al., 1980;
52. Seif et al., 1979; 53. Chen et al., 1982;
54. Danos et al., 1982.
in vO 1" 00
in m ine < < yy 2 y <y Eh Eh yy y y y
Eh y 2 yy y 2 y< En Eh yy y y En
Eh < y <y y Eh y
Eh y Eh
u Eh E- yy y y Ehf* y Eh yy y y 1 y
Eh < y yy y y 1 y
S' $ y! ^
n 81 8y y Eh yy Eh Eh y
Eh < y Eh
Eh y y yu < E- yy Eh Eh yA y yEh y Eh Ehy y Eh yEh Eh y Ehy y y yy y Eh yy < y yEh y E- Ehy y y y
Eh Eh y Ehy y Eh yy Eh y yEh y y Ehy y y y
Eh Eh y y
Eh Eh < Ehy < 2 y< y y <y c y yy y y Ehy y Eh yEh < < Eh
< y 8 <8 y Eh 8Eh < Eh EhEh y Eh Ehy y < Eh< < Eh yy Eh y Ehy Eh y yEh Eh Eh yEh Eh Eh Ehy < y Eh
En y Eh yy y y Ehu y y yy y
8 8
î
I
u
g
ii
0VO
1
8
g
I
E-vÜU
i
8
CM m Ht m
\0 vO VO VO vO
< Eh < Eh yy y y y y
2 y Eh y
2 y y y yy y 2 Eh yy Eh 2 e y
2 y y < y
2 y y y P
Eh y y y yy Eh En Py Eh e y yy y Eh y yEh y y yy Eh < yy y 1 y Py Eh y y <
Eh y yi Eh y
y le gl 8 8
ly 81 g Hy ,e Eh < Ehy 1 e Eh y yy ,Eh y Eh Ehy e y e yy < Eh y Ehy y Eh y yy < y y Eh
Eh y Eh Eh yy y Eh y Ehy c y y Eh
Eh y y < Eh
Eh < y yy y y y Ehy Eh < Eh y
Eh y y y Ehy c y Eh yy y Eh y yy y y Eh Eh
Eh y y y y
Eh e Eh y py e y Eh y
Eh < 2 Eh Ehy y 2 Eh
Eh < y y yy y y < Eh
Eh f> y y Eh
Eh y e y <
Eh y <y
g ï Îy y e < yu Eh Eh y yy y < y Py Eh Eh < y
Eh Eh y y <y y y Eh y
Eh Eh Eh Eh 2
Eh Eh Eh Eh 2
Eh Eh y < yy e Eh y y
Eh y y Ehy y y y Ehy y y
m
Ht D
0
C CM
«  1
C CT >
0 V
<JV « •O
w c  co
u > 0) 3
S CD m U
0) C -H
h «J >
> 1 > •H 0
CD < CD > U
< CD y £ <  a
X >« CDy <
Figure 65.
D) The key to abbreviations is: A-MuLV, Abelson murine 
leukaemia virus; AMV, avian myelocytomatosis virus ;
SSV, simian sarcoma virus ; GA-FeSV, Gardner-Arnstein feline 
sarcoma virus ; MSV, murine sarcoma virus ; BaEV, baboon 
endogenous virus ; SNV, spleen necrosis virus; GaLV, gibbon 
ape leukaemia virus ; ASV, avian sarcoma virus; MTV, mammary 
tumor virus.
DNA sequence data were taken from the following references :
55. Reddy et al., 1983a; 56. Reddy et al., 1983b;
57. Devare et al., 1983; 58. Hampe et al., 1983;
59. Van Beveren et al., 1981; 60. Scholl et al., 1983;
61. Tamura et al., 1981; 62. Shimotohno et al., 1980;
63. Lovinger and Schochetman, 1979; 64. Czernilofsky e^ 
al., 1980; 65. Donehower et al., 1981.
A 8 6 0 3 3 1 4 9
G 15 57 5 65 11 9 9 13
C 12 1 1 0 0 15 18 14
T 36 7 65 3 57 46 40 35
Y G T G T T Y Y
(67%) (80%) (91%) (91%) (80%) (65%) (82%) (69%)
Table 2. Derivation of the YGTGTTYY consensus from 
sequences located 24bp to 38bp downstream from the AATAAA 
signal. This represents an analysis of 71 of those 
sequences listed in Figs. 64 and 65 which contain the 
signal. Numbers indicate the frequency of occurrence for 
each nucleotide and the percentage conservation for each 
residue within the consensus is given.
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which fit this consensus is 24 to 35nuc beyond the poly A 
signal. A second conserved segment in certain HSV genes is 
a G-rich sequence downstream from the YGTGTTYY motif (Fig. 
64). A number of eukaryotic genes contain similar tracts of 
G-rich residues, however, in other 3' terminal regions a 
T-rich segment is present at a location equivalent to the 
position of these G-rich sequences (Fig. 65).
23. Functional Analysis of the YGTGTTYY Sequence.
To test the effect of removing sequences downstream 
from the poly A site, plasmid constructions were made using 
the CAT gene. An HSV-2 IE promoter fragment was inserted 
upstream from the CAT gene giving plasmid pLWl (see 
Methods, Page 99, Fig. 10), and a 'terminator' fragment 
from the same IE gene was inserted downstream to give 
plasmid pTER5.
The HSV-2 IE promoter was a 210bp Sma I/Sau 3A 
fragment from IE gene-4/-5 (see Fig. 3 for locations of IE 
mRNAs-4 and -5) which comprised 91bp of 5' flanking 
sequence and 119bp of leader sequence. This promoter 
fragment contains all the sequences required for initiation 
of transcription and the location of the mRNA 5' terminus 
is identical to that determined for HSV-2 IE mRNAs-4/-5 
synthesised in vivo (Gaffney et al., 1985). Plasmid pLWl 
has no ATG in the HSV-2 leader sequence; the first 
initiation codon in the mRNA is the CAT gene ATG.
The 'terminator' was a lOObp Sma I/Xba I fragment 
from the 3' terminus of HSV-2 IE gene-5. The 3' flanking 
sequences in this fragment extend 48bp beyond the poly A
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site. The 'terminator' fragment contains an AATAAA signal, 
and located 8nuc downstream from the poly A site is the 
sequence TGTGTTGC which fits the YGTGTTYY consensus except 
in one position (Fig. 64). A G-rich segment (GGGGACGGGGG) 
is located a further 4nuc downstream from the YGTGTTYY 
sequence. Comparison of HSV-2 and HSV-1 DNA sequences from 
the 3' terminal portions of IE gene-5 (Fig. 64) reveals 
conservation of the AATAAA signal together with two blocks 
of homology downstream from the poly A site. The conserved 
block between positions 62 to 65 (Fig. 64) forms part of 
the sequence corresponding to the YGTGTTYY consensus.
a) Construction of 'terminator' plasmids.
Fig. 66 details the construction of plasmids used 
for short-term expression assays. The 'terminator' fragment 
was blunt-ended (see Methods, Page 112) and initially 
cloned into the Hinc II site of pUC9 to give plasmid pTER3. 
A Hind Ill/Xmn I fragment containing the 'terminator' was 
then ligated to a Hind Ill/Xmn I fragment of pLWl 
containing the promoter/CAT modules to give plasmid pTER5. 
In pTER5, the 'terminator' is orientated with the AATAAA 
signal on the mRNA sense strand.
A series of deletions was made in plasmid pTER3 
from a Bam HI site located in the multiple cloning site 
downstream from the 'terminator' (Fig. 66). These deletions 
removed sequences from the 3' portion of the terminator 
and extended for different lengths through the YGTGTTYY
IE-5
AMP
Xba I Smol
pUC9
/QCl,
mes
Blunt-ended
Hinc n
XmnI XmnI
AMP AMP
Bom HI 
Exo ni 
Mung beanpLWI pTER3 pTER3A pLWI
Bom HI
CAT
Hind I I I
Hind Ill/X m n  I
Hind II I  /Xmn I Hind I I I  I Xmn I
AMP
pTER5
CAT
Figure 66. Construction of pTER plasmids. The Sma I/Xba I 
fragment (see Fig. b7) was derived from the HSV-2 plasmid 
pBam b ' (kindly provided by J.L. Whitton) and blunt-ended 
using large fragment DNA polymerase I with all four dNTPs 
(see Methods, Page 112). The multiple cloning site of pUC9 
(see Fig. ID) is designateü mes. The locations of 
restriction enzyme sites used for cloning purposes and 
deletion mutant analysis are indicated on plasmids. 
Deletions were producced in pTER3 as described in Methods, 
Page 110.
Sma I
HSV-2 I pA signal 50
IE-5 CCCGGGGACA GGGTGGTTGG TGTAATTAAT AATAAAATCG TGAAAATTGA
3' end Xba I
I YG TGTTYY |
AATCGCTTTG TGTGTTGCTG CGGGGACGGG _GGCAAATGCG TCGTGACTCT 
• •
A44 A bo
Figure 67. Nucleotide sequence at the 3' terminal region 
of HSV-2 IE mRNA-5. The AATAAA signal and sequences which 
fit the YGTGTTYY consensus are underlined; G-rich sequences 
are indicated by a dashed line. The location of the mRNA 3' 
terminus is arrowed and the positions of deletion 
end-points are indicated. Sma I and Xba I restriction 
enzyme sites, used for cloning, are also shown.
1 2 3 4 poly A site YGTGTTYY
pTERS 100(4.01) 100 100 100 + +
pTER5 A 30 35(1.41) 34 32 39 + +
pTERS A 44 3(0.12) 4 1 1 + -
pTER6 1.5(0.025) 2 0.6 1 inverted
pLWl 0.4(0.013) U U U - -
p pTERl 110(4.45) + ^  -globin +
Table 3. CAT activities obtained with various plasmid 
constructions are shown for four separate transfection 
experiments. Activities are expressed as a percentage of 
the pTER5 value; U indicates undetectable CAT activity. The 
figures in brackets from experiment 1 are typical CAT 
values expressed as nmoles converted chloramphenicol/ p q  
protein/ h. Plasmids pTER ^  30 and pTERS ^ 44 contain 
deletions in the HSV 'terminator' fragment; pTER6 has an 
inverted 'terminator' ; pLWl has no 'terminator' fragment ;
p^TERl contains a 12 5Obp rabbit ^  -globin fragment. The 
presence (+) or absence (-) of the poly A site and YGTGTTYY 
signal in each plasmid is indicated.
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homology towards the AATAAA sequence to give plasmid series 
pTER3A* Hind Ill/Xmn I fragments containing these 
'terminator' deletions were linked to the Hind Ill/Xmn I 
fragment of pLWl containing the promoter/CAT modules to 
give expression plasmid series pTER5 A  (Fig. 66).
b) Removal of 'terminator' sequences reduces CAT 
activity.
Plasmid pLWl lacks the pTERS 'terminator' and Table 
3 shows that Hela cells transfected with pLWl produced 
little detectable CAT activity whereas high levels of 
activity were obtained with pTER5. The 'terminator' 
fragment therefore was required for detectable CAT gene 
expression. To determine the effect on CAT activity of an 
alternative 'terminator', a 1250bp Bam Hl/Xho I fragment 
from the rabbit ^ -globin gene, containing all the IVS 2 
sequences and some 60Obp of flanking DNA (Banerji et al., 
1981), was inserted into the Hind III site of pLWl (see 
Methods, Page 101, Fig. 11). Plasmid p^TERl contained this 
rabbit ^-globin fragment with the AATAAA signal on the 
mRNA sense strand. Table 3 shows that CAT activity obtained 
with p ^ TERl was comparable to that obtained with pTER5.
The CAT levels obtained with the pTERSA series 
were compared with pTER5 CAT activity. Two deleted plasmids 
with reduced CAT activities were analysed, and deletion 
end-points were determined by DNA sequencing. These two 
plasmids pTER5A 30 and pTERSA 44 had 3Obp and 44bp 
respectively deleted from the 3' portion of the
1,3 A-Cm-
3 A-Cm - 
1 A-Cm - 
C m -
1a 1b 2 a 2b 3a 3b 4a 4b
Figure 68. CAT activities produced by the pTER plasmids as 
determined by thin layer chromatography. Aliquots were 
removed from each reaction after (a) 20min and (b) 40min. 
The positions of acetylated (A-Cm) and non-acetylated forms 
(Cm) of chloramphenicol are indicated. HeLa cells were
transfected with the following plasmids : tracks la, lb 
pTERS; tracks 2a, 2b pTERSA 30; tracks 3a, 3b pTER5 A44; 
tracks 4a, 4b pTER6.
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'terminator*. Locations of the deletion end-points are 
shown in Fig. 67; pTERSA^O has a deletion which removes 
the G-rich sequences and extends to 3bp from the YGTGTTYY 
signal. In pTERS A44, the YGTGTTYY signal is removed but 
the poly A site is retained.
Fig. 68 shows an autoradiograph of CAT assays 
obtained with the pTERS plasmid series and the relative CAT 
activities from a number of separate experiments are listed 
in Table 3. CAT levels produced by pTERSA 30 and pTER5A 44 
were low and trans-activation by co-transfection with the 
PRV plasmid, pPRVKpnh (see Methods, Page 100, Fig. 11), was 
required to boost activities to levels which could be 
accurately estimated. Plasmid pPRVKpnh expresses the PRV IE 
regulatory protein (Ihara et al., 1983) which increases 
transcription from other plasmid-borne eukaryotic promoters 
and from certain cellular promoters (Green et al., 1983; 
Impériale et al., 1983; Everett, 1984b).
Deletion of 30bp from the 3* portion of the 
'terminator' fragment reduced CAT levels to approximately 
35% of the pTERS value while removal of a further 14bp 
markedly reduced activity to a level of 1% to 4%; 
pTER5^44 produced CAT activities only just above the 
background levels obtained with plasmids pLWl and pTER6 
(Table 3). Plasmid pLWl has no 'terminator* fragment and 
pTER6 has the 'terminator* inserted in the opposite 
orientation to that of pTERS.
179
c) Levels of mRNA 3' and 5' termini produced by the 
pTERS plasmid series.
Cytoplasmic RNA isolated from cells transfected 
with the pTER5 plasmid series was hybridised to 
strand-separated DNA probes which were 3 '-labelled at the 
Hinf I site within the CAT coding sequences (Fig. 69). RNAs 
produced by pTER5 and pTER5A30 were hybridised to a probe 
produced from pTER5 DNA. As the deletion end-point of 
pTER5 A 44 is only 4bp from the poly A site (Fig. 67), 
hybrids produced by RNA transcribed across the poly A site 
could not be resolved from correctly-terminated RNAs, 
therefore RNA from pTERSA 44 was hybridised to a probe from 
pTER5A44 DNA. The probes from pTERS and pTER5^ 44 DNAs 
were end-labelled to similar specific activities. After 
treatment with nuclease SI, the protected DNA fragments 
were electrophoresed on a 6% denaturing polyacrylamide gel 
(Fig. 69).
RNA produced from pTERS protected a fragment of 
247nuc (Fig. 69, track 8) and this positioned the 3' end at 
position 53 (Fig. 67), the same location as the mRNA 3' 
terminus for IE mRNA-5 from HSV-2-infected cells (Whitton 
and Clements, 1984b). The 3' end of mRNA produced by 
pTERSA.30 was located at the same position as that obtained 
with pTERS but the amount of protected DNA fragment was 
reduced to approximately 30% of the pTERS value (Fig. 69, 
track 9). No discrete 3' end was detected with pTERS/^44 
RNA (Fig. 69, track 11). Hence, the levels of mRNA 3' 
termini obtained with the pTERS series reflected CAT
activities obtained with these plasmids.
M 1 2 3 4 5 6 7 8 9 10 11 12
0 0 ^  6 2 2
pTER  
5 end
4 9 2
4 0 4
ff
pTER  
3 end
2 4 2
2 3 8
201
190
160
147
p-globin  
5 e n d - 122
B
5 probe
P R O M
Eco RI Hinf I 3 probe
C AT TER
CAT mRNA
Figure 69.
A) The abundance of mRNA 5' and 3' termini produced by the 
pTER plasmids. The DNA probes used in tracks 1 to 7 were;
1) an Eco Rl/Sma I fragment 5'-labelled at the Eco RI site 
to determine the pTER CAT mRNA 5' termini and
2) a 5'-labelled Bst NI fragment derived from plasmid pRED4 
to detect the ^  -globin mRNA 5' termini (see Fig. 11).
The single-stranded DNA probes used to detect 
pTER CAT mRNA 3' termini were a Hinf I fragment from pTER5, 
3'-labelled at the Hinf I site in the CAT gene coding 
sequences (tracks 8 to 10), and a Hinf l/Bgl I fragment 
from pTER5A44, again 3'-labelled at the Hinf I site 
(tracks 11 and 12). RNA samples used were: tracks 1, 7, 10 
and 12, mock-infected RNA; tracks 2 and 8, pTER5 RNA; 
tracks 3 and 9, pTER5A30 RNA; tracks 4 and 11, pTER5 A 4 4  
RNA; track 5, pTER6 RNA; track 6, pLWl RNA. Size markers 
(M) were pAT153 DNA cleaved with Hpa II.
B) Approximate locations for the 5' and 3 termini of pTER 
CAT mRNA are shown. Restriction enzyme sites within the CAT 
coding sequences which were used for making end—labelled 
DNA probes are indicated.
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Plasmids pTER5 and pTER5A 30 have identical 
sequences up to IBbp beyond the poly A site then the DNA 
sequences are dissimilar due to the 'terminator' deletion 
(SObp) in plasmid pTER5A30. Therefore, the band below the 
fully protected probe (Fig. 69, track 9) represents 
hybridisation of the pTER5 DNA probe to pTER5A30 RNA 
transcribed through the poly A site. Hence the size of this 
band reflects the sequence homology between pTER5A30 RNA 
and the pTER5 DNA probe.
To assess the validity of the comparative 3' 
terminal data, plasmid, p^(244+)^, containing the 
^-globin promoter and the polyoma virus enhancer (see 
Methods, Page 100; de Villiers and Schaffner, 1981), was 
co-transfected with the various pTER5 plasmids. A 
strand-separated DNA probe from plasmid pRED4, 5 '-labelled 
at a Bst NX site approximately 130bp from the -globin 
mRNA 5' terminus was used to estimate ^  -globin mRNA levels 
(Fig. 11; Everett, 1983). As Fig. 69, tracks 2 to 6 
indicate, ^-globin mRNA levels were similar in all RNA 
samples.
Levels of mRNA 5' termini were estimated using a 
strand-separated DNA probe 5'-labelled at an EcoRI site 
within the CAT coding sequences of pTER5 (Fig. 69). Using 
this probe, a protected DNA fragment of 369nuc was obtained 
with RNA produced by all the pTER5 series plasmids and by 
PLWI (Fig. 69, tracks 2 to 6). A similar amount of 
labelled probe was protected with the different RNA 
samples. Therefore, unlike the situation with the 
3'-labelled probe, the levels of protected 5' probe
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obtained with pTER5A30 and pTER5 A 44 were similar to that 
obtained with pTER5 although the CAT activities were lower 
than the pTER5 values. Indeed, detectable levels of 5' 
termini were obtained with pLWl RNA in marked contrast to 
the inability of this plasmid to produce CAT activity. This 
suggests that cytoplasmic RNA with a normal 5' terminus but 
an incorrect 3' terminus does not produce functional 
protein.
DISCUSSION.
24. The Sequence YGTGTTYY is a Component of the Downstream 
Sequences Required for Efficient 3' End Formation.
Comparison of the sequences flanking HSV mRNA 3' 
termini has identified at least one element present also at 
the poly A sites of a large number of eukaryotic and viral 
genes. From conserved sequences located between 24 to 35bp 
downstream from AATAAA signals, a consensus sequence, 
YGTGTTYY, has been derived and greater than 60% of the 
genes examined contain sequences which resemble this 
consensus. A possible second element comprises either a G- 
or T-rich sequence, however, these tracts of residues occur 
less frequently than sequences which fit the YGTGTTYY 
motif.
Removal of sequences downstream from the poly A 
site of HSV-2 IE gene-5 reduces the level of 
correctly-processed mRNA 3' termini, and this effect is 
reflected in lower leVels of CAT activity. Deletion plasmid
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pTER5A 30 which lacks the G-rich sequences gives reduced 
mRNA 3' termini and CAT levels are 35% of the values 
obtained with pTER5 which contains all the 'terminator' 
sequences. Removal of a further 14bp, which includes the 
YGTGTTYY signal but not the poly A site, markedly reduces 
CAT activity to 1% to 4% of the pTER5 value, and no correct 
3' termini were detected. Therefore, it is likely that 
these conserved elements, in particular the YGTGTTYY 
signal, play an important role in the formation of mRNA 3' 
termini for a wide variety of mammalian genes and deletion 
analysis at other poly A sites would support this proposal.
McDevitt et al. (1984) have shown that T-rich 
sequences between 20 and 35nuc downstream from the poly A 
site, beyond the YGTGTTYY element, are required for 
production of functional Ad2 E2A mRNA, however 
correctly-terminated mRNA was produced at detectable 
levels. The data from the pTER5A 30 plasmid also show that 
removal of sequences downstream from the YGTGTTYY signal, 
which included a G-rich tract, reduces the level of 3' end 
formation. Comparison of HSV-2 and Ad2 sequences in this 
region reveal no significant homology, however, analysis of 
the sequences at similar locations in other genes reveal 
that a number of 3' terminal sequences contain either a T— 
or G-rich segment (Figs. 64 and 65). A deletion which 
removes the poly A site of Ad2 E2A mRNA and the sequence 
AGTGTCTC resulted in no detectable mRNA; this sequence is 
26nuc from the AATAAA signal and fits the YGTGTTYY 
consensus. Similarly, a 52bp deletion which removes the
183
poly A site together with sequences containing TGTGTTGG and 
a T-rich tract also abolishes rabbit ^-globin 3' end 
formation (Gil and Proudfoot, 1984). Deletion studies on 
the SV40 late mRNA 3' terminus indicate that there are a 
minimum of two elements which affect the efficiency of 
cleavage at the correct poly A site (Sadofsky and Alwine, 
1984; Conway and Wickens, 1985). At least part of one 
element is positioned between 21 and 38 residues from the 
AATAAA signal and this 17bp segment contains the sequence 
TATGTTTC (Conway and Wickens, 1985).
Approximately 33% of the 3' terminal DNA sequences 
examined do not contain a YGTGTTYY sequence motif. Absence 
of this sequence may be overcome by alternative downstream 
signals, and many of these 3' terminal regions contain 
T-rich residues (Fig. 65). In the HSV-1 TK gene, a T-rich 
segment between 32 and 37nuc from the AATAAA signal is 
required for efficient processing and polyadenylation (Cole 
and Stacy, 1985). The DNA sequences in this region 
(GTTTGTT) do not closely resemble the YGTGTTYY motif, 
however, these results do demonstrate that sequences 
approximately 30nuc from the AATAAA signal are functionally 
important in polyadenylation. The downstream YGTGTTYY 
sequence could therefore be analagous to transcription 
regulatory signals present upstream of the TATA box, for 
example the G+C-rich segments present in many but not all 
promoters (see Introduction, Page 62). Removal of G+C-rich 
sequences reduces the level of initiation (Everett, 1983;
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Me Knight and Kingsbury, 1982; Everett et al., 1983; Dierks 
et_^., 1983), however, as these sequences are not present 
in the upstream regions of every promoter presumably they 
are not obligatory, or other sequences mimic their 
function.
25. Role of the YGTGTTYY Motif.
There is no evidence as to whether the YGTGTTYY 
signal either in DNA or precursor RNA is involved in mRNA 
termination or processing. To date, transcription 
termination signals for RNA polymerase II genes have not 
been identified in higher eukaryotic systems, however, 
mouse ^ -globin mRNA appears to terminate at random sites 
between 700 to 2000nuc downstream from the poly A site (see 
Introduction, Page 85; Citron et al., 1984). The presence 
of a YGTGTTYY motif approximately 30nuc downstream from the 
0 -globin AATAAA signal would suggest that this sequence is 
not involved in termination within a region which is 
distant from the poly A site. Moreover, in the nucleus of 
infected cells, late polyoma RNAs have been detected which 
consist of tandem repeats of the viral genome (Buetti,
1974; Acheson, 1976). The flanking sequences of the polyoma 
late poly A site contain sequences which resemble the 
YGTGTTYY signal, again suggesting that this element is not
a termination signal.
It would also appear that the YGTGTTYY motif is not 
a regulatory signal involved in poly A site selection. 
Analysis of alternative 3* termini which are used with 
differing efficiencies in the pro 0(2(1) collagen (Aho et
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al' * 1983), ^ 2-microglobulin (Parues et al., 1983) and
mouse c< amylase genes (Tosi et al., 1981) indicates that
the presence of the YGTGTTYY signal is not associated with 
3' end selection.
A likely role for these downstream sequences is in 
the cleavage/processing of nuclear RNAs which extend beyond 
the poly A site. Cleavage/processing of primary transcripts 
is thought to be the mechanism whereby 3' termini are 
generated for both poly A mRNAs and histone messages (see 
Introduction, Page 84; reviewed in Birnstiel et al., 1985). 
Histone genes generally do not contain AATAAA signals and a 
palindromic sequence frequently is present close to mRNA 3' 
termini (Kedes, 1979; Hentschel and Birnstiel, 1981). Point 
mutations within this palindromic sequence abolish the 
ability to form a correctly-terminated mRNA and sequences 
at least 24nuc downstream from the 3' terminus are required 
for efficient processing (Birchmeier et al., 1982). Within 
this region, a consensus sequence (CAAGAAAGA) has been 
derived from conserved sequences in the 3' flanking 
sequences of vertebrate and invertebrate histone genes 
(Busslinger et al. , 1979; Hentschel and Birnstiel, 1981; 
Turner and Woodland, 1982; Birnstiel et al., 1985), 
however, the histone consensus sequence does not resemble 
the YGTGTTYY motif. This is not surprising since, although 
the mechanism for generating 3' termini in poly A and 
histone mRNAs may be similar, the processing proteins could 
be different and therefore alternative signals may be used.
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26. Correctly-terminated mRNA is Required to Produce 
Functional Protein.
Deletion of the YGTGTTYY signal reduced 3' end 
formation but had no detectable effect on initiation at the 
5 terminus. Therefore, it is likely that transcription has 
continued beyond the poly A site in plasmid pTER5 A 44, 
however, the location of the 3 ' termini of these 
transcripts has not been analysed. It is also not known 
whether the RNAs are polyadenylated. The 3 ' termini of 
extended transcripts produced as a result of the deletion 
of sequences at the HSV-1 TK poly A site map at 
approximately residue 4165 in the pBR322 plasmid sequences 
(Cole and Stacy, 1985). These RNAs are detectable in the 
poly A"^  fraction of cytoplasmic RNA preparations, 
suggesting that cryptic polyadenylation signals in the 
plasmid sequences may function following removal of the TK 
AATAAA sequence. The pTER5 plasmid series contain pBR322 
sequences from residues 2067 to 4362 and the HSV/CAT gene 
is orientated in the same direction as the TK construct 
with respect to pBR322 sequences. Thus, it is possible that 
the 3' termini of extended transcripts generated by 
pTER5A 44 also map at approximately position 4165 in the 
PBR322 sequences. An examination of the nucleotide 
sequences in this region indicates that two potential poly 
A signals are located between positions 4193 to 4198 
(AATAAC) and 4172 to 4177 (AATAAT). Neither of these 
sequences fits exactly the AATAAA signal, although the 
sequence AATAAC does occur at the poly A site of one gene
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(Wickens and Stephenson, 1985). Moreover, 36nuc downstream 
from the AATAAT sequence is a segment CGTGTCGC which 
resembles the YGTGTTYY motif. The 5' termini of the 
transcripts produced by pTER5&44 are detected in the 
cytoplasm, however, these RNAs do not produce functional 
CAT enzyme. It is possible that the pTER5A 44 RNAs adopt a 
secondary structure which prevents ribosome binding and 
thereby the translation of protein.
Alternatively, transcripts which extend beyond the 
poly A site may not be polyadenylated. The inability to 
translate these RNAs may imply that their mode of transport 
to the cytoplasm differs from that of poly A mRNAs thus 
suggesting a coupling of mRNA polyadenylation, transport 
and translation. Further analysis is required to determine 
whether pTER5A 44 cytoplasmic RNA is either polyadenylated 
or associated with polysomes.
GENERAL DISCUSSION
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The Results and Discussion section has highlighted 
three areas concerning the expression and sequence content 
of HSV genes, namely:
1 ) organisation and regulation of mRNAs encoding the viral 
ribonucleotide reductase
2) conservation between the sequences specifying the HSV 
ribonucleotide reductase and other cellular and putative 
herpesvirus ribonucleotide reductases
3) identification of a consensus sequence, YGTGTTYY, which 
is located at a conserved distance downstream from most 
mRNA 3' termini and is required for efficient 3' end 
format ion.
The General Discussion section proposes mechanisms 
for regulating HSV ribonucleotide reductase activity and 
suggests that expression of this function may be related to 
the mutagenic effect of HSV. From an interpretation of 
sequence comparisons, the possible evolution of the N- and 
C-terminal portions of the Vmwl38 ribonucleotide reductase 
polypeptide is discussed. Finally, evidence is presented on 
DNA sequences involved in efficient mRNA 3 end formation 
and alternative functions for the YGTGTTYY signal in mRNA 
3' end processing are suggested.
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1. Regulation of HSV Ribonucleotide Reductase Activity.
Ribonucleotide reductase is essential for virus 
growth, as a mutant with a ts lesion in Vmwl36 fails to 
synthesise viral DNA at the npt in resting cells (Preston 
et al., 1984b). Hence, the early synthesis of 
ribonucleotide reductase represents a critical step in HSV 
DNA biosynthesis. Previously, cellular ribonucleotide 
reductase activity has been proposed as a rate limiting 
step in DNA replication (see Introduction, Page 51); recent 
evidence indicates that changes in the concentration of 
dNTPs correlate with alterations in ribonucleotide 
reductase activity (Leeds et al., 1985). Synthesis of a 
viral reductase is necessary for at least two reasons:
1) Firstly, the level of cell ribonucleotide reductase 
activity is cell cycle-dependent (Eriksson et al., 1984; 
Engstrom et al., 1985). Enzyme activity appears to be 
controlled by the level of M2 protein which has a half-life 
of 3h and increases in abundance by three- to seven-fold 
prior to mitosis (Eriksson et al., 1984); by contrast, the 
Ml protein is produced constitutively and has a half-life 
of 15h (Engstrom et al. , 1985). Thus, infected cells which 
are not undergoing DNA replication may possess a low 
cellular ribonucleotide reductase activity which is 
insufficient to meet the requirements for HSV DNA 
synthesis.
2) Secondly, in contrast to the mammalian enzyme, HSV 
ribonucleotide reductase is not regulated by allosteric 
effectors (see Introduction, Pages 56 and 58); hence, the
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higher levels of dNTPs detected in infected cells (Cheng et 
al., 1975; Jamieson and Bjursell, 1976) would not inhibit 
the viral enzyme.
The following sections describe possible mechanisms 
for regulating this viral enzyme activity.
a) Regulation of mRNA synthesis.
The mRNAs specifying the proposed components of HSV 
ribonucleotide reductase overlap and, by nuclease SI 
analysis, are synthesised at early times p.i. In cells 
infected with HSV-1 tsk, a ts mutant containing a lesion in 
the Vmwl75 protein coding sequences which produces only the 
IE gene products at the npt, HSV-1 Vmwl36 is synthesised. 
Thus, Vmwl36, the equivalent HSV-1 protein to HSV-2 Vmwl38, 
was classified as an IE product (Preston, 1979; Watson e_t 
al., 1979). A characteristic of HSV IE genes is the 
presence of multiple copies of the activator sequence, 
TAATGARAT, upstream from IE mRNA 5' termini (see 
Introduction, Page 28), however, TAATGARAT motifs are 
absent from the promoter sequences of the HSV-1 S.Okb and 
HSV-2 4.5kb transcripts. Moreover, cells infected in the 
presence of the protein synthesis inhibitor cycloheximide 
produce IE polypeptides but synthesise a markedly reduced 
level of Vmwl36 compared with that in tsk-infected cells 
(H.S. Marsden, personal communication). While these data 
are consistent with the notion that the mRNAs encoding 
Vmwl36 and Vmwl38 are not IE products. Southern blot 
analysis with HSV-infected cell RNA indicates that 
transcripts from the ribonucleotide reductase locus are
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detectable at low levels in the presence of cycloheximide 
(Clements et al., 1977), Moreover, following the removal of 
a cycloheximide block, transcripts from this genome region 
are rapidly and abundantly synthesised and their synthesis 
precedes that of other early mRNA species including those 
encoding DNA polymerase and TK functions (Clements et al., 
1977). Hence, the transcripts encoding ribonucleotide 
reductase appear to possess promoters which are in a 
different temporal category from those of other early 
mRNAs. One possibility is that the promoters for the 
ribonucleotide reductase mRNAs are activated by proteins 
other than IE Vmwl75 (see Introduction, Page 30). A 
candidate for mediating this activation is IE VmwllO which 
is produced in tsk-infected cells at the npt and therefore 
could stimulate synthesis of the mRNA encoding Vmwl36. 
Evidence from transient expression assays using plasmid 
constructions indicates that the promoter for the HSV-2 
1.2kb mRNA encoding Vmw38 is activated by VmwllO in the 
absence of Vmwl75 (O'Hare and Hayward, 1985).
b ) Translational control of Vmw38.
As a result of the overlapping nature of HSV 
transcripts, 3' co—terminal mRNAs which are unspliced carry 
the coding sequences for more than one protein. For 
example, the 4.5kb mRNA, which specifies Vmwl38, also 
contains the coding sequences for Vmw38. In most cases, 
translation appears to begin at the 5' proximal initiation 
codon and subsequent ATG codons are utilised either with 
significantly reduced efficiency or not at all (Kozak,
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1981). In vitro translation of the HSV-1 S.Okb mRNA, which 
encodes Vmwl36 but also carries the Vmw38 coding sequences, 
produces a single polypeptide with a size of 140,000 mol. 
wt. (Anderson g.t a 1., 1981). However, these results do not 
preclude the possibility that a proportion of Vmw38
produced in vivo is translated from the S.Okb mRNA.
Within the HSV-1 TK gene, internal initiation 
occurs at two ATG codons downstream from the S' proximal 
start codon giving rise to two minor species of 39,000 and
38,000 mol. wt. (see Introduction, Page 43). Moreover, 
insertion of ATG triplets upstream from the normal 
initiation codons of HSV-1 TK and hepatitis B surface 
antigen (HBsAg) reduces the level of initiation at 
authentic start codons (Bandyopadhay and Temin, 1984; Liu 
et al., 1984). This effect can be partially suppressed by 
the presence of stop codons in phase with the inserted 
upstream ATG codons (Liu et al., 1984); such stop codons 
may allow ribosomes to rapidly reinitiate at a second ATG 
on the same RNA molecule (Kozak, 1981). The initiation 
codon for Vmw38 is 53nuc downstream from the C-terrainus of 
Vmwl38, hence, the close proximity of these N- and 
C-termini may allow ribosomes which have translated Vmwl38 
from the 4.5kb mRNA to reinitiate at the ATG codon for 
Vmw38.
The first ATG in the HSV-1 1.2kb mRNA opens a 
reading frame which extends for only five amino acids and 
thus does not specify the N-terminus of Vmw38. The presence 
of this ATG may reduce the level of initiation at the
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second ATG which marks the N-terminus of Vmw38. Vmw38 is 
almost certainly a component of ribonucleotide reductase 
(see Results and Discussion, Page 155) and enzyme activity 
in HSV-l-infected cells is less than that detected in 
HSV-2-infected cells (B. Dutia, personal communication). A 
lower level of initiation at the ATG for Vmw38 within the 
HSV-1 1.2kb mRNA as compared to that in the HSV-2 1.2kb 
transcript may contribute to this reduced ribonucleotide 
reductase activity.
2. Association of Ribonucleotide Reductase Activity with 
Cellular Transformation.
In vitro studies using separated restriction enzyme 
fragments have indicated that sequences adjacent to the 
ribonucleotide reductase locus are involved in 
morphological transformation (see Introduction, Page 48). 
However, the ability of HSV to transform cells may be 
related to its action as a mutagen. For example, increased 
mutation rates at the hypoxanthine guanine 
phosphoribosyltransferase (HGPRT) locus results from 
infection of permissive cells with partially—inactivated 
HSV-1 (Schlehofer and zur Hausen, 1982) and of 
non-permissive cells with HSV-2 (Pilon et al., 1985).
Moreover, HSV induces chromosomal aberrations (Hampar and 
Ellison, 1963; Stich et al., 1964) which may be mediated by 
an early viral function (Waubke et al., 1968; O Neill and
Rapp, 1971).
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In HSV-infected cells, chromosomal damage is 
repaired by cellular repair mechanisms (Nishiyama et al., 
1983) whose ability to faithfully replicate DNA is 
influenced by changes in dNTP pools (Ben-Hur and Ben-Oshai, 
1971; Collins et al., 1977), As infected cells contain 
higher levels of dNTPS than uninfected cells (Cheng et al., 
1975; Jamieson and Bjursell, 1976), alterations in dNTP 
pool sizes may be the basis of mutagenic changes introduced 
into cell DNA following infection by HSV. Analysis of cells 
with a mutator phenotype have shown that the production of 
increased levels of dNTPs is associated with 10- to 
100-fold increases in spontaneous mutation rate, possibly 
through competition between correct and incorrect dNTPs at 
sites of base addition (Kunkel and Loeb, 1979). In certain 
cases, such imbalances in dNTP pools result from the 
activity of cellular ribonucleotide reductases with altered 
allosteric properties such that enzyme activity is 
refractory to feedback inhibition (Oilman et al., 1980;
Chan et al., 1981; Weinberg et al., 1981; Ayusawa et al.,
1983); these data establish a correlation between mutation 
rate and ribonucleotide reductase activity. Thus, HSV 
ribonucleotide reductase, an early viral function, may act 
as a mutagen in infected cells by altering dNTP pool sizes. 
Of interest would be the mutation rate in cells possessing 
HSV ribonucleotide reductase, integrated into the cell 
genome, under the control of an inducible promoter. In such 
cells, stimulation of HSV ribonucleotide reductase activity 
may increase spontaneous mutation rate; these experiments
are currently in progress.
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3* Evolution of the Promoter for the Proposed Small Subunit 
of the HSV Ribonucleotide Reductase.
The 5 termini and flanking sequences of the HSV-2 
1.2kb mRNA encoding Vmw38 and the EBV 3.3kb mRNA encoding 
the 34,000 mol. wt. protein which has homology with Vmw38, 
lie within the C-terminal regions of the HSV-2 Vmwl38 and 
EBV 93,000 mol. wt. polypeptides respectively (Fig. 70; 
Gibson et al., 1984). The C-terminal regions of Vmwl38 and 
the 93,000 mol. wt. protein share homology (see Results and 
Discussion, Page 162), but the locations of the 1.2kb and 
3.3kb mRNA 5' termini are not at equivalent positions in 
these polypeptides (Fig. 70).
Alignment of the HSV-2 Vmwl38 C-terminal residues 
with those of the mouse Ml polypeptide sequence (Caras e_t 
al., 1985) indicates that the 1.2kb mRNA 5' terminus lies 
within an area of high homology which is also conserved in 
the EBV 93,000 mol. wt. protein (Fig. 70). The HSV-2 amino 
acid sequence immediately upstream from the 5* end of the 
1.2kb mRNA has low homology with the Ml protein and 
contains additional residues (Fig. 59). While the precise 
locations of the additional residues in the HSV-2 protein 
is unclear, the DNA sequences encoding these amino acids 
may represent transcription control signals involved in 
synthesis of the 1. 2kb mRNA, for example the TATA box 
homology.
The equivalent region of the EBV 93,000 mol. wt. 
polypeptide also appears to contain additional residues 
compared with the Ml sequences. However, the TATAA box
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Figure 70. Alignment of conserved amino acid residues 
specified by the transcripts encoding C-terminal portions 
of HSV-2 Vmwl38, the mouse Ml and EBV 93,000 mol. wt. 
proteins. Sizes of mRNAs are shown and the proteins 
specified by transcripts are given in brackets. Shaded 
areas represent regions of conserved amino acids and 
vertical dashed lines indicate their relative locations 
within equivalent polypeptides. The relative positions of 
the HSV-2 1.2kb and EBV 3.3kb mRNA 5' termini within 
protein coding regions are shown with the locations of TATA 
box homologues for these transcripts indicated by vertical 
arrows.
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Figure 71. Alignment of nucleotide sequences specifying 
the C-terminal portions of HSV-2 Vmwl38 and the EBV 93,000 
mol. wt. protein. Asterisks denote conserved residues and 
predicted amino acid residues for the 93,000 mol. wt. 
protein are shown below the EBV nucleotide sequence. Amino 
acids which are not conserved in HSV-2 Vmwl38 are shown 
above the HSV-2 nucleotide sequence. Positions of the HSV-2 
1.2kb and EBV 3.3kb mRNA 5' termini are indicated and TATA 
box homologues for these transcripts are overlined.
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motif in HSV-2 corresponds to a TACGA sequence in EBV and 
the cap site of the 3.3kb transcript is not positioned 
within 30nuc from this sequence (Fig. 71). Rather, the 
3.3kb mRNA 5 terminus is located within a C-terminal 
portion of the 93,000 mol. wt. protein which is not present 
in either of the Vmwl38 or Ml polypeptides ( Fig. 71); the 
additional amino acid sequences in the EBV protein extend 
for 75 and 50 residues beyond the C-termini of Vmwl38 and 
Ml polypeptides respectively. Thus, the promoters for the 
HSV-2 1.2kb and EBV 3.3kb transcripts appear to have arisen 
by different evolutionary events.
Additional amino acids at the C-terminus of the
93,000 mol. wt. polypeptide may be a result of a 
frame-shift in a precursor EBV protein, thereby 
incorporating untranslated sequences into a protein coding 
region. However, comparison of nucleotide sequences 
downstream from the C-termini of Ml and B1 proteins with 
those encoding the additional EBV amino acids reveals no 
detectable homology. Therefore, promoter sequences for the 
3.3kb transcript appear not to be related to the sequences 
of other reductase genes. Alternatively, novel sequences 
containing transcription control signals may have been 
inserted fortuitously into the polypeptide coding region of 
a precursor EBV 93,000 mol. wt. protein. Insertion of a 
complete promoter downstream from a primitive promoter has 
been proposed for the major human chorionic 
somatomammotropin gene (hCS gene; Selby et al., 1984);
these authors further suggest that the inserted promoter
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DNA
EBV
sequences may have included transcriptional signals which 
altered the expression of a precursor hCS gene.
The promoter for the HSV-2 1.2kb mRNA does not 
appear to have arisen from the insertion of extensive 
nucleotide sequences into a protein coding region.
Sequences upstream from the cap site of the 1.2kb RNA, 
which are absent in the Ml sequence, are present in EBV 
, although this region does not contain a promoter in 
(Fig. 71). Thus, the 1.2kb mRNA promoter signals may 
have evolved by mutation of pre-existing polypeptide coding 
sequences.
4. Is Vmwl38 a Product of Gene Fusion?
The proposed components of HSV-2 ribonucleotide 
reductase (Vmwl38 and Vmw38) share homology with the 
subunits comprising both mammalian and bacterial enzymes, 
however, Vmwl38 is considerably greater in size than either 
the mouse Ml (90,000 mol. wt.; Thelander and Reichard,
1979) or E. coli B1 (80,000 mol. wt.; Thelander, 1973) 
proteins. Moreover, the EBV and VZV polypeptides which 
share homology with Vmwl38 are of similar size to the Ml 
and B1 proteins (Gibson et al., 1984; A. J. Davison 
personal communication). Sequence comparisons between the 
various polypeptides indicate that HSV-1 Vmwl36 contains 
approximately 480 additional amino acids at the N-terminus 
compared with equivalent EBV, VZV, mouse and E._col_i 
proteins (I. Nikas, personal communication). Homology 
between the N-termini of HSV-1 Vmwl36 and HSV-2 Vmwl38
\Ad 5 DBP 'c
(59,000) '
N-TERM 1 C-TERM
2 7 %  1 61%
i i
Ad 12 DBP V - ■ - 1...  I
(55,000) \ I
N-TERM: late gene expression 
C-TERM: early gene expression; DNA replication
Figure 72. Amino acid homology between the N- and 
C-terminal portions of the Ad5 and Adl2 DNA binding 
proteins. The functions of these regions are also listed.
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suggests that the HSV-2 protein also contains an additional 
N-terminal domain. The function of these N-terminal domains 
in Vmwl36 and Vmwl38 is unknown, however, these regions may 
not be directly involved in HSV-1 and HSV-2 ribonucleotide 
reductase activity. One process which could have generated 
the additional sequences is gene fusion whereby a precursor 
of Vmwl36 or Vmwl38 may have been linked to a second 
protein with different functional properties. Thus, Vmwl36 
and Vmwl38 may comprise two functional units, the 
C-terminal portion which has a role in ribonucleotide 
reductase activity and the N-terminal region which has a 
separate but unknown function.
An example of a viral protein comprising two 
domains with different functions is the Ad DNA binding 
protein. Comparisons between coding sequences of the DNA 
binding proteins of Ad5 and Adl2 (Kruijer et al., 1981 and
1983) reveal low homology (27%) for one third of the 
protein at the N-terminus; the remainder of the protein 
sequences are essentially colinear and highly conserved 
(61%; Fig. 72). Kruijer et al. (1983) have suggested that 
these areas of different homology represent two domains in 
the Ad DNA binding protein, each with a different function. 
In support of this proposal, a 46Kd fragment from the 
C-terminal portion of the Ad5 DNA binding protein binds to 
single-stranded DNA (Horwitz, 1978) and mutations within 
this region affect DNA replication and early gene 
expression (Kruijer et al., 1981, 1982 and 1983; Klessig 
and Quinlan, 1982). However, a 26Kd fragment from
Vmw38 89%
TK 73%
gC 74%
gD 85%
Figure 73. Amino acid homology between equivalent HSV-2 
and HSV-1 proteins. These data were taken from the 
following references:
HSV-1 Vmw38, Draper et al., 1982, McLauchlan and Clements, 
1983a;
HSV-2 Vmw38, this study, McLauchlan and Clements, 1983b; 
HSV-1 TK, McKnight, 1980, Wagner et al., 1981;
HSV-2 TK, Swain and Galloway, 1983;
HSV-1 gC, Frink et al., 1983, Draper et al., 1984a;
HSV-2 gC, Dowbenko and Lasky, 1984, Swain et al., 1985; 
HSV-1 gD, Watson et al., 1982, McGeoch et al., 1985/
HSV-2 gD, Watson, 1983.
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the N—terminal region does not bind to single—stranded DNA 
(Klein et al., 1979; Linné and Philipson, 1980) and 
mutations within this fragment influence late gene 
expression (Kruijer et al., 1981). Thus, different 
homologies between the N- and C-terminal regions may be a 
result of different evolutionary pressures on protein 
domains with separate functions.
Homology between equivalent HSV-1 and HSV-2 
proteins varies from 73% to 89% (Fig. 73). Presumably, this 
variation in the degree of amino acid conservation reflects 
the evolutionary pressure on proteins which have different 
functions. If the additional N-terminal sequences in Vmwl36 
and Vmwl38 are not directly involved in ribonucleotide 
reductase activity, then the level of homology may not be 
identical at the N- and C-terminal domains. The N-terminal 
86 amino acids in Vmwl36 and Vmwl38 share lower homology 
(62%) than the C-terminal region (95%), however, a more 
extensive comparison is necessary to evaluate this 
possibility of different evolutionary rates for both 
domains. The function of these N-terminal domains in 
ribonucleotide reductase activity could be further tested 
by removing sequences at the N—termini of Vmwl36 and Vmwl38 
and examining the effect on virus enzyme activity.
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5. Limits of the DNA Sequences Involved in mRNA 3* End 
Formation.
The tandem reiterations located in intergenic 
regions of HSV DNA are putative sites for high rates of 
recombination (see Introduction, Page 15). Reiterations are 
present at a short distance, between 2 and 8nuc, beyond the 
YGTGTTYY motifs of three genes, IE genes-1 and -3 and gE 
(Fig. 64), hence, these repeats may delimit those sequences 
which function in 3' end formation. The repeats have a high 
G+C content and their sequences resemble the G-rich tracts 
found at a similar distance downstream from other 3' 
termini (Fig. 64). Therefore, it is possible that the first 
copy of each repeat may play a role in 3' end formation 
while the remaining copies are non-functional. The effect 
on CAT activity following the insertion of one or more 
tandem repeats downstream from the YGTGTTYY motif in 
plasmid pTERA30 (see Results and Discussion, Page 177) 
could test this prediction.
Analysis of gene duplications also suggests that 
downstream sequences contain signals necessary for the 
generation of 3' termini. The human 1 and oc2 globin 
genes have arisen from a gene duplication event and show 
overall high sequence homology (Proudfoot and Maniatis,
1980). Sequence conservation at the 3 portions of 1 and 
<X2 genes is markedly reduced beyond ISbp downstream from 
the poly A site; this 15bp segment has the nucleotide 
sequence GCCTGTGTGTGCCTG. Proudfoot and Maniatis (1980) 
have suggested that this segment delimits the signals
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required for either recombination or the production of 
mRNA. The 15bp segment contains the sequence TGTGTGCC which 
fits closely the consensus YGTGTTYY, hence favouring the 
proposal that the 3 boundary of the sequences involved in 
the duplication event were determined by mRNA 3' end 
processing signals. The absence of G-rich and T-rich 
segments beyond the TGTGTGCC sequence suggests that these 
tracts are not an absolute requirement for 3' end 
format ion.
6. Mechanisms of mRNA 3' End Formation.
The YGTGTTYY sequence may function as a processing 
signal either at the level of DNA or RNA. One mechanism for 
recognising a signal in RNA is through interaction with 
snRNPs since polyadenylation is inhibited in vitro by 
antisera which recognise such particles, indicating a role 
for these complexes in 3' end processing (Moore and Sharp,
1984). Berget (1984) has suggested that U4 snRNPs mediate 
3' end formation through the binding of U4 snRNA to 
complementary sequences at mRNA 3' termini, principally the 
AATAAA signal and a conserved CAYUG pentamer (Y = 
pyrimidine) which lies at a variable distance (6 to 26huc) 
beyond the polyadenylation signal. U4 RNA does not possess 
sequences complementary to the YGTGTTYY consensus, 
suggesting that either other U-type RNAs may be involved in 
the generation of poly A sites or an alternative function
for YGTGTTYY.
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SnRNPs have also been implicated in the formation 
of histone mRNA 3 termini where U7 RNA is required in 
oocytes for the processing of extended primary transcripts 
(see Introduction, Page 93). U7 RNA contains sequences 
which could base pair with the stem and loop structure and 
CAAGAAAGA motif (Strub et al., 1984) both of which are 
essential components for 3' end processing of histone mRNAs 
(see Introduction, Page 90). Altering the distance between 
the palindrome and the CAAGAAAGA sequence reduces the level 
of 3' end formation, possibly by disrupting the hybrid 
structure formed between U7 and the processing signals 
(Georgiev and Birnstiel, 1985). The distance between the 
poly A signal and the YGTGTTYY motif is relatively well 
conserved, thus the insertion or deletion of sequences 
between these elements may result in inefficient processing 
at the poly A site. This possibility could be examined by 
analysing the level of mRNA 3' end formation in plasmid 
constructions containing an altered spacing between the 
AATAAA and YGTGTTYY signals.
Alternatively, YGTGTTYY may act as a recognition 
site for proteins by altering the local configuration in 
DNA; the following studies suggest a critical role for the 
core of the consensus in producing changes in DNA 
configuration. The trinucleotide GTG occurs at a high 
frequency in eukaryotic and prokaryotic transcription 
control signals and at sites involved in DNA replication 
and recombination such as consensus sequences for phage 
replication origins, the LTRs of retroviruses and the
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consensus for recombination sites in immunoglobulins 
(Cheung et al., 1984). Furthermore, GTG forms part of the 
binding site for a gene-specific transcription factor which 
interacts with the Ad major late promoter (Sawadogo and 
Roeder, 1985). Interestingly, GTG is the most highly 
conserved segment within the YGTGTTYY consensus (Table 2) 
and recent studies confirm this high frequency of G+T-rich 
residues downstream from mRNA 3' termini (Nussinov, 1985). 
From NMR studies using synthetic oligomers, the sequence 
GTG and its complement CAC exhibit faster opening kinetics 
in double-stranded DNA (Lu et al., 1983; Cheung et al.,
1984). Moreover, the YGTGTTYY consensus contains 
alternating purine and pyrimidine residues which favour 
Z-DNA formation (Wang et al., 1979). The transcriptional 
enhancer region of SV40 also possesses alternating 
purine/pyrimidine segments which form Z-DNA and bind 
proteins (Nordheim and Rich, 1983). These analyses have led 
to the proposal that the GTG/CAC sequence may form a detent 
in DNA, thus acting as a pause site for proteins moving 
along DNA (Lu et al., 1983). This suggests that the GTG 
segment within YGTGTTYY may form part of the targetting 
signal for complexes by arresting proteins in the vicinity 
of the poly A site; the stable interaction of proteins at 
this site could then be determined by an examination of
flanking sequences.
Studies using antibodies directed against both 
Z-DNA and snRNPs would be useful to determine whether 
YGTGTTYY functions in DNA or RNA. Protection experiments
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using DNase I footprint methods would examine DNA regions 
at poly A sites which bind proteins. These binding studies 
could be extended to purify proteins from cell extracts 
which interact with 3' terminal sequences. A necessary part 
of this analysis would be the effect of point mutations 
within YGTGTTYY, in particular the effects of alteration of 
the GTG sequence on protein binding and DNA configuration. 
Analysis of a bacterial promoter region indicates that, in 
negatively-supercoiled regions of DNA, nuclease SI 
sensitive sites are positioned at TpA dinucleotides due to 
local unwinding of the DNA (Drew et al., 1985). TpG 
doublets also have a low thermal stability (Gotoh and 
Tagashira, 1981) and a single alteration in the -10 region 
of a bacterial promoter from TATGATG to TATGAAG, which 
removes a TpG dinucleotide, reduces the ability of RNA 
polymerase to form a stable initiation complex (Travers et 
al., 1983). Therefore, the precise locations of nuclease 81 
sensitive sites at poly A sites is relevant to future 
studies.
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A transcription unit at the herpes simplex vims (HSV) type 2 
transforming region, mtr-2 (map coordinates 0.580 -  0.625), 
comprises two early, unspliced mRNAs of 4.5 kb and 1.2 kb 
which are 3' co-terminal; a region including that specifying 
the 1.2-kb mRNA has been sequenced. The putative trans­
lated portions of these two mRNAs do not overlap and this 
feature, together with the arrangement of the mRNAs, is 
similar to the apparently equivalent co-linear HSV-1 locus 
which however does not transform. A putative stem and 
loops structure containing a TATA box is located upstream 
from the 5' terminus of the 1.2-kb mRNA within the trans­
lated portion of the 4.5-kb mRNA. Evidence for the genera­
tion of this structure hy intra-strand reassociation under our 
hybridisation conditions has been obtained and possibilities 
are that it may function as a transcription-activated promoter 
or as an RNA polymerase pause site. A comparison of the 
equivalent HSV-2 and HSV-1 regions reveals a conserved se­
quence downsteam from the 3' co-terminus which is present 
at a similar location in many eukaryotic genes (consensus se­
quence YGTGTTYY). The overall sequence conservation at 
this transcription unit is high except for regions located at: (1) 
the untranslated leaders of the 1.2-kb mRNAs; (2) the N ter­
mini of the polypeptides specified by the HSV 2/HSV 1
1.2-kb mRNAs; (3) the intergenic region beyond the 3' co- 
termini. Regions (2) and (3) are located within a transforming 
fragment of HSV-2. The possible significance of these data 
for HSV-mediated cell transformation is discussed.
Key words: conserved 3'-terminal sequence/DNA sequence 
homology/HSV-2 transcription unit/protein-coding regions/ 
stem and loops structure
Introduction
Two separate regions {BgUl c and mtr-2) of the herpes 
simplex virus type 2 (HSV-2) genome (Figure 1) have been im­
plicated in morphological and oncogenic transformation of 
rodent cells and hamster cells (Galloway et al., 1982; Reyes et 
al., 1979; Jariwalla et at., 1980). An interesting feature of the 
mtr-2 region, represented by the HSV-2 BgUl n fragment 
(Figure 1, map coordinates 0.580-0.625), is that the co- 
linear HSV-1 locus does not transform cells; a different 
HSV-1 region (mtr-1. Figure 1, map coordinates 0.31 -0.42) 
was found positive for transformation (Camacho and Spear; 
1978; Reyes et al., 1979). However, the equivalent HSV-2 and 
HSV-1 regions between maps coordinates 0.58 and 0.62 show 
good homology by heteroduplex mapping except for a short 
stretch at map coordinate 0.61 (Kudler et al., 1983).
We have shown that the HSV-1 region around map coor­
dinate 0.6 specifies two early, 3' co-terminal mRNAs of 
5.0 kb and 1.2 kb which are unspliced and overlapping
*To whom reprint requests should be sent, 
c IRL Press Limited, Osford, England.
(McLauchlan and Clements, 1982, 1983). They encode poly­
peptides of 140 000 and 40 000 mol. wt., respectively (Ander­
son et al., 1981). Upstream signals involved in transcription 
initiation of the 1.2-kb mRNA and sequences transcribed 
within the 5 ' leader of the 1.2-kb mRNA appear to encode 
the C terminus of the 140 000 mol. wt. polypeptide 
(McLauchlan and Clements, 1983). The HSV-1-specified 
ribonucleotide reductase activity has been mapped to this 
location (Dutia, 1983; V.G.Preston, personal communica­
tion); this activity is therefore a function of the 140 000 mol. 
wt. polypeptide though it is possible that the 40 000 mol. wt. 
polypeptide is also involved. A similar enzymatic activity has 
been described for HSV-2 and it has been suggested that ribo­
nucleotide reductase activity may be the basis of the trans­
forming ability (Huszar and Bacchetti, 1983).
This paper deals with the mtr-2 region, wherein we locate 
the 5 ' and 3 ' termini of an unspliced, early 1.2-kb mRNA 
which is 3' co-terminal with, and overlapped by, a 4.5-kb 
mRNA. The genomic DNA sequence specifying the 1.2-kb 
mRNA has been obtained, and signals involved in transcrip­
tion initiation and termination have been identified. The 
putative coding region of the 1.2-kb mRNA and the 
C-terminal portion of the polypeptide specified by the 4.5-kb 
mRNA have been determined and show that the two coding 
regions do not overlap. Comparison of this HSV-2 region 
with the equivalent locus of HSV-1 (Draper et al., 1982; 
McLauchlan and Clements, 1983) reveals high overall se­
quence conservation except for three discrete tracts of non­
homology. Beyond the 3 ' co-terminus in a region of low se­
quence homology, we have identified a conserved sequence 
which is present at a similar location in many eukaryotic 
genes.
Results and Discussion
A transcription unit located at the mtr-2 region comprises two 
early mRNAs
The HSV-1 locus between map coordinates 0.56 and 0.60 
specifies two early, 3 ' co-terminal mRNAs. To determine the 
approximate sizes and relative abundances of the mRNA 
species located at the equivalent HSV-2 locus, a nick- 
translated Bglil/BamWl fragment (Figure 1, map coordinates 
0.580-0.583), from within mtr-2, was hybridised to a Nor­
thern blot containing HSV-2 early polyadenylated RNA. Two 
bands with approximate sizes of 5.4 kb and 1.5 kb were 
detected and the 1.5-kb mRNA species was ~ 5 times more 
abundant (Figure 2); an additional band of 6.6 kb was 
observed on prolonged exposure. Jenkins et al. (1982) have 
detected mRNA species with similar sizes using radiolabelled 
Bglll fragment n. Nuclease SI and exonuclease VII analyses 
have shown the arrangement of the mRNAs at the mtr-2 
region to be identical to that observed at the corresponding 
HSV-1 locus.
The BgHl/BamHl fragment, used in the Northern blot 
analysis, was uniquely 5 ' -labelled at the BamWl site and 
hybridised to infected and mock-infected cell RNAs. A band 
of 143 nucleotides was detected with the infected cell RNA 
only (Figure 5A, lane2), and thus the 5 ' portion of a right-
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Fig. 1. Restriction endonuclease cleavage maps o f HSV-2 strain HG52 at 
the genome region located between map coordinates 0.58 and 0.63. The 
cleavage sites for Dde\ have been mapped between 0.58 and 0.61. The 
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bp
I
6600
5400
2 8 8 -
188
1500
I
Fig. 2. Identification o f the mRNAs located within a portion o f BgBl n. 
The Northern blot contains 5 /tg of HSV-2 early polyadenylated cyto­
plasmic RNA and the DNA probe was a nick-translated Bglll/BainW l frag­
ment (Figure 1, map coordinates 0 .580-0 .583). The sizes of the mRNA 
species detected are indicated.
wards-transcribed mRNA is located within this fragment. 
The 5' portion of this mRNA was analysed further using 
BamWl e (map coordinates 0.532 -  0.583), 5 ' -labelled at both 
ends. A nuclease SI product of 143 nucleotides and an exo­
nuclease Vll-resistant product of 148 nucleotides were 
detected (Figure 3A, lanes 2 and 4). The small size difference 
between the protected fragments is a result of the processive 
nature of exonuclease VII activity as described in Materials 
and methods. The result indicates that the 5 ' portion of the 
mRNA, transcribed across the BamWl site, is unspliced.
The 3' portion of the mRNA was analysed using a 
BamW l/Xho\ fragment (Figure 1, map coordinates
1954
0.583-0.595), uniquely 3 '-labelled at the BamUl site. A 
band of 1.05 kb was detected in both nuclease SI- and exo­
nuclease Vll-digested samples (Figure 3B, lanes 5, 7 and 9); it 
follows that the 3 ' portion is unspliced. Therefore, the total 
size of this mRNA is —1.2 kb and it corresponds to the
1.5-kb species detected by Northern blot analysis.
A mRNA was shown to be 3 ' co-terminal with and over­
lapping the 1.2-kb mRNA by using a BgHl/Kpnl fragment 
(Figure 1, map coordinates 0.580-0.612) that had been uni­
quely 3 ' -labelled at the BgUl site, which is upstream from the 
5' end of the 1.2-kb mRNA (Figure 3C). Nuclease SI- and 
exonuclease Vll-resistant products of 1.6 kb were detected 
(Figure 3B, lanes 1 and 3) which places the 3 ' terminus of this 
mRNA and of the 1.2-kb mRNA at the same location. The 5 ' 
terminus of the larger overlapping mRNA lies outside BgUl n 
and the mRNA is unspliced with a total size of 4.5 kb 
(J.McLauchlan and J.B.CIements, unpublished data). This 
mRNA corresponds to the 5.4-kb species detected on Nor­
thern blots.
In summary, the HSV-2 transcription unit comprises two 
early, 3' co-terminal mRNAs of sizes 4.5 kb and 1.2 kb 
which are unspliced and the 5 ' end of the smaller mRNA is 
located within the sequences specifying the larger mRNA 
(Figure 3C). The 6.6-kb mRNA species, detected by Northern 
blot analysis, is a late mRNA which also is 3' co-terminal 
with the two early mRNAs (J.McLauchlan and 
J.B.CIements, unpublished data).
The 3 ' co-terminus: an HSV-2/HSV-1 sequence comparison 
reveals conserved regions
The 3' co-terminus was positioned within a Ddel/Xhol 
fragment (Figure 1, map coordinates 0.589-0.595) that had 
been uniquely 3 ' -labelled at the Ddel site. The major 
nuclease SI product (Figure 4A, lane 2) positioned the 3 ' co­
terminus within the sequence TTGTT (Figure 4B, positions 
1452—1456), 20 nucleotides downstream from the hexa- 
nucleotide sequence AATAAA (Figure 4B, positions 
1432—1437). Minor nuclease 81 products were detected 
reproducibly which placed other 3 ' termini at three preferred 
positions up to 70 nucleotides downstream from the major 3 ' 
location.
Draper et al. (1982) have reported that the major 3' co­
terminus in HSV-1 strain KOS preceded the AATAAA 
poly(A) recognition signal (Proudfoot and Brownlee, 1976). 
Our data for both HSV-1 strain 17+ (McLauchlan and 
Clements, 1982) and HSV-2 strain HG52 unambiguously 
locate the 3' co-termini downstream from the polyadenyla- 
tion signal which is consistent with data for other eukaryotic 
genes. An AATAAA sequence (Figure 4B, positions 
1605 -1610), which could serve as a poly(A) signal for a left­
wards-transcribed mRNA, is present in the strand com­
plementary to that specifying the 3' co-terminal mRNAs. 
Similarly, a poly(A) signal for a late, leftwards-transcribed 
mRNA is present at the equivalent HSV-1 locus (McLauchlan 
and Clements, 1982). The distance between the poly(A) 
signals on opposite strands is 168 nucleotides for HSV-2 and 
125 nucleotides for HSV-1.
Upstream from the 3' co-terminus, the HSV-2 DNA se­
quence was highly homologous with the corresponding 
HSV-1 region as far as the AATAAA signal (Figure 4B, posi­
tions 1361 -  1437); beyond this point, the homology decreas­
ed markedly. In the untranscribed region, beyond the 3 ' co­
terminus, three blocks of homology were observed; 
TTGGGTCTC (Figure 4B, positions 1455 -1463); TGTGATT
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Fig. 3. Structural analysis of the mRNAs forming an early transcription unit. (A) Analysis of the 5 ' portion of the 1.2-kb mRNA. The DNA probe was 
BamlW  e (Figure 1, map coordinates 0.532—0.583), 5 ' -labelled at both BamWl sites. The RNA samples used were: lanes 1 and 3, mock-infected cytoplasmic 
RNA; lanes 2 and 4, early infected cell cytoplasmic RNA. (B) Analysis o f the 3 ' portions o f the 1.2-kb and 4.5-kb mRNAs. The DNA probes used were; 
lanes 1 — 4, for the 4.5-kb mRNA, a BglW/Kpnl fragment (Figure 1, map coordinates 0.580-0.612) was uniquely 3 '-labelled at the Bglll site; lanes 5 — 9, for 
the 1.2-kb mRNA, a BartM\/Xhol fragment (Figure 1, map coordinates 0 .583-0.595) was uniquely 3 ' -labelled at the Bam H l site. The RNA samples were: 
lanes 1, 3, 5 and 7, early infected cell cytoplasmic RNA; lanes 2, 4, 6 and 8, mock-infected cytoplasmic RNA; lane 9, early polyadenylated infected cell cyto­
plasmic RNA. After hybridisation, samples 1 and 2 in (A) and samples 1 ,2 , 5, 6 and 9 in (B) were digested with nuclease SI. Exonuclease Vll-treated 
sarnples were 3 and 4 in (A) and 3, 4, 7 and 8 in (B). The nuclease-resistant material was electrophoresed on 8% denaturing polyacrylamide gels. Nuclease- 
resistant fragments are arrowed and their sizes indicated. The size standards (M) used were: d>X174 D N A /M ncll markers and pSV 40////n/I markers in (B). 
(C) Summary of the genome map locations and orientations o f the HSV-2 mRNAs between map coordinates 0.58 and 0.60. The proposed location o f a 
leftwards-transcribed mRNA also is shown.
(Figure 4B, positions 1467 -1473), GGGGGTGG (Figure 4B, 
positions 1488 — 1495). The highly conserved sequence bet­
ween positions 1467 and 1475 is related to a consensus se­
quence YGTGTTYY which we have found to be located 
— 15 — 35 nucleotides downstream from the poIy(A) signal of 
many viral and eukaryotic cell mRNAs (J.McLauchlan and
J.B.CIements, in preparation). Sequences similar to our con­
sensus sequence have been noted by Taya et al. (1982). A por­
tion of the sequence GGGGGTGG (Figure 4B, positions 
1488 —1495) is present at a similar location downstream from 
the 3' end of the HSV-1 thymidine kinase gene (McKnight, 
1980).
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HSV-2 CACCTCGTAC GCCGGGGCCG TCGTCAACGA tctgtgaggg TCTGGGCGCC
*
HSV-1 CACCTCGTAC GCCGGGGCGG TCGTCAACGA TCTGTGAGTG TCGCGGCGCG
1450
HSV-2 CTTGTAGCGA TGTCTAACCG AAATAAAGGG GTCGAAACGG ATTGTTGGGT
* ** *****
HSV-1 CTTCTACCCG TGTTTGCCCA TAA'^_^CCT CTGAACCAAA CT TTGGGT
1500
HSV-2 CTCCGGTGTG ATTATTACGC AGGGGAG GGG1 GGTGGCGGCT GGGGAAAGGG
HSV-1 CTCAT TGTG ATTCTTGT C AGGGACGCGGG; GGTGGG
1550
HSV-2 AAGGAACGCC CGAAACCAGA GAAAAGGACC AAAAGGGAAA CGCGTCCAAC
1600
HSV-2 CGATAAATCA AGCGCCGACC AGAACCCCGA GATGCATAAT AACGTTTATT
HSV-2 ACTCTATATT ACGG
Fig. 4. (A) Precise location of the 3 ' co-terminus. A D de\/X h o \ fragment (Figure 1, map coordinates 0 .589-0 .595), uniquely 3 '-labelled at the D del site, 
was hybridised to the following RNA samples: lane 1, mock-infected cytoplasmic RNA; lane 2, early infected cell cytoplasmic RNA, Samples were digested 
with nuclease SI and electrophoresed on an 8% denaturing polyacrylamide gel alongside the sequence reaction products of the DNA probe. Arrows indicate 
the major location o f the 3 ' co-terminus. (B) DNA sequence at the 3 ' co-terminus; a comparison with a portion o f the equivalent HSV-1 region. Locations 
of the 3 ' co-termini are arrowed and the poly(A) signals for the 3 ' co-terminal mRNAs are indicated by a dotted line as is the poly(A) signal for a leftwards- 
transcribed mRNA. Translational stop codons for the HSV-2 38 000 mol. wt. and HSV-1 40 (KK) mol. wt. proteins are underlined. The asterisks denote 
nucleotides which are not conserved and the homologous regions downstream for the 3 ' co-termini are indicated by two solid lines. The sequences are 
numbered according to the HSV-2 sequence in Figure 6.
The 5 ' terminus o f  the 1.2-kb mRNA: evidence fo r  a stem 
and loops structure
We position the 5 ' terminus (Figure 5A) on the guanosine 
residue within the sequence ATGTAC (Figure 6, positions 
245—250). Upstream from the 5 ' end, a TATA box sequence 
(Corden et al., 1980) is located at positions -2 2  to -2 8  
(Figure 6, positions 221—225) and a pentameric sequence 
GGTCC (Busslinger et al., 1980) at positions -4 4  to -4 9  
(Figure 6, positions 199-203). These signals, which are 
thought to be involved in the initiation of transcription, are 
completely conserved and are located at identical positions 
relative to the 5' ends of the HSV-2 and HSV-1 1.2-kb 
mRNAs (Figure 7, positions 220-224 and 198-202).
In both HSV-2 (Figure 6, positions 164-233) and HSV-1 
(Figure 7, positions 164-232), a region upstream from the
1.2-kb mRNA, within a transcribed portion of the 4.5-kb 
mRNA, contains inverted repeats which could form the stem 
and loops structures shown in Figure 5B. The structure com­
prises a stem of 42 nucleotides (shown by R l / R l '  and 
R2/R2 ' in Figure 6) with a loop of 24 nucleotides and a loop 
of six nucleotides containing the TATA box. Under our 
DNA/RNA hybridisation conditions, a minor proportion of 
molecules were generated in which the stem and loops struc­
ture was formed by intra-molecular reassociation of the DNA 
probe. In these molecules, sequences within the stem and 
loops were unavailable for hybridisation to the 4.5-kb 
mRNA, and the intra-molecular loops were sensitive to 
nuclease SI. The remainder of the DNA probe was available 
for DNA/RNA hybridisation. The minor bands indicated in 
Figure 5 A (lane 2) correspond to nuclease SI-sensitive sites 
located within both loops; no nuclease SI cleavage sites were 
detected at the stem region. Similar nuclease SI-sensitive sites 
were observed for HSV-1 (McLauchlan and Clements, 
unpublished observations). This indicates that the stem and 
loops structure can be generated by intra-molecular reassocia­
tion but does not provide evidence for its natural occurrence 
in virus DNA.
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Fig. 5. (A) Precise location of the 5' terminus of the 1.2-kb mRNA. A BgU l/Bam H l fragment (Figure 1, map coordinates 0.580-0.583), uniquely 
5 '-labelled at the BamHl site, was hybridised to the following RNA samples: lane 1, mock-infected cytoplasmic RNA; lane 2, early infected cell cytoplasmic 
RNA. Following hybridisation, the samples were digested with nuclease SI and electrophoresed on an 8% denaturing polyacrylamide gel alongside the se­
quence reaction products of the DNA probe. The arrow indicates the location of the 5' terminus and the size of the hybrid was determined relative to 
0 X 1 7 4 ////n d l size standards (not shown). Asterisks locate the minor nuclease SI products described in the text. (B) Proposed stem and loops structures 
formed by inverted repeat sequences upstream from the HSV-2 and HSV-1 1.2-kb mRNAs. The first T in each o f the TATA boxes is indicated (▼) and the 
5 ' termini are shown. Arrows denote minor nuclease SI sites; the HSV-2 sequence is numbered as in Figure 6.
We propose that this structure may act as a promoter ele­
ment in the synthesis of the 1.2-kb mRNA. The presence of 
the larger loop would tend to destabilise the structure in 
duplex DNA, however it would form much more readily in 
denatured regions of double-stranded DNA. Transcription of 
the overlapping 4.5-kb mRNA through this locus generates a 
single-stranded DNA region which may facilitate the intra­
strand formation of the stem and loops and thereby poten­
tiate initiation of the 1.2-kb mRNA. As a consequence of this 
feature, synthesis of the 1.2-kb mRNA would be dependent 
upon transcription of the 4.5-kb mRNA and the structure 
would function essentially as a transcription-activated pro­
moter. Alternatively, if this structure is present in duplex 
DNA, it may function as a pause site for RNA polymerase 
molecules transcribing the 4.5-kb mRNA and facilitate initia­
tion of the 1.2-kb mRNA.
Transcription regulatory signals o f the 1.2-kb mRNA are 
located within the translated portion o f  the overlapping
4.5-kb mRNA
The DNA upstream from the 5' end of the 1.2-kb mRNA 
contains signals involved in transcription initiation and also is 
transcribed as part of the 4.5-kb mRNA. A single open 
reading frame which extends for 255 nucleotides and ter­
minates 82 nucleotides downstream from the 5 ' end of the
1.2-kb mRNA is present also in HSV-1 and the sequences are 
highly conserved (Figure 7, positions 1-327). We have infer­
red previously that the C terminus of the HSV-1 140 000 mol. 
wt. protein lies within the 5 ' -untranslated leader of the 
HSV-1 1.2-kb mRNA (McLauchlan and Clements, 1983). 
The corresponding HSV-2 protein of 138 000 mol. wt. 
(Docherty et al., 1981) appears to be encoded by the 4.5-kb
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CAAGCAGTGG TCTGTGGCCC AAGCCCTGCC TTGCCTGGAC CCCGCCCACC CCCTCCGGCG
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GACCTGTGTG CAGACCGCGC CCCCTATGTT GATCACAGCC AATCCATG^^C TCTGTATGTC
GTTCAAGACG GCCTTCGACT ACGACCAGGA 
CGGACGGGAC GCTCCCCGCC
R I
ACAGAGAAGG
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TCCGCCTTCT CGTCCACGCA
R2'
TATAAGCGCG GCCTGAAGAC
CAACATCGTC TGCACAAGCT GCGCGCTGTA AGCAACAGCG
CCCCGCGAGC ACCGACCCCC TAGATACCCA CGCGTCGGGG
Dde I
TGCCCCGACA TCAACCACCT TCGCTCCCTC AGCATCCTGA 
CCGAGGGCGA GCTCGGCTTC TACCGCTTTC TGTTTGCCTT 
ACAGAAGGAC ATTCTTCACT ACTACGTGGA GCAGGAATGC
GACCAGGCGC GCCGCGCCTA
TCCCGGAGAA GTTCATCCTC 
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Fig. 6. Nucleotide sequence o f the HSV-2 1.2-kb mRNA. The 5 ' and 3 ' termini are shown and the TATA box and AATAAA signals are indicated. The 
codons which represent the N and C  termini o f the 38 000 mol. wt. protein and the C  terminus o f the 138 000 mol. wt. protein are underlined as are the in­
verted repeats (R l, R l ' , R2 and R 2 ') which form the stem and loops structure shown in Figure 5B. A sequencing strategy is shown below and the sites used 
to determine the nucleotide sequence are indicated on both diagrams.
mRNA. The same open reading frame within the equivalent 
genome regions of HSV-2 and HSV-1 strongly suggests that 
the HSV-2 coding region is organised in a similar fashion to 
HSV-1 and therefore, that the translational stop codon of the 
138 000 mol. wt. protein is located at position 329 (Figure 6). 
Most of the HSV-2/HSV-1 differences in this region occur in 
the third base of the codons, and the predicted amino acid se­
quence is highly conserved (Figure 7, positions 1-327).
Two highly conserved polypeptides differing at the 
N-terminal region
Previous reports have mapped a 38 000 mol. wt. polypep­
tide to the region examined here (Docherty et a i, 1981; 
Galloway et a i, 1982). The first ATG triplet at position 384 
(Figure 6), within the sequences specifying the 1.2-kb mRNA, 
precedes a single open reading frame which extends for 337
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Fig. 7. A comparison of the HSV-2 and HSV-1 sequences in a region encoding the C terminus of the 138 000 mol. wt. protein and the N terminus of the 
38 000 mol. wt. protein. The coding regions are arranged in triplets and the amino acid sequences of the HSV-2 polypeptides are shown above the nucleotide 
sequence. HSV-1 amino acids which are not conserved are shown below the nucleotide sequence and the asterisks indicate nucleotides which are non- 
homologous. The C termini of the 138 000/140 000 mol. wt. and the N termini of the 38 000/40 000 mol. wt. proteins are underlined. The S' termini of the 
1.2-kb mRNAs are shown and the TATA boxes are indicated. The HSV-1 sequence (McLauchlan and Clements, 1983) is numbered.
codons and terminates with a TGA stop signal at position 
1395 (Figure 6). This sequence would specify a 37 500 mol. 
wt. polypeptide, which is close to the 37 800 mol. wt. obtain­
ed by in vitro translation of mRNA selected with the HSV-2 
BgBl fragment n (Docherty et al., 1981).
For the HSV-1 1.2-kb mRNA, we inferred that the first 
ATG initiation codon (Figure 7, position 313), which was 
followed by a stop codon in the same reading frame (Figure 7, 
position 328), did not encode the N terminus of the 40 000 
mol. wt. protein (McLauchlan and Clements, 1983). In­
terestingly, this ATG triplet is absent in the HSV-2 sequence 
(Figure 7). The sequences flanking the first ATG codon of the 
HSV-2 1.2-kb mRNA are identical to those at the second 
ATG triplet of the HSV-1 1.2-kb mRNA (Figure 7, positions 
396—404) which reinforces our view that the second ATG 
codon is used in the HSV-1 1.2-kb mRNA.
If the HSV-1 and HSV-2 sequences are aligned to maximise 
DNA homology, the sequence predicts that the HSV-2 pro­
tein is three amino acids shorter than the HSV-1 polypeptide 
at the N terminus (Figure 7, positions 405—413). Further 
downstream, there is a discrete region of low homology which 
results in 14 amino acid differences within a stretch of 22 
amino acid residues (Figure 7, positions 432-497). This may 
represent a different functional domain between the HSV-2 
and HSV-1 polypeptides. Following this non-homologous 
region, from positions 498 -  611 (Figure 7), which is the limit 
of our HSV-1 sequence data, the amino acid residues are 
identical in both serotypes. Recently, Draper et ai (1983) 
realised that their previously published sequence of the 
HSV-1 strain KOS 1.2-kb mRNA (Draper et a i, 1982) was 
incorrect. A comparison of the HSV-2 amino acid sequence
with their amended HSV-1 DNA sequence (obtained from
E.K.Wagner) reveals that the 38 0(X) mol. wt. and 40 000 
mol. wt. polypeptides are highly conserved apart from the 
already mentioned region of -9 0  nucleotides at the N ter­
minus. Most nucleotide differences from position 474 (Figure 
6) occur in the third base of the codons and the HSV-2 and 
HSV-1 reading frames terminate at the same stop codon 
(Figure 6, position 1395).
The polypeptide coding regions o f  the 4.5-kb and 1.2-kb 
mRNAs do not overlap
From their immunoprécipitation studies with monoclonal 
antibodies, Galloway et al. (1982) concluded that the coding 
regions of the 138 000 and 38 000 mol. wt. polypeptides were 
at least partially co-linear. This is incompatible with our fin­
dings. Galloway’s results were obtained in the absence of any 
structural analysis from this region and we have shown that 
the mRNAs encoding these proteins are unspliced. Our loca­
tions for the C terminus of the 138 000. mol. wt. polypeptide 
and the N terminus of the 38 000 mol. wt. polypeptide 
(Figure 6, positions 329 and 384, respectively) indicate that 
the two coding regions do not overlap, as also is the case for 
the corresponding HSV-1 proteins (Figure 7, positions 328 
and 399); the DNA sequences between these locations do not 
encode protein and this untranslated portion shows low 
homology between HSV-2 and HSV-1. The sequences in this 
region are non-co-linear as the HSV-1 sequence contains an 
additional 16 nucleotides (Figure 7, positions 331 -398).
The immunoprécipitation data could be the result of a 
common antigenic site within the 138 000 and 38 000 mol. 
wt. polypeptides, however, a computer-assisted comparison
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of the amino acid sequence of the 38 000 mol. wt. polypep­
tide with the available amino acid sequence of the 138 000 
mol. wt. protein revealed no homology. An alternative ex­
planation for the immunoprécipitation data might be that the 
two polypeptides are associated; hence, an antibody directed 
against one protein could precipitate both polypeptides.
Significance o f  non-homologous regions fo r  transforming 
ability
Overall homology between the HSV-2 and HSV-1 DNA se­
quences in this genome region is high, however there are 
tracts of low conservation. Two such tracts are located within 
the 2.1-kb BamHl/Pstl sub-fragment (Figure 1, map coor­
dinates 0.583—0.596) of HSV-2 BgBl n which causes the 
morphological transformation of cells in vitro (Galloway and 
McDougall, 1983). One of these tracts is downstream from 
the 3 ' co-terminus, in the intergenic region, where there are 
additional nucleotides in the HSV-2 sequence. The other tract 
is at the N terminus of the HSV-2 38 000 mol. wt. protein 
which contains 14 out of 22 amino acid changes compared 
with the equivalent HSV-1 40 000 mol. wt. polypeptide. The 
2.1-kb transforming fragment contains all the coding se­
quences of the 38 000 mol. wt. polypeptide except for the 
ATG initiation codon. Galloway et al. (1982) were unable to 
detect a viral 38 000 mol. wt. antigen in transformed cells. 
However, a 35 000 mol. wt. protein has been isolated from 
HSV-2-transformed hamster cells which has an identical 
proteolytic cleavage pattern to that of a 35 (XX) mol. wt. pro­
duct detected in HSV-2-infected cells (Suh, 1982). This 35 0(X) 
mol. wt. polypeptide may be the 38 (XX) mol. wt. protein 
described here. Ribonucleotide reductase activity is likely to 
be a function of the 38 000 and/or the 138 000 mol. wt. 
polypeptides, and mechanisms have been proposed whereby 
alterations in the regulatory control of this enzyme may cause 
mutations in cellular DNA (Weinberg et al., 1981).
The mechanism of HSV-induced cell transformation is 
unclear; Galloway and McDougall (1983) favour a ‘hit and 
run’ mechanism whereby transformation could result either 
from transient expression of a viral gene or by insertion of an 
element which may stimulate a cellular function. In the latter 
case, the activating element could be a small segment of the 
BgBl n fragment which was undetectable by the hybridisation 
procedures used. A candidate for activating cellular gene ex­
pression would be the putative stem and loops structure pre­
sent in both HSV-2 and HSV-1. This explanation would not 
account for the different transforming abilities of this region 
between HSV-2 and HSV-1 unless, for example, the efficien­
cy of integration differed. Alternatively, the region responsi­
ble for the different transforming abilities could lie outside 
the segment which we have sequenced. Whatever the 
mechanism of HSV-mediated cell transformation, it is clear 
that maintenance of the transformed phenotype is not 
necessarily dependent upon either the stable acquisition of 
viral DNA sequences or the prolonged expression of virus 
gene products.
Materials and methods
Cells and virus
Baby hamster kidney 21 (C l3) cells were grown as monolayers in 800 mi 
plastic tissue culture flasks (Clements et al., 1977). For the production of early 
RNA, cell monolayers were infected with HSV-2 (Glasgow strain HG52) at a 
multiplicity o f infection o f 10 p.f.u ./cell and incubated at 31 °C for 3 h.
Cell fractionation and isolation o f  RNA
Cytoplasmic cell fractions were prepared and RNA was isolated as describ­
ed previously (Easton and Clements, 1980).
Selection o f  polyadenylated mRNA 
Polyadenylated mRNA from HSV-2-infected cells was prepared by elution 
from oligo(dT)-cellulose as described previously (Watson et a i, 1979).
Enzymes
All enzymes were obtained from Bethesda Research Laboratories or New 
England Biolabs, with the exception of T4 polynucleotide kinase (P-L 
Biochemicals) and nuclease SI (Boehringer Corporation Limited). DNA was 
digested with restriction endonucleases at 37°C in 50 — 200 /il 6 mM Tris HCl, 
pH  7.5, 6 mM MgCl; and 6 mM 2-mercaptoethanol.
Cloning procedures 
Fragments of HSV-2 DNA, generated using restriction endonucleases, were 
cloned within the Institute o f Virology under Category I Containment (UK 
Genetic Manipulation Advisory Group). The host bacterium was Escherichia 
coli K12 HBlOl and the cloning vector was pAT 153 (Twigg and Sherratt, 
1980). Isolation o f cloned virus DNA was as described by Davison and Wilkie
(1981).
Purification and radiolabelling o f  DNA fragments
Purification o f DNA fragments from agarose or polyacrylamide gels, and 
labelling o f the 5 ' and 3 ' ends was carried out as described by McLauchlan 
and Clements (1982).
In order to generate fragments with uniquely-labelled ends, the DNA 
fragments, either 5 ' - or 3 '-labelled at both ends, were redigested with a se­
cond restriction endonuclease.
DNA was labelled by nick-translation with DNA polymerase I and [a-“ P]- 
deoxyribonucleoside triphosphates (3000 Ci/mmol) as described by Rigby et 
al. (1977).
Northern blot analysis
Cytoplasmic polyadenylated RNA was electrophoresed on denaturing for­
maldehyde gels and transferred to nitrocellulose as described by Spandidos 
and Paul (1982). Prehybridisations and hybridisation of the DNA probe to the 
nitrocellulose were performed in 50% formatnide, 1 x Denhardt’s (1966) solu­
tion (0.02% Ficoll, 0.02% polyvinylpyrrolidone, 0.02% bovine serum 
albumin), 2 x SSC (1 x SSC = 0.15 M NaCl, 0.015 M sodium citrate) and 
50 /tg/m l calf thymus DNA. Prior to hybridisation, the DNA probe was 
denatured in 100% formamide at 100°C for lOmin and then rapidly chilled in 
ice. Hybridisations were carried out at 42°C for 16 h. After hybridisation, the 
nitrocellulose was washed extensively in 2 x SSC at 60°C and the bands 
visualised by autoradiography at -7 0 °C  using Kodak X-Omat-S film.
Structural analysis o f  mRNAs
Structural analysis o f mRNAs was performed as described previously 
(McLauchlan and Clements, 1983), using the nuclease SI and exonuclease VII 
digestion procedures o f Berk and Sharp (1978), which were modified by using 
either 5 ' - or 3 ' -end-labelled DNA probes instead of uniformly-labelled DNA 
(Weaver and Weissmann, 1979).
Due to the processive nature o f the exonuclease VII activity (Chase and 
Richardson, 1974), this enzyme will leave several undigested nucleotides at a 
hybrid end. This accounts for the slightly larger size of the exonuclease Vll- 
resistant bands as compared with the equivalent nuclease SI-resistant bands.
Gel electrophoresis
Denaturing polyacrylamide gels, essentially as described by Maxam and 
Gilbert (1980), were run in 90 mM Tris, 90 mM boric acid, pH  8.3, 1 mM 
EDTA and the gels contained 9 M urea. Samples were dissolved in deionised 
formamide and denatured at 90°C for 2 min before loading. Electrophoresis 
was carried out at room temperature for 3 - 6  hat 40 watts. The radiolabelled 
bands were detected by autoradiography at -70°C.
DNA sequencing
DNA sequences were determined by chemical degradation (Maxam and 
Gilbert, 1980) o f 5 - and 3 ' -labelled DNA fragments. The restriction endo­
nuclease sites which were used to determine the nucleotide sequence are shown 
in Figure 6 and all the sequences shown were obtained for both strands of 
DNA.
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ABSTRACT
Our previous DNA sequence comparisons of 3' terminal 
portions from equivalent herpes simplex virus type 1 (HSV-1) and 
HSV-2 genes identified a conserved sequence (consensus YGTGTTYY; 
Y=pyrimidine) located approximately 30bp downstream from the 
AATAAA signal. We report here that this signal is located 
downstream from 67% of the mammalian mRNA 3' termini examined. 
Using constructions with the bacterial chloramphenicol acetyl 
transferase (CAT) gene linked to an HSV 'terminator' fragment, we 
show that deletions in the 'terminator' reduce CAT activities and 
the levels of CAT mRNA 3' termini. Specifically; (1) deletions 
of downstream sequences which extend up to the consensus YGTGTTYY 
signal reduce CAT levels to values 35% of those obtained with 
undeleted plasmids, (2) a deletion of a further 14bp, which 
removes the YGTGTTYY consensus but not the poly A site, reduces 
CAT activities to l%-4%. The levels of CAT mRNA 3' termini 
reflect the reductions in CAT activities howevever, levels of 
mRNA S' termini are unaffected by these deletions. The RNA 
produced in the absence of the YGTGTTYY signal is present in the 
cytoplasm although no CAT activity is detectable.
INTRODUCTION
Sequence comparison of genes transcribed by RNA polymerase 
II has identified a number of consensus sequences certain of 
which have been shown by functional assays to be important in the 
control of transcription. For example, the TATA homology, 
initially identified by comparison of S' flanking regions (1), 
was shown to be required for transcription initiation (2). We 
have used HSV-l/HSV-2 DNA sequence comparison of equivalent 
genomic regions to identify discrete blocks of homology and have 
shown that these correspond to transcription regulatory signals 
which are located upstream from mRNA S' termini (3, 4).
In contrast to S' end formation, analysis of DNA sequences 
required for the formation of mRNA 3' termini has received less
© IRL Press Lim ited, O xford , England. ^
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attention. The highly conserved hexanucleotide sequence AATAAA 
(5) is required for polyadenylation of mRNAs transcribed by RNA 
polymerase II (6); a point mutation within this sequence 
abolishes the ability to form correctly terminated mRNA (7), and 
a(X-thalassaemic defect is due to an altered AATAAA signal (8). 
However, it is clear that sequences apart from the AATAAA signal 
are required for the polyadenylation process since this sequence 
is present at sites other than at mRNA 3' termini.
Our HSV DNA sequence comparisons also identified a
conserved sequence (consensus YGTGTTYY) located downstream from 
the poly A site at about 30 nucleotides from the AATAAA signal 
(3, 9, 10, 11) which is similar to a sequence noted by Taya et al
(12). Our study of DNA sequences at the 3' termini of mammalian
poly A+ mRNAs reveals that the YGTGTTYY signal is present 
downstream from many genes. We also report, using plasmid 
constructions with the bacterial CAT gene, that the YGTGTTYY 
signal, together with other further downstream signals, is 
required for efficient formation of an mRNA 3' terminus.
MATERIALS AND METHODS
Growth of Cells and Calcium Phosphate Transfection
HeLa cells were grown as monolayers on 90mm Petri dishes in 
Dulbecco's modified Eagles medium supplemented with 2.5% foetal 
calf serum (Flow Laboratories) and 2.5% calf serum.
Subconfluent HeLa cells were transfected (13) with calcium 
phosphate precipitates containing 15pg of pTER plasmid, lOjug of 
the pseudorabies (PRV) plasmid, pPRVKpnh (14, 15), and lOjig of 
pp(244+)p, a ^-globin plasmid (16). In experiments where CAT 
activities alone were assayed, the p-globin plasmid was omitted. 
At 24h after addition of the calcium phosphate precipitates, the 
medium was removed and 15ml of fresh medium was added to each 
plate.
Cloning Procedures
The host bacterium was E.coli K12 strain JM 83 (17) and the 
cloning vector was pUC9 (18). Cloning procedures for the 
construction of the pTER plasmid series and for pBTERl are given 
in Results, and the construction of plasmid pLWl is described in 
Gaffney et al (19). The various deletions in plasmid pTER3 were
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generated by linearisation with Béun HI followed by treatment with 
exonuclease III; blunt-ended DNA was produced using Mung Bean 
nuclease and then ligated to give the plasmid series p T E R 3 A . 
Deletion end-points were determined by DNA sequencing (20). 
Radiolabelling of DNA Fragments
DNA fragments were either 5'- or 3'-labelled as described 
by McLauchlan and Clements (21). In order to generate 
single-stranded DNA probes, the end-labelled fragments were 
denatured and electrophoresed on a 5% polyacrylamide gel at 4°C 
(2 2 ) .
RNA Isolation and Structural Analysis of mRNAs
Cytoplasmic cellular fractions were prepared and RNA was 
isolated as described by Easton and Clements (23).
Structural analysis of mRNAs was performed using the 
nuclease SI procedure (24, 25). Either 5'- or 3'-labelled DNA 
probes and 15-20pg of cytoplasmic RNA were mixed in a buffer 
containing 50% (v/v) formamide (deionised with Amberlite monobed 
resin MB-2), 400mM NaCl, 40mM PIPES pH6.8 and ImM EDTA to a final 
volume of 30pl. This mixture was heated to 90°C for 3min and 
then incubated at 42°C for 16h. Prior to nuclease SI treatment, 
the hybridisation mixtures were quenched in ice.
Nuclease SI digestion was performed at 30°C for 2-3h in 
300pl of 400mM NaCl, 40mM sodium acetate pH 4.5, ImM ZnSO^ with 
5000 units of nuclease SI. Following phenol/chloroform 
extraction and ethanol precipitation, the nuclease Sl-resistant 
hybrids were electrophoresed on a 6% denaturing polyacrylamide 
gel.
CAT Assays
Cell extracts were prepared as described by Gorman et al 
(26). The levels of CAT activity were measured by incubating 
aliquots from cell extracts in a mixture containing ImM acetyl 
CoA, 250mM TRIS pH7.8, and 0.125pCi I^C chloramphenicol 
(68nmoles/pCi) at 37°C. Aliquots were removed at various times, 
extracted with 200\il of ethyl acetate and the organic phase was 
dried down. The ^^C chloramphenicol was resuspended in 30pl 
ethyl acetate and spotted onto 0.25mm silica gel thin layer 
chromatography plates. Ascending chromatography was performed in 
95% chloroform: 5% methanol, after which the chromatograms were
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autoradiographed. The percentage conversion to acetylated 
chloramphenicol was calculated by removing the spots from the 
chromatograms and counting in a scintillation counter. CAT 
activities were normalised by measuring the protein content of 
each extract (27) which allowed calculation of CAT specific 
activities.
RESULTS
To test the effect of removing sequences downstream from 
the poly A site, plasmid constructions were made using the CAT 
gene. An HSV-2 IE promoter fragment was inserted upstream from 
the CAT gene giving plasmid pLWl (19), and a 'terminator' 
fragment from the same IE gene was inserted downstream to give 
plasmid pTER5.
The HSV-2 IE promoter was a 210bp SmaI/Sau3A fragment from 
IE gene-4/5 which comprised 91bp of 5' flanking sequence and 
119bp of leader sequence (10). This promoter fragment contains 
all the sequences required for the initiation of transcription 
and the location of the mRNA 5' terminus is identical to that 
determined for the HSV-2 IE mRNA-4/5 synthesised in vivo (10,
19). Plasmid pLWl has no ATG in the HSV-2 leader sequence; the 
first initiation codon in the mRNA is the CAT gene ATG.
The 'terminator' was a lOObp Sma I/Xba I fragment from the 
3' terminus of HSV-2 IE gene-5. This fragment contains an AATAAA 
signal, and located 8 nucleotides downstream from the poly A site 
is the sequence TGTGTTGC which fits the YGTGTTYY consensus (10) 
except in one position. A comparison of the HSV-2 and HSV-1 DNA 
sequences from the 3' terminal portions of IE gene-5 (Fig. 1) 
reveals conservation of the AATAAA signal together with two 
blocks of homology downstream from the poly A site. The 
conserved block between positions 62-65 (Fig. 1) contains the 
sequence corresponding to the YGTGTTYY consensus.
Construction of 'terminator' plasmids
Fig. 2 details the construction of plasmids used for 
short-term expression assays. Briefly, the 'terminator' fragment 
was cloned into pUC9 to give plasmid pTER3. The 'terminator' was 
then inserted into the pLWl promoter/CAT plasmid at a site just 
downstream from the CAT gene to give plasmid pTER5. In pTER5,
1350
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3 s ite  
A44
Xbal
ISma I
u e u  . I 50 I a a 100n o v -z  CCCGGOGaCA CGGTCCTTGG TGTAATTMT AATAJÜkATCG TGAAAATTM AATCOCTTTG TGTGTTGCTG CGGGGACGGG OOCAAATGCC TCGTGACTCT
H SV -1 CCCTGTGCTA GGGCAATTTC TÀCCCTT MTIÜiATTTT ACAAACAGAT TTTATCGCAT CGTGTCTTAI TGCGGGGGAG AAAACCGATG TCGGCATAGA
FIG. 1. DNA sequence comparison at the mRNA 3' termini of the 
HSV-2 and HSV-1 IE genes-5 (10). The asterisks denote nucleotides 
which are conserved. Locations of the 3' termini and the deletion 
end-points in pTERS plasmids are indicated. The AATAAA signal and 
the sequences homologous to the YGTGTTYY motif are at positions 
31-36 and 61-68 respectively.
□pU C 9
pL W I pTER 3A pLW IpTER3
MinéfXnm
C _ Â t A  H I m d  HI
pTERB pTERBA
FIG. 2 . Construction of pTER plasmids. The Sma I/Xba I fragment 
(Fig. 1) was derived from the HSV-2 plasmid pBam b' (10) and 
blunt-ended using Klenow fragment polymerase with all four 
dNTP's. The multiple cloning site of pUC9 is designated mes.
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TABLE 1 CAT activités obtained with various plasmid
constructions are shown for 4 separate transfection
pTER5
1
100 (4.01)
2
100
3
100
4
100
poly A 
+
site YGTGTTYY 
+
pTERSL 30 35 (1.41) 34 32 39 + +
pTERS A 44 3 (0.12) 4 1 1 + -
pTER6 1.5 (0.02) 2 0.6 1 inverted
pLWl 0.4 (0.01) U U U - -
pBTERl 110 (4.45) + ^-globin +
value; U indicates undetectable CAT activity. The figures in 
brackets from experiment 1 are typical CAT values expressed as 
nmoles converted chloramphenicol/ ug protein/ h. Plasmids pTER 
A 30 and pTERS A 44 contain deletions in the HSV 'terminator' 
fragment; pTER6 has an 'inverted terminator' ; pLWl has no 
'terminator' fragment ; PBTERl contains a 1250bp rabbit p-globin 
fragment. The presence (+) or absence (-) of the poly A site and 
YGTGTTYY signal in each plasmid is indicated.
the 'terminator' is orientated with the AATAAA signal on the mRNA 
sense strand.
A series of deletions was made in plasmid pTER3 from a 
BcunHI site located in the multiple cloning site downstream from 
the 'terminator'. These deletions removed sequences from the 3' 
portion of the 'terminator' and extended for different lengths 
through the YGTGTTYY homology towards the AATAAA sequence to give 
the plasmid series pTERSA,. These ' terminator ' deletions were 
then inserted into the pLWl promoter/CAT plasmid to give the 
expression plasmid series pTERS A  (Fig. 2).
Removal of 'terminator* sequences reduces CAT activity
Plasmid pLWl lacks the pTER5 'terminator' and Table 1 shows 
that Hela cells transfected with pLWl produced little detectable 
CAT activity whereas high levels of activity were obtained with 
pTER5. The 'terminator' fragment therefore was required for 
detectable CAT gene expression. To determine the effect on CAT 
activity of an alternative 'terminator', a 1250bp Bam Hl/Xho I 
fragment of the rabbit p-globin gene containing all the IVS 2 
sequences and some 600bp of flanking DNA (28) was inserted into 
the Hind III site of pLWl. Plasmid pBTERl contained this rabbit 
p-globin fragment with the AATAAA signal on the mRNA sense 
strand. Table 1 shows that CAT activity obtained with pBTERl was
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1 A-Cm- ^  ^ . .. .
la 1b 2 a 2b 3a 3b 4a 4b
FIG. 3. CAT activities produced by the pTER plasmids as 
determined by thin layer chromatography. Aliquots were removed 
from each reaction after (a) 20min and (b) 40min. The positions 
of the acetylated and non-acetylated forms of chloramphenicol
are indicated. Lanes la, lb pTER5; lanes 2a, 2b pTER5A30; lanes 
3a, 3b pTER5A44; lanes 4a, 4b pTER6.
comparable to that obtained with pTER5.
The CAT levels obtained with the pTER5 A  series were 
compared with pTER5 CAT activity. On this basis, two deleted 
plasmids with reduced CAT activities were selected, and the 
deletion end-points were determined by DNA sequencing. These two 
plasmids pTER5 A 30 and pTER5 A  44 had 30bp and 44bp respectively 
deleted from the 3' portion of the 'terminator'. Locations of 
the deletion end-points are shown in Fig. 1; pTER5A  30 has a 
deletion extending to 3bp from the YGTGTTYY signal while in pTER5 
A 44 this signal is removed but the poly A site is retained.
Fig. 3 shows an autoradiograph of the CAT assays obtained 
with the pTER5 plasmid series and the relative CAT activities 
from a number of separate experiments are listed in Table 1. The 
CAT levels produced by pTER5 A  30 and pTERS A  44 were low and 
transactivation by co-transfection with the PRV plasmid, 
pPRVKpnh, was required to boost activities to levels which could 
be accurately estimated. Plasmid pPRVKpnh expresses the IE 
regulatory protein (29) which increases transcription from other 
plasmid-borne eukaryotic promoters and from certain cellular 
promoters (15, 30, 31).
Deletion of 30bp from the 3' portion of the 'terminator' 
fragment reduced CAT levels to approximately 35% of the pTER5 
value while removal of a further 14bp markedly reduced activity 
to a level of l%-4%; pTER5 A  44 produced CAT activities only just 
above the background levels obtained with plasmids pLWl and pTER6
1 35 3
I N u u i c i u  AAUIU3 n c a c o i v ^ i  I
M l  2 3 4 5 6 7 8 9  1 0  11 12 M
pTER
#'
#
f ? '
pT ER 
3 e n d —«- 0
¥
^  201
p - g ( o b i n
i
Î
CAT mRNA
FIG. (A) The abundance of mRNA 5' and 3' termini produced by
the pTER plasmids. The DNA probes used in lanes 1-7 were (1) an 
Eco Rl/Sma I fragment 5'-labelled at the Eco RI site to determine 
the pTER CAT mRNA 5' termini and (2) a 5'-labelled Bst NI 
fragment to detect the ^-globin mRNA 5' termini. The 
single-stranded DNA probes used to detect the pTER CAT mRNA 3' 
termini were a Hinf I fragment from pTERS 3'-labelled at the Hinf 
I site in the CAT gene coding sequences (lanes 8-10) and a Hinf 
I/Bgl I fragment from pTERS A 4 4  again 3'-labelled at the Hinf I 
site (lanes 11 and 12). RNA samples shown; lanes 1, 7, 10 and 12, 
mock-infected RNA; lanes 2 and 8, pTERS RNA; lanes 3 and 9, pTERS 
A  30 RNA; lanes 4 and 11, pTERSA44 RNA; lane 5, pTER6 RNA; lane 
6, pLWl RNA. Molecular weight markers (M) were pAT 153 DNA 
cleaved with Hpa II.
(B) Approximate locations for the S' and 3' termini of 
pTER CAT mRNA are shown. Restriction endonuclease cleavage sites 
within the CAT coding sequences which were used for making 
end-labelled DNA probes (see Fig. 4A) are indicated.
1 3 5 4
m u v i c i v  AA^iud n c 7 d c ;a io i i
(Table 1). Plasmid pLWl has no 'terminator' fragment and pTER6 
has the 'terminator' inserted in the opposite orientation to that 
of pTER5.
Levels of mRNA 3* and 5* termini produced by the pTER5 plasmid 
series
Cytoplasmic RNA isolated from cells transfected with the 
pTER5 plasmid series was hybridised to strand-separated DNA 
probes which were 3'-labelled at the Hinf I site within the CAT 
coding sequences (Fig. 4B). RNAs produced by pTER5 and pTERS 
A  30 were hybridised to a probe produced from pTER5 DNA. As the 
deletion end-point of pTER5 A  44 is only 4bp from the poly A site 
(Fig. 1), hybrids produced by RNA transcribed across the poly A 
site could not be resolved from correctly terminated RNAs, 
therefore RNA from p T E R 5 A  44 was hybridised to a probe from 
p T E R 5 A  44 DNA. The DNA probes were end-labelled to similar 
specific activities. After treatment with nuclease SI, the 
protected DNA fragments were electrophoresed on 6% denaturing 
polyacrylamide gels (Fig. 4A).
RNA produced from pTER5 protected a fragment of 247 
nucleotides (Fig. 4A, track 8) and this positioned the 3' end at 
nucleotide 54 (Fig. 1) which is the same location as the mRNA 3' 
terminus for IE mRNA-5 from HSV-2 infected cells (10). The 3' 
end of mRNA produced by pTER5 A  30 was located at the same 
position as that obtained with pTER5 but the amount of protected 
DNA fragment was reduced to approximately 30% of the pTER5 value 
(Fig. 4A, track 9). No discrete 3' end was detected with pTER5 
A 44 RNA (Fig. 4A, track 11). Hence, the levels of mRNA 3' 
termini obtained with the pTER5 series reflected the CAT 
activities obtained with these plasmids.
Plasmids pTER5 and pTER5A30 have identical sequences up to 
18bp beyond the poly A site then the DNA sequences are dissimilar 
due to the terminator deletion (30bp) in plasmid p T E R 5 A 3 0 . 
Therefore, the band below the fully protected probe (Fig. 4A, 
track 9) represents hybridisation of the pTER5 DNA probe to pTER5 
A 3 0  RNA transcribed through the poly A site. Hence the size of 
this band reflects the sequence homology between pTER5A30 RNA 
and the pTER5 DNA probe.
To assess the validity of the comparative 3' terminal data.
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plasmid, p^(244+)p, containing the p-globin promoter and the 
polyoma virus enhancer (16), was co-transfected with the various 
pTER5 plasmids. A strand-separated DNA probe, 5'-labelled at a 
Bst NI site approximately 130bp from the p-globin mRNA 5' 
terminus was used to estimate p-globin mRNA levels (32). As Fig. 
4A tracks 2-6 indicate, the ^-globin mRNA levels were similar in 
all the RNA samples.
Levels of mRNA 5' termini were estimated using a 
strand-separated DNA probe 5'-labelled at an EcoRI site within 
the CAT coding sequences of pTERS (Fig. 4B). Using this probe, a 
protected DNA fragment of 369 nucleotides was obtained with RNA 
produced by all the pTER5 series plasmids and by pLWl (Fig. 4A, 
tracks 2-6). A similar amount of labelled probe was protected 
with the different RNA samples. Therefore, unlike the situation 
with the 3'-labelled probe, the levels of protected 5' probe 
obtained with pTER5 A  30 and pTER5 A  44 were similar to that 
obtained with pTER5 although the CAT activities were lower than 
the pTER5 values. This suggests that cytoplasmic RNA with a 
normal 5' terminus but an incorrect 3' terminus does not produce 
functional protein.
DISCUSSION
Our results have demonstrated that removal of sequences 
downstream from the poly A site of HSV-2 IE gene-5 reduces the 
level of correctly processed mRNA 3' termini, and this effect is 
reflected in lower levels of CAT activity. Deletion plasmid 
pTER5 A  30 gave reduced mRNA 3' termini and the CAT levels were 
35% of the values obtained with pTER5 which contains all the 
'terminator' sequences. Moreover, the removal of a further 14bp, 
which includes the YGTGTTYY signal but not the poly A site, 
markedly reduced CAT activity to l%-4% of the pTER5 value, and no 
correct 3' termini were detected.
When the DNA sequences at the 3' terminal region of HSV-2 
IE gene-5 were compared with those of HSV-1 IE gene-5, a portion 
of the 14bp segment required for efficient 3' end formation was 
conserved (10). Furthermore, a similar downstream sequence was 
conserved in other equivalent HSV-1 and HSV-2 genes at 
approximately the same position relative to the AATAAA signal (3,
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9). The 3' terminal DNA sequences from a number of mammalian and 
eukaryotic viral genes which specify poly A"*" mRNAs were examined 
(Fig. 5) and sequences similar to those conserved downstream from 
the poly A sites of HSV genes were identified in 67% of the genes 
examined. From a study of 3' terminal sequences from 100 genes, 
we have derived the consensus sequence YGTGTTYY, and the 
preferred location for this sequence is 24-30 nucleotides 
downstream from the AATAAA signal. We conclude from our analysis 
that this conserved element is likely to play an important role 
in the formation of mRNA 3' termini for a wide variety of 
mammalian genes.
Nevertheless, it appears that other sequences further 
downstream are required for efficient polyadenylation. McDevitt 
et al (33) have shown that sequences between 20 and 35 
nucleotides downstream from the poly A site (ie downstream from 
YGTGTTYY) are required for the production of functional 
adenovirus 2 (Ad2) E2a mRNA however correctly terminated mRNA was 
produced at detectable levels. Our data also shows that removal 
of sequences downstream from the YGTGTTYY signal reduces the 
level of 3' end formation but comparison of the HSV-2 and Ad2 
sequences in this region revealed no significant homology. A 
deletion which removes the poly A site of Ad2 E2a mRNA and the 
sequence AGTGTCTC (this sequence is 26 nucleotides from the 
AATAAA signal and fits our consensus) resulted in no detectable 
mRNA. Similarly, a 52bp deletion which removes the poly A site 
together with sequences containing TGTGTTGG also abolishes rabbit 
p-globin 3' end formation (34).
Indirect but compelling evidence for the importance of 
sequences downstream from the poly A site may be derived from an 
analysis of gene duplications and from the locations of small 
tandem repeat sequences which are present downstream from the 3' 
termini of HSV mRNAs. The human (XI and OC 2 globin genes have 
arisen from a gene duplication event and have areas of high 
homology (35). Sequence conservation at the 3' portions of OC 1 
and(XI 2 genes is markedly reduced beyond 15bp downstream from the 
poly A site, and it has been proposed that this decrease in 
homology delimits those sequences involved in gene duplication.
We consider it significant that the sequence TGTGTGCC, which fits
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TABLE 2 Derivation of the YGTGTTYY consensus from sequences
located 24bp to 38bp downstream from the AATAAA signal
10 13
15
33
13
12
57 66
20 15
62 5536
TG T T Y YY G
This represents an analysis of those 70 sequences listed 
in Fig. 5 which contain the signal; numbers indicate the 
frequency of occurrence for each nucleotide.
our consensus, is contained within this 15bp stretch and suggest 
that retention of this sequence reflects the ability to correctly 
process OC 1 and OC 2 mRNAs. In HSV, small tandem repeats occur 
downstream from the 3' termini of at least three mRNAs and these 
repetitive sequences are believed to have no specific function 
(11). The HSV reiterations begin a few nucleotides downstream 
from sequences which fit our consensus and hence could mark the 
boundary of regions important in transcription.
Approximately 33% of the 3' terminal DNA sequences examined 
do not contain a YGTGTTYY sequence motif. Hence, absence of this 
sequence may be overcome by other downstream signals, and we note 
that many of these 3' terminal regions contain T-rich residues. 
The downstream YGTGTTYY sequence could therefore be analagous to 
the transcription regulatory signals present upstream of the TATA 
box, eg the GC-rich segments present in many but not all 
promoters. Removal of (3C-rich sequences reduces the level of 
initiation (32, 36, 37, 38), however, as these sequences are not 
present in the upstream regions of every promoter presumably they 
are not obligatory, or other sequences mimic their function.
While the function of sequences downstream from 3' termini 
is unclear it is likely that they are involved in the 
cleavage/processing of nuclear RNAs which extend beyond the poly 
A site. Cleavage/processing of primary transcripts is thought to 
be the mechanism whereby 3' termini are generated for both poly 
A+ mRNAs (39), and histone messages (40, 41, 42). Histone genes 
do not contain AATAAA signals and a palindromic sequence 
frequently is present close to mRNA 3' termini (43, 44). Point 
mutations within this palindromic sequence abolish the ability to
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form a correctly terminated mRNA, and sequences at least 24 
nucleotides downstream from the 3' terminus are required for 
efficient processing (45). We have not observed any sequences 
similar to our consensus downstream from histone mRNA 3' termini. 
This is not surprising since, although the mechanism for 
generating 3' termini in poly A+ and histone mRNAs may be 
similar, the processing events could be different and therefore 
alternative signals may be used.
We have no evidence yet as to whether the YGTGTTYY signal 
either in DNA or in pre-mRNA is involved in mRNA termination or 
processing. Its presence downstream from most HSV genes analysed 
so far may indicate a role in termination as the different 
transcription units are closely located on the virus genome (46). 
By contrast, genes in mammalian cells are more scattered so that 
transcription beyond the poly A site may less frequently disturb 
transcription of an adjacent gene. Examples of alternative 
processing of mRNA 3' termini include the pro O c ^ i D  collagen 
(47), ^2_microglobulin (48) and mouse CC amylase (49) genes, and 
there are situations where alternative poly A sites are used with 
differing efficiencies. Our analysis of these situations 
indicates that the YGTGTTYY signal is not associated with 3' end 
selection.
Deletion of the YGTGTTYY signal reduced 3' end formation 
but had no detectable effect on 5' end initiation; the RNA 
synthesised runs through into the pUC vector sequences and does 
not appear to be polyadenylated (data not shown). However, these 
extended RNAs are transported to the cell cytoplasm but, as 
reflected in CAT levels, are not translated. The inability to 
translate these RNAs may imply that their mode of transport to 
the cytoplasm differs from that of poly A+ mRNAs thus suggesting 
a coupling of mRNA polyadenylation, transport and translation.
The lack of transcript polyadenylation is not surprising as 
in vitro only pre-mRNAs that contain a 3' end located at or just 
downstream from the in vivo poly A site are efficiently 
polyadenylated (50). In vitro studies with pre-mRNA suggest that 
the specificity of polyadenylation is linked to RNA synthesis and 
indicate that the poly A polymerase interacts with a specific 
signal located at the 3' end of pre-mRNA (51).
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SUMMARY
This study was undertaken to examine the 
organisation and structures of mRNAs mapping at the herpes 
simplex virus type 2 (HSV-2) ribonucleotide reductase 
locus. From comparisons between equivalent HSV-2 and HSV-1 
nucleotide sequences, putative transcription control 
signals were identified, and functional analysis of certain 
control elements was performed. The positions of translated 
regions within transcripts encoding ribonucleotide 
reductase were identified as were conserved amino acid 
domains between viral and cellular reductases. In addition, 
a conserved DNA sequence, YGTGTTYY (Y = pyrimidine), 
located 30nuc downstream from the polyadenylation (AATAAA) 
signal of both viral and cellular genes, was identified. 
Functional tests showed that the YGTGTTYY signal was 
required for efficient mRNA 3' end formation.
Arrangement of mRNAs and DNA Sequence Comparisons at the 
HSV-2 Ribonucleotide Reductase Locus.
Four overlapping mRNAs have been identified at the 
ribonucleotide reductase locus. These mRNAs are unspliced 
and share common 5' and 3' termini. Two early, 3' 
co-terminal mRNAs with sizes of 4.5kb and 1.2kb encode 
HSV-2 polypeptides Vmwl38 and Vmw38 respectively which are 
almost certainly components of the viral ribonucleotide 
reductase. The other two mRNAs are late, 5' co-terminal 
species with sizes of 6.4kb and 1.7kb which appear to 
encode an identical 54,000 mol. wt. protein; the 6.4kb
transcript is 3* co-terminal with the early mRNAs. As a 
consequence of this mRNA arrangement, the 4.5kb and 1.2kb 
mRNA 5' termini and the 1.7kb mRNA 3' terminus are located 
within larger, overlapping transcripts. The genome region 
adjacent to the 6.4kb and 1.7kb mRNAs specifies three late 
transcripts synthesised in the opposite orientation; the 5 ’ 
terminal region of one of these species overlaps with the 
6.4kb and 1.7kb mRNAs.
The 1.7kb mRNA 3' terminus is located within the 
transcribed region of the 6.4kb species. Previous proposals 
suggested that read-through of HSV poly A sites is due to 
inefficient processing at certain 3' termini. Bacterial 
chloramphenicol acetyltransferase (CAT) activities produced 
in HeLa cells by a plasmid carrying the 1.7kb mRNA 3' 
terminal sequences were comparable to activities obtained 
with a plasmid containing the 3' processing signals from a 
non-internal poly A site. Read-through of HSV poly A sites 
may therefore reflect a general reduction in mRNA 3' 
processing efficiency rather than differences in the 3' 
processing signals of individual genes.
The HSV-1 transcripts equivalent to the 4.5kb and 
1.2kb mRNAs have sizes of S.Okb and i.2kb and encode HSV-1 
polypeptides Vmwl36 and Vmw33 respectively. Nucleotide 
sequence c<xq>arisons between the 5 ' flanking regiws of 
equivalent HSV-2 and HSV-1 mRNAs revealed the following 
homologies :
1) upstream from the 4.5kb and S.Okb mRNA S' termini, 
blocks of conserved sequences are present which resemble
transcriptional signals in the promoters of other genes, 
namely TATA box homologues, C-rich tracts and A+C-rich 
elements. The C-rich tracts resemble the binding site 
consensus sequence of Spl, a transcription control factor,
and, from other studies, the A+C-rich sequences could be a
component of other HSV early promoter regions.
2) the 5' terminal region of the HSV-2 1.2kb mRNA is
located within the polypeptide coding region of Vmwl38; an 
identical situation exists for the equivalent HSV-1 
transcript. The HSV-2 and HSV-1 5' flanking sequences 
contain inverted repeats which could form stem and loop 
structures; possible effects of these structures on 
transcription of the HSV-2 and HSV-1 1.2kb mRNAs are 
discussed.
Amino Acid Conservation Between Herpesvirus and Cellular 
Ribonucleotide Reductases.
Amino acid sequences for the Vmwl38 N- and 
C-terminal regions and all of the Vmw38 polypeptide have 
been predicted from nucleotide sequences. Comparisons with 
coding regions of the corresponding HSV-1 proteins, Vmwl36 
and Vmw38, reveal high homology apart from areas at the 
N-termini. Poorly conserved N-terminal regions have been 
identified in other equivalent HSV-2 and HSV-1 proteins; 
these may be non-essential for function.
In common with ribonucleotide reductases with 
similar enzymatic properties, HSV ribonucleotide reductase 
appears to contain two non-identical polypeptides, and
HSV-2 polypeptides Vmwl38 and Vmw38 almost certainly 
represent components of the virus enzyme. Both Vmwl38 and 
Vmw38 amino acid sequences share areas of homology with 
coding regions on Epstein-Barr virus (EBV) and 
varicella-zoster virus genomes; this allows identification 
of putative proteins which may be ribonucleotide reductase 
components specified by these viruses. These blocks of 
homology extend to cellular ribonucleotide reductases of 
eukaryotic and prokaryotic origin and may represent domains 
involved in enzyme function.
Vmwl38 and Vmwl36 contain large N-terminal domains 
which are absent in equivalent herpesvirus and in cellular 
ribonucleotide reductase proteins. These N-terminal domains 
could have arisen by gene fusion and may not be essential 
for ribonucleotide reductase activity.
The EBV polypeptide which shares homology with 
HSV-2 Vmwl38 has a size of 93,000 mol. wt. The C-terminal 
portions of both proteins contain the 5' terminal regions 
of mRNAs specifying the proposed small subunit of 
ribonucleotide reductases. However, these 5' termini are 
not located at equivalent positions in the Vmwl38 and 
93,000 mol. wt. polypeptides and separate evolutionary 
routes are proposed in the formation of these internal 
promoters.
The transforming ability of HSV may be linked to 
its action as a mutagen. This mutagenic effect may be due 
to the expression of HSV ribonucleotide reductase and this 
is discussed.
Sequences Downstream from the AATAAA Signal Required for 
mRNA 3* End Formation.
Comparisons of the regions flanking HSV mRNA 3' 
termini identified conserved sequences downstream from poly 
A sites. From more extensive comparisons, 67% of mammalian 
and viral genes examined contained 3 ‘ flanking sequences 
similar to those conserved in HSV. A consensus sequence, 
YGTGTTYY (Y = pyrimidine), was derived for a conserved 
downstream element, preferentially located 24 to 35nuc 
beyond the AATAAA signal. Downstream from YGTGTTYY, other 
G-rich and T-rich segments also were conserved but to a 
lesser extent. To test the functional significance of 
YGTGTTYY in mRNA 3' end formation, deletions produced in 
the 3' flanking sequences of HSV-2 IE gene-5 were inserted 
into a CAT plasmid. Deletion of downstream sequences which 
extended up to YGTGTTYY reduced CAT levels to values 35% of 
those obtained with undeleted plasmids. Removal of a 
further 14bp, which deleted YGTGTTYY but not the poly A 
site, reduced CAT activities to levels of 1% to 4%. The 
levels of CAT mRNA 3' termini reflected the reductions in 
CAT activities, but, in contrast, levels of mRNA 5' termini 
were unaffected by these deletions.
These results demonstrate a requirement of 3' 
flanking sequences, in particular the YGTGTTYY signal, for 
efficient 3' end formation of poly A mRNAs. Alternative 
functions for the YGTGTTYY sequence in either mRNA 
termination or mRNA processing are discussed.
